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Abstract
Name: Judith Weber
Title: Development of Novel Molecular Imaging Contrast Agents for Detection of Oxidative
Stress
An early and precise diagnosis of disease is a crucial requirement for fast and targeted
therapy in the era of precision medicine. Most diseases possess molecular alterations in their
early stages, which precede noticeable morphological changes. One important molecular
change that contributes to dysfunction in a wide range of pathologies, including cancer
and neurological disorders, is an increase in levels of reactive oxygen species (ROS) and
associated oxidative damage. Our understanding of how ROS influence disease biology
is currently limited by our inability to perform sensitive and specific assessment of ROS
levels with high spatial and temporal resolution in living systems. The goal of the research
described in this thesis was to overcome the challenge of assessing ROS during disease
development in cancer and neurodegenerative disease through the design, synthesis and
validation of two classes of novel bifunctional, ROS-sensitive contrast agents.
To shed light on the complex redox biology in cancer, the new method of photoacoustic
imaging was exploited. A novel activatable, targeted near-infrared cyanine dye is reported
that enables specific detection of pathological levels of hydrogen peroxide, a major and
abundant ROS in living organisms. This approach uses photoacoustic and fluorescence
imaging in cancerous tissue to evaluate the performance of the new probe under in vitro and
in vivo conditions.
In neurodegeneration, there exists a bidirectional interaction between oxidative stress and
protein aggregates. To scrutinise this relationship, both bulk and single-molecule fluorescence
imaging methods were used to assess the capability of novel bifunctional fluorescence dyes to
localise the presence of the two putative disease-causing species, ROS and protein aggregates,
simultaneously under in vitro conditions.
The data shown here provides a promising foundation for the systematic design of contrast
agents based on small molecule dyes, that possess ideal optical and biological characteristics
to study oxidative stress in a broad range of pathological applications with high temporal and
spatial resolution.
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Chapter 1
Introduction
This chapter uses material from the review titled: “Contrast agents for molecular pho-
toacoustic imaging”,[1] listed in the publication section.
Reactive oxygen species (ROS) are endogenously produced oxidising agents important
in essential biological processes. However, increased levels of ROS are critical biological
parameters and contribute to dysfunction in a wide range of pathologies, including various
types of cancer and neurological disorders (Figure 1.1).
In this context, different approaches have been reported to assess ROS levels but methods
with the potential to monitor specific ROS with high spatial and temporal resolution under
biological relevant conditions are limited. Potential new methods of cellular analysis are
emerging including “activatable” imaging probes, photoacoustic (PA) imaging as well as
high resolution microscopy. This thesis examines the properties of these emerging methods
including the development of new imaging probes for sensing specific ROS, the compilation
of experimental and analytical protocols for PA imaging and high resolution microscopy and
the evaluation of the capability of the new imaging probes combined with these imaging
techniques to detect ROS under important biological conditions.
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Figure 1.1 Levels of cellular ROS and their differential effects on cells: A low, balanced level of
ROS is essential for cell survival and homoeostasis; increased, but balanced levels of ROS can induce
oxidative modifications supporting disease initiation and progression; high, unbalanced levels of ROS
induces cellular damage and cell death.
1.1 Oxidative Stress and Diseases
1.1.1 Oxidative Stress and Reactive Oxygen Species
Oxygen is crucial for life; the air we breath enables the cells in our body to meet their
energy demands. In its molecular form, the role of oxygen in survival is associated with its
high redox potential, which allows oxygen to act as electron acceptor during mitochondrial
adenosine triphosphate (ATP) synthesis and in enzymatic reactions. During these controlled
physiological redox processes, O2 is mainly converted into H2O. However, the use of
molecular oxygen bears risks. By accepting electrons, it can form highly reactive oxygen
species (ROS), including: hydrogen peroxide (H2O2); superoxide anion radical (O2.-);
hydroxyl radical (HO.); and hypochlorous acid (HOCl) (Figure 1.2). Each of these molecules
has unique reaction properties (pathway, kinetics, rate), distinctive spatial and temporal
distribution and separately regulated production, diffusion and degradation processes [2].
Based on their high reactivity, ROS can induce DNA mutations and damage, activate
signal transduction cascades and induce alterations in lipids, proteins and transcription factors.
As a consequence, ROS significantly influence the expression of over 500 genes, regulating
cell differentiation, cell proliferation and inflammatory responses [3]. Therefore, oxidative
stress and increased levels of ROS have long been linked to ageing and the pathogenesis of
various diseases, including cancer and neurodegenerations [4, 5].
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Counter-intuitively, low levels of ROS have important roles as regulatory molecules in a
broad range of important subcellular processes, such as cell signalling, enzyme activation,
gene expression, apoptosis, and immune response [6].
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Figure 1.2 Genesis of the major ROS and their detoxification by antioxidants. O2.- is generated by
reduction of molecular oxygen through NADPH/xanthine oxidases, uncoupled endothelial nitric oxid
synthase (eNOS) and mitochondrial electron transport (MET). O2.- can be dismutated into H2O2 by
superoxide dismutase (SOD) or react with nitric oxide (NO) to form peroxynitrite (ONOO-). H2O2
can either be scavenged to H2O by catalase, glutathione peroxidase (GPx) or peroxiredoxin (Prx)
antioxidant enzymes that use thioredoxin (Trx). At inflammatory sites H2O2 gets mostly converted
into HOCl by myeloperoxidases (MPO). In presence of Fe2+ Fenton’s reaction leads to the generation
of .OH [7].
The major source of cellular ROS are mitochondria, which are double membraned
organelles in eukaryotic cells. In general, mitochondria provide energy through the oxidation
of glucose, lipids and amino acids. The electrons resulting from the oxidation process
are channelled to oxygen as a terminal electron acceptor. In the electron-transport chain,
small numbers of electrons escape from the intended pathway and mis-timed interaction
with O2 leads to ROS generation. In addition, other enzymatic (e.g. NADPH-, xanthine-,
monoamine-oxidase, cytochrome P450 system) and non-enzymatic reactions (e.g. reactions
of oxygen with organic compounds, ionising radiations) can lead to the generation of ROS
(Figure 1.2). ROS can also arise from exogenous sources, either being taken up from the
extracellular milieu (e.g. ROS released by inflammatory cells), or produced as a consequence
of the exposure to environmental pro-oxidants (e.g. pathogens, toxicants, stress) [8].
To prevent cells being damaged by ROS generation, cells have evolved different detoxi-
fication mechanisms (Figure 1.2). Such “antioxidants” may be enzymatic (e.g., glutathione
peroxidase/reductase, catalase and superoxide dismutase) as well as non-enzymatic (e.g.,
glutathione (GSH), coenzyme Q and Vitamin A/C/D/E). Cells aim to keep a balanced state
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between antioxidants and ROS; an imbalance between the production of ROS and their
scavengers is termed oxidative stress and is an early fundamental event in the pathogenesis of
several disorders, including cancer and degenerative neurological diseases (Figure 1.1) [7].
1.1.2 Oxidative Stress and Cancer
Cancer is a complex multi-stage process that includes a wide range of cellular and
molecular changes mediated by diverse endogenous and exogenous stimuli. Tumourigenesis
can be divided into initiation, promotion and progression. ROS are involved at all three
stages.
In the initiation stage, oxidation of nucleic acids can produce DNA damages leading
to mutations in key genes promoting oncogenic transformation. Common forms of DNA
modification linked to genetic mutations and alternation of gene transcription, are formation
of hydroxylated bases, sugar lesions, DNA-strand breaks and DNA-protein crosslinks.
During cancer promotion ROS modulate the expression of many genes ultimately sup-
porting tumorigenesis. One of the pathways involved is the hypoxia-response pathway. In
this pathway, ROS stabilises the hypoxia inducible factor HIFα , which in turn activates a
transcriptional network of genes that help tumour cells to adapt to hypoxic conditions by
increasing glycolysis and activating angiogenesis [4, 9].
In the progression stage, ROS can be involved in tumour cell survival, proliferation,
migration and angiogenesis [3]. This can be conducted for example by the phosphoinositide
3-kinase (PI3K) pathway, the activity of which being promoted by ROS. PI3K is a critical
growth factor response pathway and has been shown to increase tumour proliferation, survival
and mobility [10].
Additionally, cancer cells often induce an inflammatory response. Inflammatory processes
are characterised by the infiltration of leukocytes, which can release ROS to activate signal
transduction cascades subsequently contributing to the elimination of pathogens and the
recruitment of additional inflammatory cells. As a result, a sustained inflammatory and
oxidative microenvironment emerges. The prolonged exposure to inflammatory related
molecules can inflict continuous tissue damage, cell proliferation and enrichment of ROS
leading to a protumorigenic environment [11, 7]. Furthermore, the infiltrated, inflammatory
cells can protect cancer cells from host immune response as well as support tumour growth
(via angiogenic processes for instance), invasion and metastasis [7, 12]. However, the
interplay between the different developmental stages of cancer, ROS and inflammation and
their cause-correlation relationship remains poorly understood.
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1.1.3 Oxidative Stress and Neurodegenerative Disease
Even though, the brain accounts only for ∼2% of our body weight, it consumes more
than 20% of the oxygen. Brain cells are divided in two main groups: neurons and glial cells
among which are astrocytes. With the exception of a few brain regions, neurons are mostly
non-dividing cells with a long life span. Due to the high oxygen consumption and long cell
life span, the human brain is particularly prone to the effect of oxidative stress and requires
effective antioxidant protection.
ROS production in the brain occurs largely by NADPH oxidase and mitochondria. The
activation of the intracellular enzyme NADPH oxidase results in the transfer of protons across
the mitochondrial membrane and is accompanied with the generation of large quantities of
superoxide [13]. The involvement of NADPH oxidase in oxidative stress generation has been
shown in several ways for Parkinson’s (PD) and Alzheimer’s (AD) diseases. Mitochondrial
pathology is evident in many neurodegenerative disorders, including PD and AD. A number
of PD related genes (PINK1, DJ-1, Parkin) have been linked to mitochondrial dysfunction
with the result of increased levels of ROS [14]. Also, impaired activation of mitochondrial
complexes have been shown to influence the redox state in the pathogenesis of AD.
ROS contribute to the development of neurodegeneration by modulating the function
of several biomolecules. Highly discussed in the context of neurological disorders are
modifications of mitochondrial DNA and proteins. Both possess a bidirectional interaction
with oxidative stress. ROS can cause strand breaks, base modifications and DNA-protein
crosslinking in (mitochondrial) DNA. These mitochondrial DNA alterations can then lead to
respiratory chain dysfunction, reduced ATP production, calcium dysregulation and mitochon-
drial permeability. All of these have the potential to further increase the ROS generation.
Proteins are modified by ROS through the oxidation of both the backbone and side chains
which in turn react with other molecules or amino acid side chains. This often results in
nonfunctional protein adducts and misfolded proteins. Misfolded proteins are often prone
to aggregation, which is a hallmark of many neurodegenerative diseases. These protein
aggregates have been shown to increase ROS production by impairing mitochondrial activ-
ity, deregulating calcium homeostasis, causing neuro-inflammation and directly activating
NADPH oxidase [13, 14]. Neurons with long axons and multiple synapses possess increased
energy consumption and their function depends on different ions and a tightly regulated
electric potential. This makes these groups of neurons especially vulnerable to additional
disease-related oxidative stress, which often leads to impaired synaptic transmission and
nonfunctional neurons.
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Overall, many processes have been associated with the development of neurological dis-
orders: non- or dysfunctional neurons, protein misfolding and aggregation, perturbed calcium
homeostasis, neuro-inflammation and mitochondrial dysfunction. All of these processes
can either be a result or a cause of oxidative stress. Even though there are many examples
suggesting the importance of oxidative stress in the pathogenesis of neurodegenerations, it
remains unknown how critical its impact is and whether it is a primary cause or consequence
of the disease.
1.2 Imaging Oxidative Stress and Contributors
Given the high importance of oxidative stress in physiological and pathological processes,
many attempts to image ROS and antioxidant species have been reported, each approach aim-
ing to assess the significance of reactive oxygen species and oxidative damage in biological
systems.
1.2.1 Requirements for Detection of Oxidative Stress in Disease
A key characteristic of redox signalling is the generation of specific redox species at
specific times in specific locations. Cells harbour several interlinked antioxidant systems,
including glutathione and thioredoxin (Fig. 1.2), which are subject to independent regulation
and respond rapidly to endogenous and exogenous stimuli [15]. Also, ROS production occurs
in different, independent ways either enzymatically or through non-enzymatic reactions (cf.
section 1.1.1). As the redox reactions are kinetically and sterically separated, thermodynamic
equilibriation between the different species does not occur on biologically relevant time
scales. This results in a tight temporal and spatial confinement of the different redox reactions
and molecules. Thus, to gain a deeper understanding about the function and impact of redox
signalling under physiological and pathological conditions, it is crucial to measure a specific
redox species at a defined location and time as opposed to assessing the overall redox state.
This scenario is technically challenging and the results are often difficult to interpret and
prone to artefacts due to the high heterogeneity, reactivity and short half life of ROS.
An ideal redox sensor should be able to monitor dynamic changes of a specific, clearly
defined redox molecule with high sensitivity. Furthermore, the signal generated by the
sensor should be selective to the specific redox change (no cross-reactivity) and clearly
distinguishable from the background signal. To detect an unaffected redox state, the redox
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sensor must also be non-disruptive but able to accumulate at the (subcellular) location of
interest.
In addition to specific ROS probes, a suitable detection method is needed. Important
demands upon the method are high temporal and spatial resolution and, depending on the
biological question being asked, sufficient depth penetration for in vivo imaging. In addition,
it is important that the measurement does not influence the redox states themselves.
1.2.2 Current Methods for the Detection of ROS
In general, there are two approaches to assess ROS: Either detecting the damage caused
by the ROS or directly “trapping” or converting a particular ROS and measuring the quantity
of the generated molecule.
Ex vivo and in vitro Methods
Many conventional approaches are based on measuring the unique chemical fingerprint of
ROS such as oxidative DNA damage (e.g. 7,8-dihydro-8-oxo-guanosine), lipid oxidation (e.g.
oxidised low-density lipoprotein) and protein oxidation (e.g. protein carbonyls) products
[16]. These markers have been studied in different diseases but their specificity is often
questionable both with the regard to the biomarker molecule as well as the analytic method
(ELISA, HPLC, LC-MS, MS). Furthermore, these methods disrupt the cellular integrity, do
not allow detection in a spatial or temporal manner, often suffer poor chemical resolution
(in respect to the ROS species) and are subject to fluctuations due to the balance between
oxidative damage and removal of the oxidised products [17]. Thus, the results obtained by
these indirect measurements of oxidative stress need to be assessed with caution as changes
in the clearance of the biomarker can dramatically alter its level with no change in the
production of a given ROS [2]. Additionally, ROS can act as regulatory molecules without
causing oxidative damage, which will be undetected by these measurements and thus does
not allow examination of the physiological roles of ROS.
Another widely used method for ROS sensing in vitro, in biofluids or tissue samples are
fluorescence dyes such as hydroethidium (O2.- sensing), dichlorodihydrofluorescein diacetate
(DCFH-DA) (ROS sensing) and boronate-based fluorescent probes (H2O2 sensing) [18–20].
However, most of these probes are prone to side reactions and a range of associated artefacts,
lack of specificity, are unstable or influence the redox state (e.g. calcein, MitoTracker Red)
[21, 22, 18, 17]. For instance, although DCFH-DA is often described as a method to measure
H2O2, it does not react directly with H2O2 and requires a peroxidase or transition metal
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catalyst. The generated signal depends also on the cellular uptake of DCFH-DA. Additionally,
the relationship between ROS concentration and DCFH signal is not linear, DCFH is prone
to photo-sensitisation and can promote superoxide production [23, 24]. Hence, there are
various factors which affect the signal without changes in ROS.
The use of boronate-based sensors has greatly improved the selectivity of fluorescence
dyes for ROS sensing. The boronate functionality enables not only the selective detection of
hydrogen peroxide changes at concentrations relevant to oxidative stress but also has been
recently refined to detect signalling levels of ROS. In addition, their targeting to specific
organelles such as mitochondria allows localisation specific sensing [25, 19]. However, these
boronate-based dyes show an optical absorption maximum below 600 nm and thus have a
high background signal due to blood absorption and limited potential for in vivo optical
imaging due to the poor depth penetration (typically less than 2 - 3 mm).
In vivo Methods
An important contribution to the detection of redox species has been the development
of genetically encoded redox probes. These probes react selectively and sensitively with a
particular ROS, which triggers changes in fluorescence. For example, the redox-sensitive
green fluorescent protein (roGFP) enables ratiometric measurement sensitive to the gluta-
thione redox potential on the basis of disulphide formation between two cysteine residues
[26]. The disulphide formation facilitates protonation of the chromophore, which induces a
change in the absorption spectrum. To ensure a rapid adaptation to the redox state, roGFP
was further covalently fused to specific redox enzymes [27]. Also, Foerster resonance energy
transfer (FRET)-based probes have been evaluated, in which a redox sensitive peptide linker
connects two fluorescent proteins (ECFP and EYFP) [28]. The use of genetically encoded
fluorescence proteins enables targeted, transient and reversible live cell imaging and hence
the comparison of levels of a specific ROS in response to different stimuli at particular
intracellular location, which enables reporting of the localised redox changes within the cell.
However, these approaches require adequate cellular expression of the probe and the use
of transgenic animals for in vivo imaging. Furthermore, the sensitivity of some genetically
encoded redox probes depends on the environment and their dynamic response is decreased
compared to the dynamic range of small molecule fluorescence probes [29, 2]. Additionally,
excitation and emission often occurs below 600 nm limiting in vivo applications due to poor
penetration depth.
Alternatively, it is possible to employ a boronated caged [18F]Fluorodeoxy thymidine-1
(PC-[18F]FLT) tracer for H2O2 detection with positron emission tomography [30]. PC-
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[18F]FLT reacts with H2O2 to form [18F]FLT, which allows uptake and retention in proliferat-
ing cells. This approach is still in an early stage but shows promising results for non-invasive
in vivo imaging of H2O2 with sufficient penetration depth for clinical applications. However,
positron emission tomography requires radioactivity, has limited spatial resolution and needs
co-registration with another modality such as X-ray computed tomography for anatomical
information. This results in a restricted report on the localised redox changes within an
organ/cell and the exposure to ionising radiation can affect the the redox state.
Lastly, promising in vivo approaches use electron paramagnetic resonance (EPR) and/or
(hyperpolarised) magnetic resonance ((HP) MR) contrast [31, 32]. EPR is able to detect un-
paired electrons and thus can sense free radicals directly. For example, the contrast provided
by paramagnetic nitroxides can assess the redox state. Nitroxides are antioxidants and their
rate of reduction has been shown to correlate with cellular partial pressure of oxygen in
tumours and brain tissue [31]. However, the contrast achieved by EPR is relatively weak
resulting in low sensitivity, the species generating the contrast are often rapidly removed
through enzymatic metabolism or reaction with biomolecules and the interaction with an-
tioxidant systems in tissue is poorly characterised. Also, the accessibility of the required
specialised instrumentation is limiting their broad application, especially for HP MR imaging.
Overall, the lack of tools for measuring defined redox species together with the uncertainty
of interpretation of the data has been a profound limitation for fundamental research in redox
biology as well as clinical studies. Most approaches disrupt cellular integrity, influence the
redox state themselves, lack specificity and/or spatiotemporal resolution or have limited
potential for in vivo imaging. Thus, there is a great demand for new approaches that allow
the specific detection and quantification of different types of ROS in biological systems,
particularly in vivo and biofluids.
1.3 Novel Imaging Approaches for the Detection of ROS
In order to understand the biological and pathological impact of ROS, it is important
to reveal the nature of the particular ROS in the biological context. Therefore, molecular
imaging (MI) techniques are needed that allow the sensitive detection and quantification of
a specific ROS at a defined region of interest within the biological environment with high
spatiotemporal resolution.
MI uses specialised instrumentation combined with specific molecular markers to visual-
ise and quantify complex biochemical processes present in normal and pathological states
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[33, 34]. Data obtained from MI has revolutionised the biomedical understanding of bio-
chemical reactions at a nanoscale level providing insight into mechanisms of pathologies
and therapy response. Imaging of molecular processes is performed in several ways and
encompasses a broad area of research. In this section, contrast agents used for MI and two
important methods, photoacoustic (PA) imaging and single molecule microscopy, will be
described and their applicability for imaging ROS will be highlighted.
1.3.1 General Considerations for Contrast Agents for Molecular
Imaging
The main goal of MI is to characterise and quantify pathological and physiological pro-
cesses at the cellular and molecular level in a non-invasive way. To realise this, it is necessary
to use finely tuned contrast agents specific for the targeted molecular and biochemical pro-
cess. The key road blocks to the development of such contrast agents include: physiological
delivery barriers (such as the hematoencephalic barrier); suboptimal tissue perfusion (in
case of in vivo imaging); interactions with molecules in the biological environment (such
as protein binding); rapid elimination or biodegradation; imaging instability; and unwanted
off-target binding (Figure 1.3).
X
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decreased accumulation 
in non-targeted tissue
good bioavailability,
pharmacokinetic
and stability
Nucleus
Receptor
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X
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process
H+
signaling component
linker/carrier molecule
targeting moiety
Figure 1.3 Illustration of the complexity of criteria which have to be accomplished by contrast agents
for molecular imaging.
The basic principles for overcoming these limitations and improving the biological
properties of the contrast agent are:
1. Targeting: The incorporation of functional groups to target the accumulation of the
probe in the region of interest.
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2. Structural modifications: Variations in size, shape and chemical structure can help
to improve interaction with constituents in the biological environment, in vivo and
imaging stability, pharmacokinetics and rapid elimination.
Taking the above considerations into account, a contrast agent for MI should comprise a
signalling compound generating the signal during the imaging session and a targeting moiety
restricting the signal to the targeted biological entity or process.
Active Targeting
Most MI agents are actively targeted to cell surface receptors [35], transporters [36],
metabolic enzymes [37], biochemical processes [38] or pathogenic species [39] (Figure
1.3). These targets should ideally be (over)expressed at a very early stage of the disease
as well as sensitive and specific to biochemical changes. Current structures that can be
used to achieve active targeting include small molecules [40], peptides and adhirons [41],
affibodies [42], aptamers [43] and proteins [44]. While choosing the targeting structure,
particular consideration must be given to biocompatibility (minimising toxicity), interactions
with biological compounds (effect on imaging signal, triggering immune response), as well
as optimising elimination (from circulatory system and off-target sites) and target tissue
penetration.
Using small molecules for targeting maintains the benefits that they can pass physiolo-
gical barriers easily due to their small size (<1 nm). These molecules also clear rapidly
through the kidneys, which optimises biocompatibility and reduces off-target accumulation.
However, their biochemical properties are prone to changes when coupled to signalling
compounds. Peptides are relatively small targeting units and the development of solid-phase
peptide synthesis and phage display libraries allows a fast, cheap and efficient synthesis and
selection of peptides with high specificity and sensitivity [45]. In general, they show no
significant immunogenicity and their biological half-life/metabolic stability can be controlled
by cyclisation, insertion of D-amino acids or amino acid mimics and modifications of the
amide bond (e.g. N-methylation, reduction). Proteins (especially monoclonal antibodies
and their fragments) show high target affinity and specificity, and thus display little cross-
reactivity with healthy tissues [44]. Their generation is more difficult, time-consuming and
expensive than peptide synthesis and the larger size also results in poorer tissue penetration
and clearance, which can cause low signal-to-background ratios. Also, immunogenicity can
be a limiting criterion for their use. Antibody fragments such as diabodies and affibodies
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solve a few of these limitations, since they are smaller in size but retain high affinity and
selectivity [42, 44].
Passive Targeting: EPR Effect
The “enhanced permeability and retention” (EPR) effect is special for cancer imaging
and mainly relies on the hyperpermeability of tumour vasculature combined with the lack of
an intact lymphatic drainage. This allows the accumulation of macromolecules (10 - 100 nm)
inside a tumour; larger entities (> 100 nm) are in general not accumulated and will be cleared
through the reticuloendothelial system [46, 47]. Small molecules also diffuse into the tumour
tissue but do not accumulate. The EPR effect may exist in various solid tumours, but differs
between tumour types and patients depending on the tumour characteristics. The tumour
passive accumulation is influenced by inefficient orientation of microvessels in the tumour
[48] leading to low delivery of macromolecules and increased interstitial pressure reducing
extravasation of macromolecules [49]. Even though some authors have found enhanced
accumulation and retention of nanostructures without targeting ligands in tumours for longer
than 24 h [50, 51], passive targeting should be avoided as far as possible as uptake is not
specific to a biological process.
Activatable Contrast Agents
Activatable contrast agents are able to elicit a signal change upon binding or interaction
with their biological target. This reduces the background signal and thus improves quanti-
fication and offers the potential for high sensitivity of detection. Additionally, activatable
contrast agents increase the range of possible targets and allow dynamic, real-time studies
of biological processes such as enzymatic activity, pH sensing or the detection of ROS.
Although it is challenging to develop systems that respond to molecules, which are often
present in concentrations less than nanomolar, several examples across different MI methods
have shown promise.
One class of activatable contrast agents with considerable promise for fluorescence
imaging of H2O2 are dyes masked with boronic esters (e.g. MitoPY1 [25], Sulfo-QCy7
[52], PF1/PR1 [19]). These sensors react directly and selectively with low levels of H2O2
releasing the bright fluorophore and thus allowing to detect H2O2 by a turn-on fluorescence
enhancement. Similarly, the combination of a fluorescent protein with the hydrogen per-
oxide–sensitive domain of the transcription factor OxyR resulted in a genetically encoded,
activatable redox probe. In the presence of H2O2 a dithiol group is oxidised, which triggers a
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conformational change releasing the fluorescent protein [53]. Even though these fluorescent
probes show encouraging results, most of them are not targeted to a certain pathophysiolo-
gical location and fluorescence imaging has only limited application for in vivo imaging. In
MR imaging, one approach to generate a redox-sensitive, activatable contrast agent involves
the change in oxidation state of a free radical or a metal ion of the contrast agent. The
reduction of the radical or metal ion in the presence of ROS leads to a significant increase
in the T1 relaxation time constant, allowing the non-activated and activated probe to be
distinguished [53].
1.3.2 Photoacoustic Imaging
Given the importance of oxidative stress highlighted in section 1.1, the ability to image
specific ROS levels in vivo would provide powerful insight to the relevance of ROS for
physiological and pathological processes. Several approaches have been developed to tackle
this problem, yet all of them suffer from certain limitations, facing different challenges on
the way to a high-resolution, quantitative in vivo image of a specific ROS.
Photoacoustic (PA) imaging is an emerging hybrid imaging technology which has the
potential to fulfil this unmet need. PA imaging combines the high contrast of optical imaging
with the high spatial resolution and penetration depth of ultrasound [54]. Tissue heating
due to the transient absorption of short laser pulses produces acoustic waves, which can
be detected by ultrasound transducers and reconstructed to form an image of the absorbed
optical energy distribution. Since sound waves are less scattered in tissue than photons, PA
imaging bypasses the traditional limits of optical imaging. This enables non-invasive in vivo
imaging at depths of several centimetres with a resolution on the order of a few hundred
micrometres, scaling to <100 µm for shallower (<1 cm) penetration depths [55]. Given that
PA imaging is relatively affordable and portable, it has the potential to be rapidly incorporated
into clinical routine in surgery rooms as well as for diagnosis at the bedside [56]. All of this
combined makes PA imaging one of the fastest-growing molecular imaging techniques that
has successfully been adopted for preclinical in vivo imaging for a wide range of diseases.
Principles of Photoacoustic Imaging
PA signal generation starts with the absorption of photons from pulsed or modulated
continuous-wave light sources by intrinsic or extrinsic molecules (Figure 1.4). Subsequent
fast, non-radiative conversion of the absorbed light energy into heat leads to a small temper-
ature rise (on a scale of milli-Kelvin). The origin of this thermalisation depends on the nature
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of the chromophore and can be attributed to vibrational and collisional relaxation events
for small molecule dyes and intrinsic chromophores, and to electron-photon interactions
for metallic nanostructures. As PA imaging uses laser pulses in the nanosecond range, no
significant thermal diffusion occurs. The local temperature rise leads to a pressure increase
in the irradiated sample section, which relaxes into an ultrasonic wave at MHz frequencies.
These ultrasonic waves propagate to the sample surface where they are detected by ultrasound
transducers. The detected time-resolved ultrasound signals are then reconstructed to form
an image mapping the distribution of the absorbed optical energy. A photoacoustic image
contrast is therefore considered to be absorption based.
laser
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pressure
increase
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waves
detection &
image formation
Figure 1.4 Principles of Photoacoustic Imaging.
As the human body possesses its own set of chromophores, PA imaging is able to provide
structural and functional information based on these light absorbing molecules (Figure 1.5).
The main endogenous chromophores are haemoglobin, lipids, water and melanin.
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Figure 1.5 Absorption spectra of the main endogenous chromophores: oxyhaemoglobin (red, 150 g/L);
deoxyhaemoglobin (green, 150 g/L); water [57] (blue, 80% by volume in tissue); lipids [58] (yellow
(20% by volume in tissue); melanin (brown, µa corresponds to that in skin); and collagen (black).
Data from http://omlc.ogi.edu/spectra/.
1.3 Novel Imaging Approaches for the Detection of ROS 15
A PA image can be formed in several ways [59]. One of the most common configurations
is referred to as photoacoustic tomography (PAT). In PAT, a wide-field laser beam with
wavelengths in the near-infrared (NIR) range illuminates the sample. As light is scattered
in the tissue, a broad area is exposed to the diffused light beam and acoustic signals are
generated across this area. The waves, once reaching the surface, are then recorded at low
frequencies (few MHz) via multi-element ultrasonic detection. The spatial resolution is in
general frequency and thus depth dependent. As PAT aims for deep-tissue imaging with
centimetre penetration (up to 6 cm in vivo) a submillimetre spatial resolution is reached. To
generate the final image, a computer algorithm, typically based on backprojection principles,
is used [59]. An important feature of PA imaging is its multi-wavelength data acquisition
capability. Recording PA data at multiple wavelengths allows generation of a specific PA
spectral profile of the absorbing molecule. This profile can either be generated by following
the signal change at the different wavelengths before and after the contrast molecule being
present, or through multivariate statistical methods, referred to as “spectral unmixing” (for
example, linear regression) [59]. However, spectral unmixing results are strongly dependent
on accurate compensation for light fluence and strong (sufficient signal-to-noise ratio), non
overlapping spectra. Thus, molecules with broad spectra are often difficult to separate from
the systematic noise and their identification in vivo is hampered as their spectral profiles
often overlap with the biological “background” signal of the haemoglobins.
1.3.3 Photoacoustic Contrast Agents for Molecular Imaging
PA imaging with endogenous contrast can provide structural and functional information
through contrast available from hemoglobin, melanin, lipids and water (Figure 1.5). However,
oxidative stress and ROS lack sufficient intrinsic contrast and require the introduction of
exogenous contrast for MI. As highlighted before, to be used in MI, the contrast agent should
consist of a signalling unit and a targeting structure.
Photophysical Properties of PA Contrast Agents
To design an effective contrast agent for PA imaging it is critical to understand the
photophysical properties and thermodynamic interactions of the signalling compounds during
the signal generation process (cf. section 1.3.2).
The ideal signalling compound for PA imaging should generate a signal that is sufficiently
large and distinct relative to the background signal provided by endogenous molecules to
allow unambiguous detection. Therefore, a high molar extinction coefficient in the NIR
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window (620 - 950 nm) and a sharply peaked, characteristic absorption spectrum are needed.
Figure 1.6 shows the specific extinction coefficients and peak absorption wavelengths of the
most common contrast agents used in PA imaging.
Figure 1.6 Reported extinction coefficients (ε) and peak absorption wavelength (λ ) of the most
common PA signalling compounds. NP refers to nanoparticle. Values are reported for peptide-
grafted nanodiamonds [60], methylene blue [61], IC7-1-Bu [62], CDnir7 [63], IRDye800CW, ICG
(http://www.spectra.arizona.edu/), SiNc [64], gold nanospheres [65], SWNTs [66], SPN1 [66], gold
nanostars [65], porphysomes [67], GNRs [50], gold nanopopcorn [68], CP NPs [66], cellulose NPs
[69], gold nanocages [70], poly(sodium 4-styrenesulfonate) (PSS)-coated GNRs [71], gold nanocubes
[72] and gold nanoshells [73].
A high molar extinction coefficient in the NIR range maximises the amount of light
absorbed and the penetration depth, as absorption by intrinsic molecules is minimal in this
wavelength range (Figure 1.5). To generate a strong PA signal, the signalling compound
should also exhibit a good conversion efficiency of the absorbed light energy into pressure.
To ensure this, the fluorescence quantum yield should be low to maximise thermalisation.
Subsequent transformation of the thermal energy into pressure is characterised by the pho-
toacoustic efficiency, which depends on the absorber and the propagation medium [74].
Additionally, it is important that the contrast agent has good photostability to guarantee that
light irradiation throughout the imaging process does not impact the spectral features.
Signalling Compounds for PA imaging
Signalling compounds for PA imaging can be grouped into three broad classes including
small-molecule dyes, metallic or semiconducting nanostructures, and organic nanostruc-
tures. Figure 1.7 illustrates a schematic overview of the signalling compounds used for PA
imaging, including their advantages and disadvantages, and the methodology that enables
their targeting for the use in MI. It is important to consider that the targeting ligand and
signalling compound should be compatible in terms of their chemical, physical and biological
properties.
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Figure 1.7 Schematic overview of the assembly of molecular imaging contrast agents for PA imaging
combining signalling compounds with targeting structures. Examples of each approach are shown
and the relative advantages (+) and disadvantages (–) are listed [75, 37, 76–78].
While nanoparticles and organic nanostructures have been applied for the detection of
oxidative stress [79, 80, 66], other studies have shown that these species can themselves
induce oxidative stress [81]. Therefore, the focus here is directed on contrast agents based on
small molecule optical dyes, which are less perturbing to the local biology in the environment
that is being imaged.
Small molecule optical dyes are in general good candidates for PA imaging as their small
size allows them to easily pass physiological barriers and possess favourable biocompatibility,
including good biodistribution, minimal toxicity and immunogenicity as well as minor off-
target accumulation. The main classes of dyes used for PA imaging are cyanine dyes, azo
dyes, rhodamine dyes and squaraine dyes (Figure 1.8A-D). The chemical basis of these
dyes is a series of conjugated double-bonds and/or (mostly aromatic) ring systems. In these
π-conjugated structures, the energy gap between the highest occupied energy band (π-band)
to the lowest unoccupied energy band (π∗-band) of the molecule is small enough to allow
absorption in the NIR range. The wavelength of the absorbed light is defined by π-π∗-energy
gap and gives rise to a distinct absorption peak. Relaxation of the excited electrons can
occur in radiative (fluorescence or bioluminescence) or non-radiative processes, dependent
on the lifetime of the excited states (Figure 1.8E). To obtain a sufficient PA signal, a large
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non-radiative relaxation is desired and thus the contribution of fluorescence emission should
be minimal (low quantum yield, φFl).
The challenges associated with the use of small molecule dyes are mostly based on
their low molar extinction coefficient (< 3x105 M-1cm-1) and limited solubility combined
with the tendency to aggregate, bind to proteins and photobleach. However, one of the key
features of small molecule dyes is their chemical flexibility. This not only allows some of
these limitations to be addressed by attaching hydrophilic groups, introducing triplet-state
quenchers [82] and integrating stabilising groups [83] but also enables the spectral properties
of the dyes to be tailored through varying the size of the conjugated system and incorporating
electron-donating or electron-withdrawing groups. Additionally, the chemical flexibility also
facilitates the creation of (redox-) activatable contrast agents, which can in part compensate
for their low molar extinction coefficient by minimising the influence of the background
signal caused by endogenous molecules.
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Figure 1.8 Representative structures of the different dye classes used for PA imaging. Molecular
structure of A) indocyanine green (ICG) as example for a cyanine dye. Cyanines show photoin-
duced cis-trans isomerism and transition to triplet states, which leads to low φFl and thus increased
non-radiative relaxation; further they are generally easy to functionalise but possess often poor pho-
tostability and their optical properties are highly effected by the environment. B) Methylene blue as
example for azo dyes. Limited by absorption in lower NIR range and phototoxicity. C) Rhodamine
dye core structure. Rhodamine dyes show intense and sharp absorption peaks and good photostability
but are often relatively blue shifted and exhibit high φFl due to their rigid structure. D) Squarine
dye. Squarine dyes possess good photostability but are often limited by insolubility, aggregation and
chemical reactivity for modifications. E) Simplified Jablonski diagram showing energetic transitions
for an NIR dye after optical excitation.
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1.4 Single-Molecule Fluorescence Microscopy
Considering the high spatial and temporal heterogeneity of redox species within a cell,
the ability to monitor dynamic changes in specific redox processes with subcellular resolution
in the biological environment would enable a shift from inadequate quantification of “cellular
redox status” to subcellular measurements, allowing the complex interplay between different
redox pathways and major physiological and pathological phenomena to be unmasked.
Fluorescence microscopy is an indispensable tool in biomedical research as it allows
biological processes to be imaged on a single-molecule level with a high signal-to-noise ratio
while still retaining the key features in the physiological context of native biological samples.
By looking at single molecules the ensemble averaging of traditional methods is removed
and it is possible to directly measure hidden heterogeneity. Combined with high temporal
resolution this reveals fundamental molecular scale processes such as signal transduction
[84], DNA replication [84], cell division mechanisms [85] and protein folding.
Principles of Single-Molecule Fluorescence Imaging
Two main techniques for single-molecule fluorescence imaging, which are able to bypass
the classical diffraction limit and shift the optical resolution down to molecular levels,
include wide-field based single molecular localisation (SML) microscopy and confocal
based stimulated emission depletion (STED) microscopy. Both methods are able to resolve
structures below 100 nm (Figure 1.9A) and thus allow the direct and localised observation
of intracellular redox processes, which cannot be visualised using conventional methods.
Hereafter, the focus is placed on SML. A detailed comparison of the two techniques can be
found in the literature [86].
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Figure 1.9 Diffraction limited resolution. A) Schematic illustration of the scale of different biological
objects and the relative scale of the confinement of SLM and STED. B) Illustration of the blurry focal
spot obtained by a high objective lens with a high numerical aperture. The width of this spot defines
the diffraction limit, which causes that two fluorophores are not resolved if their distance is below the
diffraction limit.
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These optical microscopy techniques require the presence of a fluorophore. When imaging
the light emitted from the optically active species using the objective of a microscope, the
light forms a blurry focal spot instead of a focal point (Figure 1.9B). The scale of this spot
depends on the wavelength of the light used and the microscope setup. The intensity profile
of this spot is described by the point spread function (PSF). As a result, two fluorophores,
which are closer together than the width of the PSF, appear as a single emitter and cannot be
separated. This resolution limit is often referred to as the optical diffraction-limit of light and
is typically ∼250 nm (perpendicular to light propagation) [87]. Many biological processes
and structures are smaller than this resolution limit and therefore unresolved by conventional
fluorescence microscopy (Figure 1.9B).
Localisation microscopy exploits the knowledge that a PSF is the result of a single
point source emitter. Thus, the central position of that emitter can be determined by the
use of a Gaussian or a Lorentzian function with an accuracy below the diffraction limit.
The precision of the location is thereby determined by the number of photons emitted by
a fluorophore, the size of the point spread function, and the background [88]. In order to
assume a point source scenario, there must be only a small number of fluorophores emitting
at a time as otherwise the fluorescence from these molecules will strongly overlap and the
overall image will be blurry. Achieving this by reducing the labelling density does often
result in under-sampling accompanied with drastically reduced resolution. Thus, techniques
such as STORM (stochastic optical localisation microscopy [89]) and (f)PALM ((fluorescent)
photoactivatable localisation microscopy [90, 91]), separate the fluorophore emission in
time by ensuring that only one molecule is emitting at a time (Figure 1.10A). Therefore,
photoswitchable/photoactivatable fluorophores can be used, which are converted between an
“on” state, in which they emit light, and an “off” state, in which they do not emit light, or
emit light at different wavelengths.
An alternative SML approach to control the fluorescence emission is PAINT (point
accumulation for imaging in nanoscale topography). This method uses freely diffusing dyes
or dye-labelled ligands to target molecules of interest [92]. The fluorophores are diffusing in
and out of the excitation area and become immobilised when they bind to their target, which
then allows localisation. The signal generation and hence their spatiotemporal resolution is
not limited by the photophysics of the probe and can be tuned through the rate of interaction
between the dye and the target and thus by the affinity of the fluorophore for the biomolecule.
Specifically, DNA-based PAINT (DNA-PAINT) has been identified as a promising approach
since it adds the specificity and programmability of DNA nanotechnology, which allows
spectrally unlimited multiplexing capabilities (Figure 1.10B).
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Figure 1.10 Schematic illustration of approaches for SML microscopy. A) SML takes advantage
of photoswitching of fluorophores to generate temporally separate images of a subset of spatially
overlapping single molecules. After multiple iterations of activation and deactivation the super
resolution image can be constructed from the localisations of many single fluorescent points. B)
Principle of DNA-PAINT. DNA-PAINT uses short, dye-labelled DNA strands (imager strands) that
binds transiently to a complementary strand (docking strand, bound to the target structure) in a
sequence-specific way. The DNA sequence allows tuning of on- and off-rates and thus minimises the
impact of photobleaching. Additionally, the use of different DNA sequences and different dyes allows
the readout of different targets simultaneously.
For all SML approaches, the sample is imaged with low intensity and thus only a small
subset of fluorophores is activated to the emitting state resulting in a high resolution image of
the individual, excited fluorophores. After deactivating or bleaching this subset of emitters,
the process will be repeated until enough or all molecules have been imaged. Subsequent
localisation of all detected fluorophores enables the construction of a super-resolution image
(Figure 1.10A) [87].
Total Internal Reflection Fluorescence
A major requirement for single-molecule imaging methods, especially when examining
biological species present at low concentrations (e.g. ROS), is the ability to sensitively and
specifically detect small signals over a high background noise. Different approaches have
been used to achieve this. One of the most prominent approaches in cell biology exploits
total internal reflection fluorescence (TIRF) illumination at highly inclined angles at the
glass–sample interface to excite fluorophores in the sample (Figure 1.11) [93].
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Figure 1.11 Schematic illustration of an objective-based TIRF microscope set-up.
Total internal reflection occurs when light travels through a transparent medium with
refraction index n1, such as a glass cover-slide (n1 = 1.5) and is incident on a dielectric
interface with a medium of lower refraction index n2 (e.g. aqueous medium, n2 = 1.33) at
an critical angle. The critical angle of incident light can be determined by Snells’s law
(θC = sin-1(n1/n2)). At or above the critical angle, the incident light is refracted back into
the higher medium but a portion of the energy will be converted into an electromagentic
field, which propagates as an evanescent wave of exponentially decaying intensity, but same
frequency, into the lower medium. Due to the exponential decay of the amplitude with depth
of penetration, only fluorophores in a thin region (100-200 nm) of the sample are excited
[93]. This reduction in excitation volume increases the signal-to-noise ratio as it excludes
signals from unfocused regions and thus allows single molecules to be resolved.
1.4.1 Contrast Agents for Single-Molecule Localisation Microscopy
To study a specific biological process at the molecular level the contrast agents should
comprise a signalling unit generating the fluorescence signal and a targeting structure, which
confines the signal to the molecular target of interest.
Photophysical Properties of Contrast Agents for SML Imaging
Choosing the right signalling compound is critical for SML microscopy. An ideal probe
should fulfil several main criteria. First, it is crucial that the fluorescence probe possesses a
fluorescent “on” state at a defined wavelength range and an “off”(dark) state, which does
not emit at this range, to allow activation-deactivation cycles and to maximise the signal-to-
noise ratio. Second, a high extinction coefficient and quantum yield is needed to generate
a large number of photons in the on state, which allows high precision of localisation and
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increases sensitivity. Third, as spontaneous activation by thermal energy or the imaging laser
(instead of the activation laser (in case of switchable fluorophores)) can occur during image
acquisition, it is also critical for the probe to have a low spontaneous activation rate [87].
Fourth, a large Stokes shift is beneficial to separate the emitted light from the excitation light.
Finally, the probe should possesses a good photostability at high laser powers.
Signalling compounds for SML Imaging
The main signalling compounds used for SML are small molecule organic dyes and
fluorescent proteins. For the purposes of this thesis fluorescent proteins will not be discussed
and the focus will remain on organic dyes that can be easily introduced into an arbitrary
biological sample.
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Figure 1.12 Chemical structure of represenative dyes used for SML microscopy and their maximum
absorbance wavelength (λ abs) and quantum yields (φFl). Rhodamine dyes have a rigid dye backbone
leading to high φFl. Oxazine dyes absorb at higher λ abs and show good photostability but possess
low φFl. Coumarin dyes manifest large Stokes shifts due to their polar excited state but are rather
photoinstable. Cyanine dyes exhibit photoswitching behaviour due to cis/trans isomerisation and
transition to triplet states, which leads to low φFl.
The main classes of dyes used for SML are rhodamines, oxazines, coumarins and cyanines
(Figure 1.12). The chemical structure of organic dyes underlying their capability to absorb
and emit light is a conjugated system of π-electrons. Light induces these electrons to move
from the highest occupied energy band (π-band) into the lowest unoccupied energy band
(π∗-band) of the molecule. The electrons will then relax back and the electronic ground
state is restored. The energy gap between these bands defines the wavelength at which
absorption and emission takes place. However, due to more complex electron dynamics both
absorption and emission occur over a continuum of energies, which gives rise to an absorption
and emission spectrum instead of a sharp, discrete atomic line spectrum. The Jablonski
diagram provides a schematic representation of the processes involved in the excitation and
relaxation process of fluorophores (Figure 1.13A). The probability of this process occurring
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is dependent on the quality of the interaction between the electrons and electromagnetic field
of light, which induces motion of the delocalised electrons and thus creates an oscillating
dipole [94]. The better the interaction, the greater oscillating dipole and thus the absorption.
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Figure 1.13 A) Jablonski diagram. Solid arrows = electronic transitions, dashed arrows = vibrational
transitions, IC = internal conversion, ISC = intersystem crossing. B) Representative absorption and
emission spectra of a fluorophore. Excitation promotes the fluorophore often in energy levels greater
than S1. Due to fast vibrational relaxation to S1 before emission of the photon, the fluorescence is
shifted to longer wavelengths than the absorption (Stokes shift). This is a desirable in fluorescence
spectroscopy as it allows the two processes to be spectroscopically separated.
Excited fluorophores in the S1 state can undergo several decay processes, the most desired
one for SML imaging being emission of a fluorescence photon, which returns the molecule
to its ground state (S0). Competing de-excitation pathways are non-radiative intersystem-
crossing (ISC) to form a triplet excited state (Tn) and non-radiative internal conversion (IC)
from S1 to S0 (Figure 1.13). However, both processes are rather slow as ISC to Tn involves
electron spin conversion and the relative large energy gap between S1 and S0 limits IC [94].
For SML microscopy it is desirable that the fluorescent form of the molecule can be
recovered after the deactivation process. “Blinking” fluorophores realise this through trans-
ition to a reversible off-state. One cause for single-molecule blinking is the transition of the
fluorophore into the triplet state by ISC. As the T1 to S0 transition is formally forbidden,
T1 possesses a long lifetime (10-4 to 10-6 sec) and T1 to S0 decay (phosphorescence) is not
detected in the time regime in which SML operates, manifesting a reduction in total intensity.
Also, as oxygen is generally present and has a triplet ground state, it efficiently quenches
the dye’s triplet state and repopulates the S0 state in a non-radiative way, resulting in fast
on-off-cycles [95]. However, the interactions with oxygen lead to the generation of singlet
oxygen, which can oxidise the fluorophore resulting in irreversible photobleaching [96].
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Apart from ISC, the T1 off-state can also be reached as a result of photoinduced electron
transfer reactions of the fluorophore in its excited state [97] or through conformational
changes, which can be either photophysical or thermally induced. For example, the presence
of rotatable groups can lead to an intramolecular twisting motion in the fluorescent excited
state, which can lead to a lower energy excited state, which often decays in a non-radiative
way. Several dyes, referred to as molecular rotors, exhibit this property [98].
Organic dyes are promising contrast agents for SML as they possess a high chemical
flexibility to tune their properties. Based on this, organic dyes are versatile for labelling
with different targeting ligands including small molecules, peptides, affibodies, apatmers,
antibodies and proteins (Figure 1.7). However, if extremely high resolution is required, the
greater size of antibodies and proteins are limiting. Chemical modifications can also allow
adjustment of the optical properties of dyes. It has been shown that integrating electron-
donating and electron-withdrawing groups can increase the quantum yield of fluorophores
[99]. Furthermore, this push and pull effect, which increases the delocalisation of the π-
electrons, can help to induce a bathochromic shift in the absorption and emission spectra,
which is favourable due to the reduced background from endogenous chromophores (cf.
Figure 1.5).
During SML image acquisition, the fluorophores are surrounded by solvent molecules.
After excitation, the polarity of the fluorophore changes and thus the solvent molecules will
reorganise. This solvent relaxation helps to stabilise the excited state and contributes to
increased Stokes shifts (solvatochromism) (Figure 1.13B), especially for polar fluorophores
[100]. Thus modifying the polarity of the organic dye can help to improve their performance
in SML. However, when increasing polarity through the introduction of H-bond donor groups,
this may lead to an decrease in quantum yield [101, 102].
1.5 Project Objectives and Outline
As outlined in this introduction, there is an unmet need for a robust, accessible and
sensitive methods to measure specific types of ROS with high spatial and temporal resolution,
particularly in vivo and in patient-derived samples. To overcome the current limitations,
the fundamental objective of this thesis was to develop new optical probes for the specific
detection of ROS in cancer and neurodegenerative disorders and combine these with suitable
technologies allowing a specific readout with high spatial and temporal resolution under
biologically relevant conditions.
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Combining the high temporal and spatial resolution of PA imaging with new cell- and
redox species-specific probes is a promising approach for the accurate mapping of cellular
redox conditions in vivo. Therefore, the aim was to develop a bifunctional small molecule
PA probe for detecting a major and abundant ROS, hydrogen peroxide, which elicits a signal
change upon redox alterations and is specifically uptaken by cancer cells. Approaches to
achieve this aim are described in Chapters 2 and 3 of this thesis and involve the investigation
of the following areas:
• Synthesis and chemical and photophysical characterisation of an organic framework that
absorbs light in the NIR range, possesses suitable optical properties for PA imaging and
provides easily accessible sites for chemical modifications.
• Synthesis and characterisation of different linker-dye conjugates to evaluate their ability to
elicit a signal change upon the reaction with H2O2 that is detectable with PA imaging.
• Synthesis as well as physicochemical and biological evaluation of a bifunctional H2O2-
reactive, cancer-targeting dye.
• In vitro and in vivo application of the new bifunctional probe to study the role of oxidative
stress in cancer with the help of PA imaging.
• Development of ex vivo methods to cross validate the biological insight provided by the in
vivo data of the new bifunctional PA probe.
Single molecule fluorescence imaging allows the ultrasensitive detection of individual
nanoscale biological species with unsurpassed spatial and high temporal resolution. Merging
this technology with new bifunctional probes able to simultaneously sense ROS and patholo-
gical species of neurological diseases presents an auspicious method to overcome the hurdle
in assessing ROS changes linked to the pathology of neurodegenerations that could in future
be applied in patient samples. Chapters 4 and 5 describe the different strategies explored in
this thesis to reach this goal and include the following areas:
• Photophysical characterisation on a bulk and single molecule level of a novel fluorophore
library for detecting pathogenic protein aggregates in neurodegenerative disorders.
• Characterisation of the binding properties of this novel fluorophore library.
• Establishing the relationship between the chemical modifications of the different fluoro-
phores, their photophysical and binding properties.
• Applying the knowledge gained from the characterisation of the library to develop novel
bifunctional dyes capable of simultaneously identifying H2O2 and pathogenic protein
aggregates.
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• Characterisation of the bifunctional sensing capabilities of the new bifunctional dyes at bulk
and single-molecule levels.
The thesis concludes with a chapter that summarises the findings and provides and
outlook for additional work that would further assess the significance of H2O2 and oxidative
damage in cancer and neurodegenerative diseases with the two new developed approaches.

Chapter 2
Development of a new Activatable,
Bifunctional Photoacoustic Probe
The PA spectrometer used for acquiring PA spectra of the dyes with different concentra-
tions in different solvents was assembled under the guidance of S. Morscher (iThera Medical),
who also provided the code for the image reconstruction of these data. The study of the
absorption and fluorescence properties of commercial available cyanine dyes was done in
collaboration with a summer student L. Birnoschi, under my supervision. Dr. T.J.Zuehlsdorff
and Dr. N.De Mitri performed DFT calculations. All other work was performed and analysed
myself. Parts of this work are in review for publication.
2.1 Introduction and Motivation
Reactive oxygen species (ROS), oxidative stress and oxidative damage has long been
linked to several cancerous conditions promoting tumour initiation, promotion, progres-
sion and survival [103, 104]. Whether increased levels of ROS are a primary cause or a
downstream consequence of tumorigenesis and how the different disease stages vary from
each other in respect of their redox biology is still an open question due to limitations of
the current state-of-the-art methods for measuring ROS, particularly in vivo. Consequently,
research into new imaging probes and early detection methods for deleterious levels of ROS
have attracted significant interest in biomedical research. Thus the focus of this chapter was
to develop a new imaging probe for specific and sensitive in vivo sensing of ROS in cancer.
Therefore, PA imaging was used as it operates on a spatial and temporal resolution highly
suited to detect ROS in real-time in vivo with high spatial resolution.
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2.1.1 Near-Infra-Red Dyes and Hydrogen Peroxide Sensing
In the past few decades, new near-infra-red (NIR) fluorescence dyes with fine photophys-
ical properties, high sensitivity and multi-detection capability have been a topic of great
interest in bioimaging and therapeutics. Their chemical flexibility facilitates the conjugation
with moieties of interest and tailoring the spectral range of the contrast agent, making them
ideal candidates for disease targeted imaging and multimodality approaches.
One target for which NIR dyes are broadly exploited are reactive oxygen species (ROS).
H2O2 is a major and abundant ROS in living organisms and plays an important role as a
second messenger in physiological signal transduction and pathological processes. Thus,
several NIR dye backbone structures have been chemically modified to be capable of measur-
ing H2O2 production. Among them are rhodamine [19, 20, 25], BODIPY [105] or cyanine
[52, 106] based dyes. Frequently, a boronate functionality frames the moiety for specific and
irreversible H2O2 detection.
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Figure 2.1 Mechanism of the oxidation of boronic esters by H2O2.
In this context, the readout is based on an selective increase in fluorescence triggered
by H2O2 mediated boronate deprotection (Figure 2.1). An added benefit is that neither the
boronic esters nor the arising boronic acids show an intrinsic toxicity and their reactivity can
be tuned by means of substitution effects on the phenyl unit [107, 108]. Additionally, the
sensors have been refined to detect signalling levels of ROS (down to 100-200 nM H2O2)
and targeting to specific organelles such as mitochondria allows localisation-specific readout
[19, 25].
Even though the temporal and spatial regimes in which fluorescence imaging can operate
makes it a suitable technique for the study of ROS on a cellular basis, constrained depth of
penetration limits the application of the fluorescence based ROS-specific probes in deeper
tissues and thus for clinical in vivo imaging [33]. Photoacoustic (PA) imaging overcomes
these traditional depth limits of ballistic optical imaging and the resolution limits of diffuse
optical imaging. Additionally, it uses acoustic waves generated in response to the absorption
of pulsed laser light and thus no radiation or other source of external ROS generation is needed
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for PA imaging. Logically, using the knowledge gained from boronate-based fluorescent
dyes could allow for introduction of an activatable PA contrast agent.
2.1.2 Activatable Contrast Agents for PA Imaging
+ stimulus
 
PA signal
+ stimulus
λ1 λ1
+ stimulus
λ1 λ2λ2
λ2λ1
A B C
Figure 2.2 Schematic illustration of the mechanisms of activatable probes for PA imaging. A) The
non-activated probe generates a weak PA signal with a peak intensity at λ 1. Upon the interaction
with the biological stimulus, many probes combine and generate a significant signal increase at λ 1.
B) The non-activated probe produces a PA signal at 2 wavelengths (λ 1, λ 2) corresponding to the
absorption maxima of the 2 chromophores (green and blue star). After cleavage, only one part of the
probe carrying one of the chromophores (green star), accumulates in region of interest and results in a
PA signal at only 1 of the 2 wavelengths. C) The interaction with the biological stimulus causes a
chemical modification of the probe, which leads to a change in the PA maxima from λ 1 to λ 2.
Activatable probes for PA imaging are designed to elicit a detectable signal change upon
enzymatic activity or in response to a specific biomolecular interaction. The PA signal change
can be manifested through an increase in signal intensity [109, 37], the disappearance/local
separation of one of two initial PA peaks [110, 111] or through a shift in the peak absorption
[112] (Figure 2.2). PA images can then be acquired at the wavelengths characteristic for the
probe before and after activation, which allows internal normalisation and thus can lead to
very high signal-to-background ratios compared with conventional targeted contrast agents.
Additionally, they open up the possibility of imaging biological processes in real-time at
lower concentrations due to increased sensitivity.
However, to realise these features it is important to consider some key criteria: Firstly, it
is crucial that the activatable contrast agent possesses clear distinguishable absorption profile
before and after activation without significant signal cross-over with each other and the
background to allow spectral unmixing and maximise the signal-to-noise ratio. Furthermore,
a low spontaneous or unspecific activation rate is needed to enable the sensitive and specific
readout of the biological stimulus of interest. The activation reaction rate and reaction
kinetics must also be optimised towards the stimulus to enable the response to stimuli, which
are often present in concentrations of less than nanomolar. Finally, it is critical to study
the in vitro and in vivo properties of both the non-activated and activated probes separately
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to exclude artefacts due to differences in the interaction with the biological environment,
biodistribution, metabolism or clearance. Although relatively few examples of activatable
contrast agents exist for PA imaging, targeting matrix metalloprotease [113], metal ions
[114, 115], hypoxia [116] or nitric oxide [112] have shown promising results.
2.1.3 Bifunctional Contrast Agents for ROS Sensing
ROS are not only assigned to pathologies and ageing but also play an important role
as regulatory molecules in a range of biological processes. Consequently, ROS are present
ubiquitously and it needs to be assessed cautiously whether a change in concentration of a
particular ROS is indicative of its contribution in a pathology or physiological redox signal
[2]. Thus, to study the impact of oxidative stress towards a particular disease, the location
of the probe within the organism and the cell must be understood and controlled. This is
particularly important in complex, multistage diseases such as cancer, in which a variety
of factors lead to disease initiation and progression. Often several of these factors, such as
inflammatory processes, lead to an additional enrichment of ROS.
To examine precisely how the different factors and developmental stages vary from each
other in respect of their redox biology, we need to be able to not only get a read out of the
redox environment but also of the localisation and developmental stage of the pathological
process. This can be achieved through bifunctional probes, which on the one hand actively
target a disease inherent biomarker (over)expressed at a certain stage of the disease and found
at low levels in off-target tissues and on the other hand possess an activatable functionality
reactive towards the ROS of interest. Such an approach was explored by Dickinson et
al, who targeted a H2O2-reactive fluorescence dye towards mitochondria, which allowed
mitochondria specific H2O2 detection in cell culture and tissue models [25]. Moreover, the
active targeting moiety can be exploited to accomplish biological needs such as bypassing
physiological delivery barriers, rapid elimination, biodegradation, decreased off-target tissue
accumulation and suboptimal tissue perfusion.
2.1.4 Approach
The ideal contrast agent for accurate in vivo mapping of cellular redox conditions in cancer
by means of PA imaging must fulfil certain requirements (Figure 2.3). One main criterion
is a characteristic absorption spectrum in the NIR range with a high extinction coefficient
to maximise the amount of light absorbed and to ensure unambiguous identification by
spectral unmixing even at low molar concentrations. For the specific and irreversible H2O2
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detection, a functional group that triggers a signal change upon reaction with H2O2 is crucial.
Finally, because the spatial and temporal distributions of redox species is usually highly
heterogeneous and the redox signalling signature is specific to a certain location, the ideal
contrast agent should also comprise a cancer targeting moiety to increase patho-physiological
specificity and gain a favourable biodistribution. The target structure should ideally be
(over)expressed at a defined stage of the cancer development and found at low levels in
off-target tissues.
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Figure 2.3 Schematic illustration of the design and different features of the new activatable, PA
contrast agent.
This chapter will describe the background and fundamentals on how these different
requirements were implemented. First, different commercially available NIR cyanine dyes,
previously used for fluorescence imaging, have been studied to investigate how structural
modifications of the dye backbone influence the suitability of the dye as PA contrast agent.
Secondly, the ability of different linkers to elicit a PA signal change upon interaction with
H2O2 was examined. The chapter will finish by describing the final design, synthesis and
photophysical properties of the new bifunctional, activatable contrast agent.
2.2 Results and Discussion
2.2.1 Properties and Characteristics of Commercial Available NIR Cy-
anine Dyes
The rise of in vitro and in vivo fluorescence imaging in research and clinical use in the last
decades led to a significant number of NIR fluorescent probes being synthesised, character-
ised and later made commercially available. Heptamethine carbocyanine (HCC) dyes have
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been described among the different dye scaffolds that satisfy the optical criteria needed for
PAI and, importantly, provide easily accessible sites for chemical modifications [117, 118].
However, most of the examinations of cyanine dyes are based on fluorescence imaging and
only limited information are available about their absorption and PA characteristics under
different, especially biologically relevant, environments. Hence, the aim was to examine the
photochemical properties of different NIR cyanine dyes, which possess distinct similarities
and differences, with regard to their suitability as PA contrast agents. The structures and
characteristics of the chromophores compared are shown in Table 2.1. The main criteria for
selection were the ring size of the terminal 3-H-indole structure, the number and position of
solubilising, anionic groups and the presence and size of the carbocyclic ring bridging C3’
and C5’ of the polymethine chain. Representative spectra for different solvents and dyes can
be found in the Appendix.
Aggregate Formation
In general, cyanine dyes consist of two nitrogen centres, one positively charged the
other neutral, which are linked by a conjugated chain of an odd number of carbons. This
structure generates a push and pull effect and forms the basis of their chromophoric unit
[118]. The absorption spectrum of cyanine dyes is characterised by a maximum based on the
0-0 electronic transition and often blue shifted sub-bands caused by vibronic transitions [119].
Additionally, H- and J-aggregate formation can occur in different environments leading to
hypsochromic or bathochromic shifts, respectively [118]. Dimerisation, in particular, evokes
a peak partially overlapping with the vibronic shoulder of the monomer [119]. It is therefore
important to assess the nature of aggregation formation in these species in order to understand
the spectral shifts that may occur in vivo.
The optical examination of the 7 different dyes confirmed the following aggregation trends.
The aggregate content appears to increase with solvent polarity and ionic strength. Extending
the terminal aromatic system and thus the hydrophobicity increases the aggregation tendency
in aqueous solutions (Cy7 vs Cy7.5, Figure 2.4A). The introduction of a six-membered ring
in the heptamethine chain seems to promote the formation of additional J-aggregates, which
might be caused by the increated rigidity of the dye framework (Cy7.5 vs ICG, Figure 2.4B).
The aggregation tendency in solution between dyes with integrated 5- or 6-membered ring
(IR783 vs IR806) did not differ. However, the 5-membered ring derivative, IR806, readily
precipitated in the presence of ions whereas IR783 was soluble in buffers.
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Table 2.1 Structure and characteristics of selected commercial available cyanine dyes.
Dye Aromatic Anionic Carbocyclic Chemical Structure
Rings1 Groups Ring2
ICG 2 2 SO3- No N
SO3-
N+
-O3S
Cy7.5 2 1 CO2- Yes (6) NN+
-O2C
Cy7 1 1 CO2- Yes (6) NN+
-O2C
SulfoCy7 1 2 SO3-, 1 CO2- Yes (6) NN+
-O2C
SO3--O3S
IR800CW 1 4 SO3-, 1 CO2- Yes (6) N
SO3-
N+
-O2C
O
SO3- SO3
--O3S
IR783 1 1 SO3- Yes (6) NN+
-O3S
Cl
IR806 1 1 SO3- Yes (5) NN+
-O3S
Cl
IR680RD 1 3 SO3- No
N
SO3-
N
N
SO3-Cl
SO3-
HN
O
N
O
O
1 Relating to the aromatic rings of the terminal 3-H-indole structure.
2 Relating to the carbocyclic ring bridging C3’ and C5’ of the polymethine chain. The number
indicates the ring size.
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Addition of fetal bovine serum (FBS) or bovine serum albumin (BSA) to water or buffer
led to a significant decrease in aggregation for dyes strongly binding to proteins (Figure
2.4C). This is caused by dye-protein complex formation, which prevents dye-dye interac-
tions. The tendency of dye-protein complex formation was validated by incubating the dyes
with phosphate buffered saline (PBS) containing 3 wt% BSA and separating the different
dye-protein complexes via gel electrophoresis in native conditions (Figure 2.4D). The two
sulfo-cyanine dyes, IR800CW and SulfoCy7, showed no significant change in their spectral
shape by adding BSA or FBS, which was consistent with the absence of noticeable protein
binding.
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Figure 2.4 Aggregation trends of cyanine dyes. Absorption spectra of A) Cy7 and Cy7.5 (20 µM)
in H2O B) Cy7.5 and ICG (50 µM) in PBS and C) IR783 (20 µM) in PBS and PBS + 10 % FBS are
shown, demonstrating A) the increase in aggregation when extending the aromatic framework of the
dye, B) the influence of a more ridged backbone caused by an integrated 6-membered ring and C)
the decrease in aggregation in the presence of proteins. D) Tendency of the dyes to bind to proteins.
Protein binding of the 7 cyanine dyes was assessed in 3 wt% BSA in PBS. The bound and unbound
dyes were separated on a native gel and visualised using the 800 nm channel laser source (700 nm
channel was used for IR680RD). After scanning the first time, the gel was stained with instant blue
and imaged again with the 700 nm channel. Dyes with low protein binding (IR800CW and SulfoCy7),
show not detectable signals at the protein bands, whereas those with high protein binding show high
signals aligned with the BSA monomer (1), dimer (2), tetramer (3) and hexamer (4) [120].
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Absorptivity, Quantum Yield and Photoacoustic Properties
A summary of some of the optical properties of the dyes can be found in Table 2.2. In
general, the lowest absorption and quantum yield values are observed in buffer solutions
for all dyes. This is most likely due to the formation of self-quenching dye-dye aggregates
and the stabilisation of the more dipolar electronic excited state by ions, which decreases
the likelihood of emission [121, 118]. No significant difference was observed between
different ion contents (e.g. PBS vs. tris-buffered saline (TBS) vs. brine). However, attaching
sulfonate groups directly to the conjugated system (IR800CW, SulfoCy7) decreases the effect
of ions. The data also confirmed, that adding protein to the solution generally increases
the absorptivity (except ICG), sharpens the absorption peak, often leads to a slight red-shift
and enhances the quantum yield (Table 2.2). Overall, the most absorbing dye appears to
be IR800CW, while the least absorbing dye is IR680RD. This difference was expected on
the basis of the structure of their conjugated system. IR800CW and SulfoCy7 possess the
same backbone structure and thus - based on this feature alone - similar absorptivity would
have been expected. However, the higher absorptivity of IR800CW might be the result of the
rather symmetric chemical substitution in comparison to SulfoCy7 [122]. Also, the structure
of IR800CW comprises two extra sulfonate groups leading to different interactions with the
solvent. Integrating a 5-membered ring in comparison to a 6-membered ring results in a shift
of the absorption and emission maxima of around 25 nm.
The PA spectra obtained in the different solvents largely mirror the absorption spectra.
However, all dyes exhibited a slight broadening and a blue shift (up to 25 nm) of the spectra
compared to their absorption profile (Figure 2.5A). The exception was Cy7, for which
PA spectra exhibited a peak 25 nm red-shifted compared to its absorption maximum. The
broadening and shift was very minor for the sulfo-cyanine dyes, IR800CW and SulfoCy7. As
for the absorption spectra, the presence of proteins did increase the PA amplitude and often
sharpened the spectra (Figure 2.5B). Even though IR800CW and SulfoCy7 exhibit a strong
and sharp PA profile, photothermal stability studies suggested that the two sulfo-cyanine
dyes are the least photostable dyes among the examined dyes, whereas Cy7 showed nearly
no photobleaching over the tested time frame (Figure 2.5C). Improved photothermal stability
of asymmetric dyes, which was reported in the literature, was not found in our experiments
[82].
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Figure 2.5 Representative PA properties of some commercial available cyanine dyes.PA (solid line)
and absorption (dashed line) spectra in water of A) IR806 (5 µM) as example for a non-sulfonated
dye and B) IR800CW (5 µM) as example of a sulfonated dye. C) PA spectra of Cy7 (5 µM) in water
and FBS. D) Normalised PA amplitude at the PA maximum. D) Photostability of 5 µM dye solutions
in FBS under continuous laser exposure (9-ns excitation pulses at a 10-Hz repetition rate) for 20 min
at the same position. The normalised PA signal at the PA maximum of the dye is plotted against the
time. All PA measurements were performed in tissue mimicking phantoms.
Altogether, the high absorptivity combined with a low quantum yield and a strong, sharp
PA signature make IR800CW the best dye for photoacoustic imaging. However, the presence
of proteins did significantly improve the optical and photoacoustic characteristics for the
non-sulfonated cyanine dyes, making also Cy7 and Cy7.5 attractive candidates, especially
due to their good photothermal stability.
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Table 2.2 Summary of some properties of commercial available cyanine dyes
Dye Solvent λAbsmax λEmmax ε (105 ∆ε (105 φFlc ∆φFld Aggregate Protein
(nm) (nm) M-1cm-1) M-1cm-1)b formation bindinge
ICG H2O 710 819 0.721 0.062 0.060 0.007 med
H2O+FBS 794 819 0.257 0.054 0.173 0.014 low
PBS 776 818 0.380 0.018 0.027 0.001 high high
PBS+FBS 794 819 0.238 0.052 0.324 0.051 med
MeOH 784 819 0.0224 0.032 0.022 0.002 no
Cy7.5 H2O 727 -a 0.342 0.013 -a -a high
H2O+FBS 800 819 0.858 0.029 0.012 0.001 low
PBS 879 -a 0.197 0.012 -a -a high med
PBS+FBS 799 819 0.880 0.024 0.011 0.001 low
MeOH 784 819 1.752 0.084 0.014 0.001 no
Cy7 H2O 744 777 0.888 0.057 0.005 0.0006 low
H2O+FBS 764 790 2.035 0.024 0.014 0.0028 no
PBS 742 777 0.993 0.010 0.008 0.0006 low med
PBS+FBS 762 789 1.734 0.142 0.023 0.0037 no
MeOH 750 777 1.999 0.178 0.002 0.0002 no
SulfoCy7 H2O 750 777 1.381 0.030 0.005 0.001 no
H2O+FBS 750 783 1.527 0.013 0.007 0.001 no
PBS 750 777 1.060 0.023 0.006 0.001 no low
PBS+FBS 750 777 1.581 0.035 0.005 0.0004 no
EtOH 758 789 1.532 0.027 0.013 0.001 no
IR800CW H2O 774 805 2.714 0.112 0.026 0.004 no
H2O+FBS 777 808 3.072 0.374 0.013 0.003 no
PBS 774 799 1.151 0.032 0.026 0.003 no low
PBS+FBS 774 804 0.841 0.072 0.049 0.014 no
IR783 H2O 774 805 0.909 0.018 0.046 0.005 low
H2O+FBS 794 819 1.031 0.037 0.174 0.022 no
PBS 774 805 0.469 0.044 0.034 0.003 low high
PBS+FBS 794 819 0.910 0.020 0.145 0.014 no
MeOH 782 811 0.680 0.092 0.0002 0.00004 no
IR806 H2O 800 833 1.006 0.025 0.137 0.013 low high
H2O+FBS 792 834 0.825 0.027 0.185 0.034 med
MeOH 806 834 1.236 0.071 0.095 0.013 no
IR680RD H2O 670 702 0.614 0.022 0.003 0.0003 low
H2O+FBS 674 706 0.598 0.038 0.012 0.001 low
PBS 670 702 0.527 0.018 0.003 0.0003 low med
PBS+FBS 672 704 0.500 0.081 0.013 0.003 low
a no significant fluorescence was detected. b Error (SD) of ε
c ICG in PBS solution (φ (Fl) = 0.0270± 0.0011) was used as standard. The values were not
normalised with respect to the refractive index of the solvent as the non-normalised values are
sufficient for observing general trends among the dye solutions for the purpose of this study.
d Error (SD) of φ e Free to bound dye signal ratio: high:< 5, med: 5 - 100, low> 100.
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2.2.2 Experimental Linker Evaluation
The knowledge gained from examining the optical and photoacoustic properties of
commercially available dyes, lead to the decision to investigate the addition of a linker
structure towards H2O2 reactivity on a heptamethine cyanine frame with an integrated 6-
membered carbocyclic ring linking C3’ and C5’, terminal 1,1,2-trimethyl-1H-benzo[e]indol
units and symmetrical substituted nitrogens (Figure 2.6A, HCC). The choice to include the 6-
membered carbocyclic ring, even though it may increase the tendency for aggregate formation,
was founded on the improved physical properties and stability caused by this structural feature
[117]. Additionally, it provided an easily accessible site for chemical modifications and the
synthesis of this backbone was well described in the literature [123, 83, 124]. 1,1,2-trimethyl-
1H-benzo[e]indol was chosen above 2,3,3-trimethylindolenine due to the more red-shifted
absorption and PA maximum.
According to published procedures [123, 83, 124], the heptamethine carbocyanine dye
framework (HCC) was synthesised over three steps, as depicted in Figure 2.6A. Previous
findings, including density functional theory (DFT) calculations by J. Yin et al. [125] and by
our collaborator T.J. Zuehlsdorff (Figure 2.6B) indicate that the excitation is associated with
a redistribution of charge mainly towards the centre of the cyanine backbone. Hence, the
linker unit, responsible for the signal change, was integrated on the central hydrophobic core
of the π-system.
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Figure 2.6 A) Synthesis scheme of the heptamethine carbocyanine dye framework (HCC). Re-
agents and conditions: (a) POCl3, DMF. (b) 1,2-dichlorobenzene, 3-bromopropanoic acid. (c)
Butanol/Toluene, ∆T. B) Plot of the electron-hole density of the heptamethine carbocyanine frame-
work. Blue denotes the hole density while red denotes the electron density.
The vinylic chlorine of HCC is an attractive functionality for attaching further functional
groups to the dye backbone. Previous reports described efficient attachment of N-, O-, S-aryl
or piperazine derivatives while retaining their NIR absorptivity [125–127]. To investigate
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whether similar substituents are able to tune a signal change for PA imaging, different linker-
HCC derivatives were synthesised. To start with, 4-aminophenol, benzene-1,4-diamine
and piperazine were chosen as linker units to explore the impact of different electronic
and steric features on the optical properties. Efforts to synthesise HCC-derivatives with
benzene-1,4-diamine as linker unit were unfortunately not successful.
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Figure 2.7 Principle of the signal change of the activatable PA probe. In the presence of H2O2, the
H2O2 reactive group will get cleaved and the free linker-dye conjugate, bearing a free amine group,
will be released. As a consequence of this structural change, the optical properties of the probe will
change allowing the imaging based readout of the presence of H2O2.
In the final activatable H2O2 PA dye, a redox reactive group will be attached to the
linker via an amide bond at the para-position to the dye framework. After reaction with
the redox species this bond will be cleaved and the free linker-dye conjugate, bearing a
free amine group, will be released (Figure 2.7). This approach relies on the structural and
electronic effect of the amide bond and the attached group on the optical properties of the
dye framework. Therefore, for each linker the corresponding free linker-dye conjugate (free
amine group; uncapped dye, Figure 2.7), acetylated linker-dye conjugate (green triangle =
Ac) and bocylated linker-dye conjugate (green triangle = Boc) were synthesised to probe the
electronic and steric effects.
Synthesis of the Different HCC-Linker Derivatives
An overview of the structure and synthetic routes of the different HCC-linker derivatives
(JW7/8/11/13/14/16/17) is outlined in Figure 2.8. All reactions need to be performed under
exclusion of light and below 50 ◦C to avoid degradation. During the synthesis it was also
noticed that only the unmodified piperazine efficiently substitutes the chlorine; as soon as
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one nitrogen has been converted into an amide no further reaction occurred. Therefore, the
piperazine-nitrogen on JW8 was modified with substituents in a second step.
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Figure 2.8 Schematic overview of the synthesis of the different HCC-linker derivatives. Reagents
and conditions: (a) acetic anhydride, 4-aminophenol, H2O (47%). (b) HCC, 1-acetylpiperazine,
K2CO3, MeCN (33%). (c) Di-tert-butyl-dicarbonate, 4-aminophenol, THF (81%). (d) tert-Butyl
(4-hydroxyphenyl)carbamate, HCC, TEA, MeCN (94%). (e) JW11, TFA, DCM (82%). (f) HCC,
piperazine, TEA, MeCN (91%). (g) JW8, imidazole, acetylchloride, THF (68%). (h) JW8, tri-
methylacetyl chloride, TEA, THF (42%). (i) JW8, di-tert-butyl dicarbonate, TEA, THF (91%).
Optical Validation of HCC-Piperazine Derivatives
The absorption and fluorescence characteristics of the HCC-linker dyes were examined at
different concentrations (1 µM to 100 µM) and conditions (MeOH, EtOH, MeCN, MeOH : H2O,
H2O, PBS, sodium acetate buffer pH 4.30, ammonium carbonate buffer pH 10.45) to invest-
igate the impact of the environment, the different protonation states of the amino group and
aggregation trends. The influence of photoinduced electron transfer (PET) was also analysed
since the H2O2-reactive group is likely to be involved in PET [128]. This was performed
by adding different concentrations of triethylamine (TEA) and 4-dimethylaminopyridine
(DMAP). TEA and DMAP are known to be good electron donors to photoexcited chromo-
phores [129, 130]. During the intermolecular PET process, an electron from TEA/DMAP is
transferred to the dye molecule (acceptor) resulting in charge separation and quenching of the
fluorescence of the acceptor. Representative spectra of the dyes in the different solvents and
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concentrations can be found in the Appendix (Figure A.2). The absorption spectra showed
that all the dyes tend to aggregate in aqueous solutions, however, a clear spectra could be
obtained in organic solvents and for the uncapped derivatives also in MeOH : H2O mixtures.
The spectra recorded in organic solvents revealed that the three different 4-HCC-oxyaniline
dyes JW7, JW11 and JW13 possess identical absorption properties (Figure 2.9A). Thus, we
can conclude that 4-aminophenol is not suitable as linker for the purpose of this study since
no significant absorption shift is noticed between the different derivatives.
The recorded absorption spectra of the HCC-piperazine derivatives in organic solvents
showed a clear difference for the different nitrogen modifications. As shown in Figure 2.9, the
free amino derivative, JW8, exhibits an absorption maximum at 718 nm and a weak absorp-
tion shoulder close to 800 nm in MeOH. The acetylated derivative JW14 shows comparable
absorption maxima at around 740 nm and 800 nm whereas the bocylated derivative JW15
features one clear maximum close to 790 nm and an absorption shoulder at 730 nm. To ex-
amine whether the spectroscopic differences arise primarily from electronic or steric origins
a fourth HCC-piperazine derivative with a pivaloyl-functionalised amino group (JW16) was
synthesised. The recorded absorption spectrum shows similarities to the bocylated derivative
JW15 although further red-shifted (absorption peak at around 815 nm and shoulder at around
745 nm). For all the dyes, PET, experimentally introduced through the addition of TEA or
DMAP, did not impact the absorption properties.
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Figure 2.9 Absorption spectra of the different HCC-linker derivatives. Representative, normalised
absorption spectra of A) 4-HCC-oxyaniline dyes (10 µM) and B) HCC-piperazine dyes (10 µM) in
methanol.
Based on these results it was postulated that the electronic properties of the piperazine
substituent have a major impact on the absorption shift. Higher electron density on the
nitrogen atom leads to a more red-shifted absorption maximum (c.f. JW14/JW16 vs 15).
Steric effects seem to influence the intensity of the two absorption bands. The more sterically
demanding, the greater the difference between the capped and uncapped dye. These are
good properties for a ratiometric imaging approach. Therefore, multi-spectral photoacoustic
imaging (i.e. the acquisition of PA data at multiple wavelengths), allows image formation to
be based on the ratio of the signals obtained at two wavelengths or the application of spectral
unmixing methods. This allows correction of background signals, which do not experience
any shift in spectral signature, and artefacts e.g. due to photo-bleaching. Additionally, the
fluorescence spectra of JW8, JW14, JW15 and JW16 exhibited an emission peak around
820 nm for all four dyes, which is encouraging for dual imaging purposes (combining
fluorescence and PA imaging).
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Validation of Piperazine Linker in Aqueous Environment
Having established that the piperazine linker provides suitable spectral shift in organic
solvents, it was necessary to undertake the same study in water, to ensure the change would
still remain under physiological conditions. To achieve this, the water solubility of the dye
had to be increased without changing the backbone structure. First, the generation of an
HCC derivative bearing free carboxylic acids on the side chains was investigated (Figure
2.10). According to literature [124], this could be achieved by lowering the temperature
(105 ◦C instead of 120 ◦C) and shortening the reaction time (Figure 2.10A a)). However,
under these conditions only the esterified product has been generated. To avoid esterification,
the reaction was also carried out in neat toluene, but without success. Finally, the focus
was placed on obtaining the free diacid by ester hydrolysis of HCC and its derivatives with
t-BuONa [124] but the desired products were not synthesised.
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Figure 2.10 Schematic overview of the synthesis trials to modify the HCC-side chain. Reagents and
conditions: (a) n-BuOH/toluene or neat toluene, ∆T = 100-105 ◦C. (b) t-BuONa, THF. (c) propargyl
alcohol/toluene ∆T = 60-120 ◦C, ± catalyst (d) propargyl alcohol, catalyst, ± toluene.
A chemically convenient way to attach solubilizing (or later on targeting moieties) to
chemical scaffolds is click-chemistry. Therefore, the same reaction was performed with
propargyl alcohol instead of n-butanol in order to yield ester functionalities with a terminal
alkyne (Figure B). Variations in temperature (60 - 120 ◦C), reaction time (1.5 h - 48 h) and
addition of catalysts (tetrazole, imidazole) did not result in the desired product. Also,
alternative routes via transesterification of HCC did not succeed. Hence, the approach
was changed and two terminal alkyne groups were integrated on the side chains (Figure
46 Development of a new Activatable, Bifunctional Photoacoustic Probe
2.11). These were then used to attach two glucose units as highly hydrophilic solubilizing
units, resulting in JW35 and JW37 as uncapped and capped dye respectively. The synthesis
route is outlined in Figure 2.11. Shortly, N-alkylation of 1,1,2-trimethyl-1H-benzo[e]indole
with 4-bromo-1-butyne yielded in the quaternary indolenium salt IV. A double Vilsmeier-
Haak reaction followed by chlorination and nucleophilic substitutions with aniline afforded
intermediate V. The dye backbone VI was then obtained by a double aldol condensation
like reaction of IV and V. Subsequent substitution of the chloride by piperazine generates
intermediate VII, which then was modified with 1-azido-1-deoxy-β -D-glucopyranoside via
Cu(I)-catalysed azide-alkyne click chemistry reaction yielding in the uncapped dye JW35.
To synthesise the capped dye, JW37, the amine group of VII was first converted into the
corresponding pivaloyl amide using pivaloyl chloride. The resulting intermediate VIII
was then converted into JW37 by attaching D-glucopyranosyl residues via Cu(I)-catalysed
azide-alkyne click chemistry reaction.
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Figure 2.11 Schematic overview of the synthesis of the glucose modified HCC-piperazine derivatives,
JW35 and JW37. Reagents and conditions: (a) 4-Bromo-1-butyne, NaI, MeCN, reflux (55%). (b)
POCl3, DMF. (c) Aniline, EtOH (72%). (d) NaOAc, EtOH, reflux (42%). (e) Piperazine, Cs2CO3,
MeCN (85%). (f) 1-azido-1-deoxy-β -D-glucopyranoside, CuSO4, Na-ascorbate, t-BuOH, H2O
(51%). (g) Pivaloyl chloride, TEA, THF (62%). (h) 1-azido-1-deoxy-β -D-glucopyranoside, CuSO4,
Na-ascorbate, t-BuOH, H2O (48%).
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Both dye derivatives showed good water solubility and the absorption spectra in dif-
ferent solvents (H2O, MeOH : H2O, MeOH, EtOH, MeCN, DMSO, PBS, PBS+Glycerol,
PBS+polyethylene glycol (PEG)) proved the suitability of piperazine as linker unit (Figure
2.12). In water, the absorption maximum of both dyes appeared in the near-infrared region
with an offset of 65 nm. The capped dye, JW37, exhibits an absorption maximum at 730 nm
and a weak absorption shoulder close to 800 nm. In contrast, the uncapped derivative JW35
features one clear maximum close to 800 nm and no distinct shoulder (Figure 2.12). Al-
though, the absorption spectra of JW37 showed different shapes in different solvents, it was
promising that the two dyes were distinguishable in the tested solvents. The absorption shape
for both dyes were consistent over a range of dye-concentrations in all solvents, suggesting
that aggregation might not be the major cause for the different spectral shapes. As observed
before, ions lead to broadening of the spectra.
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Figure 2.12 Representative absorption spectra of JW35 (20µM) and JW37 (20µM) in A) H2O B)
MeOH and C) PBS + 12.5% Glycerol.
Integrated Linker
Whilst the absorption spectra of the capped and uncapped dye were well distinguishable
in water, testing in physiologically relevant buffers led to an increase in overlap in their
absorption spectra (Figure 2.12). Thus it was examined if integrating the linker directly
into the dye backbone might lead to a bigger difference between the capped and uncapped
dye. N. Karton-Lifshin et al. published a similar approach in which they integrated a
phenol ring at the position of the cyclohexene ring bridging C3’ and C5’ in the cyanine dye
backbone (Figure 2.13) [52]. This generates two positive charged nitrogens with the result of
a significantly different conjugation pattern. Deprotonation (or deprotection) of the phenol
gives a quinone derivative, which causes a significant change in the optical properties (Figure
2.13). Unfortunately, the published dye possess an absorption maximum below 600 nm
making it unsuitable for PAI in vivo .
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Figure 2.13 Chemical structure and concept behind the signal change of the published cyanine dye
with an integrated linker. Deprotection or deprotonantion (R2 = H) of the phenol leads to rearrangement
of the π-system generating a free fluorophore.
To introduce a bathochromic shift of the absorption maximum, a similar dye construct
was synthesised but using the corresponding benzo[e]indole derivative as a building block to
extend the conjugated system. Furthermore, alkyne functionalities were integrated, as before,
to then attach glucose as solubilising unit (or later other targeting structures). The synthesis
route is outlined in Figure 2.14A.
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Figure 2.14 A) Schematic outline of the synthesis route for JW44 and JW45. Reagents and conditions:
(a) Ac2O, NaOAc, 80 ◦C (55%). (b) β -D-Glucopyranosyl azide, CuSO4, Na-ascorbate, t-BuOH, H2O
(13%), on column hydrolysis yielded as well JW45 (13%). B) Absorption spectra of the capped dye,
JW44 (10 µM, yellow), and uncapped dye, JW45 (10 µM, magenta), in B) MeOH and C) H2O.
Optical characterisations of the capped (JW44) and uncapped (JW45) dye in different
solvents (MeOH,MeOH : H2O mixtures, H2O, PBS, PBS+10%FBS, FBS) showed that the
modifications moved the absorption peak by 30 nm towards the longer wavelength range and
that the spectra of the two dyes were clearly distinguishable in all tested solvents. However,
the absorption maxima were still below 700 nm in aqueous environment and the offset of
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the two maxima amounted to 25 nm, which is far less than the observed 65 nm for the
HCC-piperazine linker derivatives. Hence, this study confirmed that piperazine attached to
the HCC backbone features the most promising characteristics as linker unit.
2.2.3 Photophysical Calculations
To investigate the cause of the difference in the spectral shapes between the capped
and uncapped dye, computational calculations using density functional theory (DFT) were
performed.
Nitrogen Hybridisation States
Central to understanding the changes in spectral properties of the capped and uncapped
dyes is an understanding of the differences in the piperazine linker unit. The piperazine ring
can exist in chair, boat and twist-boat conformation. Earlier studies have shown that in a
similar dye molecule the unmodified piparazine ring exists in a classical chair conformation
with the N-H bond axial [125]. Modifications on the nitrogen could first influence the
orientation of the N-R residue and/or the hybridisation state of the nitrogen and hence the
ring conformation. This might cause different sterical interactions of the piperazine and the N-
R residue with the dye backbone, which could influence the optical properties. Additionally,
the nitrogen attached to the HCC framework might be able to interact with the conjugated
dye system. Thus, first the hybridisation state of the piperazinic nitrogens for the capped,
uncapped and protonated uncapped dye were examined. It should be pointed out that, atomic
electron hybridisation is not a property of a molecule as a whole, whose electronic structure
is better described by molecular orbitals that may extend over the entire molecule. As a
consequence, within a molecule, each atom can display a mixture of geometrical features
commonly associated to different hybridisation states. To compensate for this, the geometry
optimisation at the same level of theory was run on six reference cases, namely: pyrrolidine
(1), N-methylpyrrolidine (2), protonated pyrrolidine (3), protonated N-methylpyrrolidine
(4), pyrrole (5) and N-methylpyrrole (6). These molecules contain easily defined “sp3-like”
pyramidal nitrogens (1-4) and “sp2-like” planar nitrogens (5, 6). The geometrical features
that are being studied are (cf. Figure 2.15):
• δ : the improper dihedral angles defined by NA-Cring-Cring-R, where R can be either H or
the substituent. An entirely planar nitrogen will have all δ i = 0◦.
• θ : the improper dihedral angles defined by NB-Cring-Cring-CHCC (specific to the piperazine
moiety).
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• rC-NA: Bond length of the NA-Cring bond on the top part of the piperazine structure.
• rC-NB: Bond length of the NB-Cring bond on the bottom part of the piperazine structure
(attached to the HCC backbone; specific to the piperazine moiety).
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Figure 2.15 Schematic illustration of computational calculated geometrical features of the piperazine
linker unit. A) Definition of NA and NB and the accompanying N-C bonds. B) Illustration of the
improper dihedral angle.
The results are summarised in Table 2.3. In the uncapped dye, the top piperazine nitrogen
(NA) is as pyramidal (≈ sp3) as the reference pyrrolidine (δ = 28.9◦ comparable to 28.1◦).
Upon protonation the angle for the uncapped dye becomes slightly more pyramidal (30.1◦)
while such change was not observed for the reference compounds (protonating 1 to 3). The
enhanced sp3 character is also highlighted by the elongation of rN-C, which corresponds to
a fractionally lower bond order in NA-Cring. The nitrogen in the capped dye is much less
pyramidal than the unsubstituted one with an improper dihedral angle of δ = 5.9◦. The totally
sp3 reference (2) has 29.8◦, while the corresponding sp2 planar nitrogen, when substituted,
has δ = 2.8◦. Thus, the results indicate that substitution makes the nitrogen 89% planar.
This can be further observed by looking at rN-C. The bond length decreases only slightly
from the unsubstituted case, showing that the added π-contribution to the N-Cring-bond
is not significant. For both dyes, the dihedral angle θ of the bottom nitrogen (NB) was
assessed to be similar for the capped and uncapped dye and shows neither a planar nor fully
pyramidal geometry. This suggests that the nitrogen hybridisation is not the main reason for
the difference in the optical properties of the capped and uncapped dye.
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Table 2.3 Summary of the computational investigated geometrical properties of the piperazine linkage.
uncapped uncapped capped 1 2 3 4 5 6
dye a dye b dye
δ (◦) 28.9 30.1 5.9 28.1 29.8 28.2 28.8 0.0 2.8
θ (◦) 11.0 18.1 10.8
rC-NA (Å) 1.46 1.52 1.46 1.46 1.46 1.54 1.52 1.38 1.38
rC-NB (Å) 1.47 1.45 1.47
1 Computational calculations were performed on the optimised structure of the molecules in
gas phase.
2 Uncapped a referring to the unprotonated state of the uncapped dye, with the free amine
group; uncapped b to the protonated one version.
3 1-6 referring to the reference compounds: pyrrolidine (1), N-methylpyrrolidine (2), proton-
ated pyrrolidine (3), protonated N-methylpyrrolidine (4), pyrrole (5) and N-methylpyrrole (6).
HCC-Backbone Confirmation
The next approach was to assess the minimum-energy conformations of the capped and
uncapped dye through geometry optimisation in the gas phase using DFT. In particular, it
was of interest to investigate whether sterically demanding groups attached to the nitrogen
together with the different hybridisation of the nitrogen have an influence on the conformation
of the HCC backbone.
The results suggested a distinct difference in the conformation of the HCC-backbone
between the two dye derivatives: The two terminal benzoindole moieties in the capped
dye, JW41, are strongly twisted in respect to each other (74.0◦), whereas the uncapped
dye, JW35, has a twist of only 23.3◦ (Figure 2.16A, B). This twist-decrease of 50.7◦ going
from the capped to the uncapped dye results in an improved electron-delocalisation, which
causes the red-shift in the absorption spectra of JW35. To scrutinise if the non-planar
piperazine confirmation is the cause for this, the same calculations were performed with
the 4-HCC-oxyaniline dyes. These dyes bearing a planar aromatic linker, that can easily
align orthogonal to the HCC-backbone axis and thus minimise the steric interactions of the
nitrogen subsituents with the backbone. As clearly evident in Figure 2.16 C and D, in the
minimum-energy conformation, the axis of the aromatic linkers are orientated in an 90◦ angle
to the dye backbone axis, leave a nearly planar HCC backbone, no matter if the nitrogen
is capped or uncapped. This gives rise to the identical absorption for both derivatives, as
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Figure 2.16 Investigation of the effect of the different linker units on the conformation of the dye
backbone. The minimum-energy conformations of A) the capped-piperazine dye JW41 (see p. 57), B)
the uncapped-piperazine dye (JW35), C) the capped-oxyaniline dye (JW11) and D) the uncapped-
oxyaniline dye (JW13) were obtained through geometry optimisation in the gas phase using density
functional theory. To quantify the relative orientation of the two terminal polycyclic moieties, a
dihedral angle was defined as shown in the picture. (Calculations of the capped-piperazine dye (A)
were already performed with the aimed final contrast agent having a boronic ester attached.)
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demonstrated previously (Figure 2.9). In conclusion, computational calculations confirmed
that piperazine features promising characteristics as linker group.
2.2.4 Targeting and Dye Backbone Modification Trials
Having established a route to induce a spectral shift in the HCC framework, the next step
was to consider how to target the dye to a particular disease site of interest.
Cancer Targeting
The aim was to design a bifunctional, activatable probe, which is not only able to visualise
H2O2 generation in general, but is also specific in its read-out to a defined patho-physiological
condition. The ability of cancer cells to modify cellular ROS production is important in
malignant progression, therapy response and resistance. Combining the high temporal and
spatial resolution of PA imaging with a new cancer- and ROS species-specific probes poses a
promising approach to address the unmet need for elucidating the role of redox biology in
carcinogenesis, tumour progression and treatment response. By targeting the probe to cancer
cells, it is also possible to exploit the diversity in well studied, cancer targeting structures
and already characterised cancer mouse models in our laboratory that are well suited for PA
in vivo imaging [131].
The use of a simple one-step functionalisation via click chemistry (see 2.2.2) showed
promising results for its use to embed the targeting moiety: The attachment of the two
β -D-glucopyranoside groups via a short aliphatic spacer maintained the different optical
signatures of the capped and uncapped dyes (cf. JW8 vs JW35, JW16 vs JW37) and the
small, hydrophilic units did further support solubility of the probe. Additionally, targeting
of glycolysis with 2-deoxyglucose has been reported as a potential strategy for cancer
targeting in several studies using small molecules and NIR dyes [40, 132–134]. This targeting
approach exploits the increased demand of glucose in tumours, which is accompanied with
an over-expression of glucose transporters (GLUTs) [135, 136]. It should, however, be noted
that, targeting through 2-deoxyglucose is not exclusively specific for cancer cells and can
also lead to accumulation in inflammatory processes, as it was indicated in studies with
18F-fluorodeoxyglucose using positron emission tomography [137]. But as the temporal
accumulation profile in malignancy differs from that for inflammatory processes, it is possible
to study both simultaneously with dual- or multiple-time-point imaging strategies [137, 138].
Taking all this into account, and having already synthesised the uncapped derivative, JW35,
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β -D-glucopyranosyl azide was chosen as preliminary, clickable targeting structure to validate
the concept of the bifunctional contrast agent.
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Figure 2.17 Structure and optical properties of JW35 and JW35Mono in different environments. A)
Chemical structure of JW35Mono. Average absorption (n = 3, solid line) and fluorescence (n = 3,
dashed line) spectra of B) JW35 and JW35Mono (0.3 µM) in MeOH and EtOH : H2O and C) in water
(3 µM). Fluorescence spectra were recorded upon excitation at 785 nm.
Considering that the cellular uptake of 2-deoxyglucose-functionalised probes is based on
glucose transporters (GLUTs) [139], which mediate the cellular uptake of glucose and other
small molecules [140], it was tried to minimise the size of the new contrast agent by imple-
menting only one targeting unit instead of two. To investigate if one β -D-glucopyranosyl
group is sufficient to maintain water solubility and if an asymmetric dye structure does
influence the optical properties (decrease in molar absorptivity, see section 2.2.1), the pre-
viously described click reaction was performed with only 1 eq. of β -D-glucopyranosyl
azide to obtain JW35Mono (Figure 2.17) - the mono-functionalised derivative of JW35.
The absorption and fluorescence spectra of JW35Mono in pure organic solvent (MeOH)
as well as a solvent mixture with high proportion of organic solvent (ethanol:water (7:3))
did not show any significant difference to those of JW35 (Figure 2.17B,C) indicating that
the asymmetry does not influence the optical properties. However, the absorption as well
as fluorescence characteristics of JW35Mono in water reveals strong deviations (Figure
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2.17D) implying poor solubility in aqueous environment making this approach impractical
for biological applications. JW35 was therefore used for the remainder of the studies.
Dye Backbone Modifications
A main criterion that should be addressed by contrast agents for PA in vivo imaging is
that their photophysical properties should not be influenced by the physiological environment.
For example, the clinically approved cyanine dye, ICG, has been proposed and studied as
contrast agent in cancer imaging [141, 142]. However, the optical properties of ICG are
highly dependent on its environment, its solubility and stability in aqueous solutions is
limited (cf. section 2.2.1) and its strong plasma binding accompanied with rapid hepatic
clearance limit its tumour accumulation and restrict its in vivo application [143, 144]. To
overcome these disadvantages, it was aimed to further increase the hydrophilicity of the
probe, as it was shown to reduced plasma protein binding (cf. section 2.2.1). This should
facilitate the extravasation of the dye into the extracellular space and slow down the hepatic
clearance [144]. Another advantage of hydrophilic dyes is their reduced tendency to form
aggregates and enhanced photophysical stability in different environments (cf. section 2.2.1).
One common approach to improve the hydrophilic character of cyanine dyes is to integrate
sulfonate- or carboxyl-groups on the terminal indole moieties (e.g. SulfoCy7 vs Cy7, section
2.2.1) [144, 145]. Sulfonate groups were also shown to not strongly influence the wavelength
of the absorption and fluorescence peaks. However, most approaches are based on modifying
terminal trimethyl-3H-indole functionalities instead of benzo[e]indole analogue. Changing
the dye’s backbone towards the bicyclic structure would have been unfavorable: reducing
the number of aromatic rings causes a hypsochromic shift in the optical properties (cf. Cy7
vs Cy7.5 (section 2.2.1 and section 2.2.2) and the decreased size of the terminal polycyclic
functionality is likely to influence the capability of the piperazine linkage to generate a
significant signal change, which is based on steric and electronic interactions with the
terminal aromatic groups (cf. section 2.2.2). It was therefore aimed to use a sulfonated
2-methyl-1H-benzo[e]indole building block to generate a more hyrophilic dye backbone
[146, 147].
Different strategies based on sulfonation reactions of 2,3,3-trimethyl-3H-indole in patents
have been exploited to reach this aim. Attempts to do so are summarised in Figure 2.18.
In brief, even though some of the intermediates could be confirmed by mass spectrometry
analysis, most were highly viscous, poorly soluble and difficult to purify, which made it
challenging to ensure the formation of the correct compounds and to synthesise the complete
dye backbone based on these scaffolds. Thus this method was not further pursued. A future
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approach would be to synthesise the mono- or disulfonated building block starting from
6-amino-1,3-naphthalenedisulfonic acid [121].
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Figure 2.18 Schematic illustration of the unsuccessful attempts to generate sulfonated 1,1,2-trimethyl-
1H-benzo[e]indol derivatives.
2.2.5 Final Design, Synthesis and Photophysical Examination of the
new Activatable, Bifunctional PA Probe
Having found a suitable dye backbone, linker and targeting approach, it was next aimed
to integrate the H2O2-reactive group beyond the linker unit. In designing a chemoselective
H2O2-reactive PA imaging probe, the focus was placed on the well established oxidation-
immolation of an aryl boronate attached to a benzylic leaving group in para-position [30, 128].
The additional carbamate linkage increases the elimination kinetics upon oxidation to release
the uncapped dye bearing the free amine group.
Synthesis of the new Bifunctional, Activatable Probe
The synthesis route of the final bifunctional, activatable probe, JW41, is outlined in
Figure 2.19.
Shortly, intermediate VII (synthesised as described before, cf. Figure 2.11) was treated
with boronate X, generated by reaction of 4-nitrophenylchloroformate with 4-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol. The resulting intermediate XI was
then converted into JW41 by attaching D-glucopyranosyl residues via Cu(I)-catalysed azide-
alkyne click chemistry reaction.
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Figure 2.19 Schematic outline of the synthesis route for the final bifunctional, activatable probe,
JW41. Reagents and conditions: (a) 4-Nitrophenylchloroformate, Pyridine, DCM. (b) VII, DIPEA,
DMF (39%). (c) 1-Azido-1-deoxy-β -D-glucopyranoside, Cu(CH3CN)4PF6, TBTA, MeCN (33%).
XII JW41hydroXIhydro
N
N
N
N
O
O
B OH
HO
N
N
N
N N
N
N
N
N
O
HOHO
OH
HO
O
HOHO
OH
HO
N
O
O
B OH
HO
N
N
N
N
O
O
NO 2
BA C
Figure 2.20 Chemical structures of side products of XI and JW41. A) 4-nitrophenyl-piperazine
derivative XII B) hydrolysed boronic acid derivative, XIhydro of XI C) hydrolysed boronic acid
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It is worth mentioning that during the synthesis of intermediate XI the main product
was the corresponding 4-nitrophenyl-piperazine derivative XII (Figure 2.20A), which could
be isolated and characterised by HRMS and NMR. In addition, intermediate XI is prone
to hydrolysis forming XIhydro (Figure 2.20B) and degrades during purification by column
chromatography. Different columns for normal phase (silica, alumina) and reversed phase
chromatography as well as different solvents, including MeCN, THF, EtOH, MeOH, H2O
with the addition of either acetic acid (AcOH), formic acid (FA), trifluoroacetic acid (TFA)
or NH4OAc buffer adjusted to the higher buffering range of pH 5.7, have been tested.
Summarising the findings, none of the tested conditions were able to elute the XI from the
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column by normal phase silica chromatography; using neutral alumina as stationary phase
did allow the elution of the desired product, XI, but only by applying a steep gradient to
20% methanol causing co-elution with the 4-nitrophenyl by-product XII and the hydrolysed
product XIhydro. Using a longer gradient increased the retention time leading to further
hydrolysis and degradation. As methanol was found to promote hydrolysis, other solvents
were tested but none eluted the product XI from the neutral alumina column.
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Figure 2.21 Examples of purification trials for XI. A) and B) Representative chromatograms of condi-
tions which allowed early elution but suboptimal separation. C) and D) Representative chromatograms
of conditions which lead to too late elution of the product. E) Conditions which led to best purification
in respect of elution time and separation.
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The hydrolysis of boronic esters is acid catalysed transforming the ester (XI) into the
dihydroxy boronic acid, XIhydro. Under typical reverse phase HPLC conditions (aqueous
solvent A, organic solvent B e.g. MeCN, MeOH or THF), XI did not elute from the column
as a MeCN : water mobile phase was not strong enough to elute these highly lipophilic
analytes. Thus, a non-conventional reverse-phase mode was tested using a nearly water-free
mobile phase where two organic solvents (MeCN and THF) with different selectivities were
used for solvent A and solvent B with a C18 HPLC column. THF is a H-bond acceptor while
MeCN has a dipole. Arbitrarily, solvent A was MeCN while solvent B was THF. Using
this system without a modifier, no separation between XI, XII and XIhydro was achieved.
Only through the addition of 0.1% FA to both, solvent A and solvent B, some separation
was obtained with XIhydro, being the first to elute while XI being the most lipophilic and
thus most retained compound (Figure 2.21 A). As the separation of the product XI was
suboptimal (broad peak overlapping with XII), the pH of the mobile phase was increased to
reduce the hydrolysis of XI. Therefore, 10 mM NH4OAc at pH 5.7 was investigated as the
hydrolysis of XI should be reduced at higher pH. Using 1-5% of 10 mM NH4OAc (pH 5.7)
as a modifier for solvent A and B, some separation could be achieved depending on the start
and end ratio of solvent A to solvent B as well as the gradient rate (Figure 2.21B-E). The
chromatograms in Figure 2.21B,C and E illustrating the separation obtained with a MeCN
gradient, while Figure 2.21D shows a separation with a THF gradient. Both gradients led to
the elution order with XIhydro being first, closely followed by XII and much later the product
XI. The separations were found to be very sensitive to the gradient used and in all cases the
product XI eluted as a very broad peak. Although using MeCN + 1% 10 mM NH4OAc (pH
5.7) and THF + 1% 10 mM NH4OAc (pH 5.7) as solvents did enable a relatively fast elution
and good separation of intermediate XI (Figure 2.21E), this method could not be applied for
purification as the product degraded in THF as soon as MeCN evaporated. Thus, the best
compromise was the purification with neutral alumina and using impure XI in the next step.
Similarly to intermediate XI, the final probe, JW41, was prone to on-column hydro-
lysis resulting in the formation of JW41hydro (Figure 2.20C) and degradation into smal-
ler fragments. However, due to the increased hydrophilicity of JW41, fast elution with
good separation could be obtained by reversed phase HPLC with MeCN + 0.1% TFA and
H2O + 0.1% TFA (Figure 2.22A). The use of aqueous phase and the addition of the strong
acid TFA, is unfavourable, since both promote on-column hydrolysis and degradation. Unfor-
tunately, weaker acids (AcOH or FA) or buffers (NH4OAc buffer (pH 5.7)) and/or the use of
only organic solvent (MeCN and THF) systems were unable to wash the dye off the column
on a preparative HPLC system having an internal diameter of 1 inch, using flow rate of
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20 mL/min. Using smaller, analytical columns with an internal diameter of 4.6 mm permitted
less loading of the sample but faster chromatography resulting in reduced time of JW41 on
the column and in contact with the acidic mobile phase (Figure 2.22B). It also enabled the
use of FA as acid instead of TFA. Thus, although limiting the purification to small quantities
at a time, purification was carried out on an analytical column (internal diameter of 4.6 mm)
with MeCN 0.1% FA and H2O + 0.1% FA as solvents.
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Figure 2.22 Examples of purification approaches of JW41. A) Representative chromatogram of
purification on a preparative HPLC system. The UV signal at 600 nm is plotted. B) Representative
chromatogram of purification on a analytical HPLC system. The UV signal at 750 nm is monitored.
Photophysical Properties of the New Bifunctional, Activatable Probe
It is an essential requirement for the determination of H2O2-changes to precisely distin-
guish the capped (JW41) and uncapped (JW35) probe. Thus, to initially characterise the
efficacy of the new probe, the optical and photoacoustic properties of JW41 were assessed at
different concentrations and in different environments and compared to those of JW35. The
results obtained from absorption, fluorescence and PA spectroscopy suggest that the capped
and uncapped contrast agents are well distinguishable in aqueous environment with all three
modalities (Figure 2.23).
The absorption of JW41 and JW35 appears in the near-infrared region with peak absorp-
tion at 730 nm for JW41 and 795 nm for JW35, leading to an offset of 65 nm. It was shown to
be independent from the concentration (Appendix Figure A.5), which reinforces the assump-
tion that the effect is not aggregation-based. The emission maximum is located at ∼825 nm
for both forms, leading to a large Stokes shift of about 95 nm for JW41, which supports an in-
crease in signal to noise ratio for fluorescence imaging. Even though the capped and uncapped
dyes showing an emission maxima at around the same wavelength, the fluorescence intensity
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Figure 2.23 Optical and PA properties of the capped dye, JW41, and uncapped dye, JW35. Normalised
absorption (A), fluorescence (excitation at 740 nm) (B) and PA (C) spectra of JW41 and JW35 (10 µM
in H2O) are shown, illustrating the different Optical and PA properties of the capped and uncapped dye.
The absorption spectra are normalised to 100 % at the peak of JW35, the PA spectra are separately
normalised both to 100 % at their peak. D) Photothermal stability study of JW41 and JW35 with
IR800CW as reference (2.5 µM in FBS).
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of the uncapped dye (φFl(JW35,ex:740nm) = 0.01234± 0.00146) in aqueous environment in-
creased by over 100% relative to the one of the capped dye (φFl(JW41,ex:740nm) = 0.00626± 0.00086),
which can be reasoned by photon-induced electron transfer in the case of JW41. This
is mirrored by the total integrated emission intensity (brightness, B) of the capped dye
(B = 456.6) in water being half the brightness of the free dye (B = 950.95), with molar
extinction coefficients of εJW41(730nm) = 61400 M-1cm-1 and εJW35(790nm) = 77450 M-1cm-1
(Figure 2D). An overview of the optical properties of JW41 and JW35 in three different
environments is given in Table 2.4. The PA characteristics appeared similar to those obtained
by absorption spectroscopy (Figure 2.23C). The PA maxima of JW41 was located at 720 nm
and the PA maxima of JW35 at 800 nm, resulting in an off-set of 80 nm - a promising feature
for ratiometric measurements. Additionally, both dyes showed encouraging photothermal
stability for in vivo applications (Figure 2.23D) compared to IR800CW, the dye showing
the most promising results in previous studies (cf. section 2.2.1) and is already used in PA
imaging [148, 149].
Table 2.4 Photophysical properties of JW41 and JW35. These were obtained from bulk UV-vis
absorption and fluorescence measurements of the dyes.
Dye Solvent λAbs λEm λEm - λAbs εmax φ (Fl) B
(nm) (nm) (nm) (M-1cm-1) (a.u.)
JW41 H2O 730 826 96 61400 0.0063 456
MeOH 740 826 86 385150 0.0338 17393
EtOH:H2O 7:3 805 823 18 385150 0.0351 11313
JW35 H2O 790 822 32 77450 0.01234 951
MeOH 718 821 103 232300 0.0515 7635
EtOH:H2O 7:3 720 821 101 126200 0.0571 4010
Validation of Spectral Unmixing Feasibility
In order to get a precise read-out of the H2O2-production in vivo by the means of PA
tomography, it is essential that multispectral PA imaging is capable to accurately detect
and quantify the relative concentrations of the capped and uncapped dye if present simul-
taneously. For this purpose, different concentrations and mixtures of JW41 and JW35 in
tissue-mimicking phantoms were measured (Figure 2.24B). Subsequently, spectral unmixing
was performed to distinguish the probes from each other and the background and to calculate
the relative concentrations of the probes.
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Figure 2.24 Spectral unmixing study of JW41 and JW35 in tissue-mimicking phantoms. A) Schematic
graphic of experimental set up (left) and image of the tissue mimicking phantom (middle) with ROIs
used for analysis are illustrated. The normalised, offset corrected PA spectra, which form the
foundation for subsequent multispectra processing by linear regression, and the contrast-to-noise
ratio (n = 3) obtained in the tissue mimicking phantom are plotted. B) Phantom images containing
straws filled with different aqueous JW41-JW35 solutions are outlined in column 1 and 3, the results
obtained by linear regression in column 2 and 4 right to the associated phantom image. The weights
contributed by the JW41 and JW35 spectra to each straw signal are plotted relative to a reference
straw (1) containing 1 µM JW35. The relative accuracies for the different mixtures are: straw 2: -
3.4% (JW41), + 18.4% (JW35); straw 3: - 25.9% (JW41), - 15.4% (JW35); straw 4: + 2.5% (JW41), -
3.7% (JW35); straw 5: + 49.9% (JW41), +81.8% (JW35), 10.7% (JW41, JW35 in respect to mixture
ratio).
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Basis of the analysis were the PA spectra of JW41, JW35 and the background obtained
in a tissue mimicking phantom (Figure 2.24A), which were used for multispectra processing
by linear regression. The results are summarised in Table 2.5. The data obtained with
spectral unmixing showed a relative accuracy (% deviation from the known concentration)
between 2.5% and 25.9% for sample 1 to 4 in respect to reference straw 1 containing 1 µM
JW35. The relative accuracy of the mixture in test straw 5 (0.66 µM JW41 and 0.33 µM
JW35) in respect to the JW41-JW35 ratio was 10.7%, but above 45% when compared
to the reference straw with 1 µM JW35. This demonstrates one of the limitations of the
study. Even within the same imaging acquisition session, the absolute signal intensity varied
often between different slices and time points. The variations were more pronounced when
comparing the values obtained for the same dye solution from different imaging acquisition
sessions. Additionally, some signal-crossover is present, which can cause result in signal
misclassification. However, taking these considerations into account during the image
analysis process and normalising the values against the reference straw (1 µM JW35) present
in the same phantom (see 2.24, these findings illustrate the effective detection and separation
of the two dyes from each other in phantoms and the background with a preciseness suited to
detect changes in H2O2 under pathological conditions.
Table 2.5 Spectral unmixing studies of JW41 and JW35 in tissue-mimicking phantoms.
Concentration (%) PA signal (a.u.) PA signal (%)1
JW35 JW41 JW35 JW41 JW35 JW41
100 0 42.1± 9.3 4.0± 2.5 97 10
0 225 7.7± 4.1 90.9± 9.8 18 217
66.6 33.3 32.3± 5.6 14.1± 0.9 56 25
50 50 16.7± 1.9 17.7± 0.9 48 51
33.3 66.6 22.8± 1.5 37.5± 3.7 61 100
1 Normalised to reference straw with 1µM JW.
2.3 Summary and Conclusions
The aim described in this chapter was the development of an activatable, bifunctional
contrast agent for PA and fluorescence imaging.
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The optical and photoacoustical behaviour of different commercially available dyes have
been assessed in different environments to gain a better insight into how different structural
features influence those properties.
Thereafter, different linker-derivatives of a heptamethine carbocyanine (HCC) dye back-
bone were synthesised and evaluated. Piperazine was found to possess beneficial features as
linker unit: the piperazinyl-HCC derivatives imitating the capped probe showed, depending
on the sterical demand of the nitrogen substituent, different absorption profiles clearly distin-
guishable from the uncapped derivative. Computational calculations using density functional
theory have been applied to investigate the cause of the difference in the spectral shapes
between the capped and uncapped dye. These calculations suggest that the absorption change
is caused by a decreased twist in the relative orientation of the two terminal benzoindole
moieties going from the capped dye to the uncapped derivative.
Improved solubility and cancer targeting were achieved by conjugating two glucose
units to the side chains of the NIR dye via click-chemistry. Click-chemistry is a chemically
convenient way to conjugate biomolecules to chemical scaffolds and hence this linkage opens
the opportunity to easily exchange the glucose moieties with other targeting structures specific
for different molecular markers expressed by cancer or other pathological cells. Further
functionalisation of linker unit of the optimised dye structure with an aryl boronate attached
to a benzylic leaving group in para-position, resulted in the new activatable, bifunctional
contrast agent, JW41, promising for application in PA and fluorescence imaging. The use of
JW41 and its uncapped counter dye, JW35, in tissue-mimicking phantoms demonstrated
that the spectral unmixing of the obtained PA images can be achieved and allows the relative
quantification of the dyes concentration with accuracies between 2.5% and 25.9%. However,
truly quantitative PA measurements of the concentration of the dyes would require further
factors to be taken into account such as the light distribution over the total illuminated volume,
the generation of the photoacoustic signal as well as the influence of the dyes on the fluence.
Therefore, more complex phantoms and unmixing models should be considered. Additionally,
although phantom studies can only give a limited insight into the dye’s performance in vivo
and the molecular structure of the dye could perhaps be optimised to increase the difference in
their spectral shapes, the optical and photoacoustic properties of the new contrast agent in its
existing configuration seem sufficient for specific H2O2 imaging under biological conditions.
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2.4 Material and Methods
2.4.1 Chemical Synthesis
General Considerations
All reagents and materials used in the synthesis of the compounds described below were
bought from commercial sources, without prior purification. Solvents were either dried (THF
from LiAlH4/CaH2 with triphenylmethane as indicator; CH2Cl2, MeOH and ACN from
CaH2) and distilled in house or used as supplied.
Thin layer chromatography was carried out using with silica gel 60F (Merck) on glass
plates. Compounds were visualised by UV light (254 and 366 nm) or by using a vanillin or
basic potassium permanganate stain (3 g KMnO4, 20 g K2CO3, 2.5 mL 10 % aq. NaOH, in
400 mL deionised H2O) followed by heating. Flash chromatography was carried out either
on an automated system (Combiflash Rf+ or Combiflash Rf Lumen; UV detector was set
to a wavelength of 254 nm and 280 nm) using prepacked RediSep cartridges of silica or
alumina (pH = 7) or manually using silica gel high-purity grade (9385, Merck, pore size 60 Å,
230-400 mesh particle size) or C18-reversed phase silica gel (Merck 60757, pore size 90 Å,
230-400 mesh particle size). LCMS analysis of samples was performed on different systems:
a) A 3000 LC system connected to a Bruker amaZon X Ion Trap mass spectrometer
using 0.1 % formic acid in water and acetonitrile as mobile phase and a Kinetex C18 column
(Phenomenex, 50 x 2.1 mm, 2.6 µm). Water + 0.1 % formic acid (solvent A) and acetonitrile
+ 0.1 % formic acid (solvent B) were used as mobile phase. The gradient was adopted to the
compounds.
b) Waters Acquity H-class UPLC coupled with a single quadrupole Waters SQD2 and
a ACQUITY UPLC CSH C18 column (130 Å, 1.7 µm, 2.1 mm x 50 mm). The conditions
of the UPLC method are as follows: Solvent A: Water + 0.1 % Formic acid; Solvent B:
Acetonitrile + 0.1 % Formic acid; Gradient of 0-2 minutes 5 % - 100 %B + 1 minute 100 %
B with re-equilibration time of 2 minutes. Flow rate: 0.6 mL/min; Column temperature of
40 ◦C; Injection volume of 2 µL. The signal was monitored at 254 nm, 280 nm and 680 nm.
c) A modular Agilent 1200 Series HPLC system connected to an Agilent/Bruker ionTrap
model XCT with MSMS capabilities. Agilent XDB C18 Column (1.8 µm, 4.6 mm x 50 mm)
was used as the UPLC column. The conditions of the UPLC method are as follows: Solvent
A: Water +0.1 % Formic acid; Solvent B: Acetonitrile +0.1 % Formic acid; Gradients: 0-1.3
minutes 5 % B; 1.3-5 minutes 5-60 % B, 5-6 minutes 60-100 % B, 6-8 minutes 100 % B with
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re-equilibration time of 3 minutes. Flow rate: 0.9 ml/min; Column and injector temperature
set to 25 ◦C. The signal was monitored at 254 nm and 750 nm with 360 nm as reference
wavelength.
High performance liquid chromatography (HPLC) was performed either on a Varian
ProStar system or an or an Agilent HP-1100 preparative HPLC system equipped with a Varian
Pursuit C18 column (3 µm, C18, 100 Å, 250 x 30 mm) or a Kinetex AXIA packed HPLC
column (5 µm, C18, 100 Å, , 250 x 21.2 mm). The UV detector was set to a wavelength
of 214 nm and/or 680 nm. As eluants, mixtures of acetonitrile (MeCN) (HPLC-grade) and
millipore H2O with addition of different acids (stated in the synthesis procedure) were used.
NMR spectra were recorded on a Bruker DRX-400 (400 MHz), Bruker DPX-400 (400 MHz)
and Bruker AVANCE III HD (500 MHz, DUL13C/1H) at room temperature using deuter-
ated solvents. Calibration of the spectra was achieved using the solvent signals [150]. All
chemical shifts (δ ) are quoted in ppm and coupling constants given in Hz. Splitting patterns
are given as follows: s (singlet), bs (broad singlet), d (doublet), t (triplet), q (quadruplet), m
(multiplet).
An overview of the synthetic routes of the different linker derivatives, the different at-
tempts to synthesise sulfonated building blocks as well as of JW35, JW37 and JW41 is
outlined in Results and Discussion of this chapter (section2.2).
Intermediates I (2-Chloro-1-formyl-3-(hydroxymethylene)cyclohex-1-ene) [83], II (1-
Hydroxycarbonylethyl-2,3,3-trimethylbenzoindoleninium bromide) [124], the heptamethine
carbocyanine dye framework III (HCC) [124], N-(4-hydroxyphenyl)acetamide [151], V
(N-[5-anilino-3-chloro-2,4-(propane-1,3-diyl)-2,4- pentadiene-1-ylidene]anilinium chloride)
[152] were synthesised according to literature procedure, the analytical data correspon-
ded. 3-(but-3-yn-1-yl)-2-((E)-2-((E)-3-((E)-2-(3-(but-3-yn-1-yl)-1,1-dimethyl-1,3-dihydro-
2H-benzo[e]indol-2-ylidene)ethylidene)-2-chlorocyclohex-1-en-1-yl)vinyl)-1,1-dimethyl-1H-
benzo[e]indol-3-ium VI was synthesised based on a previous described procedure [62].
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Synthesis of 4-HCC-Oxyaniline Derivatives
Synthesis of JW7
COOnBu
N
O
N
HN
O
COOnBu
To a solution of HCC (50 mg, 0.056 mmol) in dry MeCN (0.6 mL), N-(4-hydroxyphenyl)-
acetamide IV (11.2 mg, 0.074 mmol) and K2CO3 (12 mg, 0.087 mmol) were added and
stirred at room temperature for 48 h. The insoluble K2CO3 was removed by filtration and the
filtrate concentrated in vacuo to give a dark red solid. The crude product was purified by flash
column chromatography (0 - 5 % MeOH in DCM) to yield JW7 as green solid (19.52 mg,
0.018 mmol, 32 %).
Rf: 0.49 (DCM : MeOH 10 : 1)
HRMS: m/z calculated for [M+] = 926.5103, found m/z = 926.5070.
1H-NMR: (400 MHz, CDCl3) δ [ppm] = 10.29 (s, 1H), 8.14 - 8.06 (m, 6H), 7.89 (d,
JH,H = 9.2 Hz, 6H), 7.64 (t, JH,H = 7.6 Hz, 2H), 7.46 (t, JH,H = 7.5 Hz, 2H), 7.35 (d, JH,H = 8.8 Hz,
2H), 6.98 (d, JH,H = 9.1 Hz, 2H), 6.04 (d, JH,H = 14.2 Hz, 2H), 4.43 (t, JH,H = 7.0 Hz, 4H),
4.06 (m, 4H), 2.85 (t, JH,H = 7.0 Hz, 4H), 2.71 (t, JH,H = 6.3 Hz, 4H), 2.29 (s, 3H), 2.17 - 1.25
(20 H), 0.85 (t, JH,H = 7.4 Hz, 6H).
tert-Butyl (4-hydroxyphenyl)carbamate
This compound is known and fully characterised (Ref.[153])
NH
OH
O
O
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To a solution of 4-aminophenol (296 mg, 2.71 mmol) in dry THF (4 mL), di-tert-butyl-
dicarbonate (591.5 mg, 2.71 mmol) was added over 20 min. The reaction mixture was stirred
at room temperature for 2 h. After the solvent was concentrated in vacuo, the residue was
dissolved in ethyl acetate and washed with aqueous NaHCO3. The organic layers were
washed with brine and dried over MgSO4. The solvent was removed in vacuo and tert-butyl
(4-hydroxyphenyl)carbamate was achieved as white solid (459 mg, 2.2 mmol, 81 %).
MS: m/z calculated for [M] = 209.1052, found m/z = 209.2511.
1H-NMR: (400 MHz, CD3CN) δ [ppm] = 7.20 (d, JH,H = 8.8 Hz, 2H), 6.72 (d, JH,H = 8.9 Hz,
2H), 1.46 (s, 9H).
Synthesis of JW11
COOnBu
N
O
N
HN
O
O
COOnBu
To a solution of HCC (50 mg, 0.056 mmol) in dry ACN (3 mL), 4-hydroxyphenyl)carbamate
III (17 mg, 0.081 mmol) and TEA (44.3 mg, 0.44 mmol) were added and stirred at room
temperature for 36 h. The solvent was removed in vacuo and the crude product was purified
by flash column chromatography (0 - 5 % MeOH in DCM) to yield the desired product JW11
as green solid (56.63 mg, 0.053 mmol, 95 %).
Rf-value: 0.51 (DCM : MeOH 10 : 1)
HRMS: m/z calculated for [M+] = 984.5521, found m/z = 984.5494.
1H-NMR: (400 MHz, CDCl3) δ [ppm] = 8.04 - 8.01 (m, 4H), 7.90 (d, JH,H = 8.6 Hz, 4H),
7.57 (ddd,JH,H = 8.4, 6.8, 1.3 Hz, 2H), 7.54 - 7.47 (m, 4H), 7.05 (d, JH,H = 9.1 Hz, 2H),
6.23 (d, JH,H = 14.2 Hz, 2H), 4.62 (t, JH,H = 6.7 Hz, 4H), 4.02 (t, JH,H = 6.8 Hz 4H), 2.94 (t,
JH,H = 6.6 Hz, 4H), 2.80 (t, JH,H = 6.1 Hz, 4H), 2.07 (t, JH,H = 6.0 Hz, 2H), 1.66 (s, 12H), 1.50
(s, 9H), 1.54-1.47 (m, 4H), 1.31 - 1.22 (m, 6H), 0.83 (t, JH,H = 7.4 Hz, 6H).
70 Development of a new Activatable, Bifunctional Photoacoustic Probe
Synthesis of JW13
N
O
N
H2N
COOnBu
COOnBu
To a solution of JW11 (41 mg, 0.038 mmol) in dry DCM (3 mL), TFA (65 µL, 0.85 mmol)
was added and stirred at room temperature for 36 h. The solvent was removed in vacuo and
the crude product was purified by flash column chromatography (0 - 10 % MeOH in DCM)
to yield the desired product JW13 as green solid (30.42 mg, 0.032 mmol, 83 %).
Rf: 0.39 (DCM : MeOH 10 : 1)
HRMS: m/z calculated for [M+] = 884.5002, found m/z = 884.4984.
1H-NMR: (400 MHz, CDCl3) δ [ppm] = 8.05 - 8.02 (m, 4H), 7.90 (d, JH,H = 8.6 Hz, 4H),
7.56 (ddd, JH,H = 8.4, 6.8, 1.3 Hz, 2H), 7.49 - 7.41 (m, 4H), 6.94 (d, JH,H = 8.7 Hz, 2H), 6.83
(d, JH,H = 8.5 Hz, 2H), 6.20 (d, JH,H = 14.2 Hz, 2H), 5.30 (s, 1H), 4.59 (t, JH,H = 6.7 Hz, 4H),
4.03 (t, JH,H = 6.7 Hz 4H), 2.93 (t, JH,H = 6.6 Hz, 4H,), 2.77 (t, JH,H = 6.1 Hz, 4H), 1.68 (s,
12H), 1.54 - 1.47 (m, 4H), 1.30 - 1.24 (m, 6H), 0.84 (t, JH,H = 7.4 Hz, 6H).
Synthesis of HCC-piperazine derivatives
Synthesis of JW8
N
N
N
HN
COOnBu
COOnBu
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To a solution of HCC (50 mg, 0.056 mmol) in dry ACN (3 mL), piperazine (21.2 mg,
0.24 mmol) and TEA (44.3 mg, 0.44 mmol) were added and stirred at room temperature for
20 h. The solvent was removed in vacuo and the crude product was purified by flash column
chromatography (0 - 20 % MeOH in DCM with addition of 0.1 % TEA) to yield the desired
product JW8 as green solid (48 mg, 0.051 mmol, 91 %). For absorption and fluorescence
measurements, HPLC purification was performed (aqueous ACN addition of 0.1 % TFA:
0-100 % in 30 min).
Rf: 0.44 (DCM : MeOH 10 : 1 with addition of 0.1 % TEA)
HRMS: m/z calculated for [M+] = 861.5319, found m/z = 861.5305.
1H-NMR: (400 MHz, CDCl3) δ [ppm] = 8.15 (d, JH,H = 7.6 Hz, 2H), 7.89 - 7.85 (m, 4H),
7.77 (d, JH,H = 14.3 Hz, 2H), 7.59 (ddd, JH,H = 8.4, 6.9, 1.3 Hz, 2H), 7.41 (ddd, JH,H = 8.3, 6.9,
0.8 Hz, 2H), 7.30 (d, JH,H = 10.9 Hz, 2H), 5.81 (d, JH,H = 12.9 Hz, 2H), 4.37 (t, JH,H = 6.8 Hz,
4H), 4.20 (bs, 4H), 4.07 (t, JH,H = 6.7 Hz 4H), 3.35 (bs, 4H), 2.84 (t, JH,H = 6.9 Hz, 4H), 2.53
(t, JH,H = 6.6 Hz, 4H), 2.02 (s, 12H), 1.90 - 1.87 (m, 2H), 1.57 - 1.50 (m, 4H), 1.33 - 1.28 (m,
4H), 0.85 (t, JH,H = 7.4 Hz, 6H).
Synthesis of JW14
N
N
N
N
O
COOnBu
COOnBu
To a solution of JW8 (10 mg, 0.011 mmol) in dry THF (3 mL), imidazol (1.5 mg, 0.022 mmol)
and acetylchloride (1.5 µL, 0.021 mmol) were added and stirred at room temperature for
16 h. The solvent was removed in vacuo and the crude product was purified by flash column
chromatography (0 - 10 % MeOH in DCM) to yield the desired product JW14 as blue solid
(7.33 mg, 0.0075 mmol, 68 %).
HRMS: m/z calculated for [M+] = 903.5424, found m/z = 903.5411.
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1H-NMR: (400 MHz, CDCl3) δ [ppm] = 8.10 (d, JH,H = 8.5 Hz, 2H), 7.92 - 7.89 (m, 4H),
7.85 (d, JH,H = 13.5 Hz, 2H), 7.59 (ddd, JH,H = 8.4, 6.9, 1.3 Hz, 2H), 7.46 - 7.39 (m,4H), 6.03
(d, JH,H = 13.5 Hz, 2H), 4.50 (t, JH,H = 6.9 Hz, 4H), 4.06 (t, JH,H = 6.7 Hz, 4H), 3.97 - 3.93
(m, 4H), 3.88 - 3.86 (m, 2H), 2.91 (t, JH,H = 6.8 Hz, 4H), 2.60 (t, JH,H = 6.4 Hz, 4H), 2.34
(s, 3H), 1.98 (s, 12H), 1.93 - 1.86 (m, 2H), 1.57 - 1.50 (m, 4H), 1.32 - 1.25 (m, 4H), 0.85 (t,
JH,H = 7.4 Hz, 6H).
Synthesis of JW15
COOnBu
N
N
N
N
O
O
COOnBu
To a solution of JW8 (30 mg, 0.032 mmol) in dry THF (3 mL), di-tert-butyl dicarbonate
(9.5 mg, 0.044 mmol) and TEA (20 µL, 0.14 mmol) were added and stirred at room temperat-
ure for 15 h. The solvent was removed in vacuo and the crude product was purified by flash
column chromatography (0 - 20 % MeOH in DCM) to yield the desired product JW15 as
blue solid (14.06 mg, 0.013 mmol, 42 %).
HRMS: m/z calculated for [M+] = 961.58, found m/z = 961.5811.
1H-NMR: (300 MHz, CDCl3) The peak intensities of the obtained spectrum was too weak
why accurate data analysis could not be performed.
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Synthesis of JW16
N
N
N
N
O
COOnBu
COOnBu
To a solution of JW8 (30 mg, 0.032 mmol) in dry THF (3 mL), TEA (1.5 µL, 0.021 mmol)
was added and the solution was cooled down to 0 ◦C. Then, a solution of trimtheylacteyl
chloride (1 µL, 0.089 mmol) in 500 µL THF was added and the reaction mixture was stirred
at room temperature for 19 h. The solvent was removed in vacuo and the crude product was
purified by flash column chromatography (0 - 15 % MeOH in DCM with addition of 0.1 %
TEA) to yield the desired product JW16 as green solid (30 mg, 0.029 mmol, 91 %).
MS: m/z calculated for [M+] = 945.5894, found m/z = 945.5881.
1H-NMR: (400 MHz, CDCl3) δ [ppm] = 8.09 (d, JH,H = 8.4 Hz, 2H), 7.92 (m, 4H)), 7.85
(d,JH,H = 13.5 Hz, 2H), 7.68 - 7.63 (m, 2H), 7.58 (ddd, JH,H = 8.5, 6.8, 1.3 Hz, 2H), 7.45 - 7.41
(m, 2H), 6.08 (d, JH,H = 13.5 Hz, 2H), 4.51 (t, JH,H = 6.8 Hz, 4H), 4.04 (t, JH,H = 6.8 Hz, 4H),
4.02 - 3.99(m, 4H), 3.76 - 3.72 (m, 4H), 2.91 (t, JH,H = 6.8 Hz, 4H), 2.61 (t, JH,H = 6.5 Hz, 4H),
1.97 (s, 12H), 1.54 - 1.47 (m, 8H), 1.40 (s, 9H), 1.25 (m, 4H), 0.84 (t, JH,H = 7.4 Hz, 6H).
Synthesis of Quinone-Cyanine dyes JW44 and JW45
Synthesis of IX
N
N
O
O
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Intermediate IV (182 mg, 0.70 mmol), 5-formylsalicylaldehyde (50 mg, 0.33 mmol) and
NaOAc (84 mg, 1 mmol) were dissolved in Ac2O (2 mL) and stirred for 2 h at 80 ◦C. The
solvent was removed in vacuo and the crude product was purified by flash column chromato-
graphy (0 - 20 % MeOH in DCM) to yield the desired product IX as blue solid (122.6 mg,
0.18 mmol, 55%).
Rf = 0.2 (MeOH : DCM 1 : 10).
HRMS: m/z calculated for [M] = 679.33, found m/z = 679.3331.
Synthesis of JW44 and JW45
N
N
O
O
N N
N
O
HOHO
OH
HO
N
N
N
O
HOHO
OHHO N
N
O
N N
N
O
HOHO
OH
HO
N
N
N
O
HOHO
OHHO
JW44 JW45
To a mixture of IX (21 mg, 0.031 mmol), β -D-Glucopyranosyl azide (17.5 mg, 0.09 mmol)
and CuSO4 (5 mg, 0.031 mmol) in t-BuOH:H2O (1:1, 3 mL), Na-ascorbate (10 mg, 0.05 mmol)
was added and the resulting reaction mixture was stirred at room temperature for 3 h. The
solvent was reduced in vacuo and the crude product was purified with reverse-phase HPLC
(Kinetex, 5 µm, C18, 100 Å, AXIA packed HPLC column, 250 x 21.2 mm) using H2O +
0.1% formic acid and MeCN + 0.1% formic acid as solvents. JW44 as well as the uncapped
derivative, JW45, were obtained as blue solids (JW44: 4.5 mg, 0.004 mmol, 13%; JW45:
4.2 mg, 0.004 mmol, 13%). The obtain amount of product was too little to perform accurate
analysis with these compounds.
HRMS (JW44): m/z calculated for [M] = 1090.48, found m/z = 1090.4820.
HRMS (JW45): m/z calculated for [M] = 1047.46, found m/z = 1047.4619.
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Synthesis Attempts of Sulfonated Building Blocks
3-(But-3-yn-1-yl)-1,1,2-trimethyl-1H-benzo[e]indol-3-ium-6-sulfonate
N
O3S
Method a: 3-(but-3-yn-1-yl)-1,1,2-trimethyl-1H-benzo[e]indol-3-ium (168 mg, 0.64 mmol)
was dissolved in 5 mL nitrobenzene and cooled down to 0 ◦C. Concentrated sulfuric acid
(70 mg, 0.71 mmol) was slowly added and the reaction mixture was kept at 0 ◦C for further
30 min. Afterwards, the reaction was stirred for 24 h at room temperature followed by 20 h at
100 ◦C. No formation of product was observed under this conditions.
Method b: To solid 3-(but-3-yn-1-yl)-1,1,2-trimethyl-1H-benzo[e]indol-3-ium (168 mg,
0.64 mmol) was added oleum (30%, 270 µL, 1.5 mmol) at 0 ◦C. The reaction mixture was
stirred at room temperature for 12 h and further 8 h at 60 ◦C. No product formation was
observed under this conditions.
Method c: 3-(but-3-yn-1-yl)-1,1,2-trimethyl-1H-benzo[e]indol-3-ium (435 mg, 1.7 mmol)
was dissolved in 2.5 mL nitrobenzene and cooled down to 0 ◦C. Oleum (65%, 0.4 mL) was
slowly added and the reaction mixture was kept at 0 ◦C till no further fume formation was
observed. The reaction was then brought to room temperature and stirred for additional 12 h.
No product formation was observed under this conditions.
1,1,2-Trimethyl-1H-benzo[e]indol-3-ium-6-sulfonate
N
H
O3S
Method a: 1,1,2-trimethyl-1H-benzo[e]indole (500 mg, 2.5 mmol) was dissolved in 2.5 mL
nitrobenzene and cooled down to 0 ◦C. Concentrated sulfuric acid (294 mg, 3 mmol) was
slowly added and the reaction mixture was kept at 0 ◦C for further 30 min. Afterwards, the
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reaction was stirred for 24 h at room temperature followed by 20 h at 100 ◦C. No formation
of product was observed under this conditions.
Method b: To solid 1,1,2-trimethyl-1H-benzo[e]indole (500 mg, 2.5 mmol) was added oleum
(30%, 540 µL, 3 mmol) at 0 ◦C. The reaction mixture was stirred at room temperature for
12 hours and further 8 hours at 60 ◦C. No product formation was observed under this condi-
tions.
Method c: 1,1,2-trimethyl-1H-benzo[e]indole (700 mg, 3.3 mmol) was dissolved in 3.5 mL
nitrobenzene and cooled down to 0 ◦C. Oleum (65%, 0.7 mL, 5.3 mmol) was slowly added
and the reaction mixture was kept at 0 ◦C till no further fume formation was observed. The
reaction was then brought to room temperature and stirred for additional 12 h. Distillation
using a Kugelrohr apparatus under reduced pressure yielded in a brown, highly viscous oil,
which was purified by reverse-phase chromatography using H2O and MeCN + 0.1% formic
acid. The crude product was used in the next step without further purification.
Rf = 0.1 (MeOH : DCM 2 : 10). MS: m/z calculated for [M+] = 290.08, found m/z = 290.12.
3-(but-3-yn-1-yl)-1,1,2-trimethyl-1H-benzo[e]indol-3-ium-6-sulfonate
N
O3S
Method a: Crude 1,1,2-trimethyl-1H-benzo[e]indol-3-ium-6-sulfonate (500 mg,∼ 1.7 mmol)
and K2CO3 (553 mg, 4 mmol) were dissolved in dry DMF (2 mL) under argon. 4-Bromo-1-
butyne (368 mg, 2.8 mmol) was added and the reaction mixture was stirred at 95 ◦C for 8 h.
No product formation was observed under this conditions.
Method c: Crude 1,1,2-trimethyl-1H-benzo[e]indol-3-ium-6-sulfonate (500 mg,∼ 1.7 mmol)
and 4-Bromo-1-butyne (368 mg, 2.8 mmol) were heated at 95 ◦C for 6 h under argon. The
reaction mixture was cooled down to room temperature and 15 mL Et2O was added. After
stirring for 20 min at room temperature the suspension was further cool down to 4 ◦C, filtered
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and washed three times with ice cold Et2O. No product was isolated.
Method c: Crude 1,1,2-trimethyl-1H-benzo[e]indol-3-ium-6-sulfonate (500 mg,∼ 1.7 mmol)
was dissolved in dry DMF and 4-Bromo-1-butyne (368 mg, 2.8 mmol) was added. The reac-
tion mixture was heated at 95 ◦C for 3.5 h under argon. KI (644 mg, 4 mmol) was added and
the reaction was stirred at 95 ◦C for further 3 h. Reaction monitoring with LCMS and TLC
indicated product as well as byprodcut formation, thus the reaction was stopped and purified
by reverse-phase chromatography using H2O and MeCN + 0.1% formic acid. Even though,
different buffers and acids have been used to try to elute the product from the column, no
product was isolated.
3-(2-carboxyethyl)-1,1,2-trimethyl-1H-benzo[e]indol-3-ium-6-sulfonate
N
COOH
O3S
3-(2-carboxyethyl)-1,1,2-trimethyl-1H-benzo[e]indol-3-ium (100 mg, 0.35 mmol) was
dissolved in 1.5 mL nitrobenzene and cooled down to 0 ◦C. Oleum (65%, 0.137 mg,
0.53 mmol) was slowly added and the reaction mixture was kept at 0 ◦C till no further
fume formation was observed. The reaction was then brought to room temperature and
stirred for 3 days. 5 mL water was added and the aqueous phase was washed four times with
EtO 2. Water was removed by lyophilisation. The crude product was used in the next step
without further purification.
MS: m/z calculated for [M] = 361.10, found m/z = 361.82.
1,1,2-trimethyl-3-(3-oxo-3-(prop-2-yn-1-ylamino)propyl)-1H-benzo[e]indol-3-ium-
6-sulfonate
N
O3S
O NH
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Method a: Ghosez’s reagent (25.2 mg, 0.19 mmol) in dry DCM/THF (0.8 mL, 3/1) was ad-
ded to crude 3-(2-carboxyethyl)-1,1,2-trimethyl-1H-benzo[e]indol-3-ium-6-sulfonate (31 mg,
0.09 mmol). The mixture was stirred for 30 min at room temperature before cooling down
to 0 ◦C. TEA (19.2 mg, 0.19 mmol) was added at 0 ◦C and the reaction was then stirred at
room temperature for 1 h. Propagylamine (10 mg, 0.18 mmol) in 0.5 mL DCM : THF (3 : 1)
was added and the reaction mixture was stirred at room temperature for 2 days. No product
formation was observed under this conditions.
Method b: Crude 3-(2-carboxyethyl)-1,1,2-trimethyl-1H-benzo[e]indol-3-ium-6-sulfonate
(100 mg, ∼ 0.27 mmol) was dissolved in 1 mL dry DMF under argon atmosphere. HBTU
(102 mg, 0.27 mmol) and HOBt (41 mg, 0.27 mmol), dissolved in 1 mL dry DMF were
added, followed by DIC (34 mg, 0.27 mmol). After 10 min, the mixture was cooled down
to 0 ◦C, propagylamine (15 mg, 0.27 mmol) was added and the reaction was stirred at room
temperature for 1.5 days. The reaction mixture was extracted with water and DCM. No
product could be isolated.
MS: m/z calculated for [M] = 398.13, found m/z = 398.95.
Method c: Crude 3-(2-carboxyethyl)-1,1,2-trimethyl-1H-benzo[e]indol-3-ium-6-sulfonate
(500 mg,∼ 1.38 mmol) and DMAP (17 mg, 0.14 mmol) were dissolved in 4 mL dry THF/DMF
(1/1) under argon atmosphere. DIC (174 mg, 1.38 mmol) was added and the reaction mixture
was cooled down to 0 ◦C. Propagylamine (114 mg, 2.1 mmol) was added and the reaction
was stirred for 1 day at room temperature. The solvent was reduced under reduced pressure
and the residue was extracted with water and DCM. No product could be isolated.
MS: m/z calculated for [M] = 398.13, found m/z = 398.95.
Synthesis of JW35, JW35Mono, JW37 and JW41
Synthesis of IV
N
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1,1,2-Trimethyl-1H-benzo(e)indole (600 mg, 2.9 mmol) and 4-bromo-1-butyne (572 mg,
4.3 mmol) were heated at 100 ◦C under argon for 2 h. The reaction mixture was cool down to
room temperature and 15 mL Et2O was added. After stirring for 20 min at room temperature
the suspension was cooled down to 4 ◦C, filtered and washed three times with ice cold Et2O.
The crude product was obtained as a light blue solid (497.7 mg, 1.9 mmol, 55 %), which was
used for the next step without further purification.
Rf = 0.4 (MeOH : DCM 1 : 10).
HRMS: m/z calculated for [M+H+] = 262.1596, found m/z = 262.1590.
Synthesis of VI
N
N
Cl
Freshly synthesized IV (653 mg, 2.49 mmol) and (N-[5-anilino-3-chloro-2,4-(propane-
1,3-diyl)-2,4- pentadiene-1-ylidene]anilinium chloride) (V) (404.5 mg, 1.13 mmol) were
dissolved in EtOH and together with KOAc (244.4 mg, 2.49 mmol) refluxed overnight under
light exclusion and N2-atmosphere. After completion of the reaction, the mixture was cooled
down to room temperature, concentrated in vacuo and redissolved in DCM. After three
washes with brine, and one wash with H2O, the organic layer was dried over anhydrous
magnesium sulphate (MgSO4) and DC was evaporated. The crude reaction product was then
purified by flash column chromatography (0 - 20% MeOH in DCM) to obtain compound VI
(309 mg, 42%).
HRMS: m/z calculated for [M+H+] = 659.3193, found m/z = 659.3206.
1H-NMR: (400 MHz, CDCl3) δ [ppm] = 8.46 (d, JH,H = 14.2 Hz, 2H), 8.15 (dd, JH,H = 8.5,
1.0 Hz, 2H), 7.97 (d, JH,H = 8.5 Hz, 4H), 7.65 – 7.59 (m, 4H), 7.50 (dd, JH,H = 8.0, 1.0 Hz,
2H), 6.48 (d, JH,H = 14.1 Hz, 2H), 4.67 (t, JH,H = 8.0 Hz, 4H), 2.95 (td, JH,H = 6.6, 2.7 Hz,
4H), 2.81 (t, JH,H = 6.2 Hz, 4H), 2.06 (s, 12H), 2.03 (m, 2H), 1.95 (t, JH,H = 2.6 Hz, 2H).
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13C NMR: (126 MHz, CD3CN) δ [ppm] = 175.6, 150.1, 144.1, 140.8, 134.8, 132.9, 131.3,
130.9, 128.7, 128.2, 126.2, 123.3, 112.5, 102.6, 80.9, 72.9, 52.1, 43.5, 27.9, 27.1, 21.7, 18.0.
Synthesis of VII
N
N
N
HN
VI (351 mg, 0.53 mmol) and piperazine (69 mg, 0.80 mmol) were dissolved in dry MeCN
(10 mL) and stirred for 8 h at room temperature under argon atmosphere. Cs2CO3 (130 mg,
0.40 mmol) was added and the reaction mixture was heated for 90 min at 40 ◦C. The reaction
mixture was allowed to cool to room temperature and concentrated under reduced pressure.
Purification by flash column chromatography (Al2O3, pH = 7, 0 - 20% MeOH in DCM)
yielded the desired product VII (323 mg, 0.45 mmol, 85%).
HRMS: m/z calculated for [M+] = 709.4270, found m/z = 709.4321.
1H-NMR: (500 MHz, CD3CN) δ [ppm] = 8.20 – 8.15 (m, 2H), 7.95 -7.89 (m, 4H), 7.67 (d,
JH,H = 13.2 Hz, 2H), 7.57 (ddd, JH,H = 8.5, 6.8, 1.4 Hz, 2H), 7.46 (d, JH,H = 8.5 Hz, 2H), 7.40
(ddd, JH,H = 8.5, 6.8, 1.4 Hz, 2H), 5.90 (d, JH,H = 13.2 Hz, 2H), 4.22 (t, JH,H = 6.8 Hz, 4H),
3.88-3.84 (m, 4H), 3.16-3.12 (m, 4H), 2.74 (td, JH,H = 6.8, 2.7 Hz, 4H), 2.56-2.51 (m, 4H),
2.22 (t, JH,H = 2.7 Hz, 2H), 1.85-1.79 (m, 2H). The 12H belonging to the 4 methyl groups of
the 1,1-dimethyl-1,3-dihydro-2H-benzo[e]indole unit are underneath the solvent peak at 1.94
ppm.
13C NMR: (126 MHz, CD3CN) δ [ppm] = 176.8, 170.2, 141.6, 140.4, 132.2, 131.8, 130.8,
129.2, 128.2, 124.8, 124.4, 122.9, 111.8, 95.5, 81.6, 72.2, 57.6, 50.3, 48.5, 42.5, 28.8, 25.5,
22.5, 17.4.
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Synthesis of JW35
N
N
N
N N
N
N
N
N
O
HOHO
OH
HO
O
HOHO
OH
HO
HN
VII (32 mg, 0.045 mmol), 1-Azido-1-deoxy-β -D-glucopyranoside (20 mg, 0.097 mmol)
and CuSO4 (7 mg, 0.045 mmol) were dissolved in tBuOH : H2O (1 : 1, 1.3 mL). Sodium
ascorbate (15 mg, 0.075 mmol) was added and the reaction mixture was sonicated for 30
seconds followed by stirring at room temperature for 2 h. The reaction mixture was diluted
with MeCN : H2O (1 : 1) and purified with HPLC (Kinetex, 5 µm, C18, 100Å, AXIA packed
HPLC column, 250 x 21.2 mm) using HO + 0.1% formic acid and MeCN + 0.1 formic
acid as solvents. JW35 was obtained as green-blue solid (25.7 mg, 0.023 mmol, 51%).
JW35Mono was synthesised accordingly but with the use of only 1 eq. 1-Azido-1-deoxy-β -
D-glucopyranoside. Under this conditions also some JW35 was generated but JW35Mono
was well separated by HPLC (Kinetex, 5 µm, C18, 100Å, AXIA packed HPLC column,
250 x 21.2 mm) using HO + 0.1% formic acid and MeCN + 0.1 formic acid as solvents.
The 4H from the CH2 groups directly attached to the triazole are underneath the solvent
peak at 3.31 ppm and thus not visible. Also, due to the low concentration of the sample not
all 13C-NMR signals are distinguishable from the background noise but coupling pattern
could be observed with HMBC.
HRMS: m/z calculated for [M+H+] = 1119.57, found m/z = 1119.5759.
1H-NMR: (500 MHz, CD3OD) δ [ppm] = 8.43 (s, 2H), 8.21 (d, JH,H = 8.5 Hz, 2H), 8.02
(s, 1H), 7.99 - 7.96 (m, 4H), 7.84 (d, JH,H = 13.5 Hz, 2H), 7.63 - 7.59 (m, 2H), 7.50 (d,
JH,H = 8.8 Hz, 2H), 7.46 - 7.43 (m, 2H), 5.92 (d, JH,H = 13.5 Hz, 2H), 5.53 (d, JH,H = 9.2 Hz,
2H), 4.52 - 4.46 (m, 4H), 3.86 - 3.75 (m, 8H), 3.71 - 3.64 (m, 4H), 3.56 - 3.52 (m, 4H), 3.50 -
3.43 (m, 4H), 2.61 - 2.52 (m, 4H), 2.00 (d, JH,H = 2.6 Hz, 12H), 1.94 - 1.90 (m, 2H).
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13C NMR: (126 MHz, CD3OD) δ [ppm] = 142.3, 131.57, 130.07, 129.67, 128.51, 125.24,
123.81, 123.15, 111.56, 111.39, 97.98, 89.51, 81.02, 78.46, 74.08, 70.87, 62.38, 56.47, 54.28,
51.37, 44.23, 29.44, 29.27, 29.12, 28.95, 26.06, 23.01, 22.72, 22.57, 22.42, 22.27, 22.10,
20.51, 18.25, 15.07, 13.56, 13.41, 13.26, 13.11, 12.96, 12.80.
Synthesis of VIII
N
N
N
N
O
VII (29.3 mg, 0.039 mmol) and TEA (4 mg, 0.040 mmol) were dissolved in dry THF
(2.5 mL) under argon atmosphere and cooled down to 0 ◦C. Pivaloyl chloride (6 mg,
0.05 mmol) in 0.5 mL dry THF was slowly added and the reaction was then stirred at
room temperature for 15 h. The reaction mixture was concentrated under reduced pressure,
redissolved in DCM and washed three time with water to yield VIII as green-blue solid
(19.2 mg, 0.024 mmol, 62%).
HRMS: m/z calculated for [M+] = 793.48, found m/z = 793.4833.
Synthesis of JW37
N
N
N
N N
N
N
N
N
O
HOHO
OH
HO
O
HOHO
OH
HO
N
O
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VIII (15 mg, 0.019 mmol), 1-Azido-1-deoxy-β -D-glucopyranoside (12 mg, 0.058 mmol)
and CuSO4 (5 mg, 0.031 mmol) were dissolved in tBuOH : H2O (1 : 1, 1.5 mL). Sodium
ascorbate (7.5 mg, 0.038 mmol) was added and the reaction mixture was sonicated for 30
seconds followed by stirring at room temperature for 2 h. The reaction mixture was diluted
with MeCN : H2O (1 : 1) and purified with HPLC (Kinetex, 5 µm, C18, 100Å, AXIA packed
HPLC column, 250 x 21.2 mm) using HO + 0.1% formic acid and MeCN + 0.1 formic acid
as solvents. JW37 was obtained as blue solid (10.8 mg, 0.009 mmol, 48%).
All the NMRs were measured in a very diluted sample and the solvent peaks are overlap-
ping with the signals from the methyl groups. Additionally, due to the low concentration of
the sample the 13C-NMR could not be analysed. Thus not all protons of the 7 methyl groups
are stated.
HRMS: m/z calculated for [M+] = 1203.62, found m/z = 1203.6230.
1H-NMR: (500 MHz, CD3CN) δ [ppm] = 8.30-8.10 (m, 4H), 8.04-7.85 (m, 4H), 7.72 (s,
2H), 766-7.55 (m, 2H), 7.55 - 7.33 (m, 4H), 5.78 (d, JH,H = 15 Hz, 2H), 5.39 (d, JH,H = 10 Hz,
2H), 4.40 (bs, 4H), 4.04-3.82 (m, 8H), 3.72-3.50 (m, 8H), 3.33 (dd, JH,H = 15, 10 Hz, 2H),
3.25 (bs, 2H), 3.14 (t, JH,H = 5 Hz, 4H), 2.99 (bs, 2H), 1.32-1.21 (m, 12H).
Synthesis of X
B
O
O
O
O
O
NO2
4-Nitrophenylchloroformate (120 mg, 0.595 mmol) were dissolved in dry DCM (1.5 mL)
under argon atmosphere and pyridine (53 mg, 0.670 mmol, dissolved in 1.5 mL dry DCM) was
added. After cooling down to 0 ◦C, (4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-
methanol (140 mg. 0.598 mmol) was added in 1 mL dry DCM and the reaction mixture
was stirred for 2 h. The reaction was stopped by washing once with H2O and twice with
brine. The organic layer was separated, dried over anhydrous MgSO4 and concentrated
under vacuum. The colourless solid was unstable and thus used immediately in the next step
without further purification .
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Synthesis of XI
N
N
N
N
O
O
B O
O
VII (40 mg, 0.056 mmol) and 18 mg (0.060 mmol) N,N-diisopropylethylamine were
dissolved in dry DMF (0.5 mL) under argon atmosphere. After cooling down to 0 ◦C, X
(33.6 mg, 0.084 mmol) was added in 0.2 mL dry DMF and the reaction mixture was stirred at
room temperature overnight. The mixture was diluted with ethyl acetate and washed with
water and brine. After drying over anhydrous MgSO4 and concentrating under vacuum, the
crude product was purified by flash column chromatography (Al2O3, pH = 7; 0 - 20% MeOH
in DCM). Since the product was subject to degradations during the purification step (different
conditions have been exploited), XI (dark blue solid, 21.1 mg, 0.022 mmol, 39%) with some
impurities was used for the next step. The 4-nitrophenylpiperazine by-product, could be
isolated and analysed via NMR.
HRMS: m/z calculated for [M+H+] = 969.55, found m/z = 969.5377.
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Synthesis of JW41
N
N
N
N N
N
N
N
N
O
HOHO
OH
HO
O
HOHO
OH
HO
N
O
O
B O
O
XI (20 mg, 0.021 mmol), Cu(CH3CN)4PF6 (4 mg, 0.011 mmol), TBTA (5.6 mg, 0.011 mmol)
and 1-Azido-1-deoxy-β -D-glucopyranoside (10 mg, 0.048 mmol) were dissolved in dry
MeCN (1.5 mL) and stirred at room temperature under argon atmosphere for 24 h. The
reaction mixture was purified by HPLC (Agilent XDB C18, 5 - 100% MeCN in H2O + 0.1%
TFA). JW41 was obtained as dark blue solid (9.6 mg, 0.007 mmol, 33%).
The hydrogens of the OH groups might be underneath the broad peak at 2.50 ppm. Also,
due to the low concentration of the sample not all 13C-NMR signals are distinguishable from
the background noise but coupling pattern could be observed with HMBC.
HRMS: m/z calculated for [M+H+] = 1380.69, found m/z = 1380.6700.
1H-NMR: (500 MHz, CD3CN) δ [ppm] = 8.15 (s, 2H), 8.01 – 7.88 (m, 6H), 7.77 – 7.71 (m,
6H), 7.60 (m, 2H), 7.50 – 7.36 (m, 6H), 5.80 (bs, 2H), 5.46 (d, JH,H = 9.2 Hz, 2H), 5.28 (s, 2H),
4.40 (bs, 4H), 3.79 (s, 4H), 3.77 – 3.67 (m, 4H), 3.64 (s, 4H), 3.56 (dd, JH,H = 12.0, 5.2 Hz,
2H), 3.48 (t, JH,H = 8.9 Hz, 4H), 3.42 – 3.35 (m, 2H), 3.25 (bs, 4H), 2.07 (dt, JH,H = 4.9,
2.5 Hz, 2H), 1.89 (s, 12H), 1.85 – 1.83 (m, 2H), 1.80 (dt, JH,H = 4.9, 2.5 Hz, 2H), 1.29 (s,
12H).
13C NMR: (126 MHz, CD3CN) δ [ppm] = 155.92, 144.34, 141.33, 135.56, 130.98, 130.75,
128.35, 127.74, 122.80, 118.44, 111.72, 88.37, 84.81, 79.99, 77.82, 73.40, 70.70, 67.62,
62.33, 54.9546.20, 43,89, 28.61, 25.13, 25.09, 22.46.
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νmax (solid): 3337, 2977, 2930, 2888, 1677, 1544, 1501, 1440, 1354, 1274, 1229, 1202,
11138, 1108, 1065, 1046, 1007, 914, 901, 861 cm-1.
2.4.2 Photophysical Calculations
The nitrogen hybridization states as well as minimum-energy conformations were ana-
lysed computationally by geometry optimisation in gas phase and frequency calculations
were run using Gaussian 03 [154], at the density functional theory level, using the B3LYP
functional and the cc-pvDz basis set [155, 156]. Although used by the intuitive valence
bond theory, atomic electron hybridisation is not a property of a molecule as a whole, whose
electronic structure is better described by molecular orbitals that may extend over the entire
molecule. Even though transformations can be applied to the molecular orbitals in order to
obtain a set of localised molecular orbitals, these are neither unambiguous nor they have
a definite energy level. As a consequence, within a molecule, each atom can display a
mixture of geometrical features commonly associated to different hybridisation states. Thus,
we compared the results for the hybridisation states of the nitrogens with reference cases,
namely: pyrrolidine (1), n-methylpyrrolidine (2), protonated pyrrolidine (3), protonated
n-methylpyrrolidine (4), pyrrole (5) and n-methylpyrrole (6). These molecules contain easily
defined “sp3-like” pyramidal nitrogens (1-4) and “sp2-like” planar nitrogens (5, 6). To
determine the twist in the HCC backbone, we quantified the relative orientation of the two
terminal polycyclic moieties by defining a dihedral angle with the main axis across the central
aliphatic chain and terminating in the two distal benzene rings (as shown in Figure 2.16 and
measured on the optimised structures.
2.4.3 Optical Characterisations
General Considerations
Absorption and fluorescence spectra were recorded at 25 ◦C using a fluorescence spec-
trophotometer (Cary Eclipse, Varian) and a UV-VIS spectrophotometer (Cary 300, Varian).
Therefore, samples were placed into Suprasil® quartz cuvettes with a 10 mm pathlength.
Separate absorption and emission measurements were performed at 25 ◦C on a microplate
reader (CLARIOstar, BMG Labtech or SPECTROstar, BMG Labtech). All measurements
were repeated with n≥ 3 separately prepared dye samples and errors are represented as
standard deviations.
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PA spectra of the dyes in different environments at different concentrations were recor-
ded in micro plastic cuvettes (Y200.1, ROTH; V(dye solution) = 800µL) in a custom PA
spectrometer built using a laser module (SplitLight 600 OPO ) coupled into a silica fiber
(CeramOptec), an ultrasound transducer (PANAMETRICS, 500kHz) and the data acquisition
unit of a commercial multispectral optoacoustic tomography (MSOT) system (InVision 256,
iThera Medical). The set-up was assembled and optimised together with Stefan Morscher
from iThera Medical. Figure 2.25 shows a schematic illustration of the set-up.
SplitLight 600 OPO 
laser
MSOT inVision256
(DAQ, software)
water
cuvette
bread-
board
tubus
lense
ultrasound
transducersample
fiber
Figure 2.25 Schematic illustration of custom PA spectrometer set-up.
PA spectra for assessing photothermal stability and obtaining PA spectra for spectral
unmixing were recorded in a commercial multispectral OT (MSOT) system (inVision256-TF;
iThera Medical). Detailed information of the system are described elsewhere [157, 158]. In
short, 9 nanosecond (ns) excitation pulses at a 10-Hz repetition rate are generated from a
tuneable (660 nm – 1300 nm) optical parametric oscillator (OPO) pumped by an Nd:YAG
laser with a peak pulse energy of 90 mJ at 720 nm. A uniform diffused ring of illumination
over the image plane is provided by ten arms of a fibre bundle. Ultrasound detection was
achieved with 256 toroidally focused ultrasound transducers at a centre frequency of 5 MHz
with a 60% bandwidth. The array of transducers is organised in a concave array with a radius
of 4 cm and covers an angle of 270 degree. The samples are coupled to the transducer via a
water bath filled with heavy water.
88 Development of a new Activatable, Bifunctional Photoacoustic Probe
Optical Characterisation of Commercially Available Dyes
All dye solutions were prepared in UV-transparent 96 well plates (Corning Costar, Sigma-
Aldrich) and absorption and fluorescence spectra were acquired using a microplate reader
(CLARIOstar, BMG Labtech). All measurements were conducted at 37 ◦C. For each dye
and solvent combination, 0.5,µM, 1,µM, 5,µM, 10,µM, 20,µM and 50,µM solutions were
prepared in triplicates, with the exception of Cy7 and Cy7.5 in ethanol, where no 0.5 µM
samples were used.
Table 2.6 Conditions used for optical characterisation of commercially available dyes.
Solvent ICG Cy7.5 Cy7 SulfoCy7 IR800CW IR783 IR8061 IR680RD
H2O x x x x x x x x
H2O+3wt.% BSA x x x x x x x x
H2O+10% FBS x x x x x x x -
PBS x x x x x x - x
PBS+10% FBS x x x x x x - x
FBS x x x x x x - -
TBS x x x x x x - -
normal brine x x x x x x - -
MeOH x x x - x x x -
EtOH - x x x - - - -
1 IR806 readily aggregates in the presence of ions and is insoluble in all the buffers used in this experiment.
Optical Characterisation of the Dyes for Linker Evaluation
The absorption spectra of the different HCC-linker derivatives, JW7 - JW16, and JW37,
JW44, JW45 were recorded with different solvents and concentrations (Table 2.7 and 2.8).
To obtain the corresponding emission spectra, the samples were excited at 720 nm (JW8)
or 770 nm (JW14, JW15, JW16) and emission was collected between 750 and 900 nm for
JW8 and 780 and 900 nm for JW14, JW15 and JW16. Slit emission and excitation were
defined as 10 nm.
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Table 2.7 Conditions used for optical characterisation of HCC-piperazine derivatives.
Solvent JW7 JW8 JW11 JW13 JW14 JW15 JW16
(µM) (µM) (µM) (µM) (µM) (µM) (µM)
H2O 1, 5, 10, 15 1, 5, 10, 15 1, 5, 10, 15 1, 5, 10, 15 1, 5, 10, 15 1, 5, 10, 15 1, 5, 10, 15
20, 50, 100 20, 50, 100 20, 50, 100 20, 50, 100 20, 50, 100 20, 50, 100 20, 50, 100
MeOH 1, 5, 10, 15 1, 5, 10, 15 1, 5, 10, 15 1, 5, 10, 15 1, 5, 10, 15 1, 5, 10, 15 1, 5, 10, 15
20, 50, 100 20, 50, 100 20, 50, 100 20, 50, 100 20, 50, 100 20, 50, 100 20, 50, 100
PBS 1, 5, 10, 15 1, 5, 10, 15 1, 5, 10, 15 1, 5, 10, 15 1, 5, 10, 15 1, 5, 10, 15 1, 5, 10, 15
20 20 20 20 20 20 20
NaOAc (pH 4.3) 1, 5, 10, 15 1, 5, 10, 15 1, 5, 10, 15 1, 5, 10, 15 1, 5, 10, 15 1, 5, 10, 15 1, 5, 10, 15
20 20 20 20 20 20 20
(NH4)2CO3 (pH 10.45) 1, 5, 10, 15 1, 5, 10, 15 1, 5, 10, 15 1, 5, 10, 15 1, 5, 10, 15 1, 5, 10, 15 1, 5, 10, 15
20 20 20 20 20 20 20
MeOH 5, 10 5, 10 5, 10 5, 10 5, 10, 20 20 -
MeOH+5eq.DMAP 5 5 5 5 5 - -
MeOH+1eq.TEA 10 10 10 10 10 - -
MeOH+100eq.TEA 10 10 10 10 10 - -
MeOH+20mM NaOH - - - - 20 - -
MeOH+30mM NaOH - - - - 20 - -
MeOH+20mM NaOH - - - - 20 - -
MeOH+1.5eq. TFA - - - - - 20 -
DCM - - - - - 100 -
DCM+3eq. TFA - - - - - 20 -
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Table 2.8 Conditions used for optical characterisation of JW37, JW44, JW45.
Solvent JW37 (µM) JW44 (µM) JW45 (µM)
H2O 5, 10, 20 10 10
H2O+10%DMSO 5, 10, 20 - -
PBS 5, 10, 20 10 10
PBS+2.5%PEG24 5, 10, 20 - -
PBS+5%PEG24 5, 10, 20 - -
PEG+5%glycerol 5, 10, 20 - -
PEG+12.5%glycerol 5, 10, 20 - -
PBS+10%FBS - 10 10
FBS - 10 10
MeOH/H2O 3/1 5, 10, 20 10 10
MeOH/H2O 1/1 5, 10, 20 10 10
MeOH/H2O 1/3 5, 10, 20 10 10
MeOH 5, 10, 20 10 10
EtOH 5, 10, 20 - -
MeCN 5, 10, 20 - -
Hexane 5, 10, 20 - -
Optical Characterisation of JW35 and JW41
JW35 and JW41 were optically characterised in various conditions and concentra-
tions, including: MeCN, DMF, DMSO, EtOH, EtOH : H2O 7 : 3, MeOH, MeOH : H2O
3 : 1, MeOH : H2O 1 : 1, MeOH : H2O 1 : 3, H2O, H2O+10% DMSO, PBS, PBS+10%FBS,
PBS+2.5% PEG24, PBS+5% PEG24, PEG+12.5% glycerol, PEG+5% glycerol, FBS. Fluor-
escence spectra of JW35 and JW41 were recorded by exciting close to their absorption
maximum at 740 nm, 780 nm and/or 785 nm.
Several photophysical quantities were determined from absorption and emission data at
various concentrations. These included absorption maxima (λAbs), emission maxima (λEm),
Stokes shift, molar extinction coefficient (ε), fluorescence quantum yield (φFl) and brightness
(B). Stokes shifts were calculated from the difference of λEm and λAbs. ε was determined
using the Beer–Lambert law from dilutions of solutions with known concentrations. φFl of
JW41 and JW35 in water, MeOH and EtOH : H2O (7 : 3) were measured at the excitation
wavelength of 785 nm and referenced against 1,1,,3,3,3,,3,-Hexamethylindotricarbocyanine
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iodide (HITC, Sigma-Aldrich, 252034) in MeOH (φFl=0.28) (cf. Appendix, Figure A.6)
[159]). Discrepancies in absorbency and solvent refractive index were corrected for with the
following equation [160].
θFl = θFl,Ref · [(≀I/ ≀ IRef) · ((1−10-ARef)/(1−10-A)) · (n2/n2Ref)]
with θRef being the fluorescence quantum yield of the reference dye, HITC, I is the
fluorescence intensity and n is the refractive index of the medium. Fluorescence emission
spectra of θFl HITC were collected at several concentrations in MeOH (see Appendix A.2,
Figure A.6 for calibration curve).
Photoacoustic Characterisation
The PA spectra of the commercial available cyanine dyes as well as JW41 and JW35 were
recorded at various concentrations ranging from 0.125 µM to 25 µM on the spectroscopic
set up described previously (cf. Figure 2.25) in different solvents including MeCN, EtOH,
H2O, H2O + 3 wt.% BSA, H2O + 10% FBS and PBS.
To investigate the resolution of the commercial small-animal, multispectral optoacoustic
systems (MSOT), which would be used for in vivo studies, and the influence of biological
tissue, we additionally acquired PA spectra of the commercial available cyanine dyes as well
as JW41 and JW35 in tissue-mimicking phantoms on the MSOT. The phantoms possess
defined optical properties closely mimicking the optical properties of biological tissue and
were fabricated as described previously [161]. 150 µL of dye solution (5 µM for commercial
available dyes, 2.5 µM for JW41 and JW35) in (a) water and (b) FBS were inserted into
thin-walled plastic straws, sealed and placed in holes inside the phantom as illustrated in
Figure 2.24. The phantom was clamped into a supplied rigid phantom holder and placed into
the imaging chamber of the MSOT system. To allow the phantom to adapt the water bath
temperature of 34 ◦C, measurements were recorded starting 5 min after placing the phantom
into the imaging system.
Photobleaching Studies
Photothermal stability studies were carried out in tissue-mimicking phantoms on the
commercial small-animal, multispectral optoacoustic systems (MSOT), as described before
(see 2.4.3). For examining the photothermal stability of commercial available dyes, 150 µL
of 5 µM dye solution in (a) water and (b) FBS was used; for JW41 and JW35, 150 µL of
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2.5 µM dye solution in (a) water and (b) FBS was measured. 150 µL of 2.5 µM IR800CW
in water or FBS served as reference for the assessment of the photothermal stability of JW41
and JW35. Imaging was performed at one imaging position at 680 nm, 850 nm and from 710
to 800 nm in 5 nm steps with constant 9 ns excitation pulses at a 10 Hz repetition rate. Graphs
are plotted with the values obtained at their PA maxima wavelength. Photobleaching was
confirmed by fluorescence imaging of the dye containing straws with a fluorescence imaging
system (IVIS 200, Xenogen) before and after the photothermal stability study.
2.4.4 Spectral Unmixing Evaluation
The same preparation procedure as described in section 2.4.3 was used for obtaining
the PA spectra of the dyes in tissue mimicking phantoms and evaluating the possibility
of unmixing the spectra of JW41 and JW35 using linear regression. The dye solutions
used for this purpose were prepared in deionised water at concentrations of 2.25 µM JW41,
1 µM JW35, and mixtures of 0.33 µM JW41- 0.66 µM JW35, 0.5 µM JW41 - 0.5 µM
JW35, 0.66 µM JW41 – 0.33 µM JW35. Imaging was performed over 5 scanning positions
covering the different straw positions in 1-mm steps and at 25 different wavelengths between
660 nm and 900 nm.
The acquired images were reconstructed offline with linear reconstruction and analysed
with linear regression multispectral processing, both available within the ViewMSOT software
package (version 3.8; iTheraMedical). Mean pixel intensities were extracted from the regions
of interest (ROIs) drawn within the plastic straw and the average values over the different scan
positions were used for further analysis. To obtain the PA spectra profile, offset correction
was performed by subtracting the signal at 900 nm from the other values. The contrast-to-
noise ratio (CNR) of signals in the photoacoustic images were calculated using the following
equation[122]:
CNR = |Si - S0 | /σ0
where Si is the mean of the image data within the ROI located inside the straw, S0 the means
of the image data within the background ROI and σ0 is the standard deviation of the data
of the background ROI. Linear regression with spectra for JW41, JW35 and the phantom
background extracted from the phantom study were used to produce images in arbitrary units
to obtain information about the relative weight that each spectrum redounds to a specific
image pixel. For quantifying the accuracy of the spectral unmixing, the values obtained
through linear regression were background corrected to the phantom signal, and normalised
against the value of the reference straw containing 1 µM JW35. These relative values (%)
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obtained by spectral unmixing for JW41 and JW35 in the test straw were then compared with
the actual concentration (%), which was present in the straw. The relative accuracy is stated
as the difference (%) between the actual concentration (%) and the calculated concentration
(%).
2.4.5 Protein-Binding Assay
To test the binding of commercially available cyanine dyes to proteins, the dyes were
added to 3 wt.% bovine serum albumin solution in PBS to reach a final concentration of
1 µM and incubated for 15 min, 30 min or 60 min at 37 ◦C. Next, nativePAGE sample
buffer (Invitrogen) was added to the sample in a 1:3 ratio and the samples were loaded into
a nativePAGE Bis-Tris gel (Invitrogen). The gel was run in nativePAGE running buffer
(Invitrogen) at 4 ◦C for 70 min at 150 V followed by 20 min at 200 V. The gel was imaged
on an Odyssey CLx system (LI-COR) using the 700 nm and 800 nm channel. Afterwards,
the gel was stained with InstantBlue for 1 h at room temperature and imaged again an an
Odyssey CLx system (LI-COR) using the 700 nm channel. Protein binding was classified by
forming the ratio of unbound (free) dye to protein bound dye. Therefore the average signal
intensity of the solvent front and the protein bands was determined with Fiji. A free to bound
dye signal ratio smaller than 5 was classified as high, a ratio between 5 and 100 as medium
and a ratio higher than 100 as low protein binding ability.

Chapter 3
Application of the New H2O2-Activatable
Photoacoustic Probe in Cancer
Dr. Laura Ansel-Bollepalli performed the Incucyte proliferation measurements as shown
in Figure 3.7A and the TPA-assay shown in Figure 3.12. LC-MS/MS studies of tissue samples
were performed with the help of Joshua Kent. All other work was performed and analysed
myself. Parts of this work is in review for publication.
3.1 Introduction and Motivation
Among several cancer pathways it has been shown that increased levels of reactive oxygen
species (ROS) have a broad impact on tumorigenesis and linked inflammatory processes in
breast, colon, liver, gastric, lung and pancreatic cancers [162]. For a better characterisation
and definition of their physiology and pathology, specific redox-activatable and bifunctional
contrast agents for photoacoustic imaging (PAI) possess promising features for translatable
detection of ROS with high spatial and temporal resolution in vivo.
In Chapter 2, the design and synthesis of a cancer-targeted, ROS-activatable probe, JW41,
for PAI was described, which is responsive to one of the major and most abundant ROS,
hydrogen peroxide (H2O2) (Figure 3.1). The putative bifunctional probe uses a heptamethine
carbocyanine dye scaffold for signal generation, glucose for cancer localisation and boronic
ester oxidation to specifically detect H2O2. The optical properties of the novel probe, JW41,
and the uncapped reference, JW35, were characterised using absorption, fluorescence and
photoacoustic measurements. These data indicated a distinct change in the photophysical
profile when comparing the capped (JW41) and uncapped (JW35) probe.
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Figure 3.1 Design and structure of the new bifunctional PA probe: JW41, a NIR dye designed to
exhibit a H2O2-dependent change in its optical and photoacoustic properties as well as an increased
accumulation in the targeted tissue due to a clickable targeting moiety (glucose was chosen as a
preliminary cancer targeting moiety).
In the light of the previous data, the broader challenge of biocompatibility, biodistribution
and in vivo-performance are now the key steps, which need to be evaluated. For successful
molecular imaging, the probe must be non-toxic and overcome physiological delivery barriers
(circulatory and cellular) while ensuring appropriate biodistribution (avoiding off-target tissue
accumulation) and elimination (Figure 3.1). Thus, the goal of this Chapter was to establish
the abilities of the capped dye, JW41, to operate as an activatable, bifunctional contrast agent
for PA in vivo imaging by examining the sensitivity and selectivity of JW41 towards H2O2,
its cancer targeting ability and its performance in vitro and in vivo.
3.2 Results and Discussion
3.2.1 ROS Sensing
The ability of the capped dye, JW41, to respond to H2O2 with a change in its photophys-
ical properties was evaluated with absorption, fluorescence and PA spectroscopy. Spectral
transformations were characterised following the addition of 100 µM H2O2, a physiologically
realistic concentration in a cellular environment undergoing oxidative stress, to solutions of
the probe [163]. A rapid ratiometric change in the absorption and PA profile, which allows
data normalisation, were observed following the addition of 100 µM H2O2. The optical
absorption peak at 730 nm shifted by 65 nm to 795 nm and the absorbance at 790 nm was
found to increase by over 45% (Figure 3.2A). Similarly, the photoacoustic peak shifted from
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705 nm to 775 nm with an increase of the 775 nm signal by 25% (Figure 3.2B). Furthermore,
the addition of H2O2 elicits a prompt increase in the fluorescence signal at 825 nm by over
100% (Figure 3.2C). The kinetics of this reaction was followed with all three modalities,
and revealed a fast conversion of the capped dye into the uncapped dye over a period of 10
minutes based on the absorption signal (Figure 3.2D). All measurements were cross validated
via liquid chromatography mass spectrometry (LCMS) confirming that the signal changes
were caused by the conversion of JW41 to JW35.
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Figure 3.2 Reactivity of JW41 towards H2O2. A) - D) Monitoring the reaction of the capped dye
(JW41; 10 µM) with H2O2 (100 µM) via absorption (A), photoacoustic (B) and fluorescence (C)
measurements. The change (∆) in peak absorbance at 730 nm and 790 nm was used to generate the
reaction progress curve (D).
Importantly, LCMS studies demonstrated that the above stated properties are selective
for the ROS H2O2 with no or only minor cross-reactivity observed with a wide range of
other reactive species (Figure 3.3). The generation of the different ROS was verified by
independent tests with commercially available products (see section 3.4). It should be
noted that JW41 partially hydrolyses to the corresponding boronic acid (JW41hydrol) under
aqueous conditions. However, it was ensured that this does not significantly affect the optical
properties as the photophysical characteristics did not change in the control solutions of
JW41, which were incubated in water for up to 2 h (Appendix Figure A.7). Additionally,
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the H2O2 reactivity and specificity retained for the hydrolysed form of JW41, JW41hydrol.
As the oxidation reaction is irreversible, this probe records the total H2O2 exposure to the
system, rather than the equilibrium value.
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Figure 3.3 LCMS monitoring of the response of JW41 (10 µM) towards different ROS after 60 min
incubation ([ROS] ∼ 100 µM). JW35 (10 µM) was used as endpoint-reference. UV traces at 750 nm
are plotted.
3.2.2 In Vitro Evaluation
A good contrast agent must meet the following crucial requirements: high stability
throughout the imaging time frame, being non-toxic and non-disruptive, bypassing physiolo-
gical delivery barriers (e.g. cell membrane) and the ability to accumulate in targeted tissue
but not in off-target tissue. Thus the next goal was to exploit the behaviour of the new
H2O2-specific probe under in vitro conditions to gain insight into serum stability, protein
binding, cellular toxicity, cellular uptake, cell localisation and targeting efficiency.
A first set of experiments sought to characterise the stability of the capped and uncapped
dye in biological conditions. For this JW41 and JW35 were incubated in plasma at 37 ◦C for
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up to 2 hours. Both dyes showed good stability with no formation of degradation products
detected (Figure 3.4).
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Figure 3.4 Serum stability of A) JW41 and B) JW35 over 2 h in FBS at 37 ◦C. UV traces at 750 nm of
the LCMS analysis of the dyes after 30 min, 60 min and 120 min incubation are shown (concentration
at time point of injection: 8 µM).
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Figure 3.5 Protein binding of JW41 and JW35 assessed in 3 wt.% BSA in PBS. ICG (1 µM) and
IR800CW (1 µM) are used as reference for a strong protein binding and a low protein binding dye
respectively. The bound and unbound dyes were separated on a native gel after 15 min, 30 min and
60 min incubation and visualised using the 800 nm channel laser source. 1-BSA monomer, 2-BSA
dimer, 3-BSA tetramer, 4-BSA hexamer [120]
.
Protein binding can not only influence the optical properties of dyes but also hamper
extravasation and hence affect the biodistribution of a contrast agent (e.g. by increasing
hepatic clearance). Thus, the protein binding properties of JW41 and JW35 were evaluated
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using 3 wt.% BSA in PBS. IR800CW was used as reference for a low protein binding dye
and Indocyanine green (ICG) as a strong protein binding dye (cf. Section 2.2.1). Both dye
derivatives were found to show stronger binding than IR800CW but considerably less binding
than ICG (Figure 3.5).
To establish the toxicity and uptake profiles of the new probe, two established breast
cancer cell lines, MCF-7 and MDA-MB-231, were used. These two cell lines are of particular
interest to test the properties of the new probe as they differ significantly in their ROS
production abilities with MDA-MB-231 cells producing intracellular ROS levels three times
higher than those of MCF-7 cells [164].
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Figure 3.6 Glut1 mRNA ex-
pression.
Furthermore, MDA-MB-231 cells typically feature War-
burg effect characteristics and express higher levels of glut1
mRNA than MCF7 cells [165, 166, 164]. This observation was
confirmed by quantitative real-time polymerase chain reaction
(Figure 3.6). However, one needs to keep in mind that higher
gene expression does not always translate into higher protein
levels, and it is the latter that dictates cellular uptake of the
contrast agent. Unfortunately, multiple attempts to quantify the
protein expression levels of MDA-MB-231 and MCF7 cell lines
via Western blot failed. Nonetheless, these two observations
from the literature justified the choice of the MDA-MB-231
and MCF7 cells lines to investigate the biological properties of the new probe.
Because the ideal contrast agent should maintain the cellular integrity and be non-toxic,
the cytotoxicity of the capped and uncapped probe was tested using 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) viability assays and IncuCyte proliferation
assays. Through these two assays the acute toxicity (MTT assay) as well as the long term
impact of the probes towards cell proliferation (Incucyte assay) were assessed. Cells exposed
to 0.5% DMF were used as a reference as the dyes were dissolved in that solvent. The
toxicity of the capped and uncapped probe was compared to that of ICG as this dye presents
a very low toxicity profile and is FDA-approved. Encouragingly, neither form of the new
probe showed any significant cytotoxicity in any of the assays performed (Figure 3.7), with
the notable exception of time points between 54 and 60 h for MDA-MB-231 and 72-78 h for
MCF7 cells after which the dye groups recovered confluence levels similar to the control
group. Cells exposed to ICG and 0.5% DMF showed a greater impact towards cell division
than JW41 and JW35, reinforcing no decisive toxicity of the new probes.
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Figure 3.7 Cellular toxicity of JW41 and JW35. A) Real-time evaluation of the effect of 5 µM JW41
and JW35 towards cell proliferation of MDA-MB-231 (left) and MCF7 (right) cells was performed
by IncuCyte Zoom. ICG (5 µM) was used as FDA approved control dye, H2O2 (1 mM) as toxic
control compound and DMF (0.5%) to correct for possible effects of the solvent the dye-stocks were
prepared in. The substances were added 24 hours after the cells were seeded. Images were acquired
every 3 hours for 150 hours. Statistical significance was assessed by 2way ANOVA; ∗∗∗∗p< 0.0001;
∗p> 0.024. B) Cell viability was tested by MTT assay. Cells were incubated prior with 5 µM of
JW41, JW35, ICG, 0.5% DMF or medium (=control) for 8 hours. Viability is stated relative to the
control cells. Statistical significance was assessed by unpaired t-test.
Next, the cellular uptake of the new probes were investigated. The addition of 5 µM
JW41 or JW35 to MDA-MB-231 or MCF7 cells resulted in a rapid cellular uptake (15 min
post exposure) progressively increasing over 4 hours (Figure 3.8).
To establish the intracellular distribution of the probes, microscopic examination of
live and fixed MDA-MB-231 and MCF7 cells by wide field microscopy were performed.
Briefly, the cells were co-stained with NucBlue or Hoechst (DNA binding dyes; nucleus),
WGA-AF488 (membrane-bound dye; plasma membrane), MitoTracker orange (a dye con-
taining a thiol-reactive chloromethyl moiety specifically accumulating into the mitochondria)
and LysoTracker green (a weakly basic amine accumulating in low pH organelles; lyso-
somes). The fluorescent signal signal from JW41 and JW35 was localised to the cytosolic
compartment with no nuclear or cell surface co-localisation (Figure 3.9).
102 Application of the New H2O2-Activatable Photoacoustic Probe in Cancer
B
0 30 60 90 120 150 180 210 240
0
20
40
60
80
100
Time (min)
Flu
or
es
ce
nc
e (
%
) 
JW41
JW35
MCF7A
0 30 60 90 120 150 180 210 240
0
20
40
60
80
100
Time (min)
Flu
or
es
ce
nc
e (
%
) 
MDA-MB-231
Figure 3.8 Cell uptake kinetics of 5 µM JW41 and JW35 in A) MDA-MB-231 and B) MCF7 cells.
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dye.
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Figure 3.9 Cellular localisation of JW41 and JW35. Widefield fluorescence images of: A) fixed
MDA-MB-231 and MCF7 cells stained with JW41 / JW35 (red; 2.5 µM), WGA-AF488 (green) and
Hoechst (blue); B) live MDA-MB-231 cells incubated prior with JW41/JW35 (red, 2.5 µM), NucBlue
Live ReadyProbes (blue), MitoTracker (orange) and LysoTracker green (green) and of live MCF7 cell
incubated prior with JW41/JW35 (red, 2.5 µM), NucBlue Live ReadyProbes (blue) and LysoTracker
green (green).
Furthermore, the GLUT-targeting ability of the H2O2-specific probe and whether the cel-
lular uptake is facilitated via GLUT-mediated diffusion was questioned. This was investigated
by inhibition assay, competition assay and pharmacological activation of glucose transport in
vitro. ICG and IR800CW were used as negative, non-targeted controls and IR800CW-2DG as
positive control [167]. These controls were chosen due to the same targeting structure (2-DG)
and molecular weights and near-infrared absorption and fluorescent signals in the same range
as JW41. The specificity of 2-deoxyglucose targeting was examined by pre-incubation of
MDA-MB-231 and MCF7 cells with either 2-deoxyglucose (competition assay, Figure 3.10)
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or D-glucose (competition assay, Figure 3.11). The response curves indicating that a strong
decrease in JW41 uptake occurs around 50 mM 2-DG or 20 mM D-glucose addition.
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Figure 3.10 Competition binding assay in MDA-MB-231 (A and C) and MCF7 (B and D) cells with
increasing concentrations of 2-deoxyglucose. The near-infrared dyes ICG and IR800CW were used
as a non-targeted control, IR800CW was intended as positive control. All dyes were used at 2.5 µM
concentration.
However, it is important to mention that the negative control ICG exhibited a similar
cellular uptake trend although to a smaller degree and with a smaller overall signal (Figure
3.10 and 3.11). Additionally, all the error bars (expressing standard deviations) were relatively
large and neither the competition nor inhibition study of the positive control IR800CW-2DG
resulted in the expected uptake curve. Different parameters were varied to optimise the assay
but without success. Consequently, the results of these two assays can not yet be used to
claim targeting specificity of JW41.
Finally, cellular uptake of 2-DG targeted compounds by GLUT transporters can be
pharmacologically modified by drugs either enhancing surface translocation and activity
of GLUT transporters or decreasing glucose transport. Thus, we strived to establish one
assay for each case of pharmacological alteration. To inhibit glucose uptake, the chemical
compound STF-31, which has been described to specifically inhibit GLUT1, was used
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[168, 166]. Unfortunately, the different conditions tested did not influence cellular uptake of
JW41 nor the positive or negative controls.
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Figure 3.11 Competition binding assay in MDA-MB-231 (A and C) and MCF7 (B and D) cells with
increasing concentrations of D-glucose. The near-infrared dyes ICG and IR800CW were used as
a non-targeted control, IR800CW was intended as positive control. All dyes were used at 2.5 µM
concentration.
To induce pharmacological activation of glucose transport, a 12-O-tetradecanoylphorbol-
13-acetate (TPA) uptake assay was established. The phorbol ester TPA leads to the phos-
phorylation of serine 226 in GLUT1 causing a rapid enhanced cell surface localisation of
GLUT1 and an increased glucose uptake [169, 170]. Thus, treatment of the cells with TPA
was expected to result in an increase in JW41 uptake. A fluorescence increase of greater
than 44% in MDA-MB-231 and greater than 35% in MCF7 cells occurred for IR800CW-
2DG and JW41 when treated with TPA (13 µM) 1 h prior dye incubation, whereas there
was no fluorescence enhancement observed in cells treated with IR800CW (Figure 3.12).
These results may be due to the specific recognition of JW41 by tumour cells via glucose
transporters and thus its targeting capability.
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Figure 3.12 TPA assay to investigate GLUT specific uptake of JW41. Pharmacological activation of
glucose transport in A) MDA-MB-231 and B) MCF7 cells were induced with TPA (13 µM) 1 h prior
to dye addition and led to increased uptake of JW41 and the positive control IR800CW but not of the
negative control IR800CW. Statistical significance was assessed by unpaired 2 tailed t-test; ∗p< 0.05,
∗∗p< 0.01, ∗∗∗∗p< 0.0001.
3.2.3 In Vivo Characterisation - Biodistribution and Tumour Accumu-
lation
Having obtained promising in vitro results, the next goal was to investigate the biodistri-
bution, toxicity, tumour detection efficacy and reactivity of JW41 in vivo and to ensure a
unique optical signature.
The ability to detect the dyes PA and fluorescence signal in living subjects was first stud-
ied in female nude mice bearing bilateral subcutaneous MDA-MB-231 tumours. For a 20 g
mouse, 150 µL of 150 µM JW41 was injected intravenously into the tail vein, resulting in
∼15 µM circulating concentration (assumption: 58.5 ml blood per kg; https://www.nc3rs.org.-
uk/mouse-decision-tree-blood-sampling). The PA signal was recorded between 660 nm and
900 nm for a period of 30 minutes post-injection. As illustrated in Figure 3.13, an increase
in PA signal intensity as well as a change in the PA spectrum was observed in the tumours,
liver, kidneys and spleen within the first 5 to 10 minutes post-injection and remained high up
to 30 minutes post-injection (Figure 3.13A,B). The accumulation kinetics could successfully
be monitored following the signal at 760 nm (Figure 3.13C).
The specific accumulation of the contrast agent in tumour and liver was confirmed
with fluorescence imaging acquired before probe injection, 1 h post-injection and 24 h after
injection (Figure 3.14). The strong PA and fluorescence signals persisted for 24 h in the
tumours and liver, whereas the signals in spleen and kidney were decreased close to baseline
level. This indicates a specific retention of the dye in the tumours and liver, but not in the
kidneys and spleen.
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Figure 3.13 PA in vivo characterisation of JW41 in subcutaneous MDA-MB-231 tumours in nude
mice. A) Representative PA tomography slice through MDA-MB-231 tumours (top) and kidney,
spleen and liver (bottom) before and 30 min after injection of JW41 (150 µL of 150 µM for 20 g
mouse). The regions of interest are indicated with white borders (LT = left tumour, RT = right tumour,
L = liver, S = spleen, K = kidney, C = control region). B) Specific changes in the PA spectra and an
increase in the PA signal between 700 and 810 nm were detected in the regions of interest upon
injection of JW41. Representative graphs for tumour (top) and liver (bottom) are presented. The
spectra recorded between 0 and 10 min represent the intrinsic tumour / liver spectrum (grey). The
contrast agent was injected at 14 min. C) The increase in PA signal at 765 nm up to 24 h after injection
is shown and suggests specific retention of the dye in the tumours (top) and liver, but clearance in
kidney and spleen (bottom). PA signal changes in the control regions confirm that the PA signal
kinetic data are specific to the ROIs (Appendix Figure A.8).
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Figure 3.14 Fluorescence in vivo characterisation of JW41 in subcutaneous MDA-MB-231 tumours
in nude mice. A) IVIS images before as well as 1 h and 24 h post injection of JW41. (LT = left tumour,
RT = right tumour, L = liver, C = control region). B) The specific increase in radiant efficiency in the
tumours and liver upon JW41 injection (values from the control region, C, were used for background
correction).
To enable PA imaging of H2O2 it is necessary to differentiate the capped, JW41, and
uncapped, JW35, dye in vivo. Thus, the same study was performed with an injection of JW35
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but at a 3-times lower dose as used for JW41 (50 µM instead of 150 µM). The objective of
this was to investigate if a conversion of one third of JW41 into JW35 is detectable in vivo.
Similar PA signal changes and biodistribution results were observed (Figure 3.15). However,
the clearance of JW35 occurred faster with only a low signal remaining in the tumours, liver,
kidneys and spleen after 24 h (Figure 3.15C).
These results were affirmed with fluorescence imaging acquired before probe injection,
1 h post-injection and 24 h after injection (Figure 3.16), which indicated a strong increase in
the fluorescence signal in the tumours and the liver but a fast clearance over the following 23
hours.
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Figure 3.15 PA in vivo characterisation of JW35 in subcutaneous MDA-MB-231 tumours in nude
mice. A) Representative PA tomography slice through MDA-MB-231 tumours (top) and kidney,
spleen and liver (bottom) before and 30 min after injection of JW35 (150 µL of 50 µM for 20 g
mouse). The regions of interest are indicated with white borders (LT = left tumour, RT = right tumour,
L = liver, S = spleen, K = kidney, C = control region). B) Specific changes in the PA spectra as well as
a PA signal increase were detected in the regions of interest upon injection of JW35. Representative
graphs for tumour (top) and liver (bottom) are presented. The spectra recorded between 0 and 10 min
represent the intrinsic tumour / liver spectrum (grey). The contrast agent was injected at 14 min. B)
The increase in PA signal at 765 nm up to 24 h after injection is shown and suggests accumulation
of the dye in the tumours (top) and liver and to smaller extend in kidney and spleen (bottom). PA
signal changes in the control regions confirm that the PA signal kinetic data are specific to the ROIs
(Appendix Figure A.8).
The in vivo characterisation of JW41 and JW35 showed that both versions of the new
contrast agent can be detected separately in mice. It was therefore next examined whether
spectral unmixing is able to accurately detect and quantify the relative concentrations of the
capped and uncapped dye if present simultaneously in vivo. Even though it is assumed that
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Figure 3.16 Fluorescence in vivo characterisation of JW35 in subcutaneous MDA-MB-231 tumours
in nude mice. A) IVIS images before as well as 1 h and 24 h post injection of JW35. (LT = left tumour,
RT = right tumour, L = liver, C = control region). E) The specific increase in radiant efficiency in the
tumours and liver upon JW35 injection monitored over 24 h. (Values from the control region, C, were
used for background correction).
JW41 will be partially converted into JW35 in the tumours, to ensure that both dyes were
present for the evaluation of spectral unmixing in vivo, the same in vivo study was performed,
but on this occasion with a 2 : 1 mixture of JW41 : JW35 (150 µL of 100 µM JW41 and
50 µM JW35). Analysis of the PA in vivo data with linear regression multispectral processing
using the spectra of JW41 and JW35 obtained previously in tissue mimicking phantoms
(Figure 2.24) and published spectra for oxy- and deoxyhemoglobin (http://omlc.org/spectra/)
was applied to produce images indicating the relative weight that each dye spectrum con-
tributes to a given image pixel (Figure 3.17) and thus allowing the readout of H2O2 being
present in different regions of interest (ROI). Both probes could be successfully distinguished
from the background signal and visualised. In addition, it was possible to distinguish the
two forms of the contrast agent, JW41 and JW35, from each other in vivo by means of
spectral unmixing (Figure 3.17A-C). Furthermore, monitoring the accumulation kinetics with
spectral unmixing resulted in a similar biodistribution profiles of the dyes to those obtained
by monitoring the signal increase at 765 nm (Figure 3.13 and 3.15).
Comparing the weights of JW41 and JW35 in the ROIs of the mice injected with either
only JW41 or a 2 : 1 mixture of JW41 : JW35 indicate a conversion of 57±14% of JW41 into
JW35 (average across 7 tumours). Spectral unmixing in the liver - the organ with the highest
signal - of mice treated with the 2 : 1 mixture of JW41 : JW35 mirrors the injected ratio with
an accuracy of 11% (% deviation from the known concentration). However, as it was shown
in previous phantom studies (cf. Chapter 2, Section 2.2.5) the unmixing approach did not
match perfectly and some signal crossover was obtained resulting in background signal and
contribution of JW35 to the JW41 signal and vice versa, causing signal misclassification
to some extent. In addition, each single data point represents the average of multiple
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Figure 3.17 In vivo spectral unmixing of JW41 and JW35. Column 1&2: representative PA tomo-
graphy slice through MDA- MB-231 tumours, kidney, spleen and liver before and after injection
of A) JW41 (150 µL, 150 µM) B) JW35 (150 µL, 50 µM) C) 2 : 1 JW41 : JW35 mixture (150 µL,
100 µM JW41, 50 µM JW35) analysed by spectral unmixing with linear regression. The signal of
JW41 is shown in yellow, JW35 in magenta. Signal intensity indicates the relative weight that each
dye spectrum contributes to a given image pixel. White borders indicate ROIs (LT = left tumour,
RT = right tumour, L = liver, S = spleen, K = kidney, C = control region). Column 3: representative
PA signal kinetics curves obtained by spectrally unmixing of the outlined ROIs. The plotted values
derived by linear unmixing are zeroed to the mean of the first 3 measurements, which were performed
before probe injection. Column 4: PA signal increase (obtained by spectrally unmixing for JW41 and
JW35) relative to the baseline signal (average of the first 3 measurements) in the outlined ROIs at
30 min and 24 h after injection.
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slices through the tumour (number of slices were dependent on tumour size). The tumour
heterogeneity together with the unmixing approach explaining the relatively large error bars
(representing standard deviation). Nevertheless, the results suggest a good tumour detection
efficiency (also compared to the intrinsic signal of Hb and HbO2, cf. Appendix Figure A9)
and demonstrate the applicability of the dye to monitor oxidative stress in vivo. Finally, the
contrast agent was also injected into healthy mice, which were kept alive for a month after
injection. No signs of any toxicity were observed in these mice.
3.2.4 In vivo Evaluation - Therapy Monitoring
The next aim was to evaluate the capability of the new contrast agent to monitor oxid-
ative stress response in tumours upon treatment. As highlighted previously, the two breast
cancer cell lines, MDA-MB-231 and MCF7, feature different characteristics regarding their
glut1 expression and H2O2 production. Additionally, MCF7 cells are characterised as less
aggressive, less prone to metastasise, recruiting a more complex microenvironment and
exhibiting a better differentiated phenotype associated with a pronounced paracrine activity.
In comparison, MDA-MB-231 cells are more aggressive and less differentiated, they tend to
acquire mesenchymal characteristics and are inclined to metastases [171]. Therefore, it was
expected that these two cells lines would respond differently to therapy when subcutaneously
implanted in mice. Taking this as the starting point, the aim was to further investigate
the in vivo H2O2 reactivity of JW41 and the capability to monitor treatment response in
subcutaneous MDA-MB-231 and MCF7 tumour bearing mice. Liposomal doxorubicin
(Doxil), was used as anti-cancer treatment. Doxorubicin is an anthracyline chemotherapy
drug, which is routinely used in the treatment of several cancers including breast cancers.
One of the proposed mechanisms by which doxorubicin acts in cancer cells is the generation
of oxidative stress through reactive oxygen species, which damages cellular membranes,
DNA and proteins [171]. The liposomal version of doxorubicin acts in the same way but was
shown to reduce cardiac toxicity and increase tumour accumulation [171]. The study design
is outlined in Figure 3.18.
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Figure 3.18 Schematic illustration of the design of the in vivo study to examine the capability of
JW41 to monitor the response to the anticancer drug Doxil. On day 0, subcutaneous MDA-MB-231
and MCF7 tumour bearing mice were dosed with JW41 and imaged with MSOT and IVIS. After the
imaging session, the mice were treated with Doxil for the first time. Further MSOT and IVIS imaging
was performed on day 1, 2 and 3 and additional Doxil treatments were given on day 2 and 5. On day
6, mice were imaged before and after administration of a second dose of JW41. 24 h later, the mice
were imaged, culled and organs were collected for ex vivo examination. One cohort of mice for each
tumour type did not receive Doxil treatment but passed the same imaging process. One subcutaneous
MDA-MB-231 tumour bearing mouse was only treated with Doxil but not with JW41 to investigate
possible signals arising from Doxil.
PA and fluorescence imaging revealed a similar biodistribution and accumulation kinetics
to those observed in previous in vivo studies (cf. Section 3.2.3). The specific accumulation
of the contrast agent in the 2 different tumour types was confirmed (Figure 3.19 and 3.20).
Unfortunately, this study was confounded by some technical difficulties as the PA data
acquisition stopped regularly in between running imaging session, which required that the
mouse needed to be taken out of the scanner and placed in after restarting, along with
issues due to low and variable laser energy due to a faulty flashlamp. Additionally, mouse
health related issues did emerge during this study: the oestrogen dependent MCF7 tumours
required the implantation of oestrogen pellets. These pellets caused skin rashes as well as
bladder obstruction, which made the MCF7 tumour bearing mice rather weak. Amongst
other issues, this forced JW41 to be injected 5 minutes after the mouse was placed in the
MSOT, prohibiting baseline stabilisation before the start of the biodistribution study. These
circumstances led to an unstable baseline and variable PA data with low signal sensitivity,
which did not lead to acceptable and trustable results using spectral unmixing analysis.
On the other hand, fluorescence data revealed a slower signal reduction in the tumours
when compared to the liver, especially after the injection of the contrast agent in Doxil
treated mice (Figure 3.20). This may indicate either an overall prolonged retention of the
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Figure 3.19 PA signal kinetic data of the first injection of JW41 for A) MDA-MB-231 and B) MCF7
tumour bearing mice of treatment response study. The plotted PA signal at 760 nm is normalised for
each organ separately.
dye in tumours or the partial conversion of JW41 into JW35, which is accompanied with a
fluorescence signal increase. As the fluorescence imaging instrument used cannot distinguish
the two forms of the dye, it is not possible to draw further conclusions from these data.
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Figure 3.20 IVIS image (left) of A) MDA-MB-231 and B) MCF7 tumour bearing mice of treatment
response study 24 h after the first injection of JW41. IVIS signal kinetic curves over the time frame of
the whole treatment response study for A) MDA-MB-231 and MCF7 tumour bearing mice (n = 3)
divided into two cohorts, non treated (middle) and Doxil-treated (right) mice.
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3.2.5 Histopathology and Microscopy ex vivo Analysis
To examine the behaviour of the new contrast agent in greater depth, the localisation of
the dye in the tumours was investigated by ex vivo histopathological analysis on consecutive
sections that were either processed with Haemotoxylin and Eosin (H&E) or Caspase 3
(an apoptosis maker) stainings or directly imaged to detect the JW41 and JW35 signal.
Comparing necrotic areas of tissue, as assessed by H&E staining with the JW41 and JW35
signal by wide-field microscopy suggests that the dye accumulates to a greater extent in viable
areas or more JW41 gets converted into JW35 in these areas (Figure 3.21). Co-staining with
DAPI also provided confirmation that the dye gets uptaken into the cytosol of the cells in
vivo as was shown before for in vitro conditions (zoom, Figure 3.21). Further experiments
would be needed to differentiate JW41 and JW35 in these sections.
To confirm this observation, the tumour fluorescence intensity (determined on the IVIS
after necropsy) was compared to the tumour viability assessed by H&E staining (Figure
3.22A). Three out of the four tumours seem to support the assumption that less necrotic
areas present either an increased dye accumulation and/or greater conversion of JW41 into
JW35. However, it must be taken into account that viability assessment was performed on
one section through the tumour and hence does not reflect the whole tumour viability, which
is often heterogeneous.
Histopathological analysis was also used to investigate the effect of the doxil treatment.
Firstly, the level of tissue necrosis was assessed with H&E staining, but no significant
difference was observed between the treated and non-treated cohorts (Figure 3.22B). Next,
sections were stained for cleaved caspase-3. Caspase-3 is a critical executioner of apoptosis
and thus used as apoptosis marker [172]. Again, no response was seen to the Doxil treatment
(Figure 3.22C). Hence, for the tumour models and treatment conditions used here, Doxil
treatment was not observed to induce cell death. The target in this case was to induce
oxidative stress rather than necrosis, which was validated separately using LC/MS (see
section 3.2.6), so it was expected that little or no significant difference would be observed
between the cohorts.
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Figure 3.21 Histopathological and microscopy ex vivo characterisation of tumour tissues from in
vivo studies with A) JW41, B) JW35 and C) 2-1 JW41-JW35 mixture. First column illustrates
representative H&E stained section of frozen MDA-MB-231 tumours. The necrotic area is indicated
with the white line. Representative wide-field fluorescence images of a consecutive tumour section
section after formaldehyde fixation and staining with DAPI in mounting media (blue), are displayed
in the middle column. On the right, a magnification of the wide-field image is pictured, allowing the
localisation of the dye signal into the cytosol of the cells.
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Figure 3.22 A) Relationship between necrotic areas assessed by H&E staining and fluorescence
signal measured in the tumours after necropsy. Each bar represents a tumour from a mouse treated
with JW41. A) and B) Histopathological ex vivo examination of tumours from treatment response in
vivo study questioning the correlation between the different tumour types and between the treated and
non-treated cohorts.
3.2.6 Ex Vivo Evaluation by LC-MS/MS
It is important to cross-validate the in vivo conversion of JW41 into JW35. Fluorescence
imaging confirmed the specific accumulation of the contrast agent in tumour and liver but
because both, the capped and uncapped probe, share the same emission profile, it was not
possible to determine if a stronger fluorescence intensity is caused by a higher tumour accu-
mulation of JW41 or by the conversion of JW41 into JW35. Liquid chromatography tandem
mass spectrometry (LC-MS/MS) is a powerful, sensitive and discriminating tool for the
accurate detection of different molecules. Especially, when combined with multiple reaction
monitoring mass spectrometry (MRM-MS) methods, it enables highly sensitive quantification
of molecules in complex biological matrixes. In contrast to traditional mass spectrometry
methods, which attempt to detect all the chemicals in the sample in an indiscriminate manner,
MRM allows the MS to be calibrated to detect only the compounds of interest at the expected
range of concentration.
Thus it was sought to use this method to accurately quantify the relative concentrations of
JW41 and JW35 in tumours and livers to confirm the conversion of the capped dye into the
uncapped dye and to validate the accuracy of the spectral unmixing analysis. Additionally,
an established LC-MS/MS method was used to question the efficacy of the Doxil treatment
by quantifying the amount of glutathione (GSH) and glutathione disulfide (GSSG) in each
sample [173].
116 Application of the New H2O2-Activatable Photoacoustic Probe in Cancer
Workflow for LC-MS/MS Analysis of JW41 and JW35
The target molecules, JW41, JW41hydrol and JW35, were extracted from homogenised
tissue samples with MeCN : H2O (8 : 2) and separated by their chromatographic retention.
Subsequent mass analysis with MRM-MS was performed, where the specified parent ion of
each dye derivative was isolated from all other ions entering the MS and targeted for further
fragmentation. The detected MRM signal was then integrated and used to determine the
concentration of the dye within the tissue sample, by comparing it with a calibration line of
dye standards in tissue matrix. To validate the calibration line and the status of the analytical
system, six quality control (QC) samples at three known concentrations were run before and
after the biological samples [174]. Reproducible extraction of analytes from a biological
matrix is challenging and often affects the accuracy of mass quantification. This can be
improved by the use of an internal standard (IS), which is added to the biological samples,
calibration standards and QCs and helps to correct for variability in the extraction efficiency
and matrix effects [175]. Quantification is then performed by calculating the ratio of the
integrated areas of the MRM peak of the dye and that of the internal standard. An overview
of the workflow is illustrated in Figure 3.23.
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Figure 3.23 Schematic illustration of LC-MS/MS workflow for ex vivo evaluation studies. After the
sample preparation, which includes organ collection, homogensiation, extraction and spiking with the
IS, the samples are separated by chromatographic retention and eluted into the MS ionsource. There
the selected compounds are isolated as the parent ions and fragmented in the MS-MS mode. Only the
selected fragments (“daughter ions”) are then further isolated and detected. The MRM transition from
parent to daughter ion is quantified as a peak area.
Internal Standard and Validation of Matrix Effects, Calibration Curves and Detection
Limits
Ideally, the internal standard is embodied by an isotopically labelled version of the
analyte itself, since it bears the same chromatographic and ionisation characteristics but
exhibits a unique mass signal, which can be used for separate integration. Unfortunately, the
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synthesis requirements and instability of the dye molecules under certain conditions made it
challenging to synthesise an isotopically labelled derivative.
N
N
N
N N
N
N
N
N
O
HOHO
OH
HO
O
HOHO
OH
HO
N
O
O
Figure 3.24 Molecular struc-
ture of JW56.
Thus, a structurally similar molecule was synthesised,
which possesses a specific fragmentation pattern and a reten-
tion time similar to those of the analytes. The first attempt,
was to prepare the boc-protected derivative of JW35, JW56
(Figure 3.24). Even though JW56 gave a distinct mass signal
(m/z = 1220.624 (z = 1) transition to m/z = 282.82), which could
be used for integration, and eluted similarly to the analytes, its
signal intensity and profile showed great variability indicating
JW56 to be unstable in the matrix and under the LC-MS/MS
chromatographic conditions. During the dye development pro-
cess, the JW35-derivative JW35Mono was synthesised, which carries only one glucose
moiety (cf. Chapter 2.2.4, Figure 2.17). Its structural features looked promising for its
suitability as IS due to the similarity to JW35 and JW41. LC-MS/MS analysis confirmed
that JW35Mono eluted similarly to JW35 and JW41 and showed a unique and stable mass
signal for quantification (Figure 3.25) (consistency was validated over a range of four concen-
trations in matrix as well as MeCN : H2O (8 : 2)). Although, JW35Mono was contaminated
with trace levels of JW35, the signal of this impurity was below the threshold in the noise
range and thus negligible.
Next, the most abundant fragments for JW41 and JW35 were identified, which will be
used for quantification (Figure 3.25B-D). The strongest parent ion for JW35 appeared to be
the doubled charged ion (m/z = 560.30 (z = 2)) and hence this was used for fragmentation
(Figure 3.25). Due to the tendency of JW41 to hydrolyse in aqueous solutions and especially
on-column under the acidic conditions (solvent A: H2O+0.1% FA; solvent B: MeCN+0.1%
FA), the fragmentation pattern for JW41hydrol was also determined (Figure 3.25C). All three
analytes (JW41, JW41hydro and JW35) were well distinguishable through their fragmenta-
tion patterns (Figure 3.25B-D) as well as their retention times (Figure 3.25E-F). The nearly
simultaneous elution of the IS (JW35Mono) with JW35 and JW41hydro did not influence
the quantification process, as MRM operates by targeting the defined parent ions separately
(Figure 3.26). For quantification of the IS (JW35Mono), in the first quadrupole segment
Q1 only the ions with m/z = 914.5 are isolated from all ions entering the MS. Subsequently,
the isolated m/z = 914.5 ions entering the collision chamber Q2, where they get fragmen-
ted into their daughter ions (m/z = 161.11, 172.11, 187.12, 201.14, 215.15) (Figure 3.25E).
When entering the third quadrupole segment Q3, all daughter ions are removed except the
118 Application of the New H2O2-Activatable Photoacoustic Probe in Cancer
MS/MS fragmentation of
JW41hydro (m/z)=1297.6
In
te
ns
ity
 (a
.u
.)
m\z (Da)
830.3936 846.4097
845.4066
831.3912
10000
4000
2000
6000
8000
800 850 900
0
832.3943
D
MS/MS fragmentation of
JW35 (m/z)=560.3
In
te
ns
ity
 (a
.u
.)
m\z (Da)
217.0808
928.5027
220.1044
208.1036
1200
600
300
900
190 210 230 250
194.0904
247.1148
201.1307
0
F
MS/MS fragmentation of
JW41 (m/z)=1379.7
In
te
ns
ity
 (a
.u
.)
m\z (Da)
869.4911 914.4876
928.5027
927.4978
913.4826
6000
1000
3000
2000
4000
5000
850 900 950 1000
0
B
JW41 (m/z=1379.67, z=1) 
JW41hydro (m/z=1297.61, z=1) 
JW35 (m/z=560.30, z=2) 
IS (m/z=914.48, z=1) 
MS/MS fragmentation of
IS (m/z)=914.5
In
te
ns
ity
 (a
.u
.)
m\z (Da)
187.1223
201.1378
161.1111
160 170 200 210
215.1533172.1100
0
H
180 190
2.5x105
5x105
1x105
5x104
In
te
ns
ity
 (a
.u
.)
3.23
JW41hydro
Time (min)
E MRM for JW41hydro
0
1x104
2x104
2 2.5 3 3.5 4
In
te
ns
ity
 (a
.u
.)
0
1x104
5x103
2 2.5 3 3.5 4
Time (min)
3.47
JW41
C MRM for JW41
In
te
ns
ity
 (a
.u
.)
0
1x104
2x104
3.08
JW35
G MRM for JW35
Time (min)
2 2.5 3 3.5 4
6x106
1x106
5x106
4x106
3x106
2x106
0
0 3.3 3.5
Time (min)
3.4 3.73.63.2
In
te
sn
sit
y (
a.
u.
)
Ion chromatogram
3.3 3.53.4
1x106
0
In
te
ns
ity
 (a
.u
.)
0
1x106
1.5x106
5x105
3.12
IS
I MRM for IS
Time (min)
2 2.5 3 3.5 4
Figure 3.25 LC-MS/MS chromatograms of JW41(75 nM), JW35 (38 nM) and the IS (JW35Mono,
190 nM). A) Representative ion chromatogram of of JW41, JW35 and the IS. B), D), F) and H)
Fragmentation of the parent compounds JW41 (m/z=1379.67), JW41hydro (m/z=1297.61), JW35
(m/z=560.30) and IS (M/z=914.48), respectively. MRM peaks for JW41 (monitoring m/z=1379.67
transition to m/z=913.48), JW41hydro (monitoring m/z=1297.60 transition to m/z=831.39), JW35
(monitoring m/z=560.30 transition to m/z=208.10) and IS (monitoring m/z=914.48 transition to
m/z=161.11) are shown in C), E), G) and I), respectively.
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selected daughter ion (m/z = 161.11), which then gets detected. This selective process results
in a characteristic and very sensitive MRM peak for the IS (JW35Mono; transition from
m/z = 914.5 to m/z = 161.1; Figure 3.25). Similarly, the specific JW35 ions with m/z = 560.1
(z=2) are isolated in Q1, entering the collision chamber Q2, where they are fragmented
into the daughter ions (m/z = 220.1, 217.1, 208.1, 201.1, 194.1 (all with z = 2)). In Q3
only the daughter ion with m/z = 208.1 gets directed to the detector and a characteristic and
very sensitive MRM peak for JW35 manifests (transition m/z = 560.2 (z = 2) to m/z = 208.1
(z = 2), Figure 3.25). The same procedure generates the unique MRM peak for JW41hydrol
(transition m/z = 1297.6 to m/z = 831.4) and JW41 (transition m/z = 1297.6 to m/z = 831.4).
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Figure 3.26 Schematic illustration of MRM quantification.
Evaluation of matrix effects and extraction recovery of the dyes and IS was performed in
liver matrix and tumour matrix (n≥ 3). Therefore, standard solutions were added either to
the tissue, the tissue matrix (tissue homogenate) or MeCN : H2O (8 : 2) and processed the
same way. The matrix effect led to a signal increase of 2.9% for JW35Mono and of 4.4%
for JW35, while for JW41 a signal suppression of 21.5% was observed.
As work was carried out with frozen tissue samples, it was assumed that frozen tissue is
unable to take up any of the dye and thus in the following studies the calibration standards
and IS solutions were only added after homogenisation of the tissue.
The lower limit of quantification was determined using samples with known concentra-
tions of analytes and defined as the lowest concentration of analyte that was quantifiable in a
matrix sample with a precision within 20% and an accuracy of 80–120%. This was 473 pM
for JW35 and 945 pM for JW41. The higher detection limit for JW41, which is double the
value of JW35, is likely due to the hydrolysis of JW41 leading to two separately detected
compounds and thus reducing the effective concentration for each. Calibration lines in both
tumour and liver matrix were constructed for each dye with an accuracy of 80–120% (Figure
3.27A,B). The calibration lines were cross-validated by six QC samples at three different
concentrations.
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As discussed in Chapter 2 (section 2.2.5), JW41 undergoes hydrolysis in aqueous solu-
tions, which increases greatly on-column and under acidic conditions. Unfortunately, it was
necessary to extract the dyes from the tissues with 20% water content and to use acidic
conditions to obtain fast elution of the dyes. As a consequence of this, the MRM peak area of
JW41 in the standard samples run at later time points of the assay, the concentrations were
lower than expected due to hydrolysis of JW41 to JW41hydr. However, the loss appeared
to be compensated by the increase in the MRM peak area of the JW41hydr. Based on these
data and given that the hydrolysis of JW41 could not be avoided under the experimental
conditions, the peak area of the MRM transitions of JW41 and JW41hydr were added to-
gether to represent the original concentration of JW41. This assumption was reinforced by
two linearity curves, each run at four concentrations ten times over a time frame of 10 hours
(Figure 3.27C). The robustness of the method was validated by measuring five of the tumour
samples at different concentrations and three of them again on a different day. The intra- and
inter-batch variation of the relative concentrations was below 3%.
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Figure 3.27 Calibration lines for ex vivo quantification of A) JW35 and B) JW41 by LC-MS/MS.
For each study a new calibration curve was acquired before and after running the samples. One
representative calibration line for JW35 and JW41 is shown. The coloured symbols representing
values obtained from the calibration samples, the crosses are indicating the values of the QC samples
validating the calibration curve. C) Linearity curves for JW41, JW41hydr and JW41total being the sum
of JW41 and JW41hydr.
Detection and Quantification of JW41 and JW35 in Tissue Samples
The optimised and validated method was used to quantify the relative concentrations of
JW35 and JW41 in tumour and liver samples to investigate differences in the conversion
rate of JW41 into JW35 in tumour vs. liver, MDA-MB-231 tumours vs. MCF7 tumours and
Doxil treated tumours vs. non-treated tumours.
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Examining the tumours from the biodistribution and tumour accumulation in vivo study
(cf. section 3.2.3) via LC-MS/MS in multiple reaction monitoring mode (MRM-MS) indic-
ated that the total concentration of dye (JW41 + JW41hydro + JW35) being present in the
tumours was between 726 pmol/g and 1261 pmol/g for the mice treated with JW41 (150 µL,
150 µM) and between 103 pmol/g and 247 pmol/g for the mice treated with the 2-1 mixture
of JW41-JW35 (150 µL, 100 µM JW41, 50 µM JW35) (Figure 3.28A). Unfortunately, as
the boronate groups of JW41 are partially hydrolysed to give JW41hydro by the aqueous
and acidic conditions required for the LC-MS/MS analysis, the resulting values of total
JW41total concentration and thus also the total dye concentration cannot be interpreted as
absolute. Hence, only the relative values were considered for interpretation. This led to
the following observations: A significant difference between the conversion of JW41 into
JW35 in the livers and tumours was detected. In the liver less than 8% of JW41 reacted with
H2O2, whereas in the tumours more than 36% was transformed (Figure 3.28B). This was
expected as the H2O2 production in the liver should be relatively small in comparison to the
tumour. The ratio of JW35 to JW41 was also calculated for the mice treated with the 2-1
JW41-JW35 mixture. However, as shown before, JW35 presents a different biodistribution
profile than JW41 and gets nearly completely cleared after 24 hours. Since the organs were
only collected 24 hours after injection of the contrast agent, very little increase in the amount
of JW35 in the tumours was observed, as was the case for the mice treated only with JW41.
This is confirmed by the data obtained via LC-MS/MS analysis since the conversion ratio
mirrored the one from the mice where pure JW41 was administered. To exclude mistakes
made during the sample preparation, samples were measured at different concentrations and
on different days. The concentration and batch-to-batch variation was less than 3%.
Next, the difference in JW41-transformation between Doxil treated and non-treated
mice was investigated. For both tumour types, the mice treated with Doxil showed a
higher conversion than the mice that did not receive Doxil treatment (Figure 3.28B). These
results suggest that while both tumour types responded to the Doxil treatment in terms of
oxidative stress, the MCF7 tumours generate slightly more oxidative stress than MDA-MB-
231 tumours.
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Figure 3.28 Results of JW35 and JW41 ex vivo LC-MS/MS analysis of tumour and liver samples. A)
Calculated total concentration of JW41total and JW35 24h after injection of JW41 or the 2 : 1 mixture
of JW4 : JW35. The results of 4 tumors where the mice received an injection of JW41 alone and 3
tumors where mice received an injection of 2 : 1 JW41 : JW35 solution are shown. B) Comparison of
the relative amount of JW41 that got converted into JW35 in MDA-MB-231 tumours and livers of mice
treated either pure JW41 or a 2 : 1 mixture of JW41 : JW35. C) Comparison of JW41-conversion in
Doxil treated and non-treated MDA-MB-231 and MCF7 tumour bearing mice. Statistical significance
was assessed by 2way ANOVA; ∗∗∗∗p< 0.0001; ∗∗∗p= 0.0002, ∗∗p= 0.008, ∗p< 0.05.
Detection and Quantification of GSH and GSSG in Tumour Tissue
The redox balance in a cell does not exclusively depend on the generation of ROS.
Glutathione (GSH) is one of the most abundant sources of cellular reducing equivalents and is
crucial for the redox balance. Consequently, the effect of Doxil on GSH levels was examined
following an established procedure to detect GSH and its oxidation product Glutathione
disulfide (GSSG) in tumour homogenates by LC-MS/MS [173, 176]. As IS, commercially
available 13C and 15N labelled GSH and GSSG (GSH-glycine-13C2,15N; GSSG-glycine-
13C2,15N) were used. The data indicated that there was no significant changes in the total
glutathione concentration nor in the GSH/GSSG ratio following Doxil treatment. Moreover,
no difference was observed between the two tumour types (Figure 3.29). Hence, Doxil does
not appear to influence the GSH to GSSG ratio or the total glutathione concentration in the
examined tumours. Prior work demonstrated that Doxil leads to an increase in GSH in A2780
tumours (Dr. Tim Witney, not yet published results). However, discrepancies between this
work and previous findings can be explained by tumour diversity and the fact that the spatial
and temporal distribution of different redox species is highly heterogeneous in tumours and
regulated by different, independent systems.
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Figure 3.29 Results of GSH/GSSG LC-MS/MS analysis in tumour samples of treatment response
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different cohorts.
3.3 Summary and Conclusions
New methods for the specific detection and quantification of ROS in vivo will be critical
to advance the clinical understanding of severe diseases. Accordingly, the goal of this chapter
was to evaluate the new activatable, targeted contrast agent towards its application in H2O2
imaging in cancer.
The ability of the new probe to detect rapidly and specifically physiological amounts of
H2O2 via PA, absorption and fluorescence spectroscopy was demonstrated. In addition to this,
it was shown that spectral unmixing allows the relative quantification of the concentration
of the original probe, JW41, and the H2O2-transformed probe, JW35 in tissue mimicking
phantoms.
In vitro studies indicated the new contrast agent has no significant toxicity and demon-
strated the specific uptake of the dye into the cytosol of cells. Furthermore, the cellular
uptake could be effectively increased by treating the cells with TPA suggesting effective
GLUT targeting.
In vivo studies yielded promising results with the absence of toxicity over four weeks, the
accumulation of the contrast agent in tumour tissue accompanied with specific changes in the
PA tumour spectra and the H2O2-dependent conversion of the contrast agent into its uncapped
form. Additionally, spectral unmixing approaches were introduced to successfully generate
images indicating the presence of the new activatable contrast agent and its conversion
product.
Finally, ex vivo analyses revealed a heterogeneous cytosolic localisation of the contrast
agent in tumour tissue with a decreased accumulation in necrotic tumour areas. Additionally,
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LC-MS/MS analysis confirmed the transformation of JW41 into JW35 in tumour tissue and
indicated the applicability of the activatable contrast agent for treatment response monitoring.
However, further work is required to improve the unmixing approach described in this
manuscript. Currently signal misclassification exists, this is caused by signal cross over,
shadowing, motion and fluence effects. Signal misclassification can occur when using
a linear regression approach due to the similarity in the in vivo spectra of JW41, JW35
and intrinsic chromophores. The latter issue could be partially evaluated by studying the
influence of the blood oxygenation state on the dye’s signal in phantoms and by evaluating
more precisely the detection limit and resolution depending on the concentrations of the dyes.
Furthermore, spectral colouring, the process whereby shorter wavelengths are preferentially
attenuated in tissue, may distort the spectra measured at depth in vivo. Therefore, applying a
fluence correction to the data and using more complex unmixing models coping with further
nonlinear interactions may improve the quantification capabilities but was not possible in
the software used for analysis during this study. Spectral unmixing could also be improved
with structural modifications generating narrower peaks and greater spectral differences
between the capped and uncapped dye. Modifying the dye structure would also allow the
use of different disease-specific targeting moieties and extend the use of this new activatable
contrast agent to the study of oxidative stress in a broad range of pathological conditions,
with a high temporal and spatial resolution in living subjects.
3.4 Material and Methods
3.4.1 ROS Sensing
Absorption and fluorescence spectra were recorded at 25 ◦C using a fluorescence spectro-
photometer (Cary Eclipse, Varian) and an UV-VIS spectrophotometer (Cary 300, Varian).
Samples were placed into quartz cuvettes (Suprasil) with a 10 mm pathlength. Monitoring
the reaction with H2O2 by PA spectroscopy was recorded in micro plastic cuvettes (Y200.1,
ROTH) in a PA spectrometer using a laser module (SplitLight 600 OPO) coupled into a
silica fiber (CeramOptec), an immersion transducer (A392S, Olympus-NDT) and the data
acquisition unit of MSOT inVision256. The set-up was assembled and optimised together
with Stefan Morscher from iThera Medical and a schematic illustration can be found in the
Chapter 2, Section 2.4.3).
To assess the optical responses of JW41 to H2O2, the dye (10 µM) was incubated with
100 µM H2O2 and the absorption, fluorescence and PA spectra were recorded before and
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up to 90 minutes after addition of H2O2 at either 5 minute intervals over the whole period
or at 1 minute intervals for the first 10 minutes followed by 5 minute intervals. JW41 in
water without the H2O2 supplement served as controls. To prove that the product of the
reaction, JW35, does not react further, the same measurements were performed with JW35.
All experiments were repeated with n≥3 separately prepared dye samples and errors are
represented as standard deviations.
LCMS analysis of the reaction of the dyes with H2O2 was performed using an Agilent
LC-MSD ionTrap model XCT LCMS equipment in electrospray mode. Agilent XDB C18
Column (1.8 µm, 4.6 mm x 50 mm) was used as the UPLC column. The conditions of the
UPLC method are as follows: Solvent A: Water +0.1% formic acid; Solvent B: Acetonitrile
+0.1% formic acid; Gradients: 0 - 1.3 minutes 5% B; 1.3 - 5 minutes 5 - 60% B, 5 - 6 minutes
60 - 100% B, 6 - 8 minutes 100% B with re-equilibration time of 3 minutes. Flow rate:
0.9 ml/min; Column and injector temperature set to 25 ◦C; Injection volume of 20 L. The
signal was monitored at 254 nm and 750 nm with 360 nm as reference wavelength.
In order to verify that the optical changes triggered by 100 µM H2O2 are due to the
conversion of JW41 into JW35, the 10 µM JW41 reaction solution from the UV-VIS and
fluorescence measurements were subjected to LCMS analysis at multiple time points without
further modifications.
To prove the oxidative cleavage of the boronic esters is selective to H2O2, aqueous
10 µM JW41 solution was incubated at 37 ◦C for 1 hour with different ROS. 100 µM H2O2,
100 µM tBuOOH, 100 µM OCl-, 100 µM ONOO- and 100 µM KO2 were prepared by
directly diluting commercially available H2O2 (9.7 M), tBuOOH (70 wt.% in water), NaOCl
(10-14% W/W), KO2 (solid). 200 µM 1O2 was produced from H2O2 catalysed by Na2MoO4
and 100 µM .OH and tBuO. were generated from Fenton reaction between H2O2 or tBuOOH
and Fe(ClO4)2 [177, 178]. The presence of ROS in the solution used for the assay was
validated with DCF-DA, CellRoxGreen and/or Quantofix peroxides test sticks. For CellRox
green based cross validation, unspecific double stranded DNA (length of 30 basepairs) was
added.
Serum Stability
Serum stability of the dyes was assessed with LCMS using the same method as described
in the previous section 3.4.1.
20 µM dye solutions in FBS were incubated for 0, 30, 60 and 120 min at 37 ◦C. After the
incubation period, 35 µL sample was taken, 50 µL cold MeCN was added and the sample
was centrifuged for 15 min at 4 ◦C at 5000 rpm. The supernatant was collected and injected
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directly into the LCMS (20 µL injection volume). Measurements were repeated three times
with separately prepared dye solution.
3.4.2 Protein-Binding Assay
To test the binding of JW41 and JW35 to proteins, both dyes as well as ICG and
IR800CW were added to 3 wt.% bovine serum albumin solution in PBS to reach a final
concentration of 1 µM and incubated for 15 min, 30 min or 60 min at 37 ◦C. Next, native-
PAGE sample buffer (Invitrogen) was added to the sample in a 1:3 ratio and the samples
were loaded into a nativePAGE Bis-Tris gel (Invitrogen). The gel was run in nativePAGE
running buffer (Invitrogen) at 4 ◦C for 70 min at 150 V followed by 20 min at 200 V. The gel
was imaged on an Odyssey CLx system (LI-COR) using the 700 nm and 800 nm channel.
Afterwards, the gel was stained with InstantBlue for 1 h at room temperature and imaged
again an an Odyssey CLx system (LI-COR) using the 700 nm channel.
3.4.3 In vitro Cell Experiments
General Considerations
The two human adenocarcinoma cell lines MDA-MB-231 (Oestrogen Receptor neg, OR
neg) and MCF-7 (Oestrogen Receptor pos, OR pos) were obtained from the Cancer Research
UK (CRUK) Cambridge Institute Biorepository from the University of Cambridge. The
experiments were performed when cells were between passage 22-35 for MCF-7 and between
passage 30 to 43 for MDA-MB-231. Authentication using Genemapper ID v3.2.1 (Genetica)
by STR Genotyping (11/2017) showed exact match with the reference sequence in both cases.
Cells were maintained in Dulbeccos Modified Eagle Medium (21885-025, ThermoFisher
Scientific, UK) with 10% heat inactivated fetal calf serum (1050064, ThermoFisher Scientific,
UK) at 37 ◦C in 5% CO2. The cells were routinely subcultured when reaching 85% confluence
(1:10 for MCF-7 and 1:20 for MDA-MB-231).
Quantification of GLUT Expression by rtPCR
To confirm the different GLUT expression levels of MDA-MB-231 and MCF7 cell lines
quantitative PCR was performed. Cells were grown in 6-well plates to reach 90% confluency.
RNA was isolated using solutions, materials and protocol supplied by ThermoFisher within
the PARIS kit. Reverse transcription of the isolated RNA was performed using the high-
capacity cDNA reverse transcription kit (appliedBiosystems) and quantitative real-time
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polymerase chain reaction (PCR) was carried out with the use of TaqMan Gene Expression
Master Mix and SLC2A1-specific PCR primers (Hs00892681 m1, ThermoFisher). TATA
sequence binding protein (TBP) served as reference gene. The thermal cycling conditions
were as follows: 2 min at 50 ◦C, 10 min at 95 ◦C and 40 cycles of 15 sec at 95 ◦C followed by
1 min at 60 ◦C.
Cell Toxicity Studies
Cellular toxicity of the dyes was examined by quantifying cell proliferation and viability
via standard MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay and
IncuCyte proliferation assay. For the MTT assay, cells were seeded at 40 000 cells per well
in a 96-well plate and grown to 80% confluency. The media was replaced by 100 µL fresh
media containing either 5 µM JW41, 5 µM JW35, 5 µM ICG, 0.5% DMF or no supplements
(control) and incubated for in total 8 hours. After 5 hours of incubation, MTT reagent was
added to each well to reach a final concentration of 0.5 mg/mL and the cell were incubated
for the remaining hours. After the incubation time, 100 µL lysis buffer (20% SDS in 50%
dimethylformamide) was added per well and incubated at room temperature overnight. The
absorbance was measured at 590 nm. The values are normalised against the control group.
Error bars are expressed as standard deviation (n = 4).
Cellular proliferation measurements were conducted with an Incucyte Zoom System
(Essen Bioscience, UK). Cells were seeded in complete medium in 48-well plates (Corning,
UK) at a density of 50 000 cells per well and immediately placed in the Incucyte for imaging.
Twenty-four hours later, the cells were exposed to the following compounds for 6 hours:
JW35 (5 µM), JW41 (5 µM), ICG (5 µM) or vehicle (DMF 1%). A reference group (not
exposed to any compounds) as well as a positive control group exposed to 1 mM H2O2
(H1009, Sigma-Aldrich, UK) were also included. Four replicates were performed for each
condition. At the end of the 6 hour incubation, a media change was performed and well
confluence was tracked for a further 120 hours. Images were analysed with the Incucyte
Zoom software version 2016.
General Cell Uptake Studies
Cellular uptake kinetics of JW41 as well as JW35 were examined in MDA-MB-231 and
MCF7 cells. Cells were seeded at 50000 cells per well in phenol red free media in 24-well
plates. After reaching 90% confluency, the media was replaced with fresh phenol red free
media containing 5 µM JW41 or 5 µM JW35 and incubated for 15 min, 30 min, 45 min,
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60 min, 90 min or 240 min. The assay was stopped by washing three times with PBS (2 min
each) followed by imaging with Odyssey CLx (LI-COR) using the 800 nm channel. Error
bars are represented as standard deviations (n≥ 3); the normalised intensity was calculated
as percentage of the maximum obtained fluorescence intensity within a group.
Cellular localisation was assessed by wide-field microscopy. MDA-MB-231 and MCF7
cells were seeded at 40 000 cells per well in a 96-well plate and grown to 80% confluency. For
live cell imaging, the medium was aspirate and replaced with phenol red free media containing
2.5 µM JW41/35. 45 min before completion of the incubation time, MitoTracker orange was
added (final concentration of 300 nM), 30 min into the incubation time LysoTracker green
was added (final concentration of 60 nM) and 15 min before the end of the incubation time
NucBlue Live ReadyProbes Reagent was added. Next, the cells were washed three times with
PBS and kept under phenol red free media for imaging. Fluorescence imaging was performed
on a wide-field fluorescent microscope (Zeiss Axio Observer Z1) in a CO2 and temperature-
controlled incubation chamber (set to 5% CO2, 37 ◦C) under a 63x oil-immersion objective
lens. Fixed Cells were used for co-staining with Wheat Germ Agglutinin-Alexa Fluor 488
(WGA-AF488). As before, cells were incubated in phenol red free media containing 2.5 µM
JW41/35 for 60 min. 45 min before completion of the incubation time, MitoTracker orange
was added to reach a final concentration of 300 nM. After incubation, cells were washed
three time with PBS and fixed with 4% paraformaldehyde solution in PBS at 37 ◦C for
15 min. Following fixation, cells were stained with WGA-AF488 (5 µg/mL) and Hoechst
(5 µg/mL) for 10 minutes at room temperature, washed three times with PBS and imaged on
a wide-field fluorescent microscope (Zeiss Axio Observer Z1) under a 63x oil-immersion
objective lens. The fluorescence of JW41/35 was collected upon excitation, which was
centred at 770 nm, 580 nm centred excitation was used for MitoTracker orange, 490 nm
centred excitation for LysoTracker green and 365 nm centred excitation for NucBlue/Hoechst.
Zen 2.3 (blue edition) was used for imaging analysis.
GLUT Dependent Cellular Uptake Studies
Binding and specificity of JW41 were tested by fluorescence based inhibition, compet-
ition and pharmacological induction/suppression assays using MCF-7 and MDA-MB-231
cells. ICG, IR800CW were used as a non-targeted control dye, IR800CW-2DG and 2-NBDB
were used as positive controls (results for 2-NBDB are not shown since the assay needs
further optimisation). Cells were grown in high/low glucose media in a 96-well plate to
80-90 % confluency.
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2-DG Inhibition Assay
For 2-DG inhibition assay, the cells were starved for 2 h in no-glucose DMEM supplemen-
ted with 10% FBS and 1 x GlutaMAX supplement (100 x concentrate, ThermoFisher). After
the starvation period, the media was replaced with no-glucose DMEM containing 2.5 µM
JW41/JW35/ICG/IR800CW/IR800CW-2DG or 100 µM 2-NBDG and increased concentra-
tions of unlabeled 2-Deoxyglucose (0, 1, 6.25, 12.5, 25, 50, 100 mM) and incubated for an
additional hour at 37 ◦C. For 2-NBDG the cells were incubated for only additional 20 min.
The inhibition assay was stopped by washing with PBS and fixation with 4% formaldehyde
solution for 20 min at room temperature. The fixed cells were then washed three times with
1x PBS + 0.02% Triton to permeabilise the cells and remove unbound dye. Following this
step, the plates were blocked in Odyssey Blocking Buffer (1x in PBS; LI-COR Bioscience)
for 60 min and consecutively stained for 5 min with DRAQ5 (5 µM in PBS; 5 min at room
temperature) to normalise for the cell number per well. After three washing steps with
1 x PBS + 0.02% Tween-20 and one washing step with 1x PBS, the 96-well plates containing
the NIR dyes JW41/JW35/ICG/IR800CW/IR800CW-2DG were imaged with Odyssey®
CLx (LI-COR Bioscience). The dye fluorescence signal detected from the 800 nm channel
was normalised in a ratiometric way using the 700 nm signal generated by DRAQ5. For
the wells containing 2-NBDG the read out was performed on a Typhoon imaging system
using the Cy2 channel (488 nm excitation) for 2-NBDG and the short-red channel (685 nm
excitation) for DRAQ5.
Pharmacological STF-31 Inhibition Assay
GLUT1 specific inhibition was carried out by pre-incubating the cells in low glucose
DMEM with STF-31. For MDA-MB-231 cells a STF-31 concentration of 10 µM was
used and the cells were pre-incubated for 8 h, 16 h, 24 h and 32 h. For MCF-7 cells a
STF-31 concentration of 5 µM was used and the the pre-incubation times were set to 2 h,
4 h, 6 h and 8 h. After the pre-incubation period, the media was replaced with low glucose
DMEM containing the above stated concentration of STF-31 and 5 µM ICG or 2.5 µM
JW41/JW35/IR800CW/IR800CW-2DG and incubated for an additional hour.
Glucose Competition Assay
To evaluate the competitive effect of glucose in respect of the cellular uptake of JW41 and
JW35, the cells were pre-incubated with no-glucose DMEM (supplemented with 10% FBS
and 1 x GlutaMAX supplement (100 x concentrate, ThermoFisher)) and increasing concentra-
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tions of D-glucose (0, 5, 10, 25, 50, 100 mM) for 3 h. After the incubation period, the media
was replaced with no-glucose DMEM containing 2.5 µM JW41/JW35/ICG/IR800CW/
IR800CW-2DG or 100 µM 2-NBDG and the same concentrations of D-glucose (0, 5, 10, 25,
50, 100 mM) as used for the starvation period. After an additional hour (20 min for 2-NBDG)
of incubation at 37 ◦C, the plates were washed with PBS and fixed, permeabilised, blocked,
stained, imaged and analysed as described above.
Pharmacological TPA Activation Assay
GLUT dependent uptake was evaluated by immunofluorescent assay. Cells were grown
to 60-90% confluency in 96-well plates and incubated with 13 µM TPA in media for 1 h
at 37 ◦C. After washing twice for 2 min with PBS, glucose free media supplemented with
IR800CW, IR800CW-2DG or JW41 (2.5 µM) was added and incubated for an additional
hour at 37 ◦C. After 1 h of incubation DRAQ5 was added to each well to reach a final
concentration of 5 µM and incubated for 10 min. The assay was stopped by washing three
times with PBS (2 min each) followed by imaging with a microplate reader (ClarioStar, BMG
Labtech), exciting at 763-15 nm and 646-15 nm with emission collected at 810-14 nm (LP785
dichroic filter) and at 697-20 nm (670.2 dichroic filter) respectively. Quantification was
normalised by ratiometric analysis of the fluorescent signals obtained from both channels.
Error bars are represented as standard deviations (n = 4).
3.4.4 In vivo Studies
General Considerations
All mice procedures conducted meet the standards required by the UKCCCR guidelines
and were performed under the authority of project and personal licenses issued by the Home
Office, U.K., reviewed by the Animal Welfare and Ethical Review Board at the CRUK
Cambridge Institute [179]. 300000 MDA-MB-231 and 500000 MCF7 cells in a final volume
of 100 µL of 1:1 DMEM (GIBCO) and matrigel (BD) were inoculated orthotopically in
the mammary fat pad of both flanks of 10 seven to eight-week-old immunodeficient female
nude (BALB/c nu/nu) mice (Charles River). For MCF-7, endogenous oestrogen levels were
supplemented by surgical implantation of oestrogen pellet (0.18 mg/pellet, 90 days release;
Innovative Research of America) in the scruff of the neck. All mice were kept with 5R58 diet
(PicoLab) in Tecniplast Green Line cages, individually ventilated in 12/12 h ON/OFF light
cycles. Tumours were measured externally with Vernier callipers and the tumour volumes
were calculated with a x b x b with a being the longest axis of the tumour and b the shortest. It
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was ensured that the overall tumour size was less than 1.5 cm diameter and the overall tumour
volume was less than 10% of the body weight of the mouse. The contrast agent was injected
and the mouse imaged when tumour size was between 0.5 and 1 cm diameter. Animals were
killed by exsanguination and cervical dislocation as confirmation of death. Tumours, liver,
kidney, spleen, heart and brain were collected for ex vivo fluorescence imaging. Afterwards,
tumours and livers were divided into 3 to 4 parts for histopathology, microscopy and LC-
MS/MS analysis. Kidney, spleen, heart and brain were collected for paraffin embedding.
Tumours which were too small were not analysed ex vivo.
All PA in vivo imaging was performed with the multispectral optoacoustic tomography
(MSOT) system described above (inVision 256-TF, iThera Medical GmbH). The mice were
prepared for imaging following our standard operating procedure [180]. Briefly, <3%
isoflurane was used to anaesthetise the mice before they were placed in a custom animal
holder (iThera Medical), wrapped in a thin polyethylene membrane. A thin layer of ultrasound
gel (Aquasonic Clear, Parker Labs) was used to couple the skin to the membrane. The holder
was then placed within the MSOT system and immersed in heavy water maintained at 36 ◦C.
The respiratory rate of the mice was maintained in the range of 70-80 b.p.m. with 1.5-2%
isoflurane concentration for the entire scan time.
In vivo fluorescence imaging was carried out on a fluorescence in vivo imaging system
(IVIS 200, Xenogen). Scans were recorded with filter set 4 using 705-780 nm as excitation
passband, 810-885 nm as emission passband and 665-696 nm as background passband. Auto-
fluorescence was corrected by subtracting the background filter image from the primary filter
image. ROI were drawn on the black and white image without displaying the fluorescence
signal. The average radiant efficiency obtained in the control region C was subtracted from
the average radiant efficiency within the ROI.
Biodistribution and Tumour Accumulation Study
5 minutes after the animal was placed into the PA imaging system, the scan was initialised
and the baseline was monitored for further 14 minutes, to stabilise the signal. 14 min into the
scan 150 µL (for a 20 g mouse) of the contrast agent was injected intravenously in the tail
vein. The concentration used were 150 µM JW41, 50 µM JW35 or 100 µM JW41 + 50 µM
JW35 for the 2-1 mixture. Images were acquired at one slice centred on the liver, one
slice centred on the kidneys, spleen and liver, and several slices covering the whole length
of both tumours in 1-mm steps. Scans were recorded at 21 wavelengths between 660 nm
and 900 nm with 10 averages (continuous averaging) for up to 50 min in 5 min intervals.
24 h after injection of the contrast agent the mouse was imaged once again before culling.
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Fluorescence in vivo imaging was performed before the injection of the probe, after the
PA image acquisition (50-60 min post injection of the contrast agent) as well as 24 h post
injection.
Treatment Response Study
5 minutes after the animal was placed into the PA imaging system, the scan was initialised
and the baseline was monitored for 4.5 minutes. Then, 150 µL (for a 20 g mouse) of 75 µM
JW41 was injected intravenously in the tail vein. Images were acquired at one slice centred
on the liver, one slice centred on the kidneys, spleen and liver, and several slices covering the
whole length of both tumours in 1 mm steps. Scans were recorded at 22 wavelengths between
680 nm and 900 nm with 10 averages (continuous averaging) for up to 65 min in 5 to 15 min
intervals. Further PA images were acquired 24 h, 48 h and 72 h after the first injection of the
contrast agent. 6 days after the first injection of JW41, the procedure of the first day was
repeated and 150 µL (for a 20 g mouse) of 75 µM JW41 was injected again and monitored
for up to 60 min. 24 h after the second injection, the mouse was imaged once again before
culling. Fluorescence imaging was acquired before and after the injection of the contrast
agent as well as before the PA imaging sessions on day 1, 2, 3 and 7. Doxil (10 mg/kg eq.
active doxorubicin) was injected IP on day 0 after the imaging session, day 2 and 5.
Image Analysis of PA in vivo Data
The acquired images were reconstructed off-line with linear reconstruction and analysed
with linear regression multispectral processing, both available within the ViewMSOT software
package (version 3.8; iTheraMedical). Linear regression was performed with published
spectra for oxy- and deoxyhemoglobin (http://omlc.org/spectra/) as well as JW41 and JW35
spectra obtain from phantom studies described above. ROI were drawn around the liver,
left kidney, spleen and tumours as indicated in the Figures on the appropriate tomographic
sections. Reference values from ROIs drawn as indicated were taken in the same anatomical
plane. The PA spectra in the imaged organs were generated by averaging the mean pixel
signal intensities of each ROI from every section. For the PA tumour spectra, the average
of all tumour spectra of each tomographic section was formed. To correct for the intrinsic
background signal, the spectra acquired at t = 0 was subtracted from the subsequent images.
For the biodistribution and tumour accumulation study, to monitor the enrichment kinetics of
the probe in the different organs, the raw mean pixel intensity values at 760 nm and 900 nm
were used and the ratio was formed. To generate the PA signal kinetic plot based on spectral
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de-mixing data obtained by linear regression, the values obtained before injection of the
contrast agent in the ROI were averaged and used as baseline to allow comparison with the
24 h time point signal. In case of the treatments response study, the 760 nm signal was plotted
against the time to generate the enrichment kinetics curve.
3.4.5 Histophathology and Widefield Microscopy of Tissues from in
vivo Studies
For histopathological analysis organs were fixed in neutral buffered 10% formalin (24 h)
for haematoxylin and eosin (H&E) and cleaved caspase 3 staining. For comparable histo-
pathology and wide-field microscopy examination, tumours were mounted on a cork base
using OCT solution (VWR Chemicals) and snap frozen in an isopentane bath cooled on dry
ice . Formalin fixed, paraffin embedded tumours and livers were sectioned with 3 µm and
imaged at ×20 magnification using an Aperio ScanScope (Leica Biosystem) scanner. Frozen
blocks were sectioned with 6 µm thickness. Two consecutive slices were generated, of which
one was stained with haematoxylin and eosin (H&E); the other section was fixed with 4%
PFA for 5 min at room temperature, washed carefully twice with PBS, mounted in mounting
media with DAPI (ProLong Gold Antifade Mountant with DAPI, LifeTechnologies) and
scanned using a wide-field fluorescent microscope (Zeiss Axio Observer Z1) with excitation
wavelengths centred on 365 nm (for DAPI) and on 740 nm for JW41/JW35 under a 63x
oil-immersion objective lens.
3.4.6 LC-MS/MS Analysis of Tumour and Liver Samples
Sample Preparation for LC-MS/MS Analysis of JW41 and JW35
Synthesis of JW56
General experimental details are the same as stated in Chapter 2, Materials and Methods
2.4.1.
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VII (32 mg, 0.045 mmol) and DIPEA (15 muL, 11.1 mg, 0.086 mmol) were dissolved in
dry THF (1.5 mL) and cooled down to 0 ◦C. Di-tert-butyl dicarbonate (12.8 mg, 0.056 mmol)
dissolved in 1 mL THF was added and the reaction mixture was stirred at room temperature
for 10 h. After concentrating under reduced pressure, the reaction was purified by flash
chromatography (silica, gradient: 0-20% MeOH in DCM), yielding the intermediate XIII as
blue solid (12 mg, 0.015 mmol, 33%).
XIII (12 mg, 0.015 mmol), 1-Azido-1-deoxy-β -D-glucopyranoside (7 mg, 0.033 mmol)
and CuSO4 (2.3 mg, 0.015 mmol) were dissolved in H2O : tBuOH 1:1 (1 mL). Sodium
ascorbate (5 mg, 0.025 mmol) was added and the reaction mixture was sonicated for 30
seconds followed by stirring at room temperature for 5 h. The reaction mixture was diluted
with MeCN/H2O (1/1) and purified with HPLC (Kinetex, 5 µm, C18, 100Å, AXIA packed
HPLC column, 250 x 21.2 mm) using HO + 0.1% formic acid and MeCN + 0.1 formic acid
as solvents. JW56 was obtained as blue solid (1.1 mg, 0.001 mmol, 6%).
HRMS(XIII): m/z calculated for [M+] = 809.48, found m/z = 809.4781.
HRMS(JW56): m/z calculated for [M+H+] = 1220.62, found m/z = 1220.6240.
1H/13C-NMR: (400/126 MHz, CD3CN) The peak intensities of the obtained spectrum were
too weak why accurate data analysis could not be performed.
Preparation of Standard, QC and IS Solutions
All work was done on ice and in the dark. A 2 µM IS spiking solution was prepared in
MeCN : H2O (8 : 2) from a 1 mM stock solution in DMSO. To prepare the standard and QC
solutions, a 1 mM stock solution of JW41 (in DMF) and a 1 mM stock solution of JW35 (in
DMF) were diluted into MeCN : H2O (8 : 2) to give a final concentration of 10 µM for JW41
and 5 µM for JW35. This dilution was then used to generate the different standard spiking
solutions (SSS) and QC spiking solutions (QSS) (cf. Table 3.1). 7 µL of the respective
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spiking solution was than added together with 7 µL of the IS solution (2 µM) to 60 µL
of either MeCN : H2O (8 : 2) or liver / MDA-MB-231 or MCF7 tumour homogenate from
mice, which did not receive any treatment. The spiking solutions were only added after
the homogenisation step due to the assumption that frozen tissue does not take up any of
the dye. The samples were vortexed, centrifuged (2 min, 4 ◦C, 13000 g) and 60µL of the
supernatant was transferred into a 96 well plate used for injecting onto the LC-MS/MS
system for analysis.
Table 3.1 Concentrations of standard and QC samples for LC-MS/MS analysis.
Solution ID JW41 concentration (µM) JW35 concentration (µM)
SSS1 0.01 0.005
SSS2 0.05 0.025
SSS3 0.075 0.0375
SSS4 0.1 0.05
SSS5 0.2 0.1
SSS6 0.4 0.2
SSS7 0.8 0.4
SSS8 1 0.5
QSS1 0.05 0.025
QSS2 0.2 0.1
QSS3 0.8 0.4
Preparation of Tissue Samples from in vivo Studies
All work was done on ice and in the dark. Snap frozen tissue samples were cut, balanced
and homogenised in MeCN : H2O (8 : 2, LCMS grade, Fisher) to give a 100 mg/mL homo-
genate. 60 µL of tissue homogenate were transferred into an eppendorf tube and 7 µL of
the IS spiking solution as well as 7 µL MeCN : H2O (8 : 2) were added. The samples were
vortexed, centrifuged (2 min, 4 ◦C, 13000 g) and 60µL of the supernatant was transferred
into a 96 well plate used for injecting onto the LC-MS/MS system for analysis.
LC-MS/MS Method Details for JW41 and JW35 Analysis
The concentration of the activatable contrast agent JW41 and its conversion product,
JW35, in tissue samples were determined by LC-MS/MS against a reference standard
solution of JW35Mono. JW41 hydrolyses under aqueous, acidic conditions gradually to
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JW41hydrol. Thus, JW35, JW41 and JW41hydrol were identified from their retention time
and from their specific mass transition in multiple reaction monitoring mode. JW35 elutes
at 3.08 min, with a transition from 560.30 to 208.106, JW41 elutes at 3.47 min, with a
transition from 1379.67 to 913.44, JW41hydrol elutes at 3.23 min, with a transition from
1297.60 to 831.36 and the IS elutes at 3.12 min with a transition from 457.25 to 160.62.
JW41 and JW41hydrol share 652.33 as a common fragmentation ion. The concentration
of JW35, JW41 and JW41hydrol was determined as the peak area obtained from their
mass transition in multiple reaction monitoring mode. The analysis was performed using
the hybrid Quadrupole-TOF LC/MS/MS mass spectrometer (TripleTOF 6600, AB Sciex
Instruments) with a Shimadzu LC-30AD system. The details of the method are as follows.
Column: Acquity UPLC HSS T3 column from Waters (1.8 µm, 2.1 ID x 100 mm length);
Chromatographic conditions: Solvent A: Water +0.1% Formic acid; Solvent B: Acetonitrile
+0.1% Formic acid; Gradient: 0 - 1. minutes 0% B; 1.2 - 3 minutes 0 - 95% B, 3 - 5 minutes
95% B, 5 - 5.1 minutes 95 - 0% B; 5.1 - 9 minutes 0% B; Flow rate: 0.4 ml/min; Injector
module temperature: 5 ◦C; Column temperature: 25 ◦C; Injection volume: 20 µL.
The assay of liver and tumour samples were always performed separately to be able to
use the correct matrix. All assays were run the same way, starting with the injection of a test
solution in MeCN : H2O (8 : 2), followed by 2 washes, then injecting standard solution 1, 3, 5
and 7, 3 washes, QC1, QC2, QC3, 2 washes, tissue samples, 3 washed, QC1, QC2, QC3, 2
washes, standard solution 2, 4, 6 and 8, 2 washes, test solution in MeCN : H2O (8 : 2).
In order to evaluate the potential for hydrolysis of JW41, a kinetic study was performed
over 10 hours. The peak area of the 1379.67 to 913.44 transition of JW41 lost through
hydrolysis appeared to be compensated by the increase in the peak area of the 1297.60 to
831.36 transition of JW41hydrol. Therefore based on this data and impracticality to avoid the
hydrolysis under the acidic chromatographic conditions, the peak area of the MS transitions
of JW41 and JW41hydrol were added together to assume the concentration of JW41 if this
had not suffered hydrolysis.
The calibration line was calculated by linear regression with GraphPad Prism6. The
calibration line was accepted as long as a minimum of 10 out of the 14 samples showed
accuracy in between 80 and 120% (8 calibration samples, of which minimum 5 needed to
pass the accuracy criteria, and 6 QC samples, minimum of 4 needed to pass the accuracy
criteria). Exception was the calibration line for JW41 for the assay run with the liver samples
of the treatment response study. In this case, the calibration curve was calculated only by the
calibration samples run after the samples, due to fluctuations at the beginning of the assay.
This assumption was reinforced by the R2 value of 1.0 for the calibration curve calculated
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this way and by the six QC samples, which showed good accuracy with this calibration and
of which three were run before the liver samples and three afterwards.
Statistical analysis was performed using GraphPad Prism6. Each tumour was considered
as an independent biological replicate. All data are shown as mean±SD.
LC-MS/MS Measurement of Reduced and Oxidised Glutathione
GSH and GSSG were measured following the protocol previously described in the lit-
erature [173, 176]. Briefly, tissue samples were homogenised at 50 mg mL-1 in 25 : 75
water : methanol containing 1.25 mM 4 fluoro-7-sulfamoylbenzofurazan (ABD-F, thiol-
derivatizing reagent),0.025 M sodium borate and 0.25 mM EDTA disodium salt to derivatise
GSH to prevent oxidation of GSH and thus enable reliable analysis. Derivatised GSH and
GSSG were separated on a Waters Acquity UPLC HSS T3 column (1.8 µm, 2.1 ID x 100 mm
length) with the following chromatographic conditions: Solvent A: Water +0.1% Formic acid;
Solvent B: Acetonitrile +0.1% Formic acid; Gradient: 0 - 1.2 minutes 0% B; 1.2 - 3 minutes
0 - 95% B, 3 - 4 minutes 95% B, 4 - 4.01 minutes 95 - 0% B; Flow rate: 0.3 ml/min; Column
temperature: 25 ◦C; Injection volume: 2.5 µL. The corresponding ions were identified in
MRM-MS using their specific mass transition (GS-ABD: 505.02 to 376.11, GSSG: 613.06
to 355.01) and retention time (GS-ABD: 3.59 min, GSSG: 3.30 min). The analysis was
performed using the hybrid Quadrupole-TOF LC/MS/MS mass spectrometer (TripleTOF
6600, AB Sciex Instruments) with a Shimadzu LC-30AD system. GSH-glycine-13C215N and
GSSH-glycine-13C215N were added as internal standard.

Chapter 4
Development of Novel Fluorescent
Probes for the Study of Amyloids
The synthesis of the ME- and E-derivatives was performed by James Fyfe, Omaru Kabia
and Dung Do. αSyn was purified by Ewa Klimont and Aβ by Dimitri Sideris. Catherine Xu
supplied the stable oligomers. Juan Valera performed the analysis of the degree of modulation
shown in Figure 4.20, 4.21 and 4.22. Bulk fluorescence and absorption measurements and
analysis of the dyes were equally performed by Lisa-Maria Needham and I. I performed
αSyn aggregations, all fluorescence and SPR based binding assays, αSyn and Aβ kinetic and
inhibition assays, single aggregate fluorescence anisotropy measurements and the synthesis
of the DNA-PAINT probe.
4.1 Introduction and Motivation
A growing number of diseases such as cancer, Alzheimer′s and Parkinson′s disease are
associated with protein aggregation. Most of these pathologies share the common hallmark
of converting soluble proteins into insoluble amyloid deposits, which often impairs essential
cellular functions, initiating and/or promoting the development of diseases [181, 182]. Since
the formation of protein aggregates occurs in the early stages of the disease preceding
noticeable symptoms, the aggregates can serve as biomarker for early disease detection,
prognosis and treatment response. However, at the present there is a lack of tools for
measuring defined protein aggregates at low concentrations with high specificity, which
would allow the detection of the different pathologic oligomers and fibrils in patient samples
at an early disease stage [183]. Consequently, research into new imaging probes and early
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detection methods for deleterious oligomeric species have attracted significant interest in
biomedical research.
Thus the focus of this chapter was to investigate new imaging probes with improved
binding and imaging properties to detect, characterise and study the formation of early patho-
logical species and their role in the development of neurodegenerative disorders. Therefore,
high resolution fluorescence microscopy was used as it operates on a spatial resolution highly
suited to detect low populations of small, heterogeneous oligomeric species.
4.1.1 Protein Aggregation and Diseases
Proteins are involved in almost every biological process. A typical mammalian cell
expresses around 30 000 different proteins, synthesised as linear chains composed of up to
several thousand residues [184]. In order to function, these chains undergo post-translational
modifications and fold into defined 3-dimensional structures. However, these folded struc-
tures possess only limited stability and somatic or hereditary mutations as well as changes
in intracellular environment can tip the balance towards misfolded protein structures and
subsequent protein aggregation. Various forms of protein aggregates exist and most of them
get cleared by several control systems in our body. However, a subset of so called amyloid
fibrils are resistant to common proteolytic “cleaning”-pathways and their accumulation is
involved in the pathogenesis of many diseases [185].
The insoluble amyloid aggregates possess the main structural hallmark of an ordered
arrangement of a double row of β -sheets, which run along the length of the fibril [186]. Their
formation follows mainly a nucleation dependent growth model starting with a lag phase.
In this phase, soluble, misfolded monomeric species are formed, which then assemble to
soluble oligomeric species and protofibrils. In the following elongation phase, the oligomeric
precursors act as template to accumulate other monomers or oligomers resulting in the rapid
formation of insoluble fibrillar aggregates (Figure 4.1) [184, 187].
Recent studies suggest that small soluble oligomeric species, formed early on in the
aggregation process, are the primary cytotoxic components [188, 189]. Unfortunately, these
potentially toxic oligomers are highly heterogeneous in their size and structure and rare in
abundance (in the order of pg/mL) making them challenging to identify and characterise
[190, 191].
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Figure 4.1 Schematic illustration of the nucleated pathway of amyloid fibril formation starting from
monomeric proteins.
4.1.2 Imaging Protein Aggregates
To expand our understanding of the pathology of neurological disorders, it is important
to visualise, characterise and quantify the toxic protein aggregates associated with these
diseases. Fluorescence imaging is widely used for this purpose. To quantify the presence of
fibrils or the kinetics of amyloid fibril formation, several fluorophores have been exploited.
Among those are Congo Red, conjugated oligothiophenes, Nile red and thioflavin T (ThT)
(Figure 4.2) [192–195].
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Figure 4.2 Chemical structures of five important and broadly used dyes for protein aggregate sensing
- A) Congo Red, B) p-FTAA as example for a conjugated thiophene, C) Nile red and D) ThT and
Pittsburgh compound B (PiB), the most used aryl-benzothiazoles.
Congo red was discovered as a stain for amyloid fibrils nearly 100 years ago and since
then has been commonly used as diagnosis marker (Figure 4.2A). The detection mechanism
of amyloid fibrils by Congo red relies on its birefringence when bound to fibrils. In the bound
state, the molecule is arranged along the fibril in a way that all light absorbing atomic-bonds
are in the same orientation causing the appearance of anomalous colours. In solution, Congo
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red molecules are randomly orientated and thus the specific optical signature is not detectable
[194, 192]. However, Congo red is thought to interfere with the aggregation of various
different amyloid proteins and the exact binding mechanism between the dye and the fibrils
is not well understood [196, 197]. Thus, its use for in situ detection of aggregates is limited.
In the last decade, conjugated thiophenes have attracted interest as dyes for amyloid
aggregate detection (Figure 4.2B). Binding to amyloid evokes an environment specific
conformation change in the thiophene backbone, which leads to a change in its spectral
characteristics. This spectral change is specific towards the protein environment as well as
the binding site and thus it allows the detection of aggregated species preceding amyloid
fibril formation [193].
Nile red represents another fluorophore used for the detection of amyloid fibrils (Figure
4.2C). Its hydrophobic structure causes poor solubility in aqueous environment accompanied
by fluorescence quenching. The binding to hydrophobic surfaces of proteins, revealed in
misfolded proteins, leads to a turn on response in its fluorescence signal. As the generated
fluorescence is dependent on the environment and binding site, Nile red is able to detect early
stage aggregates and to compare fibrils from different proteins. However, due to the high
affinity towards lipids and other biological structures, Nile red is restricted to in vitro studies
and incompatible with tissue imaging [198, 195].
One of the main tests for studying amyloid fibril formation relies on the use of aryl-
benzothiazoles. Aryl-benzothiazoles are sensitive to β -sheet rich structures and have been
used across different imaging modalities. The uncharged, radiolabelled aryl-benzothiazole
Pittsburgh compound B (PiB) is able to cross the blood-brain barrier and was the first probe
used for positron emission tomography (PET) that allowed the detection of insoluble β -
amyloid fibrils in Alzheimer’s patients [39]. PiB possess a high binding affinity (nM) for
fibrils but rarely detects soluble and oligomeric species, meaning a significant proportion of
misfolded protein aggregates are not visualised in vivo [199]. Its charged analogue, ThT, has
become the most common fluorescent dye used for the detection of amyloid fibrils and for the
in vitro kinetic study of amyloid formation [200]. Upon binding to β -sheet rich structures,
the fluorescence quantum yield of ThT increases by several orders of magnitude, making it a
sensitive and efficient reporter of the amyloid structure [201, 202]. However, as with PiB,
ThT binds predominantly to late stage aggregates with extended β -sheet structures limiting
the effectiveness of ThT to monitor the early stages of amyloid fibril formation. Nevertheless,
ThT possesses unique photophysical characteristics, which are subject of great interest in
current research.
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4.1.3 Characteristic Features of Thioflavin-T
Photophysical Nature of ThT
Over the last few decades, ThT has become the gold-standard among amyloid dyes for
studying amyloid formation due to thr large fluorescence enhancement observed upon fibril
binding [203].
ThT consists of a dimethylaminobenzene ring coupled to a positively charged ben-
zothiazole ring by a rotatable C-C bond. The internal rotation around this bond is responsible
for the presence of two electronic excited states of ThT - the locally excited (LE) and twisted
intramolecular charge transfer (TICT) state (Figure 4.3).
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Figure 4.3 Jablonski excited-state deactivation
scheme for ThT in solvents with low viscosity.
(adapted from ref.[204])
In low viscosity solvents, a low-energy bar-
rier allows free rotation around the C-C bond.
This results in the conversion of the LE fluor-
escent state (S1; ϕ ∼ 37 ◦) to a non-fluorescent
TICT state (S1’) with favourable energy. In
the TICT state, the twist angle between the
two ring systems and thus the corresponding
π orbitals is ϕ ∼ 90 ◦.[205] This geometric ar-
rangement prohibits the efficient delocalisation
of the π-electrons across the whole chromo-
phoric structure causing a shift in the excita-
tion and emission maximum from ∼450 nm
to ∼ 385 nm and from ∼482 nm to ∼445 nm
respectively [203]. In addition, due to geomet-
ric relaxation and reduction of the oscillator
strength in the twisted confirmation, the energy
level of the TICT state S1’ is close to the energy level of the ground state, resulting in a
non-radiative relaxation and thus poor fluorescence in solution (φFl = 0.0001, in water at room
temperature) [206, 204, 207]. However, the nonradiative rate constant, kLE-TICT, is highly
dependent on the environment. High viscosity solvents, or binding to fibrils, limit the rotation
around the C-C bond hindering in turn the adoption of the TICT state. The fluorescence
emission from the LE state is therefore dominant, which results in a strong increase in the
fluorescence quantum yield (e.g. φFl = 0.43, bound to insulin fibrils) [207, 203, 208]. This
is the foundation of the amyloid detection property of ThT, the fluorescence quantum yield
enhancement attained upon binding to β -sheet containing species. However, ThT suffers
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from a relatively small Stokes shift and fluorescence intensity, even in the bound state, which
in addition to its poor oligomer detection, limits the effectiveness of ThT to monitor the early
stages of amyloid fibril formation in biological samples with high background signals.
Protein Binding
As the photophysical properties of ThT are highly dependent on the environment, it is
important to understand the binding properties of ThT under pathological conditions. ThT is
able to bind to amyloid aggregates formed from a large variety of proteins and thus it is most
likely, that it recognises a common structural motif of amyloids [209].
Figure 4.4 Common cross-β sheet motif of amyl-
oid fibrils and proposed ThT binding mode. The
common cross-β sheet motif of amyloid fibrils is
formed by layers of cross-β sheets, which leads to
a specific arrangement of side-chains (R) forming
a channel-motif parallel to the fibril axis. ThT is
thought to bind transiently along this channel.
One key structural feature common
between different amyloid fibrils is the lay-
ers of cross-β sheets, which run parallel to
the fibril axis (Figure 4.4). The β -strands
within a β -sheet layer present an ordered
array of side chains towards the surface.
These side chains form a channel-like mo-
tif also running parallel to the long fibril
axis. It has been suggested that the chan-
nels are rich in aromatic and hydrophobic
amino acids, which strengthens the bind-
ing of ThT through π-π stacking and hy-
drophobic interactions [203, 200]. The dis-
tance between the β -strands and thus the
side chains was defined by X-ray diffraction
to be 4.8 Å. This distance did not change
upon binding of ThT, indicating that ThT
binds on the β -sheet surface aligned with
the channel. Since the length of the long axis of ThT accounts for 14-15 Å, it is thought
that ThT recognises 4 continuous β -strands in a β -sheet [210]. As fibrils contain extended
β -sheet structures, several ThT molecules can bind along the fibril axis leading to a regular
arrangement of ThT molecules. As binding induces a planar conformation of ThT, this leads
to the specific “light-up” response of ThT in the presence of β -sheet aggregates. It was
further shown, that aryl-benzothiazoles with increased hydrophobicity bind deeper inside the
binding groove, which strengthens the aromatic and hydrophobic interactions resulting in an
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improved binding affinity. This is mirrored by the ∼135-fold increased binding affinity of
the neutral aryl-benzothiazole PiB towards Aβ aggregates compared to ThT [211].
Even though the surfaces of cross-β structures with the channel-arrangement of side
chains is thought to be the main recognition motif, ThT is also capable to bind to other
protein sites, of which not all result in the characteristic fluorescence increase [211–214].
However, the lack of high resolution structural data and appropriate methods prevents detailed
understanding of the different binding sites and binding modes of ThT.
ThT and High Resolution Imaging Techniques
A key requirement in understanding the pathogenic properties of misfolded proteins is
the identification and detailed characterisation of these species. Until recently, it was difficult
to detect and visualise protein species with such transient nature and a size less than 200 Å.
Due to the development of new high resolution fluorescence techniques it is now possible to
resolve structures of around 50 nm, which brings research a step closer to the study of the
initial stages of protein aggregation [215].
The high resolution technique SAVE, single aggregate visualisation by enhancement,
makes use of the unique optical profile of ThT and couples its low fluorescence signal in
solution, the rapid quantum yield increase upon amyloid binding and the accompanied Stokes
shift with single-molecule instrumentation [216]. The method is based on direct imaging
and counting of the number of amyloid aggregates that bind ThT and become fluorescent
and uses total internal reflection fluorescence (TIRF) to enhance the signal to background
noise. Additionally, as the binding affinity of ThT towards the amyloid structure is in the
low µM range, there is a fast exchange of dye molecules on the surface of amyloid fibrils,
which prevents photobleaching restrictions [200]. Combining these advantages enables
the observation of amyloid aggregates at high resolution both in vitro as well as in human
biofluids [216].
Despite this promising achievement, the photophysical and binding properties of ThT have
limited the potential of these high resolution methods. The poor oligomer detection ability
and binding affinity in combination with a relatively small Stokes shift, molar extinction
coefficient and quantum yield, makes it poorly suited for the detection of smaller, low
concentration oligomeric species, particularly in biological samples with high background
signals. Thus, there is a great demand of new dyes with improved photophysical and binding
properties to detect, characterise and study the formation of these early species and their role
in the pathogenesis of neurodegenerative disorders.
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To address this unmet need, the aim of this chapter was to find variants of ThT with
improved fluorescence and binding properties, which would enable one to sensitively and
specifically detect and quantify the concentration and composition of oligomers and fibrils in
cerebrospinal fluid (CSF) or plasma at an early disease stage.
4.1.4 Approach
During the aggregation process a large number of structurally similar binding sites
are generated. This provides the opportunity to exploit a multivalent probe design for the
generation of new ThT analogoues with improved properties. This hypothesis is supported by
published work of Qin et al, which shows a 70-fold enhanced affinity for Aβ40 amyloids of
ThT dimers linked by short polyethylene glycol (PEG) chains [217]. However, there was no
significant improvement of the specificity of aggregate detection nor of the optical properties.
To advance optical and binding properties simultaneously the following key features were
aimed to be explored and optimised: the ligand group (by introducing structural modifications
onto ThT (R1, R2)), the linker length, the linker composition and the multivalent structure
and design (R3) (Figure 4.5).
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Figure 4.5 Possible modification sides to generate ThT analogues with improved properties.
In addition to the improvement based on structural modifications of ThT, it was also
aimed to use the multivalent design and combine it with the single-molecule localisation
microscopy technique, DNA-PAINT (cf. Chapter 1.4), which can be used to improve the
imaging sensitivity and resolution independent from the optical properties of ThT and thus
may allow the detection of small, low concentrated early stage oligomers in biological
samples [218].
4.2 Results and Discussions
4.2.1 Ligand Group Modifications - new ThT Analogues
As highlighted above, the photophysical characteristics of ThT make it an interesting
fluorescent probe for the study of amyloid. However, the photophysical properties as well
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as binding affinities and specificity of ThT are poorly suited for fluorescence imaging in
biological samples with high background and for the detection of early stage oligomers.
Hence, there is a great demand of new ThT analogues, that outperform ThT in its binding and
optical characteristics but keeps the most significant property of ThT, the specific fluorescence
quantum yield enhancement attained upon binding to β -sheet containing species. To achieve
this, a library of neutral (“E-derivatives”) and charged (“mE-derivatives”) ThT derivatives
with different head groups (R1, Figure 4.6) were synthesised by our collaboration partners,
which we then analysed towards their photophysical and binding affinities in comparison to
ThT.
mE10 mE13
mE20
mE26
mE27mE28
R1
N
S
NThT
R2
E10 E13
E20
E26
E27E28
charged mE-Derivatives
neutral E-Derivatives
Figure 4.6 Chemical structures of the new charged (mE, green) and neutral (E, blue) ThT derivatives.
The structural differences between the derivatives and ThT are highlighted by the coloured circles on
the ThT structure as well as through colours in the chemical structures of the derivatives.
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To ensure specific amyloid binding and the unique fluorescence turn on response of ThT,
it is essential to maintain the aryl-benzothiazole core with its rotatable C-C bond (Figure
4.6). To increase the electron density of the core structure, we converted the aromatic methyl
group of ThT into a methoxy functionality and expanded the aliphatic unit on the dimethyl
amino moiety. To further question the relationship between the chemical structure and the
binding and optical properties, different modification of the dimethyl amino moiety were
explored. Therefore, special attention was paid on how increased sterical demand, a more
restrained amino moiety and increased lipophilicity influence the properties of ThT. This was
realised by introducing different aliphatic ring systems on the dimethyl amino moiety (R1,
purple circle, Figure 4.6). It was already shown, that the lack of positive charge leads to a
deeper insertion of the aryl-benzothiazole core into the surface groove and thus strengthens
the dye-amyloid binding [211]. To separate the influence of the charged methyl amino group
and the modification on the “head” of the aliphatic unit (R1), the charged (mE, green) as
well as neutral (E, blue) ThT derivatives were synthesised. Even though previous reports
have demonstrated that modifications on position 6 of the benzothiazole unit (grey circle) do
not significantly influence the amyloid binding ability, the ThT analogue bearing only this
modification was synthesised as well (mE26, Figure 4.6), to confirm previous results and
question its influence towards the optical properties.
Photophysical Properties
One of the goals of this chapter was to generate new dyes with improved optical character-
istics (higher quantum yield and greater molar extinction coefficient than ThT) while keeping
the most significant property of ThT, the fluorescence quantum yield enhancement attained
upon binding to β -sheet containing species. Thus, it is essential to initially characterise the
bulk photophysical properties of the different mE and E derivatives under physiologically
relevant conditions in PBS (pH 7.4) and in the presence of amyloid aggregates as well as
under different viscosity environments to ensure that the behaviour as molecular rotor stays
unaffected by the structural modifications made. αSynuclein (αSyn) was chosen as test
system for our validation studies. αSyn is presynaptic nerve terminal protein and the major
constituent of Lewy bodies, the hallmark of Parkinson′s disease [219].
Photophysical Properties in PBS and 2-Propanol
The main characteristic of molecular rotors is the distinct difference in fluorescence
signal of the “free” dye (unbound/low-viscosity solvent) and the “confined” dye (bound/high-
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viscosity solvent), caused by the ability of the dye to undergo an intramolecular twisting
motion in the fluorescent excited state (cf. section 4.1.3) [220]. In the case of ThT, this is
manifested by non-radiative relaxation in its “free” state (twisted intramolecular charge trans-
fer (TICT) conformation) and a strong fluorescent quantum yield increases in its “confined”
state (planar (LE) conformation). Thus, to test the suitability of the new ThT derivatives to
function as suitable molecular rotor, it is important to first examine their optical properties in
a biological relevant environment (PBS) but in the absence of protein aggregates, to ensure
low background fluorescence. Next, to affirm the general ability of an turn-on response, the
analysis of the photophysical features in a high-viscosity solvent is required. For this, 2-
propanol was chosen as representative solvent with higher viscosity (viscosity(2-PrOH) = 2.1
vs viscosity(H2O) = 0.9).
The results obtained from absorption and fluorescence measurements of ThT in PBS
were in good agreement with values reported in the literature and confirmed a moderate
extinction coefficient of ελ=413nm = 36000 M-1cm-1 at λ abs,max = 413 nm with a negligible
quantum yield of φFl < 0.01 [200, 220].
The charged mE derivatives exhibited well defined absorption and fluorescence spectra
with maxima - and consequently Stokes shifts - similar to those of ThT (Table 4.1, Figure 4.8).
Exceptions were the two analogues bearing a six-membered ring, mE28, with δ abs = 380 nm
and δ em = 513 nm, and mE13, with δ abs = 326 + 416 nm and δ em = 512 nm. A summary of
the optical properties of the mE derivatives can be found in table 4.1. It was promising,
that mE26, which only differs from ThT by the methoxy functionality on position 6 of
the benzothiazole ring (grey circle, Figure 4.6), possess a nearly identical absorption and
fluorescence maximum to those of ThT with δ abs = 414 nm and δ em = 484nm. However, it
showed clear differences in the extinction coefficient, quantum yield and brightness. The
extinction coefficient was decreased by more than 2.5-fold compared to ThT. This was a
common characteristic across all mE derivatives, which might be caused by the increase in
electron density through the methoxy group. As there are now two electron donating moieties
attached to the aryl-benzothiazole systems (methoxy group on the benzothiazole ring and
dimethylamino group on the aryl ring), the oscillator strength might be lowered and thus
also the transient dipole moment leading to a decreased extinction coefficient. In contrast to
the trend of the extinction coefficient, the quantum yield of mE26 as well as the remaining
mE derivatives, was increased by minimum 10-fold, accompanied with an overall increase
of the brightness of the dyes, but to a lesser extent than their quantum yield. These results
indicate, that the replacement of the methyl group on position 6 of the benzothiazole ring by
a methoxy-group does not influence the absorption and emission range but has an impact
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towards their performance as photon absorbers and background fluorescence in their “free”
conformation.
Table 4.1 Summary of photophysical properties1 of the charged mE derivatives and ThT in
PBS.
Dye λ abs λ em λ em - λ abs εabs φFl B R1-structure
(nm) (nm) (nm) (M-1cm-1) (a.u.)
ThT 413 488 75 36000 0.001 39.4
mE26 414 484 70 14088 0.02 281.8
mE10 420 494 74 31130 0.04 1245.2
mE13 326 / 416 512 96 4394 0.01 43.9
mE28 380 513 133 20638 0.03 619.1
mE20 423 500 77 26318 0.03 789.5
mE27 423 498 69 19471 0.05 973.6
1 Values were obtained from bulk UV-vis absorption and fluorescence measurements of the dyes in
PBS buffer (pH 7.4).
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Table 4.2 Summary of photophysical properties of the neutral E derivatives and ThT
in PBS.1
Dye λ abs λ em λ em - λ abs εabs φFl B R1-structure
(nm) (nm) (nm) (M-1cm-1) (a.u.)
ThT 413 488 75 36000 0.00 39.4
E26 301 432 131 2542 0.04 101.7
E10 370 429 59 5394 0.01 53.9
E13 328 433 105 1305 0.02 26.1
E28 325 439 114 4822 0.02 96
E20 371 445 74 1963 0.01 19.6
E27 300 440 141 1346 0.02 26.9
1 Values were obtained from bulk UV-vis absorption and fluorescence measurements of
the dyes in PBS buffer (pH 7.4).
The neutral E derivatives showed absorption maxima at lower wavelength than the
charged dyes and ThT (between 300 nm and 371 nm) and a more than 6-fold decrease in
the extinction coefficients (ε < 6000 M-1cm-1) (Table 4.2, Figure 4.9). This finding might
be explained by the greater electron-withdrawing ability of the positively charged nitrogen
atom. This leads to greater delocalisation of the electrons from the aryl amino group and a
decrease in the energy gap between the HOMO and LUMO, thus shifting the absorption to
longer wavelength. In addition, the removal of the positive charge may reduce the oscillator
strength, which in turn can result in an decrease in extinction coefficient. The emission
maxima of the neutral derivatives were, as for the absorption maxima, hypsochromically
shifted relative to ThT (λ em,ThT = 488 nm vs λ em,E = 429 - 445 nm). In addition, the quantum
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yield and brightness of the neutral dyes in PBS was increased compared to ThT and similar to
their charged equivalents. This behaviour is supported by previous results from the literature
stating a higher energy barrier between the LE and the TICT state caused by the absence
of the methyl group and thus positive charge, which in turns results in a higher quantum
yield [221]. The increased quantum yield is unfavourable for the use of these analogues as
turn-on imaging probes, as the baseline signal increases and thus the signal to background
ratio decreases. Nevertheless, the Stokes shifts were comparable with those of ThT and the
charged analogues, which might be caused among others by the molecular rotor behaviour
[220, 222].
Having established the influence of the methoxy group and the charged nitrogen atom,
it was then necessary to examine the influence of the modifications on the aryl nitrogen.
Comparing the different structural modifications made on this nitrogen with the results gained
from determining the optical properties of the mE and E derivatives, revealed the following
trends. Converting the two methyl groups into a 5-membered ring and thus generating a
more conformationally restricted benzothiazole salt with increased lipophilicity, induced a
bathochromic shift of the absorption maxima and an increase in the extinction coefficient
(cf. (m)E26 vs (m)E10). Increasing the ring size by one or more carbons leads to a greater
sterical demand and causes different confirmation of the ring, evoking the opposite effect:
the maxima shifted hypsochromically and the extinction coefficient decreased. Adding an
oxygen to the 6-membered ring did not significantly influence the absorption maximum
but enhanced the extinction coefficient ((m)E13, (m)E28), probably due to the increase in
polarity. Expanding the ring size even further positively influenced the absorption properties
of the charged mE derivatives (raised extinction coefficient for mE20, mE27) but was less
favourable for the neutral analogous, E20 and E27, which might be caused by the decreased
solubility of these hydrophobic E derivatives in PBS.
As it was shown that the hydrogen bonding capabilities of the aryl nitrogen do effect the
twist between the benzothiazole and aryl unit and thus the efficiency of the π-orbital overlap,
this might be one of the reasons explaining the observed trends - different ring sizes and
conformations result in different hydrogen-bond patterns and thus different twists [223, 224].
The greater the twist, the poorer the π-orbital overlap, the more hypsochromically shifted
the absorption maxima. Another aspect which could have an impact is the difference in
hybridisation state of the nitrogen, going from predominantly sp3-hybridised nitrogen in
ThT and 6-membered rings to a nitrogen with more sp2-character in 5-membered rings. The
greater the sp2-character the stronger the interactions of the nitrogen with the aryl unit.
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In respect to the quantum yield and brightness, no correlation between the ring size
and the obtained values were observed. However, when interpreting the data obtained from
bulk absorption and fluorescence measurement in PBS, it is important to keep in mind the
unique nature of the photophysical properties of these molecular rotor based dyes and their
high environment dependence, which can be strongly influenced by their solvation state.
This is especially relevant for the neutral derivatives as they suffered from poor solubility in
aqueous environment, aggregate or micelle formations at concentrations higher than 2 µM
was observed. This might also cause the broad absorption spectra observed for these dyes.
However, the spectral shapes of the absorption and emission curves did not change in the
concentration range tested (0.1 -10 µM) and all the calculations were performed by only
taking the linear part of the concentration curves into account.
To finally prove that the introduced modifications did not impact the ability of the dyes
to function as molecular rotors, UV-Vis absorption and fluorescence spectra of ThT and a
subset of E and mE derivatives ((m)E10, (m)E13, (m)E26) were assessed in 2-propanol,
as representative high-viscosity solvent. The absorption spectra of both derivatives were
unaffected by 2-propanol. However, the fluorescence spectra showed the desired increase in
quantum yield by increasing solvent viscosity (Figure 4.7).
The charged mE-derivatives showed an increase of over 4-fold in the total integrated
emission in 2-propanol compared to water (Figure 4.7B, D). For the neutral E-derivatives,
when changing the solvent from water to 2-propanol, the increase was greater than 30-
fold (Figure 4.7C, D). These results suggest, that both, the neutral as well as charged ThT
analogues, behave as a molecular rotor and a change in viscosity in the environment leads to
the restriction of the carbon-carbon bond torsion resulting in preservation of the fluorescent
excited state. The effect of 2-propanol towards this behaviour was more significant for
the neutral derivatives, which showed a > 100 times higher integrated emission in higher
viscosity solvent than ThT and the charged equivalents (Figure 4.7D). However, this can
not be directly transferred to the dyes behaviour bound to amyloid aggregates as not only
the viscosity but also other properties of the micro-environment are influencing the complex
behaviour of molecular rotors [98, 225]. Nevertheless, the results are encouraging, suggesting
that all dyes of the library can function as molecular rotors and thus are suitable for amyloid
detection.
154 Development of Novel Fluorescent Probes for the Study of Amyloids
 In
te
ns
ity
 (a
.u
.) 
/1
03
400 420 440 460 480 500
0
10
20
30
40
50
60
400 420 440 460 480 500
Wavelength (nm)
400 420 440 460 480 500
440 480 520 560 600
0
0.1
0.2
0.3
0.4
0.5
 In
te
ns
ity
 (a
.u
.) 
/1
03
440 480 520 560 600 440 480 520 560 600
H2O
2-PrOHmE10 mE13 mE26
Wavelength (nm)
H2O
2-PrOHE10 E13 E26
440 480 520 560 6000
0.1
0.2
0.3
0.4
 In
te
ns
ity
 (a
.u
.) 
/1
03
Wavelength (nm)
0.5
H2O
2-PrOH ThT
A
B
C
R1
N
S
N
R1= R1= R1=
R1= R1= R1=
H2O
2-PrOH
0
10
20
30
40
To
ta
l in
te
gr
at
ed
 
em
iss
ion
 /1
05
 (a
.u
.)
E10 E13 E26
E derivatives
0
0.1
0.2
0.3
0.4
mE10 mE13 mE26 ThT
To
ta
l in
te
gr
at
ed
 
em
iss
ion
 /1
05
 (a
.u
.)
mE derivativesD
Figure 4.7 Fluorescence spectra of A) ThT (10 µM), B) mE10, mE13, mE26 (10 µM) and C) E10,
E13, E26 (10 µM) in H2O and 2-PrOH. D) Bar graph illustrating the fluorescence increase of ThT,
mE derivatives (left) and E derivatives (right) in 2-PrOH compared to H2O.
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Photophysical Properties in Presence of αSynuclein
The key feature of ThT in respect to amyloid sensing is the specific fluorescence quantum
yield enhancement attained upon binding to β -sheet containing species. Ideally, the new
ThT analogues feature the same behaviour but with improved optical properties. Thus the
next step was to test the library of charged and neutral ThT derivatives under physiological
conditions in the presence of αSyn aggregates.
In agreement with the literature, ThT experienced a great enhancement in its quantum
yield in the presence of αSyn (πFl,αSyn = 0.24 vs πFl,PBS < 0.01) (Figure 4.8, Table 4.3).
Likewise, the quantum yield of the charged mE analogous raised significantly when αSyn
was added (Table 4.3, Figure 4.8, 4.10). However, the increase was not as pronounced as for
ThT (Figure 4.10). Whereas ThT exhibited a ∼ 1000 fold higher quantum yield with αSyn
compared to PBS, the highest enhancement of the mE analogues was ∼ 30-fold for mE13.
The Stokes shift decreased slightly for ThT as well as all mE dyes, which is unfavourable
since it results in a decrease in signal to noise ratio for fluorescence imaging. Among all the
cationic dyes, mE10 attracted particular attention as not only its absolute quantum yield in
presence of αSyn was ∼ 3-fold higher than that of ThT but also its brightness outperformed
the brightness of ThT by ∼5-fold making mE10 a promising candidate for the detection of
early oligomeric species with higher sensitivity.
The neutral ThT analogues also exhibited a fluorescence quantum yield enhancement
upon binding to β -sheet containing species. However, the fluorescence increase accounted
for less than 5-fold, making the E derivatives less suitable probes based on their fluorescence
turn-on behaviour (Figure 4.10). This was manifested in their overall higher quantum yield
in PBS as well as lower quantum yield in the presence of αSyn compared to the charged
equivalents. As for ThT and the mE dyes, the Stokes shift decreased upon binding to protein
aggregates. The results of the E derivatives, however, should be treated with caution due to
the possible aggregation of these derivatives.
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Figure 4.8 Absorption and emission spectra of 10 µM (A) ThT, (B) mE10, (C) mE26, (D) mE13,
(E) mE28, (F) mE20 and (G) mE27 in PBS (orange) and in the presence of ∼2 µM recombinant
αSyn aggregates (green). Normalisation of the absorption and fluorescence spectra was performed in
respect to the maxima of the absorption/fluorescence maxima obtained in the presence of αSyn. Each
spectrum represents the mean of results from 3 independent preparations of dye.
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Table 4.3 Summary of photophysical properties of the charged mE derivatives and ThT in
the presence of αSyn.1
Dye λ abs λ em λ em - λ abs εabs φFl B R1-structure
(nm) (nm) (nm) (M-1cm-1) (a.u.)
ThT 414 483 69 25283 0.24 6067
mE26 420 483 63 14000 0.26 7070
mE10 421 490 69 33107 0.81 31590
mE13 326 / 416 491 71 26400 0.61 16104
mE28 382 506 124 17000 0.58 9860
mE20 424 495 71 26400 0.61 16104
mE27 432 491 66 20300 0.58 9860
1 Values were obtained from bulk UV-vis absorption and fluorescence measurements of the dyes
(0.1 - 11 µM) in PBS buffer (pH 7.4) with recombinant αSyn aggregates (2 µM monomer concen-
tration).
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Figure 4.9 Absorption and emission spectra of 10 µM (A) E10, (B) E26, (C) E13, (D) E28, (E) E20
and (F) E27 in PBS (sky blue) and in the presence of ∼2 µM recombinant αSyn aggregates (blue).
Normalisation of the absorption and fluorescence spectra was performed in respect to the maxima of
the absorption/fluorescence maxima obtained in the presence of αSyn. Each spectrum represents the
mean of results from 3 independent preparations of dye. (The spectral shapes were consistent across
the measured concentration range 0.1 - 10 µM).
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Table 4.4 Summary of photophysical properties of the neutral E derivatives and ThT
in the presence of αSyn.1
Dye λ abs λ em λ em - λ abs εabs φFl B R1-structure
(nm) (nm) (nm) (M-1cm-1) (a.u.)
ThT 414 483 69 25283 0.24 6067
E26 305 429 124 2000 0.11 220
E10 367 425 58 1800 0.04 72
E13 330 425 95 3300 0.08 264
E28 320 427 107 4300 0.04 172
E20 373 427 54 3100 0.05 155
E27 374 431 57 1100 0.09 99
1 Values were obtained from bulk UV-vis absorption and fluorescence measurements of
the dyes in PBS buffer (pH 7.4) with 2 µM recombinant αSyn aggregates.
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Figure 4.10 Quantum yield increase of mE and E derivatives upon αSyn binding (error are represented
as propagated standard deviations of three measurements with separately prepared dye solutions).
In summary, all dyes were able to sense the presence of amyloid aggregates by an increase
in their quantum yield. The mE derivatives manifested a greater fluorescence turn on response
than the E derivatives, making them more suitable probes for fluorescence based imaging
of amyloid. However, the photophysical properties obtained upon binding to αSyn must
be viewed with caution as the amyloid aggregates are very heterogeneous and different
binding affinities, binding sites and binding conformations have a great impact on the optical
properties of dyes working as molecular rotors.
Binding Properties
Having gained an overview about the photophysical characteristics of the new ThT
analogues, it was then necessary to examine their binding capabilities towards amyloid
in order to deconvolute these from the optical properties. Thus, the next goal was to
determine the binding affinities of the dyes towards αSyn and study the effect of different
substituents towards their binding behaviour. It is worth emphasising that all binding affinity
measurements were performed with αSyn aggregates obtained via a previously published
protocol, that allows the generation of fibrils with a narrow size distribution and good
reproducibility between independent batches [226].
Fluorescence-based Binding Affinities
One common way to experimentally measure the binding affinity of ThT towards fibrils
is based on fluorescence spectroscopy exploiting the quantum yield increase upon protein
binding. Thus, the binding affinities were measured through direct titration experiments,
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in which an increasing amount of dye was added to a solution of constant concentration of
αSyn.
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Figure 4.11 Representative binding curves of the mE derivatives and ThT obtained in the presence
of 2 µM αSyn. The binding curves of 3 E derivatives are also shown to illustrate the difficulties to
obtain useful data by direct titration due to the aggregation of the compound in PBS.
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Table 4.5 Binding affinities obtained by fluorescence titration of the mE derivatives and ThT in the
presence of 2 µM αSyn. The errors presenting standard deviations of 3 independent measurement.
KD (µM) ThT mE26 mE10 mE13 mE28 mE20 mE27
mE 4.8± 1.3 6.21± 1.6 0.68± 0.1 4.74± 0.7 2.66± 0.9 1.53± 0.85 2.66± 0.09
The binding affinity of ThT was measured here to be KD = 4.8± 1.3 µM, which agrees
with previously measured values for other amyloid aggregates ranging from KD = 0.0035 µM
(ASSAM fibrils, pH 9) to KD = 64 µM (insulin fibrils, pH 1.6) [200]. All methylated, charged
derivatives showed similar KD values with the exception of mE10. With a KD value of
0.68± 0.1 µM, mE10 exhibited a one order of magnitude better binding affinity than ThT.
As mE26, which only differs from ThT through the methoxy group on the benzothiazole
ring, has a KD value of 6.21± 1.6 µM and thus similar to ThT, it is possible to exclude that
the introduction of the oxygen and any implicated electrostatic interactions significantly
impacts the binding of the dyes to αSyn. Thus, the origin of the improved binding of mE10
is probably result of the conversion of the dimethyl group into a 5-membered ring, which
entails a more restricted conformation and may cause a greater sterical demand. However,
increasing the ring size or adding an oxygen into the ring system did not result in improved
binding affinities.
As highlighted previously, the neutral E analogues suffer from only a minor quantum
yield increase upon binding to amyloid (Figure 4.10) as well as aggregation, which makes
it difficult to obtain accurate binding affinities through direct titration experiments (Figure
4.11). Additionally, the E analogues did not exhibit a significant shift in their absorption
profile when binding to αSyn (Figure 4.9). This, combined with the fact that they suffer from
low extinction coefficients and tend to aggregate at higher concentrations meant absorption
measurements were also not suitable to accurately determine the capability of the neutral
derivatives to bind to αSyn. Hence, a competition assay was performed using ThT to measure
the decrease in fluorescence signal as the compound competes for the ThT binding site. The
binding affinities of the E derivatives obtained through the competition assay are summarised
in Table 4.6.
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Figure 4.12 Fluorescence competition assay. A) Representative competition curves of E competing for
the ThT binding site on αSyn. The curves obtain from 2 different ThT concentrations (3 µM (dashed
line), 9 µM (solid line)) in the presence of 2 µM αSyn are illustrated as examples.B) Competition
curves of E10 in the presence of 1 µM, 3 µM, 6 µM, 9 µM and 15 µM ThT as example of the influence
of different ThT concentrations being present. C) Curve obtained when plotting the fluorescence
intensities of the competition curves reached at the plateau against the ThT concentration being
present.
Table 4.6 Binding affinities of E derivatives obtained by fluorescence competition assay with ThT
in the presence of 2 µM αSyn. The errors presenting standard deviations of n≥ 4 independent
measurement.
Dye ThTBS1 ThTBS2 E26 E10 E13 E28 E20 E27
KD (µM) 3.1± 0.1 5.4± 0.2 0.09± 0.09 0.12± 0.08 0.17± 0.09 0.06± 0.04 0.06± 0.02 0.10± 0.03
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The calculated KD values suggest that the E derivatives are a significantly stronger binders
than the mE equivalents and ThT in respect to αSyn aggregates. This is in agreement with
the literature, which claims a greater stabilisation of the dye by the micro-environment in the
binding channel due to the increased hydrophobicity of the neutral dyes and the loss of the
positive charge [211].
As the quantum yield of unbound ThT is negligible and none of the E derivatives exhibits a
significant fluorescence signal when excited at 440 nm, the signal intensity was expected to go
down to nearly zero when all ThT molecules are displaced by the E derivative. Interestingly,
the fluorescence intensity decreased in average only about 34% at most, indicating only
a partial displacement of ThT by the E analogues (Figure 4.12A). This suggests different
fluorescent binding sides of ThT as well as different binding affinities of ThT and the neutral
dyes towards these binding sides. The E derivatives seem to mainly bind to one of the binding
sites (in the following referred to as first binding site (BS1)) with binding affinities obtained
through this competition assay. The affinity of the E dyes towards the other binding side
(“second binding site” (BS2)) is too low to be measured, as the neutral dyes are not able to
displace ThT from this position.
To support this hypothesis and to examine the binding affinity of ThT towards the
second binding site, the competition assay was repeated with different concentrations of
ThT ranging from 1 µM to 15 µM (Figure 4.12B). Fluorescence titration of ThT provided a
KD value of ThT of 4.8± 1.3 µM (cf. Table 4.5) and thus the chosen concentration range
covered concentration below and above the KD value. The plateau of the competition curves
was reached at different fluorescence intensities for the different ThT concentrations being
present. This plateau intensity therefore provides a measure of how much of the second
binding site is bound to ThT. When plotting the “plateau”-fluorescence intensities against
the ThT concentration it was possible to calculate the KD value for the second ThT binding
site (Figure 4.12C). With a value of KD,BS2 = 5.4± 0.2 µM, the binding affinity of ThT
towards the second biding side was close to the affinity obtained by direct titration of ThT
(KD,total = 4.8± 1.3 µM). As KD,total represents the weighted average of the two different
binding sites (weighted by means of fluorescence intensity and the population of the two
sites), this result indicates that the two different sites possess similar affinities for ThT.
Surface Plasmon Resonance based Binding Affinities
The results gained from fluorescence based binding affinity studies was especially useful
to compare ThT and the charged mE derivatives and reveal different fluorescent binding
sites of ThT, but to get an insight into non-fluorescent binding sites, further analysis, not
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relying on the optical properties of the dyes, was needed. Thus, the binding capabilities of the
mE and E derivatives towards αSyn aggregates was further assessed with surface plasmon
resonance (SPR) spectroscopy. SPR is a surface method with high sensitivity and able to
give insight into a) the rate of interaction between the target (αSyn aggregates) and ligand
(dyes) and thus the kinetic rate constant, and b) the binding level, which then can then be
used to determine the affinity constant [226].
To use this technology for our purpose, αSyn aggregates were covalently attached to a
gold surface via an amide bound. The αSyn coated surface was then exposed to different
concentrations of the dyes. Concentrations of the dyes tested covered a range between
0.25 µM and 30 µM. Data of lower concentrations were in the noise of the data acquisition,
higher concentrations were avoided as titration experiments indicated micelle/aggregate
formation starting around 30 µM. The binding experiments yielded good data quality for all
all dyes, tested on three different chips and thus three different batches of immobilised αSyn.
The results obtained were independent of the immobilization level and allowed a readout
about the binding levels obtained for the different concentrations as well as the association
and dissociation kinetics of the different dyes.
Examining the equilibrium resonance response in respect to the dye concentration enabled
the calculation of KD values for the different dyes (Figure 4.13, Table 4.7) in a similar way as
for the fluorescence measurements. The KD measured for ThT was 79.4± 6.1 µM, which was
an order of magnitude higher than the value obtained by fluorescence titrations. However, care
must be taken when comparing results from surface methods with results obtained in solution,
as physical interactions might differ. During the SPR measurements, the fibrils are fixed
on the surface and continuously exposed to a solvent flow whereas the fluorescence-based
measurements were carried out in steady solution. Additionally, fluorescence based methods
are limited to assess binding sites inducing a fluorescence increase, whereas SPR is able
to take additional interactions into account. Nevertheless, overall the SPR results revealed
similar trends as observed by fluorescence titrations (Table 4.7): mE26 and ThT showed
the same KD value (KD(ThT) = 79.4± 6.1 µM, KD(mE26) = 72.3± 6.68 µM) reinforcing
that the ThT–amyloid interaction is tolerant against the methoxy substituent at position 6 of
the benzothiazole ring. With a binding affinity of KD = 38.1± 2.3 µM, mE10 featured, as
obtained earlier, the greatest affinity towards αSyn among the charged ThT analogues.
All E derivatives outperformed ThT as well as their corresponding mE partners by more
than an order of magnitude, which was in agreement with the literature [211]. In addition, it
was noticeable that whilst ThT and the mE dyes showed affinity curves best fitted by a one-
binding side fit, all E derivatives revealed a hump between 1 µM and 5 µM dye concentration
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Figure 4.13 Binding affinity curves obtained from SPR experiments of ThT, mE and E derivatives
binding to immobilised αSyn aggregates on a gold surface. Each spectrum represents the mean
of results from 3 independent preparations of dye solutions and SPR chips; error bars are shown
as standard deviations. One-site specific binding fit is shown for mE derivatives and ThT, two-site
specific binding fits are applied for E derivatives. The KD,Hi value stated represents the KD value
towards the stronger binding site. KD,Low values can be found in Table 4.7.
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and therefore a 2-binding side fit was better suited for their quantification. This supported the
hypothesis that the neutral analogues feature different binding sites, of which the stronger
binding site is less prone to bind ThT and the charged derivatives (cf. Figure 4.12).
Having studied the concentration dependent equilibrium affinities, the interaction between
αSyn aggregates and the dyes was examined from a kinetics point of view. Representative
sensograms for ThT, one mE and one E derivative are depicted in Figure 4.14. ThT and the
charged dyes, showed an immediate association onto the surface bound αSyn aggregates with
a steep association phase. mE10, with the highest calculated KD value based on equilibrium
affinity measurements, exhibited the steepest slope, which might indicate the fastest binding
among the tested dyes (Figure 4.14 vs A and C). The dissociation of ThT and the mE dyes
was very rapid, resulting in a negligible dissociation phase. This indicates a rather weak
binding to the fibrils as they get washed of from their binding sites immediately.
On the contrary, the neutral analogues showed a distinct slower association to the fibrils
with a clear dissociation phase. These findings are difficult to interpret as many factors can
influence the on- and off-rate. However, one could speculate that the slower association
might be caused by less accessible bindings sites or by some conformational changes after
the initial binding. The slower dissociation points towards a stronger interaction of the E
derivatives with the aggregates.
The response sensograms were further analysed using a heterogeneous ligand model
(Figure 4.14). The goodness of the heterogeneous ligand fits were compared between ThT, the
mE and E derivatives and did support the assumption that both, the charged and neutral ThT
analogues, bind to multiple binding sites. However, even though the fits showed promising
χ2 values, especially for the charged dyes, the KD values calculated from heterogeneous
ligand fits were inconsistent when comparing the KD values from runs of the same dye using
different chips (cf. errors stated in Table 4.7). Thus there is some uncertainty associated with
these results. The main reasons for the difficulty in modelling the dye-amyloid interaction
with a kinetic approach arise from the high heterogeneity of the αSyn aggregates, the
undefinable number of binding sites and the relative low affinity. It is also stated in the
literature, that “because of the difficulties associated with obtaining definitive kinetic data on
the BIAcore, equilibrium binding analysis is more reliable” [227]. Consequently, for further
discussions only the binding affinities obtained through equilibrium binding analysis (Figure
4.13) are considered.
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Figure 4.14 Representative SPR sensograms obtained from SPR experiments of A) ThT, B) mE10,
C) mE13 and D) E13 binding to immobilised αSyn aggregates on a gold surface. E) Goodness
of heterogeneous ligand fit. Error bars are represented as standard deviations of the χ2 values
obtained from fitting 3 independent SPR measurements using separately prepared dye solutions and
different gold chips with immobilised αSyn aggregates. 2.8 µM αSyn aggregate solution was used
for immobilisation; the dyes were tested at 11 different concentrations ranging from 0.1 µM to 30 µM.
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Table 4.7 Binding affinities of ThT, mE and E derivatives towards immobilised αSyn aggregates on a
gold surface obtained by SPR measurements.
Dye ThT mE26 mE10 mE13 mE28 mE20 mE27
KD,Aff1(µM) 79.4± 6.1 72.3± 6.7 38.1± 2.3 118± 23.4 78.7± 11.8 47.5± 4.9 64.2± 5.8
KD1,Kin2(µM) 7.55± 5.4 1.94± 2.7 11.9± 17.3 26.6± 22.5 0.9± 1.1 0.3± 0.1 2.9± 4.9
KD2,Kin2(µM) 90.2± 81.4 21.2± 29.8 143± 148 513± 136 776± 793 23.2± 18.5 8.5± 7.5
Dye ThT E26 E10 E13 E28 E20 E27
KD1,Aff3(µM) 79.4± 6.1 0.33± 0.03 0.22± 0.03 0.45± 0.07 0.18± 0.04 0.36± 0.06 0.10± 0.23
KD2,Aff3(µM) -4 -4 -4 242± 451 65.0± 22.2 37.6± 6.0
KD1,Kin (µM) 7.55± 5.4 0.3± 0.02 0.1± 0.00 0.2± 0.02 0.7± 0.9 0.3± 0.08 7.1± 7.1
KD2,Kin (µM) 90.2± 81.4 39.5± 6.3 27.2± 9.7 27.4± 2.6 54.9± 16.3 23.2± 18.5 5330± 9188
1 KD,Aff states the KD value obtained by one-site specific binding fit of the equilibrium binding affinity
curves.
2 KD1,Kin states the KD value of the stronger binding site, and KD2,Kin the KD value of the weaker binding
site obtained by heterogenous-ligand fit of the kinetic SPR curves.
3 KD1,Aff states the KD value of the stronger binding site, and KD2,Aff the KD value of the weaker binding
site obtained by two-site specific binding fit of the equilibrium binding affinity curves.
4 Value too large.
Taken together, the results from the different binding studies, the neutral derivatives
showed more than 10-fold higher binding affinities than ThT and their charged equivalents.
Both, fluorescence based competition assay as well as SPR measurements reinforce the
assumption of the presence of multiple binding sites on amyloid aggregates, of which not
all trigger a fluorescence response. Among the charged dyes, mE10 possessed the highest
binding affinity regardless of the method used.
Projecting the knowledge gained about the binding characteristics of the dyes onto the
results from the previous photophysical quantifications, reveals a linear dependency between
the binding affinity and the quantum yield in the presence of αSyn for the charged mE
derivatives: a weaker binding resulted in a lower quantum yield. There was no correlation
between the optical and binding properties observed for the E derivatives, which further
affirms the occupation of different binding sites by the neutral and charged ThT analogous.
Interestingly, mE10 showed overall superior properties when compared to ThT and the
other dyes: Its brightness in the presence of amyloid was ∼5-fold higher than the brightness
of ThT and fluorescence titrations indicated a 7-fold improvement in its binding capabilities
compared to ThT.
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Monitoring Aggregation Kinetics
The comprehension of the aggregation process of amyloid proteins is a crucial require-
ment for the understanding of the diseases development.
All data obtained so far, indicated that mE10 exhibits improved features as amyloid
stain compared to ThT. Hence, it was next tested whether mE10 can be used to monitor the
aggregation process of amyloid proteins. First, bulk kinetic measurements of recombinant
αSyn protein aggregation were performed with mE10 as the stain. ThT, the gold standard
for monitoring amyloid fibril formation, and Nile red were chosen as positive controls. Nile
red has been reported to bind earlier aggregates than ThT and thus should help to investigate
the ability of mE10 to detect earlier aggregates [195].
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Figure 4.15 A) Kinetics of αSyn amyloid fibril formation (70 µM) monitored by mE10 (18 µM), ThT
(18 µM) and Nile red (1 µM). The solid lines indicates the fitted sigmoidal growth curve, the lighter
lines the averaged values obtained from minimum 7 independent αSyn aggregations. B) Bar graph
indicating the time points, when the average fluorescence signal was 5% above the baseline signal.
Error bars are represented as standard deviations of minimum 7 independent αSyn aggregations.
Statistical significance was assessed by unpaired. two-tailed t-test; ∗∗∗∗p< 0.0001; ∗∗∗p= 0.0003.
αSyn amyloid fibril formation followed a sigmoidal growth curve where a 15-20 h lag
phase was observed by mE10 and Nile red before a fluorescence change was detected (Figure
4.15A). For ThT, the lag phase appeared longer with 20-30 h. A clear signal, whose intensity
was 5% above the baseline signal, was reached at 26.28± 1.4 h for mE10, at 24.89± 0.6 h
for Nile red and 34.13± 0.8 h for ThT (Figure 4.15B). This data indicated that mE10 was
able to detect aggregate formation significantly early than ThT, similar to the detection limit
of Nile red.
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Figure 4.16 αSyn inhibition assay. The aggregation process of αSyn (70 µM) was monitored with
and without A) ThT (18 µM) or B) mE10 (18 µM) being present to investigate the influence of the
dyes toward aggregate formation. Error bars are represented as standard deviations of 3 independent
aggregations.
The aggregation assay was performed whilst the dyes were present. Previously, it has
been shown that the presence of dyes can influence the aggregation kinetics. Thus, it was
necessary to examine the inhibitory effect on the aggregation of αSyn of mE10 in comparison
to ThT to exclude that the earlier fluorescence response of mE10 is not caused by different
abilities of mE10 and ThT to inhibit the aggregation. To test the inhibitory properties of
mE10 and ThT, αSyn was aggregated under the same standard aggregation conditions for
55 h alone or in the presence of mE10 or ThT. At different time points of the aggregation
process, aliquots were taken and imaged by bulk fluorescence measurements. Neither dye
prevented the formation of fibrils at the concentration being used (Figure 4.16). However,
mE10 seemed to have a stronger, slightly inhibitory effect on the formation of fibrils than
ThT, which increases the emphasis on the ability of mE10 to detect even earlier aggregation
species in the case of recombinant αSyn.
Having demonstrated that mE10 is able to report on earlier aggregation events of αSyn, it
was then questioned if mE10 outperforms ThT in monitoring the aggregation process of other
amyloid proteins. Thus, bulk kinetic measurements of synthetic Aβ42 protein aggregation
were performed with mE10 and ThT. Aβ42 is deposited early and selectively in the senile
plaques of Alzheimer′s disease and hence directly related to the pathogenesis [228].
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Figure 4.17 Kinetics of Aβ amyloid fibril formation (4 µM) monitored by 10 µM mE10 and ThT.
The graph shows the average values of minimum 3 different aggregations.
The Aβ42 protein is known to exhibit a fast kinetic profile in comparison to αSyn, with
a short lag phase between 1 - 2 h when measured in bulk with ThT [229]. The kinetic curve
obtained with ThT was in accordance with these reports and did reveal a lag phase of ∼1 h
with a plateau reached at ∼6 h. In comparison to this, nearly no lag phase was observed with
mE10 and the plateau phase was reached after 3 - 3.5 h. These results further strengthened the
assumption that mE10 is a promising candidate as new fluorescence probe for the detection
of early oligomeric species with high sensitivity across different amyloid proteins.
Single Aggregate Fluorescence Anisotropy Imaging
Amyloid aggregates possess a large diversity in respect to their size, structure and
formation mechanism [230]. Bulk measurements are able to characterise mE10 in respect to
the average features of these heterogeneous species but to better understand the fundamentals
behind this superior performance on a structural level, further analysis of the binding and
fluorescence response on a single aggregate level is needed. Previously, high resolution
fluorescence experiments have been able to investigate in vitro the structural changes in
individual oligomers formed during the aggregation process. The results of these studies
indicated a structural uniformity present in fibrils and a structural rearrangement of the
aggregates before growing into these ordered fibrillar structures [188, 231, 232]. During the
rearrangement and fibril growth the β -sheet content and the structural order increases.
ThT is thought to bind preferentially into the channel motif on the surface of the β -sheets
with its long axis parallel to the long axis of the fibril (cf. section 4.1.3) [200]. Varela et
al have previously provided evidence to reinforce this assumption of axial-specific binding
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by using fluorescence anisotropy measurements combined with a single-aggregate imaging
technology [231].
Figure 4.18 Schematic illustra-
tion of the fluorescence aniso-
tropy set-up [231].
Within their set-up, a rotating polariser was placed
between the tube lens and the dichroic of a total internal
fluorescence microscopy (TIRF) arrangement (Figure 4.18),
which enabled them to examine fluorescence specific to dif-
ferent polarisation states. When single αSyn fibrils stained
with ThT were imaged under these conditions, the detected
fluorescence intensity varied in a sinusoidal way as the po-
lariser rotated resulting in a maximum when the polariser
and the long axis of the fibril were aligned. As fluorophores
that bind in a defined orientation, emit a highly polarised
fluorescence, this result indicated that ThT is predominantly
aligned with the axis of the αSyn fibril.
To find out whether mE10 binds in the same orientation
to αSyn fibrils as ThT, fluorescence anisotropy measure-
ments with the same imaging set-up were performed using
late-stage recombinant aggregates of αSyn. For both dyes,
mE10 and ThT, the fluorescence intensity modulated sinus-
oidally: a maximum signal intensity was reached when the
axis was aligned with the fibril and a minimum intensity appeared when the axis of the
polariser was perpendicular to the fibril (Figure 4.19). This was in agreement with previous
published results for ThT. As the modulation phase was the same for ThT and mE10, it can be
assumed that the two dyes are oriented the same way when bound to fibrils. Additionally, the
intensity for both dyes went down to nearly zero when the polariser and the fibril axis were
orthogonally placed. This indicates that the majority of dyes responsible for the fluorescence
signal are bound in an ordered way, aligned with the axis of the late-stage recombinant
αSyn aggregates. If other major fluorescent binding sites with different structural features
were present for mE10, the fluorescence intensity of mE10 should manifest a constant offset
in the sinusoidal response curve as some of the dye molecules would be binding to these
additional binding sites in a different orientation. Taken together, these data indicated that
the fluorescence turn-on response of mE10 and ThT is mostly based on the same binding
order for the detection of late-stage amyloid aggregates. However, other binding sites might
exist, which lead only to a weak or no fluorescence response.
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Figure 4.19 Fluorescence anisotropy measurements of late-stage αSyn (7 µM) aggregates with mE10
(5 µM) and ThT (5 µM). The detected fluorescence of mE10 and ThT modulated sinusoidally between
a maximum when the polariser axis is aligned with the fibril and a minimum if the axis of the polariser
is perpendicular to the fibril axis.
Previous aggregation kinetic measurements demonstrated that mE10 detects earlier
aggregation events than ThT in bulk. Knowing now that mE10 and ThT are binding to
β -sheet containing aggregates in the same ordered way, the cause for the earlier fluorescence
response in bulk was further questioned by analysing the degree of modulation obtained by
the anisotropy assay. It was reported, that the amplitude of the fluorescence signal of ThT
obtained by fluorescence anisotropy measurements can be used as a measure of the extent of
ordered β -sheet structures in individual aggregates [231]. Therefore, the fluorescence was
fitted as described in the literature to y = acos(bx + c) + d, with a being the amplitude of
the signal, b the angular frequency (constant, user-defined rotation speed of the polariser),
c the phase and d an offset. The “modulation” value was then defined as 2a/(a + d).
Aggregates that lead to a small modulation value (modulation< 0.5) were categorised as
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non-modulating and thought to contain mostly disordered β -sheet units; species with a larger
value (modulation> 0.5) are classified as modulating species owning spatially aligned β -
sheet content. To apply this concept to deepen the understanding of the superior performance
of mE10 above ThT, the fluorescence anisotropy measurements were repeated but with the
focus of αSyn species being present in the lag phase of the aggregation process. More
precisely, samples were taken from three different aggregation reactions at 6 hours. All the
detected aggregates were then analysed separately to measure their degree of modulation
(Figure 4.20).
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Figure 4.20 Fluorescence anisotropy measurements of αSyn aggregates (7 µM) in the aggregation lag
phase with mE10 (5 µM) and ThT (5 µM). The response to anisotropy measurement was measured
for the same number of fields of view for both A) ThT and D) mE10. Scatter plots of aggregate
intensity vs modulation show that these parameters are not correlated for either B) ThT or E) mE10.
Representative fluorescence images are shown for both C) ThT and F) mE10. The dyes were only
added for the imaging and not present during the aggregation process.
mE10 showed an overall higher sensitivity in detecting aggregate species in this early
stage samples compared to ThT (cf. count values in Figure 4.20A vs D). Furthermore, mE10
was able to detect both, modulating and non modulating species, whereas ThT reported
mostly on modulating aggregates. This indicates that mE10 is not only able to detect more
advanced aggregates, in which a certain degree of spatially aligned β -sheet content is already
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present, but also possesses a high sensitivity towards earlier oligomeric species arising
before the structural rearrangement and thus having mostly unordered β -sheet units. Another
striking feature was that the degree of modulation was not correlated to the fluorescence
signal intensity (Figure 4.20F), which suggests on the one hand, that the number of binding
sites remains roughly constant during the structural rearrangement of the aggregates, and on
the other hand that the ability of mE10 to detect the different species is not caused by the
greater brightness of mE10. This was further investigated by imaging the samples from three
different aggregation reactions with mE10 using lower excitation power in order to obtain
emitted photon counts comparable to ThT imaging. The lowest laser power chosen was 5
times lower than the one used for ThT and hence should compensate for the∼5-times greater
brightness of mE10. By doing so, any effect towards the detection of different species relying
on the greater brightness of mE10 should be excluded. Even though the number of detected
aggregates (“counts”, Figure 4.21) decreased with decreasing laser power, the histogram did
continue to manifest the presence of modulating and non-modulating populations, ensuring
that the ability of mE10 to detect more of these non-modulating species than ThT is not
relying on its increased brightness.
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Figure 4.21 Fluorescence anisotropy measurements of αSyn aggregates (7 µM) in the lag phase with
mE10 (5 µM) using different laser powers (A) 35 mW, B) 21 mW and C) 7 mW).
To cross validate that the applied definition of non-modulating species describes the
signal response of amorphous oligomers, stable oligomers were imaged under the same
conditions. Therefore, three different stable oligomeric αSyn species, wild-type (WT), E46K
and H50Q, were tested [233]. All three stable oligomers had similar size (average diameter
∼20 nm), morphologies and secondary structures validated by dynamic light scattering,
transmission electron microscopy and Fourier-transform infrared spectroscopy. Additionally,
their β -sheet content was analysed to be between that of monomers and fibrils and arranged in
an amorphous way. Thus, imaging these structures with mE10 and ThT should confirm, that a
modulation value below 0.5 can be interpreted as signal generated by oligomeric species with
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unordered arrangement of β -sheet units. As depicted in Figure 4.22, fluorescence anisotropy
measurements of WT, E46K and H50Q resulted in modulation values centred between 0.2
and 0.3. These data confirmed the assumption that modulation values smaller than 0.5 can be
correlated to non-modulating species.
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Figure 4.22 Fluorescence anisotropy measurements of stable αSyn oligomers with A) ThT and B)
mE10. All individual species detected are plotted against the number of species being detected
(counts).
Taken together, all the fluorescence anisotropy measurements indicate that, due to its
higher affinity, mE10 is able to detect different and early arising aggregation events of
αSyn aggregates, that might have a more disordered arrangement of cross-β motifs. This
combined with its higher sensitivity makes mE10 a better αSyn stain than ThT, which might
allow the study of the formation of these early species and their role in the pathogenesis of
neurodegenerative disorders even at low concentrations in biological samples with higher
background.
4.2.2 Improving Sensitivity and Resolution by DNA-PAINT
Another way to overcome the limitations of ThT based on its optical properties is to
combine its binding specificity with other dyes featuring a higher extinction coefficient and
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quantum yield at a different, preferentially red-shifted, wavelength. Since DNA-PAINT
combines the high resolution of single-molecular localisation microscopy with the well
known sensitivity and selectivity of DNA nanotechnology, it allows precise, programmable
single-molecule imaging with sub-5-nm spatial resolution. Thus, DNA-PAINT methodology
was considered as an alternative to development of new fluorescent probes in improving
the sensitivity of ThT for small, low concentrated early stage oligomers. Using ThT as the
targeting structure ensures β -sheet specificity and, additionally, can elucidate the binding
behaviour of ThT. The signal generation is not based on the fluorescence increase of ThT
and thus this approach might allow detection of ThT-binding sites, which have been kept in
the dark due to their lack in introducing a ThT turn-on response.
To implement this method, a short DNA strand (“docking strand”), that can pair up with
the complementary DNA strand linked to a dye (“imager strand”), needs to be attached to
ThT without disturbing its binding affinities. The reported ThT dimers showed improved
binding affinities and thus embodied a promising starting point [217]. In addition, the linker
structure can be designed in a way to provide an easily accessible site for the attachment
of the DNA docking strand. A chemically convenient way to conjugate biomolecules, such
as DNA, to chemical scaffolds is click-chemistry. The classical click-reaction describes a
1,3-dipolar cycloaddition of azides and alkynes. Azides are chemical inert towards common
biological moieties, meaning it does not interfer with any inherent functionalities of DNA,
which makes them ideal groups for bio-orthogonal reactions [234]. Furthermore, even if no
native peptide bond is formed at the ligation site, the resulting triazole moiety is considered to
mimic an amide bond by electronic and steric means and thus should not disturb the binding
towards protein aggregates [235].
To rationalise the concept, the linker was composed of two ethylene glycol units connected
via a diethylamine bridge. The central amine functionality allowed then the attachment of
the alkyne group, which presents the anchor point for the DNA docking strand. To further
improve the binding affinity, an uncharged ThT analogue was chosen as targeting moiety.
This decision was based on the ∼ 100-times higher binding affinity of the neutral aryl-
benzothiazole PiB in comparison to ThT. The linker was attached on position 6 of the
benzothiazole core structures as it was shown previously that modifications on this position
do not interfere with the ThT - amyloid interaction [236, 217]. The design and synthesis is
depicted in Figure 4.23.
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Figure 4.23 Synthesis scheme of DNA-PAINT probe. Reagents and conditions: (a) KOH, ethylene
glycol, ∆T. (b) 4-(dimethylamino)benzaldehyde, DMSO, ∆T. (c) BBr3, DCM. (d) Na2CO3, toluene,
∆T. (e) Boc2O, NaHCO3, THF. (f) MsCl, TEA, DCM. (g) NaH, DMF, ∆T. (h) HCl, MeOH (i)
4-Pentynoic acid, HATU, DIPEA, DMF. (Intermediates XIX, XX and XXI were synthesised with the
guidance of previous synthetic routes from our collaborators in the lab of Thomas Neil Snaddon)
The neutral ThT analogue XVI was synthesised in 3 steps utilising a published pro-
cedure [236, 217]. Briefly, basic hydrolysis of 2-amino-6-methoxybenzothiazole resulted
in the corresponding ortho-aminothiophenol XIV, which was subsequently reacted with 4-
(dimethylamino)benzaldehyde and selectively O-demethylated at position 6 to yield the final
aryl-benzothiazole XVI bearing a free hydroxy group for further modifications. The linker
unit was synthesised starting with 2-(2-chloroethoxy)ethanol and 2-(2-aminoethoxy)ethanol
followed by boc-protection of the nitrogen and subsequent activation of the hydroxy func-
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tionalities as mesylates. Coupling of the deprotonated 6-hydroxy aryl-benzothiazole XVI to
the dimesylated linker unit XIX and boc-deprotection of the linker nitrogen resulted in the
ThT analogue dimer XXI carrying a free amine group, which was then used to incorporate
the alkyne functionality via amide formation with 4-pentynoic acid.
Having successfully synthesised the dimeric ThT framework with the terminal alkyne
group, the next step was to attach the DNA docking strand to it. As the docking strand, an 11
base pair long oligonucleotide with the sequence XTATACATCTA with X = 5’azidodT was
chosen (MW = 3315 g/mol) as this sequence was shown to provide good blinking kinetics
[218]. However, the sequence can readily be varied to tune the binding duration and thus
the blinking kinetics to optimal conditions needed for different samples and dyes. The
azide-DNA strand was aimed to be attached by simple click chemistry followed by size
exclusion chromatography and LCMS validation. The general procedure was as follows:
the azide DNA and alkyne compound were dissolved separately and degassed. The catalyst
solution was prepared, degassed, added to the alkyne solution and the mixture was then
degassed again. The mixture of catalyst and alkyne was added to the azide DNA solution,
the reaction mixture was degassed and kept under shaking throughout the reaction. Different
procedures have been reported in the literature for click reactions using oligonucleotides. A
common approach is to use 1.1 eq. alkyne species, 1 eq. azide compound, a large excess
of reducing agent (in general Na-ascorbate, 50 - 200 eq.) and CuSO4 (50 - 70 eq.), and
5 eq. of Cu-stabilising ligand (e.g. TBTA, THPTA) [237–239]. The solvent systems used in
the literature were adopted according to the solubility of the compounds and ranged from
buffer to mixtures of organic solvent/H2O/tBuOH (3:1:1, v/v/v). As XXII was not soluble in
aqueous solutions, DMSO was added as organic solvent to the reaction to ensure solubility
of all compounds. To start with, the procedures described in the literature were applied using
1.1 eq. XXII, 1 eq. N3-DNA, 50 eq. CuSO4, 50 eq. Na-ascorbate as reducing agent and 5 eq.
TBTA as Cu-stabilising ligand. Different variations of these “standard conditions” have been
tried through changing:
1. reaction time: 1 h, 3 h, 7 h
2. reaction temperature: 25 ◦C, 37 ◦C, 45 ◦C, 60 ◦C
3. solvent system: 7:3 H2O:DMSO, 1:1 H2O:DMSO, 1:2 H2O:DMSO, 12:7:21 H2O:
DMSO:tBuOH
4. Cu-stabilising ligand: TBTA to THPTA
5. Cu(II): decreased CuSO4 concentration (10 eq.); using Cu(OAc)2 as Cu(II) compound.
6. Cu(I): using Cu(I) salts, CuBr and CuI, instead of Cu(II)
7. Alkyne equivalents: increased XXII concentration (10 eq., 50 eq)
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Table 4.8 displays some of the conditions tried. Unfortunately, none of these approaches
succeeded as either starting material or unspecific side product (mass increase compared
to starting material: 98.02 g/mol) were isolated and identified by LCMS. As the work was
carried out in small scales (2.25 µg N3-DNA) the side product was not further analysed. To
investigate the cause of the unspecific side product formation, the reactions were repeated
with pentyonic acid instead of XXII (Figure 4.24). However, the same side product was
obtained. Thus, the N3-DNA was incubated without the alkyne compound in the presence of
50 eq. CuSO4, 50 eq. Na-ascorbate and 5 eq. THPTA. This lead to the formation of the same
side product, indicating unspecific adduct formation of the N3-DNA. As the addition of a
base in (DNA-)click chemistry was reported in the literature [240, 241] to accelerates the
reaction rate, it was next investigated if the presence of a base (0.3 eq. DIPEA) or the use
of buffer (66 mM TEA-AA buffer) instead of water might firstly increase the reactivity of
the alkyne compound and secondly prevents the formation of this side product. This attempt
also resulted in the formation of the side product. The current focus is placed on exploring
different conditions to click other azides to compound XXII and if successful, the optimised
conditions will then be tried with different azide-DNA strands.
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Figure 4.24 DNA-click reaction was tried with A) compound XXII and B) pent-4-ynoic acid.
Table 4.8 Exemplary conditions tried for DNA click chemistry
XXII Cu-catalyst Cu-ligand Solvent Reaction Temp. Others
time [h] [◦C]
1.1 eq. CuSO4 (50 eq.) THPTA (5 eq.) 1:1 H2O:DMSO 7 37
50 eq. CuSO4 (50 eq.) THPTA (5 eq.) 1:1 H2O:DMSO 5 45
1.1 eq. CuSO4 (10 eq.) THPTA (5 eq.) 1:1 H2O:DMSO 5 60
1.1 eq. CuSO4 (50 eq.) TBTA (5 eq.) 1:1 H2O:DMSO 7 37
10 eq. CuSO4 (50 eq.) TBTA (5 eq.) 1:1 H2O:DMSO 5 45
1.1 eq. CuSO4 (50 eq.) THPTA (5 eq.) 12:7:21 H2O:DMSO:tBuOH 5 45
1.1 eq. CuSO4 (50 eq.) THPTA (5 eq.) 12:7:21 H2O:DMSO:tBuOH 5 45 0.3 eq. DIPEA
1.1 eq. CuSO4 (50 eq.) THPTA (5 eq.) 12:7:21 buffer:DMSO:tBuOH 5 45 66 mM TEA-AA buffer
1.1 eq. Cu(OAc)2 (50 eq.) THPTA (5 eq.) 12:7:21 H2O:DMSO:tBuOH 5 45
1.1 eq. CuBr (50 eq.) THPTA (5 eq.) 12:7:21 H2O:DMSO:tBuOH 5 45
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However, the synthesised neutral ThT-dimer bearing an alkyne functionality cannot only
be exploit for DNA-PAINT but also for attaching further targeting structures or other dyes
to the framework. Furthermore, by varying the linker length and/or composition, further
improvement of the binding affinity might be possible.
4.3 Summary and Conclusions
The comprehension of protein misfolding and formation of aggregates is a crucial require-
ment to expand our understanding of several neurodegenerative disorders, such as Parkinson′s
and Alzheimer′s disease. Despite the success of ThT, the current most common fluorescent
dye used for the detection of amyloid fibrils, it displays significant limitations. The most
prominent ones are the selective labelling of only amyloid species present in the later stage
of the aggregation process and its rather low quantum yield. As small soluble oligomeric
species of misfolded proteins have recently been described as critical to the pathogenesis
of neurodegenerative disorders, the inability of ThT to detect and assess these in biological
samples represents a major limitation, hampering further research.
To address this unmet need, the goal of this chapter was to find fluorescence probes with
improved optical and binding properties and higher sensitivity than ThT, which allow the
detection and characterisation of earlier arising aggregation events at low concentrations. To
pursue this objective two approaches were discussed: First, improving the photophysical
properties and binding affinity/selectivity of ThT by modifying the substituents on the aryl
nitrogen; secondly, utilising emerging high-resolution techniques, such as DNA-PAINT,
and combining these with multivalent ThT-based targeting structures to merge the specific
amyloid targeting ability of ThT with dyes with improved optical properties.
In search of structural modifications to improve ThT as an amyloid specific fluorescence
probe, a library of charged and neutral ThT-derivatives were examined in respect to their pho-
tophysical properties and binding affinities. As the cationic (mE) and neutral (E) derivatives,
were - apart from the methyl group on the benzothiazole nitrogen - structurally identical, this
allowed further investigation of the importance of this structural feature, which differentiates
also ThT and PiB. All structural modifications made, did not impact the ability of the dyes
to act as molecular rotors. This was manifested by a low quantum yield in low viscosity
solvents and a significant increase in fluorescence when surrounded by an environment with
higher viscosity or bound to fibrils.
The E derivatives exhibited a much smaller extinction coefficient and fluorescence
increase upon binding to αSyn aggregates compared to ThT making them poorly suitable
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for fluorescence imaging. The cationic mE equivalents, by contrast, showed a fluorescence
response suitable for imaging applications, even though the signal increase in the bound state
was less than that achieved by ThT. As for probes acting as molecular rotors, the optical
properties go hand in hand with their environment and thus their binding ability, different
methods were exploited to validate the binding affinities of the mE and E derivatives towards
recombinant αSyn aggregates. Fluorescence based assays as well as SPR measurements
manifested a 1-2 orders of magnitude higher binding affinity of the neutral dyes as opposed
to their charged analogues and ThT.
Outstanding throughout all optical and binding assay was the charged derivative mE10.
The conversion of the dimethyl amino moiety into a pyrrolidine group generated a more
restrained benzothiazole salt with increased lipophilicity improving the brightness upon
binding to αSyn aggregates by 5-fold and enhancing the binding affinity compared to ThT.
These improved proprieties enabled the detection of early oligomeric species with higher
sensitivity in bulk aggregation kinetic assays as well as on a single aggregate level when
looking at early stage αSyn aggregates. Furthermore, mE10 was able to sense different αSyn
species in these early stage samples by quantifying the degree of modulation of individual
aggregates. Following on from here, further characterisation should be carried out including
monitoring the aggregation kinetics on a single aggregate level, exploring the detection
limit by using single-aggregate techniques and evaluating the ability of mE10 to be used
for high resolution single molecule imaging. Simultaneously, additional validation using
other amyloid proteins should be performed. If this work yields positive results additional
characterisation in biological samples such as human cerebrospinal fluid of Parkinson′s
disease patients might be executed. However, taken all together, the results suggest that
mE10 is a promising new fluorescence probe with improved photophysical and binding
properties, which might allow the detection and characterisation of early oligomeric species
and thus shine light onto their role in the pathogenesis of neurodegenerative disorders.
Combining new, high-affinity ThT-analogues with super-resolution microscopy using
DNA-PAINT is a promising approach as it allows to finely tune the binding affinities of the
ThT-derivatives without being considerate of influencing the optical properties of ThT. Thus,
the focus of the future work of this project is divided into two parts. Further click-chemistry
conditions including different DNA strands as well as other ways of covalently linking the
docking strand onto the ThT-dimer should be explored. Should this succeed, subsequent
DNA-PAINT imaging should be performed to prove the concept. Simultaneously, different
linker length, linker compositions and topologies should be evaluated to find multivalent
ThT-probes with high affinities towards protein aggregates. Additionally, it might be worth
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trying to incorporate mE10 as targeting structure, as it shows increased binding affinity and,
assumed from previous results, might additionally sense early stage amorphous oligomers.
Similarly, integrating one charged dye (e.g. mE10) and one neutral dye (e.g. E10) as targeting
structure might even allow to bind to two different binding sites and thus allowing the read
out of different structural features of aggregates in different stages.
This project is ongoing and the group of Prof. C.A. Hunter is at the moment successfully
developing and evaluating different multivalent ThT-structures. Thus, when combining
all the different promising results it might be possible to find new amyloid probes with
high sensitivity, selectivity to oligomeric structures and specificity towards the different
pathological proteins (e.g. αSyn vs Aβ ).
4.4 Material and Methods
4.4.1 Chemical Synthesis
General experimental details are the same as stated in Chapter 2, Materials and Methods
2.4.1
Synthesis of mE and E Derivatives
The synthesis of the mE and E derivatives was performed in the lab of T.N. Snaddon
and adapted after a literature procedure [242]. An overview of the synthetic route including
reactants and conditions is shown in Figure 4.25.
N
SO
Br
N
SO
NR2 N
SO
NR2a) b)
Figure 4.25 Synthesis scheme of mE and E derivatives. Reagents and conditions: (a) Pd2(dba)3
(1 mol%), BINAP (3 mol%), NaOtBu (1.4 eq.), toluene, 80 ◦C, 18 h. (b) Methyl iodide (excess), PhCl,
110 ◦C, 18 h.
Synthesis for the DNA-PAINT Approach
Intermediates XIV, XV and XVI were synthesised following a previously reported pro-
cedures, the analytical data corresponded [236, 217]. Compounds XIX, XX and XXI were
synthesised with the guidance of previous synthesis routes from our collaborators in the lab
of Thomas Neil Snaddon.
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Synthesis of XVII
HO O N
H
O OH
11.2 g (106.5 mmol) of 2-(2-Aminoethoxy)ethanol, 3 g (28.3 mmol) Na2CO3 and 60 mL
toluene were refluxed for 5 min. 3.3 g (26.5 mmol) β -chloroethoxyethanol in 6 mL tolu-
ene was then added dropwise and the resulting solution was refluxed for 48 hours using a
Dean-Stark apparatus. After cooling down to room temperature, the reaction was filtered and
concentration in vacuo. The concentrate was then purified using a Kugelrohr apparatus. The
desired product was obtained at 8 mbar and 270 ◦C as colorless oil (4.01 g, 20.74 mmol, 78%).
HRMS: m/z calculated for [M+H] = 194.13, found m/z = 194.1181.
1H-NMR: (400 MHz, CDCl3) δ [ppm] = 3.70 (t,JH,H = 4.7 Hz, 4H), 3.55 (t, JH,H = 4.7 Hz,
6H), 3.51 (t, JH,H = 5.4 Hz, 4H), 2.85 (t, JH,H = 5.4 Hz, 4H).
Synthesis of XVIII
OHONOHO
Boc
2 g (10.36 mmol) XVII and 4.2 g (50 mmol) NaHCO3 were dissolved in 11 mL dry THF
and cooled down to 0 ◦C. 2.7 g (12.4 mmol) Boc2O was added and the reaction mixture
was stirred at room temperature for 8 h. After concentration in vacuo, the residue was
partitioned between EtOAc (10 mL) and H2O (10 mL) and separated. The organic layer
was washed once with brine and the combined aqueous layers were then re-extracted with
EtOAc (3 x 10 mL). The combined organic fractions, were dried over anhydrous MgSO4,
filtered, and concentrated. The residue was purified by flash column chromatography (silica,
hexane / (6:1 EtOAc:EtOH, gradient). The product was obtained as slightly yellow oil (2.53 g,
8.6 mmol, 83.2%).
HRMS: m/z calculated for [M+Na] = 316.1737, found m/z = 316.1732 matched M+Na.
1H-NMR: (400 MHz, CDCl3) δ [ppm] = 3.69 (m, 4H), 3.65 (bs, 4H), 3.57 (m, 4H), 3.45 (bs,
4H), 2.87 (t, JH,H = 5 Hz, 2H), 1.46 (s, 9H).
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13C NMR: (101 MHz, CDCl3) δ [ppm] = 160.58, 84.74, 81.99, 77.16, 74.34, 66.46, 52.92,
33.21.
Synthesis of XIX
OMsONO
MsO
Boc
1.0 g (3.4 mmol) XVIII and 1.2 g (11.9 mmol) TEA were dissolved in 7 mL dry DCM and
cooled down to 0 ◦C. 974 mg (8.5 mmol) methanesulfonyl chloride in 3 mL dry DCM was
added dropwise and the reaction mixture was stirred at room temperature over night. 1N HCl
(30 mL) was added while stirring and the mixture was extracted with DCM (4 x 25 mL). The
combined organic layers were washed with NaHCO3 solution, dried over MgSO4, filtered,
and concentrated to give the desired product as colourless oil (1.1 g, 2.4 mmol, 72%).
HRMS: m/z calculated for [M] = 472.1287, found m/z = 472.1284 matched M+Na.
1H-NMR: (400 MHz, CDCl3) δ [ppm] = 4.35 (m, 4H), 3.71 (m, 4H), 3.59 (m, 4H), 3.44 (m,
4H), 3.05 (s, 6H), 1.45 (s, 9H).
Synthesis of XX
ONO
Boc
N
SO
N
N
S O
N
NaH (60% in mineral oil, 19mg, 0.44 mmol) was added to a solution of XVI (110 mg,
0.4 mmol) in dry DMF (4 mL). The reaction mixture was stirred at room temperature for
1 h before XIX (90 mg, 0.2 mmol) in 1 mL dry DMF was added. The reaction was then
stirred at 80 ◦C for 18 h. After cooling down to room temperature, 15 mL H2O was added
and extracted with EtOAc (3 x 20 mL). The combined organic layers were washed with brine
(1 x 15 mL), dried over MgSO4, filtered, and concentrated to give the desired product as
white solid (57.2 mg, 0.07 mmol, 35%).
HRMS: m/z calculated for [M+H] = 798.33, found m/z = 798.3370.
1H-NMR: (400 MHz, CDCl3) δ [ppm] = 7.95-7.87 (m, 6H), 7.34 (m, 2H), 7.05 (dd, JH,H = 9,
2.5 Hz, 2H), 6.76 (d, JH,H = 9 Hz, 4H), 3.73-3.68 (m, 4H), 3.67-3.56 (m, 4H), 3.52-3.43 (m,
4H), 3.07 (s, 12H), 1.48 (s, 9H).
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13C NMR: (101 MHz, CDCl3) δ [ppm] = 166.6, 156.2, 155.5, 151.9, 149.1, 135.7, 128.5,
122.7, 115.4, 111.7, 105.4, 79.7, 70.1, 69.5, 69.4, 68.1, 48.0, 47.8, 40.2, 28.5.
Synthesis of XXI
O
H
NO
N
SO
N
N
S O
N
To 22 mg (0.028 mmol) XX was added 1.2 mL of 4M HCl in MeOH and the solution was
stirred at room temperature for 1 h. The reaction was quenched with 3.3 mL 3M NaOH and
the resulting suspension was extracted with EtOAc (3 x 3 mL), dried over MgSO4, filtered,
and concentrated to yield the desired product as white solid (16.8 mg , 0.024 mmol, 86%)
HRMS: m/z calculated for [M+H] = 697.28, found m/z = 697.2880.
1H-NMR: (400 MHz, CDCl3) δ [ppm] = 7.88 (d, JH,H = 9 Hz, 4H), 7.84 (d, JH,H = 9 Hz,
2H), 7.29 (d, JH,H = 2.5 Hz, 2H), 7.04 (dd, JH,H = 9, 2.5 Hz, 2H), 3.73-3.68 (m, 4H), 6.72 (d,
JH,H = 9 Hz, 4H), 4.15 (t, JH,H = 5 Hz, 4H), 3.83 (t, JH,H = 5 Hz, 4H), 3.68 (t, JH,H = 5 Hz, 4H),
3.04 (s, 12H), 2.86 (t, JH,H = 5 Hz, 4H).
13C NMR: (101 MHz, CDCl3) δ [ppm] = 166.7, 156.3, 152.0, 149.2, 135.8, 128.6, 122.8,
121.7, 115.5, 111.8, 105.5, 71.0, 69.7, 68.2, 49.4, 40.3, 28.6.
Synthesis of XXII
ONO
N
SO
N
N
S O
N
O
4-Pentynoic acid (6 mg, 0.06 mmol) and HATU (23.3 mg, 0.06 mmol) were dissolved
in 1 mL dry DMF and stirred for 10 min at room temperature. 43 mg (0.06 mmol) XXI in
1 mL dry DMF was added and after 5 more minutes stirring at room temperature, DIPEA
(19.4 mg, 15 mmol) was added. The resulting solution was stirred at room temperature for
further 10 h. The reaction mixture was then partitioned between EtOAc and LiCl (5%), the
aqueous layer was re-extracted with EtOAc and the combined organic fractions were dried
over anhydrous MgSO4, filtered, and concentrated. The residue was purified by flash column
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chromatography (silica, DCM:(9:1 DCM:MeOH), gradient). The product was obtained as
colourless oil (22.6 mg, 0.029 mmol, 48%).
MS: m/z calculated for [M+H] = 778.30, found m/z = 778.3034.
1H-NMR: (400 MHz, CDCl3) δ [ppm] = 7.86 (ddd, JH,H = 15, 9, 2.0 Hz, 6H), 7.31-7.27 (m,
2H), 7.03 (ddd, JH,H = 9, 4, 3 Hz, 2H), 6.72 (dd, JH,H = 9, 3 Hz, 4H), 4.12 (m, 4H), 3.79 (m,
4H), 3.70 (m, 4H), 3.62 (m, 4H), 3.04 (s, 12H), 2.66 (m, 2H), 2.51 (m, 2H), 1.92 (t, J = 2.5
Hz, 1H).
13C NMR: (101 MHz, CDCl3) δ [ppm] = 171.6, 166.7, 156.24, 156.1, 151.9, 149.1, 135.8,
128.5, 122.7, 121.6, 115.3, 111.7, 105.5, 89.3, 83.7, 69.9, 69.8, 69.6, 69.5, 68.6, 68.1, 68.0,
48.9, 46.7, 40.2, 32.2, 14.57.
Considerations for DNA-click Chemistry
Compound XXII was dissolved in the organic solvent and degassed using argon. N3-DNA
was dissolved in water and degassing was performed through freeze-pump-thaw cycles.
Size exclusion chromatography was performed using Bio-Rad Micro Bio-spin 6 Chroma-
tography columns (Cat.no.732-6200).
Oligomer LC-MS analysiswas performed using a XTerra MS C18 column (2.5µM,
2.1x50 mm), using solvents A (100 mM 1,1,1,3,3,3-hexafluoro-2-propanol, 10 mM NEt3)
and B (MeOH), at a flow-rate of 0.2 mL/min, with a gradient 5%–30% B increasing at 1%
per min. The signal was monitored at 260 nm. The identity of the compounds was assessed
by ESI-MS with negative polarity in ultra-scan mode. Data was acquired between 1000-2800
m/z.
4.4.2 Preparation of αSynuclein Aggregates
The purification of monomeric wild-type αSyn from Escherichia coli was performed
following a published protocol[243].
αSyn aggregates used for photophysical characterisation and binding affinity measure-
ments were generated as described by Buell at al[226]. Briefly, monomeric αSyn was diluted
into 50 mM sodium phosphate (pH 7.4) to reach a final concentration between 150 and
300 µM. Samples were incubated at 45 ◦C for in total 72 h whilst stirring at maximum speed
with a Teflon flea. After every 24 h the aggregation reaction was sonicated (3 cycles of 10 sec
at 30% power (Branson digital Sonifer, model 250, Branson, St Louis MO, USA). Finally,
the aggregation mixture was aliquoted, flash frozen in liquid N2 and stored at -80 ◦C till
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used. The αSyn concentration stated in the different experiments is reported as the monomer
equivalent concentration.
αSyn aggregates used for fluorescence anisotropy measurements were generated by
diluting monomeric αSyn into 1x PBS buffer supplemented with with 0.01% NaN3 to
prevent bacterial growth. The solution was then incubated in the dark at 37 ◦C with constant
shaking of 200 rpm for the time stated in the experiment.
4.4.3 Preparation of Synthetic Aβ42
The synthetic Aβ peptide (1-42, here called Aβ42), was purchased from Abcam (beta-
Amyloid Peptide (1-42) (human) (ab120301)) and purified as described previously [244]. In
short, the Aβ42 peptide was dissolved in 6 M GuHCl, purified with a Superdex 75 10/300
GL column (GE Healthcare Bio-Sciences AB SE-751 84 Uppsala, Sweden) and the centre of
the elution peak was used for the experiments. To determine the concentration of the purified
peptide, the known absorption at λ = 280 nm was used (ε280 = 1490 L mol -1cm -1).
4.4.4 Preparation of Dye Stock Solutions
Stock solutions of the different mE and E derivatives as well as ThT (Sigma-Aldrich,
T3516) were prepared by dissolving solid into dry dimethyl sulfoxide (DMSO, Sigma Aldrich,
276855) to reach a final concentration of 10 mM. These were aliquoted and stored in the
dark at -80 ◦C till used. Before the experiment, the stock solutions were diluted into filtered
(0.02 µm syringe filter, Whatman, 6809-1102) PBS (pH 7.4), sonicated and filtered (0.02 µm
syringe filter, Whatman, 6809-1102). For ThT, the final concentration was determined from
the absorbance at 412 nm, using an extinction coefficient of 36 000 M-1cm-1.
4.4.5 Photophysical Characterisation
Absorption and fluorescence spectra were recorded at 25 ◦C using a fluorescence spectro-
photometer (Cary Eclipse, Varian) and an UV-VIS spectrophotometer (Cary 300 Bio, Varian).
Therefore, samples were placed into Suprasil® quartz cuvettes with a 10 mm path length.
Fluorescence and absorption spectra of E, mE dyes and ThT were recorded at various con-
centrations free in PBS (1x, pH 7.4) and in the presence of 2 µM late stage αSyn aggregates.
Each condition was measured with a minimum of 3 separately prepared dye samples. Buffer
blanks and blanks of 2µM late stage αSyn aggregates were collected for both fluorescence
and absorption spectra and used for background correction. The fluorescence and absorption
190 Development of Novel Fluorescent Probes for the Study of Amyloids
measurements in 2-propanol (99.5%, Sigma-Aldrich 278475) were performed at a final
concentration of 10 µM.
Photophysical properties, including absorption maxima (λ abs), emission maxima (λ em),
Stokes shift, molar extinction coefficient (ε), fluorescence quantum yield (φFl) and brightness
(B = ε · φFl), were determined from bulk absorption and fluorescence measurements using
a custom Matlab script. Stokes shifts were calculated as the difference of λ em and λ abs,
absorption coefficients were determined from the absorbance of solutions with known
concentrations and sample path length using the Beer–Lambert law. The quantum yield of the
dyes were calculated by referencing against quinine sulfate (Sigma-Aldrich, Q0132) in 0.1 M
H2SO4 (φFl = 0.5) (see Appendix A.4, Figure A.11 for calibration curve). Discrepancies in
absorbency and solvent refractive index were corrected for (cf. 2.4.3) [160].
4.4.6 Fluorescence based Binding Assays
All samples were prepared in low-binding Eppendorf tubes (Eppendorf AG, Hamburg,
Germany).
Fluorescence and absorption titrations were recorded at 25 ◦C using a fluorescence spec-
trophotometer (Cary Eclipse, Varian) and a Varian Cary 300 Bio UV-VIS spectrophotometer,
using standard titration protocols. Typical procedure: 4 µM αSyn dilutions were prepared
by dilution of the corresponding amount of stock solution in filtered (0.02 µm syringe filter,
Whatman, 6809-1102) PBS 1X. Dye stock solutions were diluted into filtered (0.02 µm
syringe filter, Whatman, 6809-1102) PBS 1X to prepare seven solutions with concentrations
ranging between 19.5 µM and 1 mM, which were then sonicated carefully. 0.1 mL of the
4 µM αSyn dilution was removed, diluted down to 2 µM, transferred into a Suprasil® quartz
cuvette and the fluorescence and absorption spectrum were recorded. Defined volumes of
dye dilutions were then added to the same volume of 4 µM αSyn dilutions to avoid dilution
of αSyn during the titration. Aliquots of this solution were successively added to the cuvette,
the solution was thoroughly mixed and the spectra were recorded after each addition. The
same protocol was carried out without the presence of αSyn. Fluorescence spectra of ThT
and the mE10 derivatives were acquired with an excitation wavelength of 440-5 nm and
emission was collected between 465 nm and 600 nm with an emission slit of 5 nm. For the
neutral E derivatives the samples were additionally recorded with an excitation wavelength
of 355-5 nm and emission collection between 375 nm and 600 nm. Fluorescence spectra were
analysed using a Microsoft Excel spreadsheet to fit the changes in fluorescence intensity
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at fixed wavelengths to a 1:1 binding isotherm by optimising the association constant and
fluorescence intensity of the free and bound dye using purpose written VBA macros.
The fluorescence competition assays were carried out in a similar way but with different,
constant concentrations of ThT (1-15 µM) being present. This implicates that the 4 µM
αSyn dilution was supplemented with double the ThT concentration aimed for in the final
sample (e.g. in case of a final ThT concentration of 3 µM, the 4 µM αSyn dilution would be
supplemented with 6 µM ThT to avoid dilution of αSyn and ThT during the titration). As a
control, the same protocol was carried out with a constant ThT concentration in PBS and
subsequent addition of solutions of E derivatives. Fluorescence spectra were analysed using a
Microsoft Excel spreadsheet to fit the changes in fluorescence intensity at fixed wavelengths
to an isotherm that allowed for both ThT and dye binding in competition to the first protein
binding site (BS1). The value of KA,ThT (the association constant for ThT binding to the
first binding site) was fixed at the value measured by direct titration. For each point in the
titration an iterative procedure implemented as VBA macros was used to solve simultaneous
equations 1-5 for the concentrations of all of the species present.
(1) [BS1 · ThT] = KA,ThT[BS1free] · [ThTfree]
(2) [BS1 · dye] = KA,dye[BS1free] · [dyefree]
(3) [dyetotal] = [dyefree] + [BS1 · dye]
(4) [ThTtotal] = [ThTfree] + [BS1 · ThT]
(5) [BS1total] = [BS1free] + [BS1 · dye] + [BS1 · ThT]
(6) [I]obs = I(BS1 · ThT) · [BS1 · ThT] + I0
Equation 6 was then used to calculate the fluorescence intensity. A simplex optimisation
was used to obtain values of KA,dye (and thus KD,dye), [BS1]total, I(BS1·ThT) and I0 that
provided the best fit to the experimental data. I0 is the plateau fluorescence intensity due to
ThT bound to the second binding site BS2.
4.4.7 Surface Plasmon Resonance Measurements
SPR studies were performed at 25 ◦C using a Biacore T200 in HBS-EP+ buffer (10 mM
HEPES, 150 mM sodium chloride, 3 mM EDTA, and 0.05% v/v surfactant P20 in MQ water;
filtered through a vacuum driven 0.22 µm filter system from Millipore) containing 5% v/v
DMSO. αSyn, prepared as described prior, were covalently coupled to a Research Grade
CM5 sensor chip (BIAcore) via primary amino functionalities of the fibrils using the amine
coupling kit provided by BIAcore. For surface coating, αSyn was injected at a concentration
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of 2.8 µM in 10 mM sodium acetate buffer (pH 4.0) at a flow rate of 10 µL/min for 12
minutes. Coupling levels ranged from 2146 to 11350 RU. A second flow cell was treated
identically including all immobilisation chemistry but without αSyn to function as reference
for analysis.
30 µM dye solutions were prepared by dilution 10 M dye stock solutions into down to
HBS-EP+ buffer with a final concentration 5% DMSO. The concentration series (30 µM,
20 µM, 15 µM, 10 µM, 5 µM, 2.5 µM, 1 µM, 0.75 µM, 0.5 µM, 0.25 µM, 0.1 µM) was then
prepared by further diluting the 30 µM solution.
To correct for the DMSO content in the samples, a solvent correction assay was performed
at the beginning and at the end of each measurement set. After stabilisation of the baseline,
response units for each dye sample were acquired by using a flow rate of 30 µL/min for 60
seconds. Dissociation time was set to 400 seconds. No further regeneration step was needed.
The measurements of each dye concentration series was conducted in a randomised order
and the 10 µM sample was measured a second time after the whole concentration series of
the dye to prove consistency. In between the measurements of different dyes a 5 µM ThT
sample was measured as control sample. The whole SPR measurement set for each dye was
at least repeated three times on different flow cells with fresh immobilised αSyn and new
prepared concentration series.
All data are solvent corrected and reference subtracted. Equilibrium binding analysis
was performed by normalising the obtained binding levels at the equilibrium from each
concentration series and averaging the normalised values over the replicates (n≥ 3). The
averaged values were then plotted as a function of concentration (Figure 4.13). KD values
were obtained with GraphPad Prism 6 by non-linear curve fitting to these values using the
equation Y = Bmax ∗ X / [KD + X ], where Y is the response, X the concentration, Bmax the
maximum specific binding response (same unit as Y) and KD is the equilibrium binding
constant (in the same units as X). Kinetic analysis was performed using the heterogeneous
ligand fit provided in the Biacore software.
4.4.8 Measuring Aggregation Kinetics of wild-type αSyn
To study the aggregation kinetics of αSyn, wild-type αSyn monomers were diluted
into filtered (0.2 µm syringe filter, Whatman, 6780-1302) PBS (pH 7.4) supplemented with
0.01% NaN3 and 18 µM ThT, 18 µM mE10 or 1 µM Nile red to reach a final concentration
of 70 µM. Each sample was then pipetted into multiple wells of a 96-well, low-binding
polyethylene glycol coating plate (Corning 3881, Kennebuck ME, USA) with a clear bottom,
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at 100 µL per well. The 96-well plate was sealed with a gas permeable plate seal, placed in
a plate reader (CLARIOstar; BMG Labtech, Ortenberg, Germany) and incubated at 37 ◦C.
Fluorescence was measured using excitation and emission filters of 440-10 nm and 490-15 nm
for mE10 and ThT, and 520-10 nm (ex) with 660-20 nm (em) for Nile red. Measurements
were performed every 10 min for a period of up to 63.5 h. Plates were subjected to double
orbital shaking at 200 rpm for 540 sec after each reading.
To investigate the inhibitory effect of mE10 and ThT, wild-type αSyn monomer were
diluted into filtered (0.2 µm syringe filter, Whatman, 6780-1302) PBS (pH 7.4) supplemented
with 0.01% NaN3 and divided into 12 aliquots. 3 of the aliquots were supplemented with
18 µM ThT and 3 with 18 µM mE10. The remaining 6 aliquots served as controls. All
samples were prepared in low-binding Eppendorf tubes (Eppendorf AG, Hamburg, Germany)
and the final concentration of αSyn monomer in each aliquot was 70 µM. The solutions
were then incubated in the dark at 37 ◦C with constant agitation (200 rpm) for 55 h. The dye
solutions used to supplement the aggregation mixtures mentioned above, was also incubated
under the same conditions and used for supplementing the control samples before imaging.
At t = 0, 15, 25, 33 and 55 h, samples of the different aggregation reactions were taken
and mE10 or ThT were added to the control samples. Each sample was then pipetted into
multiple wells of a 384-well plate (Corning, black polysterene, clear bottom) at 20 µL per
well. The plates were placed into a plate reader (CLARIOstar; BMG Labtech, Ortenberg,
Germany) using excitation and emission filters of 440-10 nm and 490-15 nm. It was ensured
that the concentration of αSyn was the same for all samples thought the process and the
concentration of dye while imaging was 18 µM in all cases.
4.4.9 Measuring Aggregation Kinetics of Synthetic Aβ42
For kinetic experiments, the synthetic Aβ42 monomer was diluted with filtered (0.2 µm
syringe filter, Whatman, 6780-1302) PBS (pH 7.4) to a concentration of 4 µM and sup-
plemented with 10 µM ThT or 10 µM mE10. All samples were prepared in low-binding
Eppendorf tubes (Eppendorf AG, Hamburg, Germany) on ice. Each sample was then pipetted
into multiple wells of a 96-well, low-binding polyethylene glycol coating plate (Corning
3881, Kennebuck ME, USA) with a clear bottom, at 70 µL per well. The 96-well plate was
placed in a plate reader (CLARIOstar; BMG Labtech, Ortenberg, Germany) and incubated at
37 ◦C under quiescent conditions using the bottom reading mode (ThT/mE10: 440-15 nm
excitation, 480-15 nm emission)For each new preparation of protein, the aggregation kinetics
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were checked by performing aggregation reactions at different concentrations of Aβ and a
minimum of three replications per condition.
4.4.10 Fluorescence Anisotropy Measurements
Sample preparation
General Consideration
All samples were prepared in low-binding Eppendorf tubes (Eppendorf AG, Hamburg,
Germany).
Borosilicate glass coverslips (VWR international, 22 x 22 mm, product number 631-0124)
were cleaned using an argon plasma cleaner (PDC-002, Harrick Plasma) for at least 1 h
to ensure that any fluorescent residues are removed from the coverslip. Frame-Seal slide
chambers (9 x 9 mm, Bio-Rad, Hercules,CA, product number SLF-0201) were attached to
the coverslip, and 50 µL of poly-L-lysine (70-150 kDa, Sigma-Aldrich, product number
P4707-50 ML) was added on the inside of the slide chamber. After incubation for 20-30 min,
the surplus of poly-L-lysin was aspirated carefully and gently washed three times with filtered
PBS.
To correct for any fluorescent artefacts caused by the coverslips or any of the solutions
being used, dye solutions (5 µM, 50 µL) in PBS without αSyn were imaged for each experi-
ment and used as blanks.
Samples for Evaluation of Binding Order of mE10 on Late Stage αSyn Aggregates
αSyn was aggregated under the conditions stated before for 48 h and stored in the dark at
4 ◦C for several weeks. The 70 µM αSyn samples were diluted into filtered PBS supplemen-
ted with 5 µM dye to yield a final concentration of 7 µM αSyn. 50 µL of this solution was
then added on the inside of the slide chamber and imaged. For each condition a minimum of
2 different coverslips were imaged at 3-5 different positions per slide.
Samples for Evaluating Modulation Degree on Early Stage αSyn Aggregates
αSyn was aggregated under the conditions stated before for 6 h. After 6 h, they were put
on ice and subsequently used for imaging. Therefore, the 70 µM αSyn samples were diluted
into filtered PBS to yield a final concentration of 7 µM αSyn. 50 µL of this solution was then
added on the inside of the slide chamber and incubated for 10 min at room temperature. After
10 min, the surplus was carefully removed and the slide was washed twice with PBS. Finally,
50 µL of 5 µM dye solution was added and images recorded. For each dye, three separate
4.4 Material and Methods 195
aggregation reactions were tested and slides were imaged at minimum three different frames.
Stable Oligomers
The stable oligomers were supplied in PBS (pH 7.4) containing 0.01% NaN3 at concen-
trations of 52.4 µM (E46K), 18.4 µM (WT) and 31.1 µM (H50Q). The samples were diluted
into filtered PBS supplemented with 5 µM dye to yield final concentrations of either 1 µM
(E36K+mE10, E46K+ThT, WT+mE10) or 0.5 µM (WT+ThT, H50Q+mE10, H50Q+ThT).
50 µL of this solution was then added on the inside of the slide chamber and imaged. For
each condition 2 different coverslips were imaged at minimum 3 different positions per slide.
Imaging
The imaging set up was the same as described in the literature [231]. Briefly, Imaging
was performed on a total internal reflection fluorescence microscope using a 405 nm laser
(LBX-405-50-CIR-PP, Oxxius), which was passed through a quarter wave plate (WPQ05M-
405, Thorlabs) aligned parallel to the optical axis at the edge of a 60x Plan Apo TIRF, NA
1.45 oil-immersion objective lens, (Nikon Corporation) mounted on an Eclipse TE2000-U
microscope (Nikon Corporation). Fluorescence emission was also collected by the same
objective and selected by the presence of a dichroic (ZT 405/532 rpc) and subsequently
passed through an emission filter (FF01-480/40/25). A polariser (10LP-VIS-B, Newport)
mounted on a stepper motor rotation mount (K10CR1/M, Thorlabs) was placed between
tube lens and the microscope body. During image acquisition, the polariser was rotated
360 degrees at 2 degrees per second for each field of view and images were recorded on
an EMCCD camera (Evolve 512, Photometrics) at 20 frames per second with an exposure
time of 50 ms during a full 360 ◦ spin. Each pixel was 241 nm. Micromanager software
was used to control the microscope [245]. The excitation power was 35 W/cm2 measured in
epifluorescence mode for all samples. For mE10 samples studying the modulation degree,
the same samples were additionally imaged by using a laser power of 21 and 7 W/cm2 for
each frame.
Image Analysis
The image stacks corresponding to the full spin of the polariser were denoised in ImageJ
(NIH, Bethesda) by sub-averaging 30 frames. To correct for the small circular drift caused by
the rotation of the polariser, the images were aligned using “Align Images” plug-in available
in GDSC utility plug-ins from the University of Sussex (http://www.sussex.ac.uk/gdsc/-
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intranet/microscopy/imagej/utility). After alignment, the entire stack was averaged and
by using the Find Maxima function in ImageJ each protein aggregate was detected. The
threshold was set to 50. To obtain the sinusoidal fluorescence response of the dyes bound to
fibrils, ROIs were drawn on different horizontally and vertically orientated fibrils and the
signal intensity at these ROIs was plotted against the polariser angle.
To obtain the modulation signal for each species detected, analysis was performed by
Juan Varela as described in the literature [231]. Shortly, the signal intensity of a 3×3 pixels
square in each detected species was calculated and the local background was subtracted.
The resulting signal was then plotted and fitted with a cosinusoidal curve of the form
y = acos(bx + c) + d. In case of the phase c of the aggregate being similar to the phase c of
the background, the aggregate was not considered in the analysis. If quality was appropriate,
modulation was calculated by modulation = 2a/(a + d).
Chapter 5
Bifunctional Fluorescent Probes for
β -Amyloids and Hydrogen Peroxide
Detection
The results presented in this chapter are published in the paper “Bifunctional fluorescent
probes for detection of amyloid aggregates and reactive oxygen species”[246], listed in
the publication section. The synthesis of the dyes was performed by James Fyfe, Omaru
Kabia and Dung Do. αSyn was purified by Ewa Klimont. Lisa-Maria Needham performed
fluorescence measurements; the data was analysed by Lisa-Maria and myself. Margarida
Rodrigues and I prepared the αSyn fibrils. I performed binding assays, LCMS measurements,
NMR stability studies.
5.1 Introduction and Motivation
Having found the ThT-analogue mE10 with superior photophysical and binding properties,
the aim of this chapter was to apply this knowledge and integrate it into a bifunctional
fluorescence probe able to detect amyloid aggregates and reactive oxygen species (ROS)
simultaneously.
ROS are endogenously produced oxidising agents important in essential biological
processes. However, high levels of ROS can induce, among others, protein alternations,
DNA mutations and impair mitochondrial function, all of which are known to contribute
to the development of neurodegenerative diseases. Thus, oxidative stress has long been
suggested to play an important role in the pathogenesis in a range of neurodegenerative
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disorders [247, 13, 248]. Conversely, it was also shown that amyloid species formed in
neurodegenerative diseases are capable of inducing free radical production [249]. Together,
this generates a bidirectional relationship between protein aggregation and oxidative stress.
Even though it is possible to detect both oxidative stress and amyloid aggregates, separ-
ately in in vitro and in vivo models of neurodegeneration as well as in post-mortem brains
[250, 13], the interplay between ROS and the pathogenesis of neurodegeneration remains
poorly understood: What is causation, what is correlation and how exactly do the different
developmental stages of the disease vary from each other in respect of their amyloid species
and redox biology [250, 13]? Thus, the ability to image increased levels of specific ROS
together with amyloid aggregates could help to elucidate this complex interplay.
As highlighted in previous chapters, assessing ROS levels is technically challenging due
to their short half-life and high reactivity, demanding non-interruptive methods with high
spatial and temporal resolution. High-resolution fluorescence imaging operates on a temporal
and spatial scale highly suited to meet this needs. Additionally, it enables visualisation
and quantification of amyloid aggregates on a single aggregate level [216]. Therefore, the
goal of this work was to combine single-molecule fluorescence instrumentation with new
bifunctional fluorescence probes to enable the concurrent readout detailing both the presence
and characteristics of different amyloid species as well as a specific ROS.
5.1.1 Approach
ThT is the most common fluorescent dye used for the detection of amyloid fibrils. As
previously confirmed by the results in Chapter 4, mE10 has been demonstrated to outperform
ThT in respect to its optical and binding properties while maintaining the most significant
property of ThT, the fluorescence quantum yield enhancement attained upon binding to
β -sheet containing species. In addition to a 5-fold increase in brightness and a 7-fold higher
binding affinity, the results described in chapter 4 indicated the suitability of mE10 for the
detection of early arising aggregation events including amorphous oligomers. These features
make the mE10 scaffold a promising base for the generation of a new bifunctional contrast
agent.
Hydrogen peroxide (H2O2) is generated in numerous biological processes and represents
an important biological ROS, which is highly involved in redox signalling. Additionally, the
often relatively high activation energy of reactions with H2O2 leads to an increased stability in
the biological environment, which results in greatly enhanced in vivo concentrations in several
diseases including neurodegenerative disorders [251–253]. H2O2-mediated conversion of
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aryl boronic acids and esters has been broadly used as strategy to generate probes that respond
effectively and selectively to H2O2 over other competing ROS [19, 20].
Based on this foreknowledge, the goal of this work was to design new H2O2-reactive,
amyloid sensitive fluorescence probes based on the mE10 benzothiazole core for amyloid
targeting and aryl boronic esters for H2O2 sensing (Figure 5.1). The presence of H2O2
should trigger the conversion of the boronic ester functionality into the corresponding phenol,
thereby causing a change in the sterical and electronical properties of the dye. This, in turn,
should lead to a change in the optical profile of the probes while maintaining their capability
to bind to amyloid aggregates.
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Figure 5.1 Background and concept of the bifunctional fluorescence sensor design. A) Pathway
of amyloid fibril formation starting from the monomeric protein and the suggested interplay with
oxidative stress. B) Schematic illustration of the bifunctional fluorescence sensor design. One part
of the sensor allows amyloid sensing by binding towards amyloid fibrils, which leads to an increase
in fluorescence, whereas the other part of the sensor is sensitive to H2O2 and causes a change in the
optical properties of the sensor after reacting with H2O2. C) Molecular structure of the bi-functional
fluorescence sensor. In the unbound state, the sensor shows low fluorescence intensity, which increases
when bound to amyloid aggregates. Additionally, in the presence of H2O2 the boronic ester undergoes
oxidative cleavage forming the corresponding phenol, which causes a change in the optical properties
of the sensor.
Converting the aryl dimethyl amino group of ThT into a pyrrolidine unit (mE10), showed
promising results. Thus, the boronic ester equivalent to mE10, mBE1, was designed, in
which the pyrrolidine functionality was converted into a boronic acid pinacol ester. As this
modification introduces sterical and especially electronical alternations, which are likely
to influence the behaviour of the bifunctional probe, the approach was complemented by
synthesising the 6-membered ring analogue, mBE2, as well as the corresponding neutral
derivatives, BE1 and BE2 (Figure 5.2), to gain an insight into the relationship between the
chemical structure, reactivity and specificity.
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Figure 5.2 Chemical structure of the four bifunctional probes, of which mBE1 and mBE2 are the
charged derivatives and BE1 and BE2 the neutral equivalents. The chemical structure of the dyes after
the reaction with H2O2 are also shown, which are referred as mBE-Ox and BE-Ox.
5.2 Results and Discussion
5.2.1 Photophysical Properties
The foundation of the success of ThT as amyloid stain relies on its low fluorescence in
its free state and the turn on response upon binding to amyloid aggregates. Thus, in order
to sense amyloid species, the new bifunctional probes need to fulfil these criteria. To prove
that the boronic ester modifications did not impact the underlying molecular rotor behaviour,
the four new derivatives were first examined towards their bulk fluorescence and absorption
properties in PBS without the presence of protein aggregates.
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Figure 5.3 Fluorescence spectra of the four bifunctional probes free in PBS (5 µM). The intensities
are normalised towards the maximum intensity of BE01.
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As for the mE and E derivatives described in Chapter 4, the four dyes showed low
quantum yield values in PBS (∼ 0.01 for mBE dyes, 0.04-0.06 for BE dyes), even though the
dyes showed over 10-times greater quantum yields than that of ThT (Table 5.1). Additionally,
their extinction coefficients were decreased compared with ThT and mE10, leading to a
over 4-times higher brightness than ThT but more than 3-fold lower brightness than mE10,
making the four dyes promising probes for the purpose of this study as low brightness is
desirable. Overall, the neutral derivatives exhibited overall higher quantum yields compared
to the cationic equivalents but with overall lower extinction coefficients. These findings
correlated well to previous results obtained from the E and mE derivatives and reinforce the
assumption of a higher energy barrier between the non-fluorescent twisted intramolecular
charge transfer (TICT) and the fluorescent locally excited (LE) state in the neutral derivatives
as well as a reduced oscillator strength in absence of the positive charge.
Through scrutinising the effect of the exchange of the aryl nitrogen against electron
withdrawing groups it was shown that the charged derivatives are influenced by modifications
on this position to a greater extent than the neutral analogues. The absorption and fluores-
cence maxima of the cationic probes experienced a hypsochromic shift of 90 nm and 77 nm
respectively when compared to mE10, making the absorption and emission wavelength range
equivalent to those of the neutral analogues. For the non-charged dyes, the maxima shifted
hypsochromically to a lesser extent (40 nm (abs), 12 nm (em)) compared to the neutral mE10
equivalent, E10. The conversion of the aryl boronic esters into the phenol did not significantly
alter the appearance of the maxima of the charged mBE dyes. The BE derivatives experienced
a minor chromatic shift in their emission maximum of 6 -10 nm, which is not significant to
be used as readout for the conversion of the boronic ester into the phenol. These findings
together suggest that the electron withdrawing nature of the substituent decreases the extent
of electron delocalisation significantly whereas sterical modifications show minor impact.
In respect to the extinction coefficient, the data suggested that the more electron deficient
and sterically demanding the group, the lower the extinction coefficient (ε(mE10)> ε(mBE-
Ox)> ε(mBE1)> ε(mBE2)). This resulted in a ∼ 4.5-fold increase in brightness for the
charged probes, and a greater than 2.7-fold increase for the neutral probes when converting
the aryl boronic ester into its phenol. The increase in brightness can serves as basis for
the readout of the presence of H2O2 in biological environment and thus supports the probe
design to be useful for specific ROS sensing.
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Table 5.1 Summary of photophysical properties1 of mBE and BE derivatives in PBS compared
to ThT and mE10.
Dye λ abs λ em λ em - λ abs εabs φFl B R1-structure
(nm) (nm) (nm) (M-1cm-1) (a.u.)
ThT 413 488 75 36000 0.00 39.4
mE10 420 494 74 31130 0.04 1245.2
mBE1 330 417 87 16800 0.010 174 B
O
O
mBE2 330 417 87 14800 0.010 152 B
O
O
BE1 330 416 86 6400 0.061 390 B
O
O
BE2 330 412 82 4200 0.041 172 B
O
O
mBE-Ox 328 416 88 20500 0.083 782 OH
BE-Ox 325 406 81 12700 0.037 1059 OH
1 Values were obtained from bulk UV-vis absorption and fluorescence measurements of the dyes in
PBS buffer (pH 7.4).
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5.2.2 H2O2 Sensing
Having established the suitable photophysical properties of the new bifunctional probes,
characterised by a relative low quantum yield in PBS and a greater brightness of the phenol
derivatives, it was necessary to prove the ability of the dyes to react with H2O2 and hence
triggering a change in the photophysical properties. This was initially evaluated with bulk
fluorescence spectroscopy and liquid chromatography mass spectrometry (LCMS) upon the
addition of a physiologically realistic H2O2 concentration of 100 µM [163]. To control for
external factors such as photobleaching and ROS generated though oxygen quenching by the
triplet state of the fluorophore, the same assay was performed with all dyes in the absence of
H2O2.
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Figure 5.4 A) Reaction kinetics of the four bifunctional probes (5 µM) upon addition of 100 µM
H2O2. The dashed line indicates the time point at which H2O2 was added. B) Fluorescence intensity
of the four dyes vs time of control experiment in PBS.
Fluorescence data showed an instant enhancement in signal intensity within less than
30 seconds resulting in an fluorescence increase of 15.4-, 3.3-, 1.5- and 1.1-fold for mBE1,
mBE2, BE1 and BE2 respectively (Figure 5.4). After this initial boost, the reaction was
further monitored for 5 h leading to a final fluorescence enhancement of 19.6-fold for mBE1,
4.6-fold for mBE2, 4.2-fold for BE1 and 1.9-fold for BE2. The corresponding kinetic profile
displayed linear increase for all four dyes over the monitored time range, but with different
rates (mBE1= 0.011 min-1, mBE2= 0.015 min-1, BE1= 0.112 min-1, BE2= 0.017 min-1).
These findings indicate that mBE1 is the most promising dye in respect to its signal-to-noise
ratio as the presence of H2O2 triggered an over 4-times greater turn on response as opposed
to the other dyes. Unexpectedly, BE1, which possesses the same boronic ester functionality
as mBE1, showed the greatest reaction kinetic, which was ∼ 10-times faster compared to
mBE1. It was shown that the oxidation rate is strongly dependent on the para substituent,
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which is here represented by the benzothiazole unit [107]. Based on the results from the
literature as well as the mechanism behind the oxidative cleavage, the mBE derivatives were
thought to show a higher reaction rate, as the positive charge makes the benzothiazole more
electron withdrawing and thus should facilitate the nucleophilic attack of H2O2. However, as
highlighted before and indicated by the lower quantum yield, it is likely that the methyl-group
reduces the energy difference between the LE and the TICT state. This in turn would lead
to a more pronounced TICT state conformation and consequently a reduced conjugation
between the aryl and benzothiazole system decreasing the influence of the benzothiazole unit
on the boronic ester reactivity.
To cross validate that the observed increase in fluorescence intensity is based on the
oxidative cleavage of the boronic ester by H2O2, the dyes were analysed via LCMS before
and after 60 min incubation with 100 µM H2O2. 60 min incubation in PBS without H2O2
served as control. A summary of the LCMS results can be found in the Appendix. The
data confirmed the conversion of the boronic esters of all four probes into the corresponding
phenols. Opposed to this, no phenol formation was detected after 1 hour without H2O2
reinforcing that the changes observed in the optical measurements are based on the oxidative
cleavage of the boronic esters by H2O2.
However, the conversion rate for the four derivatives was different. BE1 was converted to
100%, whereas mBE1 was only 73% converted into the corresponding phenol. The conversion
rates for the 6-membered ring analogues BE2 and mBE2 were 90% and 88% respectively.
This correlates with the reaction kinetics of BE1 from fluorescence measurements but
contrasts to the continuous fluorescence increase of BE1 over 5 hours. Additionally, as BE1
and BE2 get converted into the same phenol derivative, the fluorescence intensities should
have been relatively close in case of a 90%-oxidation of BE2 into BE-Ox. This was not
the case for the kinetic fluorescence study, as the signal of BE1 was ∼ 3 times greater than
the one for BE2 after 60 min. A number of repetitions of both, fluorescence and LCMS
measurements, showed significant variability especially in the fluorescence data. This might
be caused by several factors including errors caused by the limited sensitivity of the bulk
fluorescence spectrometer as the signal changes are rather small, balancing errors when
preparing the different stock solutions for extinction coefficient calculations and inherent
sensitivity of the dyes to competing processes.
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Figure 5.5 Representative LCMS traces of mBE2 after 60 min incubation with A) 100 µM H2O2 in
PBS and B) PBS. The values are representing relative area under the curve in the UV chromatogram
monitored at 254 nm.
It was noticeable that for all samples - at t = 0 min and t = 60 min, with and without the
presence of H2O2 - the boronic acid instead of the boronic ester was detected via LCMS
(Figure 5.5). This is often perceived due to on-column hydrolysis of the boronic esters,
which is promoted by the acidic pH of the mobile phase, the column as well as the column
temperature, as well as partial in situ hydrolysis of the esters under the aqueous conditions
[254, 255]. However, as it is known that boronic esters have a tendency to hydrolyse under
biological conditions, which would lead to mBE1 and mBE2 as well as BE1 and BE2 being
the same molecules, it was necessary to ensure that the boronic acid generation happened
predominantly during LCMS analysis. Therefore, direct mass spectrometry (ESI and ESCI)
as well as LCMS analysis of the samples diluted in MeCN were performed. Both confirmed
the contribution of the acidic solvent, on-column hydrolysis and ionisation towards the
detection of the boronic acid instead of the ester. Further LCMS and NMR studies in DMSO
as well as D2O/d6-DMSO confirmed the stability of the four dyes under these conditions.
Taken together, it can be assumed that the boronic esters are the predominant species present
during the studies.
Besides of the detection of the hydrolysed product, it was further detected that in the
mBE samples which were exposed to H2O2, up to ∼ 19% of the oxidised product was
de-methylated (Figure 5.5A). De-methylation did not appear in the samples without H2O2
(Figure 5.5B) and hence the partial demethylation can be attributed to the presence of H2O2.
However, the fluorescence emission of the BE and mBE samples in PBS did not show any
change in signal intensity over the course of 5 hours, which indicates that these extraneous
factors could be neglected. As a further control, the fluorescence of ThT was also measured
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before and after the addition of H2O2 and as expected no effect on the emission or LCMS
signal was detected.
Among the four probes, BE1 showed the highest fluorescence signal, which is promising
for sensitive detection of lower quantities of H2O2. Thus, the reaction of BE1 was additionally
monitored with different concentrations of H2O2 ranging from 1 µM to 100 µM (Figure
5.6. The results after 5 h manifested a graduated increase in the emission reaching a plateau
between 25 µM and 60 µM H2O2 and thus allowing the readout of different amounts of
H2O2.
Wavelength (nm)
375 400 425 450 475 500 525 550
0
50
100
150
200
250  100 
 25 
 10 
 1 
 0 
[H2O2] (μM)
 F
luo
re
sc
en
ce
 In
te
ns
ity
 (a
.u
.)
[H2O2] (μM)
0 20 40 60 80 100
50
100
150
200
250
 F
luo
re
sc
en
ce
 In
te
ns
ity
 (a
.u
.)
BA
Figure 5.6 H2O2 sensitivity of BE1. A) Fluorescence spectra of BE01 (5 µM) after 5 h incubation
with H2O2 at concentrations from 0 - 100 µM. B) H2O2 response curve of BE1 (5 µM) after 5 h
incubation with different concentrations of H2O2.
Taken together, even though hydrolysis in aqueous solutions and variability in the reaction
kinetics occurred, both, fluorescence and LCMS measurements confirmed the ability of the
new bifunctional probes to sense physiologically realistic H2O2 concentrations. Additionally,
BE1 appeared to be promising for the sensitive detection of H2O2 at quantities smaller than
100 µM.
5.2.3 Amyloid Sensing
The bifunctional probes were designed to respond to H2O2 as well as the presence of
amyloid sprecies. Thus, after having established their ability to function as H2O2 sensors,
it was then necessary to examine the capability of the dyes to report on the presence and
characteristics of amyloid species. Therefore, the optical properties of the dyes in the
presence of late stage αSyn aggregates were examined (Table 5.2).
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Table 5.2 Summary of photophysical properties1,2 of mBE and BE derivatives in the presence of αSyn compared
to ThT and mE10.
Dye λ em λ em,PBS - λ em,αSyn φFl φFl,αSyn/φFl,PBS B BαSyn/BPBS R1-structure
(nm) (nm) (a.u.) (a.u.)
ThT 483 5 0.24 ∼1000 6067 154.0
mE10 490 4 0.81 20.3 31590 25.4
mBE1 386 31 0.013 1.3 218 1.3 B
O
O
mBE2 392 25 0.022 2.1 325 2.1 B
O
O
BE1 391 25 0.110 1.8 704 1.8 B
O
O
BE2 393 19 0.140 3.4 588 3.4 B
O
O
1 Values were obtained from bulk UV-vis absorption and fluorescence measurements of the dyes in the presence of
10 µM late stage αSyn aggregates. 2 Due to the significant overlap of the absorption spectrum of the dyes and αSyn
aggregates, it was not possible to determine accurate extinction coefficient values for the dyes bound to amyloid.
All four probes exhibited an increase in their quantum yield and brightness upon binding
to late stage αSyn aggregates. However, the increase was relatively low compared to mE10
and especially ThT. Whereas mE10 experienced a more than 20-fold increase in its quantum
yield and an 25.4-fold increase in brightness, the greatest difference in quantum yield and
brightness of the four probes bound to amyloid compared to PBS was reached for BE2 with
an increase of 3.4-fold. This was in reverse to what was previously found for the mE and E
analogues, for which the neutral derivatives exhibited a smaller fluorescence response than
the charged equivalents. Additionally, the 6-membered ring mBE/BE dyes showed a stronger
response towards αSyn aggregates than the 5-membered boronic ester derivatives, which
was also in contrast to previous findings (mE10 vs mE13, Chapter 4). Besides the greater
quantum yield of the pinacol boronic esters in their free state, this could be the result of
different interactions of the dyes with the protein aggregates which may have contributed to
changes in their ground and excited states.
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Furthermore, it was striking that the quantum yield and brightness ratios for the boronic
ester probes yielded the same values. This was similar to the findings for mE10 and was
caused by an increase in extinction coefficient upon binding. For ThT the brightness ratio
was much smaller than that of the quantum yield, which could be linked to the decrease in
its extinction coefficient upon binding. Thus, it is likely that the boronic ester derivatives
experience an increase in their extinction coefficient in the presence of αSyn aggregates.
Even though the fluorescence response was smaller than that observed for mE10 and
ThT, all four bifunctional probes did manifest a significant shift in their fluorescence maxima
between 19 nm and 31 nm. This led to 7.8-fold greater shift in the fluorescence maximum of
the bound versus the unbound dye when comparing mE10 and its boronic ester equivalent
mBE1. Such offset between the free and bound state might offer an additional quantification
of the binding towards protein aggregates and thus complement the fluorescence turn on
response.
5.2.4 Binding Affinities
The optical properties of fluorescence dyes are often very sensitive towards their environ-
ment, especially fluorophores acting as molecular rotors [207]. Thus, to better understand the
observations about the optical properties of the bifunctional dyes upon binding to amyloid
species, the next goal was to determine the binding affinities of the dyes towards αSyn. The
binding affinity measurements were performed with αSyn aggregates obtained via a previ-
ously published protocol, that allows the generation of fibrils with a narrow size distribution
and good reproducibility between independent batches [226].
As discussed in Chapter 4, fluorescence based measurements of binding affinities are
limited by the performance of the dyes as emitters and are only able to report on binding sites
triggering a fluorescence response. Since the four bifunctional probes responded towards
the presence of αSyn aggregates with a distinct but rather low fluorescence increase and the
main purpose of the affinity measurements was to compare all four dyes and their phenol
equivalents. Surface plasmon resonance (SPR) measurements were performed to assess the
binding affinities. αSyn aggregates were covalently attached to a gold surface via an amide
bond and exposed to different concentrations of the dyes (cf. Chapter 4 for more details).
The SPR binding experiments yielded good data quality for all dyes with very minor error
bars obtain across three different chips (represented as standard deviations).
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Figure 5.7 Binding affinity curves obtained from SPR experiments of mBE and BE dyes (before and
after incubation with H2O2 (100 µM and 10 mM)), ThT and mE10 binding to immobilised αSyn
aggregates on a gold surface. Each spectrum represents the mean of results from 3 independent
preparations of dye solutions and SPR chips; error bars are shown as standard deviations.
Analysing the equilibrium resonance response in respect to the dye concentration yielded
binding affinities for the four dyes with KD values between 1.97± 0.15 µM (BE2) and
35.2± 3.3 µM (mBE1) and thus below the KD of ThT and mE10 (Figure 5.7). In accord-
ance with previous findings, the neutral analogues, BE1 and BE2, appeared to bind more
strongly to αSyn aggregates than the charged dyes (mBE1, mBE2, mE10, ThT) but around
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one order of magnitude weaker than their E-derivatives (E10 (KD = 0.22± 0.03) and E13
(KD = 0.45± 0.07), Chapter 4). This confirms the hypothesis, that the gain in hydrophobicity
by the loss of the positive charge supports the insertion of the dye into the binding groove and
strengthens the protein-dye interactions [211]. The decreased binding abilities of BE1 and
BE2 as opposed to their E analogues further reinforced the enhanced interactions of more
hydrophobic dyes with the amino acid side chains of the binding sites, as the incorporation
of the two oxygen atoms through the boronic ester entity decreases the hydrophobicity. The
change in hydrophobicity and steric did not significantly influence the binding of the charged
mBE derivatives. This might be explained by the less deep binding of the charged dyes
accompanied with less distinct interactions with the predominant hydrophobic amino acid
side chains, which could generate a greater tolerance towards the modifications.
In line with the strongest fluorescence turn on response among the four bifunctional
dyes, BE2 exhibited the strongest binding affinity. Thus, BE2 appeared to be promising for
sensitive detection of lower concentrations of amyloid aggregates.
It was not only important to prove the binding affinities of the new probes towards
amyloid but also to show that this property stays unaffected by the transformation of the
boronic ester into the phenol triggered by H2O2. Therefore, the dyes were incubated for 1 h
with 100 µM H2O2 prior to SPR analysis. None of the four dyes showed a significant change
in their binding affinities (Figure 5.7). Interestingly, BE1 and BE2 persisted to show different
equilibrium response curves and thus affinities after the incubation with 100 µM H2O2. This
was unexpected as both dyes convert into the same phenol. However, as mentioned before,
the reaction rate between the dyes varies and thus the phenol might have been present to
different degrees. Thus, the experiment was repeated with 10 mM H2O2 to ensure complete
conversion. LCMS analysis was performed beforehand to ensure that 10 mM H2O2 does
not cause any other transformations of the dyes. Under these conditions the response curves
of BE1 and BE2 converged, as expected. No significant change was observed in the mBE
derivatives as they appeared alike under all conditions.
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Figure 5.8 Representative SPR sensogram obtained from SPR experiments of 10µM mBE1, mBE2,
BE1 and BE2 binding to immobilised αSyn aggregates on a gold surface.
After having examined the concentration dependent equilibrium affinities, the kinetics of
the interaction between αSyn aggregates and the new bifunctional probes was questioned.
Representative sensograms for the four dyes are depicted in Figure 5.8. No significant
difference in their on and off rate behaviour was noticeable: all boronic esters as well as
their oxidised analogues showed an immediate association onto the surface bound αSyn
aggregates with a steep association phase. The dissociation was very rapid, resulting in a
negligible dissociation phase. This mirrors the behaviour of the mE dyes and indicates a
rapid exchange of dye molecules.
Taken together, the data suggested that any change in the fluorescence signal upon
addition of H2O2 was not due to affinity changes but rather a modification of a fluorescence
property of the dye itself.
5.2.5 Bifunctional Sensing
Having validated the ability of all four boronic ester derivatives to detect H2O2 and
the presence of αSyn separately, it was essential to prove the feasibility of simultaneous
detection of these two crucial factors common in most neurological pathologies.
Assessing the bulk fluorescence response of the four dyes when H2O2 was combined
with αSyn aggregates manifested a striking enhancement in the total fluorescence emission
of the two neutral dyes, BE1 and BE2 (Figure 5.9). Upon binding to αSyn species the signal
intensity of BE1 increased 3.3-fold, BE2 4.8-fold. In the presence of H2O2, the emission
signal of BE1 was enhanced by 2.0-fold, whereas the emission of BE2 showed no significant
change. However, adding both simultaneously resulted in a total rise of the fluorescence
signal of 7.5-fold for BE1 and 19.6-fold for BE2, which indicates their great suitability as
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bifunctional fluorescence sensors for concomitant detection of H2O2 and αSyn aggregates.
Another beneficial feature, which facilitates their use as bifucntional probes, results from
their shift in emission maximum in the presence of αSyn aggregates and H2O2 (Figure
5.9). In contrast to the neutral BE probes, the cationic mBE derivatives did not display a
strong change in their emission properties when H2O2 and αSyn were present simultaneously
compared to the response to H2O2 or αSyn aggregates alone. Thus, mBE1 and mBE2 were
able to function as sensors for H2O2 and αSyn aggregates independently but did not allow a
readout of the concomitant presence of these pathogenic factors.
The superior fluorescence response of the neutral BE derivatives might be caused, among
others, by their stronger binding towards αSyn aggregates. This could lead to different
interactions with functional groups in the protein binding site affecting the polarity and
reactivity of the boronic ester and thus their optical properties and conversion rate.
The distinct fluorescence response as well as overall greater integrated fluorescence
intensity of BE1 and BE2 enabled further verification of their bifunctionality on the single ag-
gregate level using single-aggregate visualisation by enhancement (SAVE) imaging. Without
the presence of H2O2, BE1 did not enable the detection of any αSyn aggregate. However,
after the addition of H2O2 BE1 visualised 0.020± 0.004 aggregates/µm2 (Figure 5.10).
Similarly, BE2 only detected a minor quantity of aggregates (0.005± 0.004 aggregates/µm2)
to begin with but increased its sensitivity by 5-fold to 0.025± 0.004 aggregates/µm2 upon
the addition of H2O2. These results indicate that both dyes can function as bifunctional H2O2
and αSyn aggregate sensors in bulk as well as on single aggregate level.
214 Bifunctional Fluorescent Probes for β -Amyloids and Hydrogen Peroxide Detection
5.3 Summary and Conclusion
The accumulation of abnormally aggregated proteins and high levels of ROS are key
features of many neurodegenerative disorders including Parkinson’s and Alzheimer’s disease.
Thus, new methods able to detect the presence of amyloid aggregates and ROS simultaneously
will be critical to expand our understanding of their interplay and their role in the pathogenesis
of neurodegenerative disorders.
To address this unmet need, the design and successful application of new bifunctional
fluorescence probes for the concomitant detection of αSyn aggregate and H2O2 were de-
scribed in this chapter. Combining established structures for the independent detection of
amyloid aggregates and H2O2 resulted in four dyes, mBE1, mBE2, BE1 and BE2, com-
posed of a β -sheet sensitive aryl-benzothiazole core and H2O2-reactive boronic ester moiety.
The mBE and BE derivatives differ from each other only in the N-methylation of the ben-
zothiazole unit resulting in one charged and one neutral analogue. This minor structural
change appeared to have a pronounced effect on the binding and optical properties as well as
the bifunctional capabilities of the dyes. Despite showing weaker binding affinities and a less
distinct fluorescence turn on response in the presence of either H2O2 or amyloid aggregates,
the charged mBE dyes were able to sense αSyn aggregates and H2O2 independently. How-
ever, the combination of both, protein aggregates and H2O2 did not result in a signal change
making them poor bifunctional probes. Opposed to this, the neutral dyes exhibited stronger
binding affinities and beneficial optical properties compared to their charged analogues. Most
strikingly was their large increases in ensemble fluorescence intensity when αSyn aggregates
and H2O2 were present at the same time. This not only indicated the great potential of the
two BE probes as bifunctional sensors but also allowed their application on a single aggregate
level. Taken together, the neutral boronic ester aryl-benzothiazoles, BE1 and BE2, represent
promising bifunctional dyes which possess the potential to study protein aggregation and
oxidative stress simultaneously in in vitro models of neurodegeneration.
Despite their promise, further work is required to better understand the non-linear changes
in the emission properties of BE1 and BE2 in the presence of the two species simultaneously
and to evaluate their feasibility to differentiate the presence of H2O2, αSyn aggregates or
H2O2 +αSyn aggregates. Also, it might be useful to perform anisotropy measurements sim-
ilar to those described for mE10 to question the binding mode of these dyes under different
redox conditions as well as in the presence of amyloid species at different aggregation stages.
Following on from this the same experiments may be carried out with other proteins known
to form amyloid aggregates and associated with neurodegeneration (e.g. Aβ , tau) to asses
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selectivity and specificity. Additionally, studies with patient derived samples (e.g. CSF, brain
tissue) would allow insight into their binding properties in a patho-physiological environ-
ment and thus also reveal non-specific binding to proteins, enzymes and cell components.
Furthermore, additional modifications on the benzothiazole core or the aryl unit linked to the
boronic ester might be explored to tune the optical properties as well as reactivity of the dyes.
This may allow the generation of new analogues with an increased turn on response and
distinct H2O2 reactivities, which then could allow more effective and sensitive bifunctional
sensing.
5.4 Material and Methods
5.4.1 Chemical Synthesis
The synthesis of the mBE and BE derivatives was performed in the lab of T.N. Snaddon
and adapted a procedure previously described by Wolfe et al [242]. An overview of the
synthetic route including reactants and conditions is shown in Figure 5.11.
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Figure 5.11 Synthesis scheme of mBE and BE derivatives. Reagents and conditions: (a)
Pd(dppf)Cl2∗CH2Cl2, B2(OR)2, 1,4-dioxane, 100 ◦C, 18 h. (b) Me3OBF4, DCM, 25 ◦C, 24 h.
5.4.2 Photophysical Characterisation
All solvents were filtered (0.2 µm syringe filter, Whatman, 6780-1302) before used.
Samples were placed into a quartz fluorescence cuvette (Hellma Analytics, 3 x 3 mm)
and bulk fluorescence spectra were recorded using a fluorescence spectrophotometer (Cary
Eclipse, Varian). Fluorescence spectra of BE, mBE dyes and ThT (5 µM) were recorded free
in PBS (pH 7.4), in the presence of H2O2 (100 µM), in the presence of αSyn aggregates
(∼ 10 µM) and in the in the presence of both H2O2 and αSyn aggregates simultaneously at
excitation maxima. The response towards H2O2 was recorded at 20-minute intervals over a 5
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hour time period; the response towards αSyn aggregates was measured instantly. To assess
the bulk fluorescence response towards both, H2O2 and αSyn aggregates, the dyes (25 µM)
were incubated with H2O2 (100 µM) for 60 minutes, diluted to 5 µM and the emission
spectra were recorded with αSyn aggregates. The error bars represent standard deviations
from experiments with n = 3 separately prepared dye samples.
Form these data and bulk absorption measurements, several photophysical quantities
were determined as described in Chapter 4 (4.4.5).
5.4.3 Surface Plasmon Resonance Measurements
The binding affinities were assessed analogue to the procedure described in Chapter 4
(4.4.7). To acquire the binding curves of the oxidised dyes, the 30 µM sample was incubated
for 1 h with 100 µM or 10 mM H2O2 before further dilution.
5.4.4 LCMS Quantification of Reaction with H2O2
LCMS analysis of the reaction of the dyes with H2O2 was performed using a Waters
Acquity H-class UPLC coupled with a single quadrupole Waters SQD2. ACQUITY UPLC
CSH C18 Column, 130Å, 1.7 µm, 2.1 mm x 50 mm was used as the UPLC column. The
conditions of the UPLC method are as follows: Solvent A: Water +0.1% Formic acid;
Solvent B: Acetonitrile +0.1% Formic acid; Gradient of 0-4 minutes 5% - 100% B + 1 minute
100% B with re-equilibration time of 2 minutes. Flow rate: 0.6 mL/min; Column temperature
of 40 ◦C; Injection volume of 2 mL. The signal was monitored at 254 nm. Samples were
prepared by diluting the stock solutions of the BE and mBE compounds into PBS (pH 7.4)
or MeCN to a concentration of 30 ◦CM. The diluted dye solutions were analysed via LCMS
directly after dilution (t = 0) as well as 1 hour after dilution (t = 1h). To prove the oxidative
cleavage of the boronic esters to a phenol triggered by H2O2, the diluted dye solutions were
exposed to 100 µM H2O2 and analysed via LCMS after 1 hour of incubation. To ensure
stability of the dyes in the presence of 10 mM the same procedure was repeated with 10 mM
H2O2.
To question to which degree the stationary phase of the column affects the boronic ester
hydrolysis, the samples were also injected directly into the MS without the chromatographic
separation. ESI and ESCI were used as ionisation methods.
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5.4.5 NMR Stability Tests
The dyes (1 mg in 700 µL) were incubated for 5 h in D2O spiked with d-DMSO till fully
dissolved. BE2 was not fully solvable at this concentration even with 50% d-DMSO and
thus no NMR spectrum was recorded. After incubation, NMR spectra were recorded on
a Bruker AVANCE III HD (500 MHz, DUL 13C/1H) at room temperature and compared
with the original NMR spectra. Calibration of the spectra was achieved using the solvent
signals.[150] All chemical shifts (δ ) are quoted in ppm and coupling constants given in Hz.
Splitting patterns are given as follows: s (singlet), bs (broad singlet), d (doublet), t (triplet), q
(quadruplet), m (multiplet). The 1H-NMR signals after 5 h incubation were as follows:
mBE1
1H-NMR: (500 MHz, D2O) δ [ppm] = 8.15 (d, JH,H = 9.5 Hz, 1H), 8.09 (d, JH,H = 8.0 Hz,
2H), 7.90 – 7.88 (m, 2H), 7.83 (d, JH,H = 2.5 Hz, 1H), 7.60 (dd, JH,H = 9.5, 2.5 Hz, 1H), 4.30
(s, 3H), 4.02 (s, 3H), 1.23 (s, 12H).
mBE2
1H-NMR: (500 MHz, D2O) δ [ppm] = 8.15 (d, JH,H = 9.5 Hz, 1H), 8.09 (d, JH,H = 8.0 Hz,
2H), 7.90 – 7.89 (d, JH,H = 8.0 Hz, 2H), 7.83 (d, JH,H = 2.5 Hz, 1H), 7.60 (dd, JH,H = 9.5, 2.5
Hz, 1H), 4.31 (s, 3H), 4.02 (s, 3H), 3.38 (s, 4H), 0.89 (s, 6H).
BE1
1H-NMR: (500 MHz, D2O) δ [ppm] = 8.03 (d, JH,H = 8 Hz, 2H), 7.94 (d, JH,H = 9 Hz, 1H),
7.81 (d, JH,H = 8 Hz, 2H), 7.67 (d, JH,H = 2.5 Hz, 1H), 7.14 (dd, JH,H = 9, 2.5 Hz, 1H), 1.29 (s,
13H).
5.4.6 Single-Aggregate Fluorescence Imaging
In short, single aggregate fluorescence imaging experiments were carried out in total
internal reflection fluorescence (TIRF) mode microscopy with the bespoke inverted micro-
scope (Olympus, IX73) set-up. Excitation of BE, mBE compounds and ThT in the presence
of αSyn aggregates were performed with a collimated 405 nm laser (Oxxius, Laserboxx,
LBX- 405-50-CIR-PP) which was aligned parallel to the optical axis and directed into an
oil immersion objective lens (1.45 NA, 60×, Plan Apo, TIRF, Nikon) above the critical
angle to ensure TIR at the coverslip–sample (glass/water) interface. Fluorescence emission
was also collected by the same objective and selected by the presence of a dichroic (Di01-
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R405/488/561/635, Semrock) and subsequently passed through appropriate emission filters
(BLP01-488R-25, Semrock). Images were then recorded by an EMCCD camera (Evolve
delta 512, Photometrics) with an electron multiplication gain of 250 running in frame transfer,
clear presequence mode. Each pixel on the image was 275 nm. Images were recorded at
100 ms exposure for 200 frames using automation through Micro-manager software [245].
Images were analysed with a bespoke ImageJ macro. Image stacks of 200 frames taken
as 100 ms per frame of the BE dyes and ThT with αSyn aggregates and either in the presence
or absence of H2O2 were compressed in time to create single frame images representing
the average pixel intensities. Pixels of intensity above background were determined with a
fixed threshold and αSyn aggregate species in each field of view identified and counted. The
density of species was determined from the division of the number of species by the area
of the field of view (4726 µm2). Five fields of view in the presence of H2O2 and five in the
absence of H2O2 were analysed for each dye. Error bars represent the standard deviations of
the species density between the five fields of view.
Chapter 6
Conclusion and Future Work
Reactive oxygen species (ROS) and associated oxidative stress contribute to dysfunction
and cell death in nearly all pathologies [256, 257]. However, the lack of tools for measuring
defined redox species in normal and diseased states has been a profound limitation for
fundamental research in redox biology as well as clinical studies. Most approaches disrupt
cellular integrity, influences the redox state themselves, lack specificity, possess insufficient
spatiotemporal resolution or have limited potential for in vivo imaging. To overcome this
unmet need, the fundamental objective of this thesis was to develop new optical probes
for the specific detection of ROS in cancer and neurodegenerative disorders and combine
these with suitable technologies allowing a specific readout with high spatial and temporal
resolution under biological relevant conditions.
ROS encompass a broad and diverse range of species from which each molecule has
unique reaction properties (pathway, kinetics, rate) and distinctive spatial and temporal
distribution [2]. Therefore, it is crucial to focus on a particular molecule when questioning
their physiological and pathological impact. H2O2 is a major and abundant ROS in living
organisms and plays an important role as a second messenger in physiological as well as
pathological processes. Hence, H2O2 was chosen as the ROS of interest in the work presented
in this thesis.
Although mostly assigned to oxidative stress and damage, ROS play an important role
as regulatory molecules in a range of biological processes, which results in a ubiquitous
presence of ROS [2]. To study the impact of oxidative stress towards a particular disease,
the location of the probe within the organism and the cell must be understood to detangle
physiological ROS generation from pathological. This makes a bifunctional probe design
crucial as it allows the simultaneous detection of a disease specific marker and the ROS of
interest. The main approach used in this thesis for this purpose was to combine a targeting
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moiety specific towards a disease inherent biomarker with a H2O2 reactive boronic ester.
Together, this ascertained a disease specific binding/accumulation of the dye and a prescribed
signal change in the presence of H2O2. Prior to the application of the bifunctional probes,
it was crucial to understand the photophysical and biological properties of the new dyes
and how they interact with their environment. Only an in-depth understanding of these
underlying factors enables the accurate interpretation of the data and precise tailoring of the
photophysical and biological features of the dye through chemical modifications to maximise
sensitivity and selectivity.
Different pathological conditions entail different challenges and thus not only is the
probe design is crucial for a successful implementation but also the technology used for
the assessment. As the scope of this work spanned two separate pathologies, cancer and
neurodegenerative diseases, with different research foci, photoacoustic (PA) imaging and
single aggregate fluorescence imaging were exploited as imaging modalities.
PA imaging is an emerging method that combines the high contrast of optical imaging
with the high temporal and spatial resolution of ultrasound [54]. Since sound waves are
less scattered and diffracted by biological tissues than photons, this technique bypasses
some of the drawbacks of traditional optical imaging techniques, which makes it suited
to study complex disease, such as cancer, in vivo in real-time with high spatial resolution.
Additionally, PA imaging uses non-ionising radiation in the near infrared range and thus does
not influence the redox state during image requisition. Taking all these features together, PA
imaging is highly qualified to study oxidative stress in cancer.
The development of single-molecule fluorescence techniques is fundamentally changing
biological research as it allows visualisation nano-scale biological structures and dynamic
processes with unrivalled resolution in both time and space [87]. This is of great importance
when questioning pathological changes on the molecular level. One main application of
single-molecule fluorescence imaging is the study of diseases associated with the aberrant
aggregation of misfolded proteins, such as Parkinson’s and Alzheimer’s diseases. Due to
the highly transient and heterogeneous nature of protein aggregates and their small size of
less than 200 Å, conventional techniques fail to identify and characterise these pathological
species. Thus, due to its unprecedented spatial resolution combined with its high temporal
resolution, single-molecule fluorescence microscopy is well suited to question the interaction
of ROS and protein aggregation during the pathogenesis of neurodegenerations.
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6.1 Imaging Oxidative Stress in Cancer using PA Imaging
Oxidative stress and increased levels of ROS have long been linked to cancer initiation,
progression and therapy response. However, whether the increased levels of ROS observed in
cancer are cause or correlation and how they affect the different disease stages and treatment
response is still an open question. Consequently, one aim of the work presented in this thesis
was to develop a bifunctional probe for PA imaging to characterise and define the pathology
of ROS in cancer in vivo.
This work was introduced with the characterisation of heptamethine cyanine dyes and the
synthesis and detailed investigation of structural modifications on a heptamethine cyanine
backbone that enable the development of a PA probe encompassing: good peak absorption in
the NIR window, efficient PA signal generation, sufficient photostability, water solubility,
cancer targeting and the ability to exhibit a signal change upon the reaction with H2O2.
The results allowed for greater understanding of the relationships between structure and
photophysical and biological function laying the foundations for the design and synthesis
of a new bifunctional, H2O2-activatable PA probe based on a heptamethine carbocyanine
dye scaffold. The new bifunctional probe uses glucose for cancer localisation and a boronic
ester moiety for the rapid and specific detection of physiological amounts of H2O2 via PA,
absorption and fluorescence spectroscopy. In vitro studies indicated no significant toxicity of
the new bifunctional probe and demonstrated the specific uptake of the dye into the cytosol
of cells. In vivo and ex vivo studies showed promising results with the absence of toxicity
over four weeks, accumulation of the probe in tumour tissue accompanied with specific
changes in the PA tumour spectra and the H2O2-dependent conversion of the activatable dye.
Additionally, spectral unmixing approaches were introduced to successfully generate images
indicating the presence of the new activatable contrast agent and its conversion product.
The results presented here, suggest the promising application of this approach for studying
the interplay between tumourigenesis and oxidative stress in vivo with high spatial and
temporal resolution. Building up from here, further work is required to improve the dye-
structure to generate narrower absorption and PA peaks and greater spectral differences
between the capped and uncapped dye, which would improve the applicability for further in
vivo studies. Furthermore, it is necessary to advance the unmixing approach described in
this thesis, for example by applying a fluence correction to the data. Should this work yield
positive results, additional in vivo studies in more realistic orthotopic and transgenic mouse
models should be carried out to investigate the feasibility of the approach to monitor tumour
development and treatment response. Moreover, the contrast agent could then be combined
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with the endogenous contrast of haemoglobin and oxyhaemoglobin to allow the visualisation
of oxidative stress, tumour vascularisation and hypoxia at the same time in vivo (Figure 6.1).
Multiple wavelengths 
imaging
λ1
λ2
λ3
λ4
λ5
Visualisation of 
specific molecules
Near-infrared
dye
HbO2
Hb
Biomarker 1
Biomarker 2
Spectral unmixing
1
0.8
0.6
0.4
0.2
0
no
rm
ali
se
d A
bs
or
pt
ion
λ1 λ2 λ3 λ4 λ5
Wavelength (nm)
700 750 800 850 900
Oxyhemoglobin
Deoxyhemoglobin
Near-infrared dye
Hypoxic Stress
endogenous
Oxidative Stress
exogenous
Figure 6.1 Multispectral optoacoustic tomography and its application for simultaneous visualisation
of oxidative and hypoxic stress (adapted from ref. [258]).
Finally, different disease-specific targeting moieties should be explored to extend the
use of this new activatable PA probe to the study of oxidative stress in a broad range of
pathological conditions. This would facilitate the measurement and thus the investigation
of the impact of H2O2 towards a specific pathological progress in vivo. The consequent
knowledge about the interplay between ROS and disease development might then open new
doors for therapeutic approaches.
6.2 Imaging Oxidative Stress and Amyloid Aggregates in
Neurodegenerative Diseases with Single-Molecule
Fluorescence Imaging.
Protein aggregation into amyloid deposits and oxidative stress are key features of many
neurological disorders. Thus, new methods for the detection of ROS and protein aggregates
are critical to advance our clinical understanding of neurodegeneration. Accordingly, the
work presented here demonstrated bifunctional fluorescent probes for the simultaneous
detection of both amyloid aggregates and H2O2.
A set of novel neutral and cationic fluorescent dyes derived from Thioflavin-T (ThT), the
most common fluorescent dye used for the detection of amyloid fibrils, were first investigated
in terms of their amyloid binding properties and unique bulk and single-aggregate fluores-
cence properties to gain a better understanding of the relationships between the chemical
structure and these features. The neutral analogues, although exhibiting impaired optical
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properties compared to ThT, revealed different binding sites compared to ThT and the charged
derivatives. The charged dyes showed overall optical and binding properties competitive with
ThT. Interestingly, one dye, mE10, showed superior properties and allowed the detection
of early arising and more amorphous amyloid aggregates on a bulk and single aggregate
level. Moreover, it has laid the foundation for the development of four bifunctional probes
for amyloid aggregate and H2O2 sensing. These probes were based on the mE/E scaffold
for amyloid detection and combined with a H2O2 reactive boronic ester functionality. Bulk
and single aggregate measurements showed that two probes, BE1 and BE2, were able to
successfully detect the simultaneous presence of both H2O2 and αSyn aggregates in vitro.
These findings form a promising foundation for studying earlier arising amyloid species
as well as their interplay with increased levels of H2O2 in vitro. Continuing from here,
further characterisation of mE10 as well as BE1 and BE2 using other amyloid proteins,
cellular studies of neurodegeneration and human cerebrospinal fluid of patients would help
to validate the feasibility of these new probes to detect and characterise potentially toxic
oligomeric species and their interactions with H2O2. Furthermore, applying high resolution
single molecule imaging techniques would enhance the sensitivity of the new probes and
get a better insight into the aggregate-dye-H2O2 interaction during the different stages of
protein aggregation. Therefore, it would also be necessary to interrogate more deeply the
anti-aggregation properties of the dyes and how they are related to their chemical structure.
This might additionally reveal a new avenue for new therapies. Finally, the knowledge
gained about the relationship between chemical structure and photophysical and binding
properties can now be implemented into multivalent probes. Combining the features of mE10
and BE1/2 into a such a multivalent probe design and expanding it to other high resolution
imaging techniques, such as DNA-PAINT, might allow the development of multi-functional
probes with superior binding and optical properties and to tune the selectivity to specific
oligomeric structures and pathological proteins.
6.3 Concluding Remarks
ROS are critical biological parameters and play a dual role as both physiological and
pathological agents. However, studying ROS generation and its function is limited by the
current state-of-the-art methods.
Thus, there is a urgent need for better approaches to detect and quantify the different types
of ROS in biological systems, especially in vivo. In developing such new probes it is important
to understand the location of the probe within the organism and cell, the chemistry, reaction
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kinetics and selectivity of the probe as well as its metabolism/decomposition. Furthermore, to
minimise misinterpretation, it is crucial to understand the signal generation process, effects of
the biological environment on the signal and the limitations of the applied detection method.
Combining these considerations and applying them to biological validation studies in realistic
animal models of disease, might allow a robust readout of the levels of a particular ROS
within various tissues and cell types and how these levels change during disease development
and treatment. This will then not only help to unravel the physiological and pathological roles
of specific ROS in vivo but also allow one to assess the efficacy of redox-based therapies.
It is through the development and detailed characterisation of new ROS- and disease-
specific imaging probes combined with suitable imaging technologies that research in the
oxidative stress and free radical field will progress and new frontiers are reached.
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Figure A.1 Representative spectra of commercial cyanine dyes (20 µM) in A) H2O, B) H2O +
10%FBS C) PBS, D) PBS + 10%FBS, E) MeOH. D) Spectra of 5 µM IR800CW in different solvents
showing that neither ions nor proteins do influence the spectra of sulfo-dyes.
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Figure A.2 Representative spectra of the piperazine-linker derivatives, JW8 (A, 20 µM) and JW16
(B, 20 µM), in different solvents. Interestingly, the absorption shape of JW8 changed in the different
solvents whereas the absorption spectra of JW16 stayed mostly constant in the solvents, in which JW16
was solvable. The changes in different solvents was questioned with DFT calculations shown in Figure
A.3. C) The influence of PET towards the absorption properties is demonstrated for representative
absorption spectra of JW8 (5 µM) and JW14 (5 µM) in MeOH, MeOH + TEA (50 µM) and MeOH +
DMAP (50 µM). No changes were observed under the different tested conditions.
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Figure A.3 Computational investigation of the geometrical properties of JW8 in A) MeOH and C)
H2O illustrating how the different solvent molecules are interacting with the amine functionality of
the piperazine unit leading to a different twist in the dye backbone structure. This twist can be used to
explain the different absorption shapes of JW8 in MeOH (B) and H2O (C).
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Figure A.4 Representative spectra of the four piperazine-linker derivatives, JW8 (A), JW14 (C),
JW15 (D), JW16 (E), at different concentrations (20 µM, 15 µM, 10 µM, 5 µM, 1 µM) in MeOH.
The corresponding normalised fluorescence and absorption spectra are shown in B), D), F) and H).
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Figure A.5 Representative spectra of JW41 and JW35 in H2O in different concentrations indicating
that the different shapes in their absorption spectra are not concentration and thus aggregation based.
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Figure A.6 Calibration curve of fluorescence standard HITC. Linear regression (y=mx + c) resulting
in an average slope 3.68 x 105.
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Figure A.7 H2O2 reactivity controls: Absorption (A), photoacoustic (B) and fluorescence (C) spectra
of JW41 (10 µM) in water monitored over up to 100 min confirming that the partial hydrolysis of
JW41 to the hydrolysed boronic acid, JW41hydro, does not influence the photophysical properties of
the dye.
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Figure A.8 PA signal kinetics of control regions illustrated in Figure 3.13 and 3.15.
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Figure A.9 In vivo spectral unmixing of Hb and HbO2. Representative kinetics curves of the PA
weight of Hb and HbO2 obtained by spectrally unmixing of the outlined tumour ROIs in A) Figure
3.17A, B) Figure 3.17B and C) Figure 3.17C.
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Figure A.10 Contrast to noise (CNR) spectra of the in vivo spectra of JW41 and JW35 obtained by
spectral unmixing of the outlined tumour and kidney ROIs in A) Figure 3.17A, B) Figure 3.17B and
C) Figure 3.17C. The CNR was calculated as follows: CNR = (dye mean signal of the tumour or
kidney ROI - dye mean signal of the control ROI) / SD of the dye signal in the control ROI.
A.3 Chapter 4
0 10 20 30 40
0
1
2
3
4
Concentration (µM)
Int
eg
ra
ted
 Fl
uo
re
sc
en
ce
/1
04
0.0 0.5 1.0 1.5
Concentration (µM)
0
1
2
3
Int
eg
ra
ted
 Fl
uo
re
sc
en
ce
/1
03
A B
Figure A.11 A) Calibration curve of fluorescence standard quinine sulfate. B) The linear parts of the
curves were fitted with linear regression (y=mx + c) resulting in a slope 2.12 x 103.
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Figure A.12 LCMS validation of the reaction of the mBE and BE probes with H2O2. Mass: mass
detected with LCMS; Rel. Area: relative area under the curve in the UV chromatogram (monitored at
254 nm). Hydrolysed: boronic acid derivative of dye; Boronate ester: dye with boronate ester func-
tionality; Oxidized: phenol derivative of the dye after oxidative cleavage. Oxidized, de-methylated:
phenol derivative of the dye after oxidative cleavage and loss of methyl group on Nitrogen.
